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ABSTRACT 
Development of the female mammary gland involves the proliferation and 
morphogenesis of epithelial cel ls within a matrix of adipose and connective tissue which 
constitutes the mammary fat pad. The objective of this research was to investigate the 
mechanisms by which this stromal environment locally regulates postnatal 
mammogenesis. 
Initial experiments showed that the mouse mammary fat pad liberates a diffusible 
activity in vitro which stimulates the growth of mouse mammary epithelial cells and 
enhances their proliferative response to insulin-like growth factor-I, epidermal growth 
factor and insulin. This effect was specific to these mitogens, and of a variety of cell 
lines tested was most pronounced for mouse mammary epithelial cells. Subsequent 
investigations indicated that these responses were likely induced by unsaturated fatty 
acids, particularly linoleic acid, from mammary adipocytes. Such responses may be 
effected by increased intracellular signalling via the actions of protein kinase C. 
The mitogenic capacity of the mouse mammary fat pad was also evaluated across 
several physiological states. Mammary fat pad-stimulated proliferation during the estrus 
cycle was increased at estrus concomitant with a phase of ductal elongation in vivo. In 
certain medium treatments there was evidence for epithelial upregulation of the 
mitogenic effect of the mammary fat pad, where intact mammary tissue was more 
stimulatory than mammary fat pad cleared of endogenous epithelium. Further 
experiments demonstrated that while the mitogenic effect of the mammary fat pad was 
unaltered by ovariectomy, ovarian function was required for this effect to be increased 
by exogenous progesterone. The effect of estrogen was independent of ovarian function 
but was altered by the local epithelial-stromal interaction, where it increased the 
mitogenic effect of epithelium-free mammary fat pad and decreased that of intact 
mammary tissue. Mitogenic stimulation by mammary tissues also declined during 
virginal development to be least in mature virgin and mid-pregnant states. Stimulation 
by intact mammary tissue increased during lactation, while that from epithelium-free 
mammary fat pad remained constant in the presence of steroid hormones and increased 
in the presence of growth factors. 
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Further experiments investigated the stromal regulation of epithelial growth within the 
ruminant mammary gland. Differences between the ruminant and rodent mammary fat 
pad were emphasised in vitro where ovine mammary fat pad stimulated the growth of 
mouse mammary epithelial cells but did not markedly potentiate their growth factor­
responsiveness. A subsequent study examined the expression of stroma-derived growth 
factors within the ruminant mammary gland during postnatal development, and their 
regulation by several physiological influences. The level of insulin-like growth factor 
(IGF)-I mRNA in the ovine mammary fat pad was elevated prior to puberty and during 
late gestation, while IGF-ll mRNA was upregulated in mammary parenchyma of virgin 
ewes in a transcript-specific manner. Abundance of IGF-I mRNA in mammary tissues 
of prepubertal ewe lambs tended to be increased by exogenous estrogen whereas IGF-ll 
mRNA levels were reduced. Messenger RNA for keratinocyte growth factor (KGF) was 
detected within the ovine mammary fat pad throughout development as 2.4 and 1 .5 kb 
mRNA transcripts which were expressed by stromal adipocytes and fibroblasts, 
respectively. The level of KGF mRNA in mammary tissues of prepubertal lambs was 
increased by ovariectomy and decreased by estrogen, while KGF mRNA expression in 
cultures of mammary fibroblasts was suppressed by dexamethasone. Messenger RNA 
for hepatocyte growth factor, a paracrine mitogen and morphogen for mammary 
epithelial cells, was expressed in the ovine mammary fat pad and by cultured mammary 
fibroblasts. The abundance of basic fibroblast growth factor (bFGF) mRNA was highest 
within the ovine mammary fat pad, while in vitro results suggest bFGF may be a 
paracrine/autocrine mitogen for multiple cel l  types within the mammary gland. Basic 
FGF gene expression in mammary tissues of prepubertal ewes was reduced by estrogen 
treatment. For each of these growth factors there was evidence suggesting that their 
expreSSIOn within the mammary fat pad was upregulated by the adjacent mammary 
epithelium. 
In conclusion, these findings indicate that the mammary fat pad may stimulate the 
proliferation of mammary epithelial cells during postnatal mammogenesis by a variety 
of influences. Such mechanisms may involve the direct stimulation of epithelial growth 
or the modulation of epithelial responsiveness to other mitogens. These effects may 
function to mediate the actions of certain mammogenic hormones. Furthermore, strong 
iii 
evidence indicates that mammary growth may be locally regulated by the interaction 
between epithelial and stromal cells . 
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1.1 ONTOGEN Y O F  MAMMAR Y GLAND DE VELOPMENT 
The mammary gland of the female mammal undergoes extensive development during 
embryonic and postnatal growth, its ultimate function realised at parturition when it 
synthesises and secretes milk to nourish the offspring. During this development, 
mammary epithelial cells undergo extensive proliferation and morphogenesis within the 
confines of a stromal matrix, the mammary fat pad. This unique pattern of 
organogenesis is regulated by an array of systemic and local influences, many of which 
are specific to certain reproductive states. An appreciation of this process is 
fundamental to more in depth investigation into specific areas of mammary 
developmental biology. 
1.1.1 Embryonic de velopment 
The first structures to arise in the mammary gland are the mammary bands; bilateral 
zones of ectodermal thickening on the ventrolateral body wall which become apparent 
in the rodent around day 1 1  of embryonic life (reviewed by Topper and Freeman, 1 980). 
This structural formation is associated with the local morphogenetic movement of cells 
rather than cell proliferation (Balinsky, 1 950) . The mammary bands subsequently 
divide into paired individual buds, the number and position of which correspond to the 
ultimate glands in the mature female (Knight and Peaker, 1 982). Underlying these 
mammary buds are two distinguishable mesenchymal compartments. A dense 
mesenchyme comprised of several fibroblastic layers directly associates with the 
epithelial anlage while a second compartment develops separately from the mammary 
anlage and is the precursor tissue for the mammary fat pad (Kimata et al. , 1 985). Lipid 
accumulation occurs in this latter tissue at day 1 6  of embryonic development (Sakakura 
et al. , 1 982). 
The rodent mammary bud grows very slowly to day 1 5 .5 of embryonic development 
(resting phase), although recent evidence indicates that this period is associated with 
extensive DNA synthesis in the primary duct (Cunha and Horn, 1 996). Rapid 
proliferation between days 1 6  and 2 1  of embryogenesis results in the formation of a 
mammary rudiment consisting of several branched, canalised cords that have penetrated 
the dense mesenchyme and which lie positioned within the fat pad precursor tissue at 
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birth (Balinsky, 1 950). Such development is associated with the formation of one or 
more primary sprouts, the number of which dictates the number of galactophores per 
teat or nipple. Cows, goats, sheep, mice and rats have one opening while humans have 
1 5-25 (Anderson, 1 978). 
A generally similar pattern of development is observed in the embryonic ovine and 
bovine mammary gland (Knight and Peaker, 1 982; Raynaud, 1 96 1 ) . The mammary 
gland of male sheep grows at a constant rate of 2.8 times that of body weight while the 
female gland grows at 5 times that of body weight between days 44 and 70 of embryonic 
development (Martinet, 1 962). By day 70, secondary ducts have developed, the teat 
cistern is evident, and parenchymal tissue is well developed. Mammary growth then 
declines to 1 .7 times the rate of body growth until birth (Martinet, 1 962) . The four 
mammary buds are apparent in the bovine foetus at the 4 to 8 cm stage; at the 1 9  cm 
stage the mammary cord becomes canalised to form the streak canal and cistern, and at 
the 1 6  to 23 cm stage secondary branches arise from the dilated cistern (Raynaud, 1 96 1 ). 
The mammary rudiment of the embryonic female bovine undergoes most rapid growth 
from the 7th month of gestation. 
Within the mammary gland of the foetal human, a mass of epithelium l ies embedded in 
mesenchyme at 5 weeks of gestational age, and by 1 3  weeks the mammary bud forms 
cords surrounded by a fib rob lastic stroma (reviewed by  Raynaud, 1 96 1 ;  Kellokumpu­
Lehrinen et al., 1 987). Canalisation of ducts occurs at 20 weeks and epithelial cells 
develop a secretory appearance by the last trimester of pregnancy (Tobon and Salazar, 
1 974) . 
Sexual dimorphism in the embryonic mammary gland involves hormonal action via 
unique epithelial-mesenchymal interaction (Sakakura, 1 99 1 ). Development of the 
mammary rudiment in male and female rodents is similar up until day 1 4  of embryonic 
development. The production of androgens by the foetal testis and the presence of 
epithel ial-induced androgen receptors in the mammary mesenchyme at this time 
(Heuberger et al. , 1 982) causes mesenchymal condensation around the mammary bud 
and rupture of the epithelial stalk (Kratochwil and Schwartz, 1 976). The mammary 
rudiment in male mice undergoes extensive necrosis whereas in the male rat it remains 
within the mammary fat pad but is disconnected from the epidermis (Imagawa et al., 
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1 994a). Induction of the opposite sexual phenotype can be induced by male gonad­
irradiation, or by treatment of females with testosterone (reviewed by Imagawa, 1 994a). 
1.1.2 Prepubertal de velopment 
A substantial degree of mammary growth occurs in rodents, and indeed in other species, 
prior to the onset of puberty. Ductal end buds on the mammary rudiment of neonatal 
rodents are probably formed in response to maternal hormones. These are transient and 
do not reappear until around 3-4 weeks of age (Imagawa et al., 1 994a). 
Correspondingly, the rate of mammary growth in rats and mice is isometric until the 
onset of positive allometric growth at around 3-4 weeks of age. This phase of growth 
involves the ramification of epithelium into the mammary fat pad to establish a highly­
branched network of ducts lined with a single layer of luminal epithelial cells (Flux, 
1 954). 
The perinatal human breast demonstrates epithelial differentiation and synthesis of 
"witches milk" in response to both maternal and endogenous hormones (Mayer and 
Klein, 1 96 1 ). Morphological development within the prepubertal human breast is 
variable, where mammary parenchyma may range from being a collection of simple 
elongate ducts to a well developed set of branched ducts with terminal lobules 
(Anbazhagan et al., 1 99 1 ) .  The human breast then remains relatively dormant until 
puberty. Rat mammary tissue closely resembles that in the human gland due to the 
presence of terminal lobular units and an associated intralobular connective tissue 
(Sakakura, 1 99 1 ). Mammary parenchyma in the prepubertal heifer consists of a gland 
cistern and a duct system lined with double-layered epithelium; associated with these 
ducts are terminal alveolar structures (Mayer and Klein, 1 96 1 ). This parenchymal tissue 
as a whole expands and becomes less elongate during this development (Swett et al. , 
1 955). 
Mammary gland area in rats (Sinha and Tucker, 1 966) and mice (Flux, 1 954) increases 
at 3 .5  and 5 times that of metabolic body weight gain to 40 and 56 days of age, 
respectively. Positive allometric mammary growth commences in heifers at 2-3 months 
of age; thereafter the rate of increase in mammary DNA content is 3 .5 times faster than 
that for metabolic liveweight until 9 months of age (Sinha and Tucker, 1 969b). In ewe 
lambs, a period of rapid mammary parenchymal growth has been recorded between 8 
5 
and 1 2  (Wallace, 1 953), and 1 2  and 1 6  weeks (Anderson, 1 975) of age. Similarly, 
lohnsson and Hart ( 1 985) recorded positive allometric mammary growth in ewe lambs 
between 4 and 20 weeks. This period of allometric mammary growth is particularly 
critical for subsequent mammogenesis and the milk yield potential of heifers and ewes 
(Sejrsen, 1 994). Attempts to predict the milk yield potential of dairy heifers based on 
the extent of mammary development in the prepubertal mammary gland" have proven 
unreliable (Elliott, 1 957). 
It is well established that this prepubertal phase of mammogenesis requires ovarian 
function in mice (Flux, 1 954; Bresciani, 1 968) and heifers (Wall ace, 1 953 ;  Purup et aI. , 
1 993b). This likely reflects a requirement for oestrogen, given its ability to restore 
ovariectomy-abrogated growth (Silver, 1 953). Several reports similarly indicate that 
mammogenesis in prepubertal rats requires ovarian function (Cowie, 1 949; Silver, 1 953;  
Paape and Sinha, 1 97 1 ) . However, the reviews of Imagawa et al. ( 1 990; 1 994), quoting 
such studies as Astwood et al. ( 1 937) and Reece and Leonard ( 1 94 1 ), state that 
mammogenesis in prepubertal rats is ovary-independent. This discrepancy likely 
reflects the type of measurements made, and that development of the rat gland is 
probably suppressed, although not completely abrogated, by ovariectomy. Three 
separate studies (Wallace, 1 953; lohnsson, 1 984; Ellis et al., 1 996a) have indicated that 
prepubertal allometric mammary growth in sheep is ovary-independent. Using 
hypophysectomised, ovariectomised and adrenalectomised female mice it has been 
established that completely normal prepubertal mammary development requires 
oestrogen + adrenal corticoid + growth hormone, where progesterone can substitute for 
adrenal corticoids (reviewed by Imagawa et al. , 1 990). 
1.1.3 Peripubertal and postpubertal de velopment 
Allometric ductal growth in mice continues after the onset of puberty at 28-42 days of 
age, slows between 56 and 84 days, and plateaus by around 1 00 days (Flux, 1 954). 
Likewise, there is only a small increase in total mammary DNA between 50-60 and 1 10 
days of age in female rats (Tucker, 1 969). Peripubertal mammogenesis in rodents 
involves the elongation and branching of mammary ducts until the ductal tree has 
extended to the bounds of the mammary fat pad. Ductal elongation is directed by highly 
mitotic terminal end bud structures which are able to penetrate the surrounding fatty 
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stroma (Daniel and Silberstein, 1 987; Section 1 .2.2). Some mice and rats may also 
display tertiary alveolar budding within the ductal network; the extent to which this 
occurs depends upon the strain (Imagawa et al. , 1 994) and their stage of oestrous 
(Dulbecco et al. , 1 982). 
The onset of puberty not only initiates stromal and epithelial proliferation within the 
human breast, but also results in a conspicuous increase in its size due to the deposition 
of substantial amounts of fat in mammary adipocytes (Russo and Russo, 1 987). 
Parenchymal growth is associated with the formation of terminal end buds and alveolar 
structures, where alveolar buds are clustered around a ductal termination to form 
terminal duct lobular units (Moffat and Going, 1 996). Formation of lobules commences 
1 -2 years after the first menses; these lobules first appear at the periphery of the breast 
and extend centrally (Monaghan et al., 1 990) . 
Mammary gland growth in heifers continues to be allometric to around 9 months of age, 
thereafter slowing so that total mammary DNA content of 1 2- and 1 6-month old heifers 
is not different (Sinha and Tucker, 1 969b). This development corresponds to the growth 
of mammary parenchyma toward the bounds of the mammary fat pad (Swett et al., 
1 955). A similar pattern of parenchymal development has been observed in sheep 
(Wallace, 1 953). 
1.1.4 Oestrous cycle growth 
The mammary epithelium undergoes cyclical patterns of cell proliferation and 
morphogenesis during early puberty in response to the changing hormonal profiles of 
the oestrous cycle as the ductal tree extends toward the bounds of the mammary fat pad. 
This leads to net cumulative increases in mammary gland size (Sinha and Tucker, 
1 969a; Vonderhaar, 1 988). Total mammary DNA content in rats undergoes the greatest 
increases during the first and second cycles (Sinha and Tucker, 1 969a). Within the 
oestrous cycle of the mature rat, the mitotic index of mammary epithelium is greatest at 
metoestrus and dioestrus while the duration of DNA synthesis is longest at metoestrus 
(Grahame and Bertalanffy, 1 972; Purnell and Kopen, 1 976). Using immature and 
pubertal rats, Dulbecco et al. ( 1 982) examined DNA synthesis in epithelial cells of ducts 
and terminal end buds during the oestrous cycle. End bud labelling showed peaks at 
early oestrus and late oestrus-metoestrus, where the distribution of this label was 
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dependent upon the epithelial cel l  type (based on nuclear appearance) examined. Duct 
and ductule labelling was highest in late oestrus-metoestrus. The mammary gland is 
described as being most morphologically developed at oestrus and least developed at 
dioestrus (Lotz and Krause, 1 978). It has not been determined whether morphology of 
the mammary gland and the type of epithelial cells that proliferate within it during the 
oestrous cycle at the onset of puberty (when the fat pad is not fully occupied) differs 
from that in a fully mature gland (when ductal elongation has ceased) . It is conceivable 
that differences do exist; such temporal alteration may be present in the results of Sinha 
and Tucker ( 1 969a), where elevated mammary DNA content at pro-oestrus and oestrus 
was maintained into metoestrus in the first and second cycles, while peak DNA content 
was only measured at oestrus in cycles 3-5 . The significance of these changes within 
the mammary gland is emphasised by the fact that the stage of the oestrous cycle at 
which chemical carcinogen is administered to rats influences the extent and latency 
period of tumorigenesis (Lindsey et al. , 1 98 1 ;  Ratko and Beattie, 1 985). 
Epithelial DNA synthesis within the mammary gland of parous women is greater in the 
luteal than the fol licular phase of the oestrous cycle (Masters et aI., 1 977; reviewed by 
Laidlaw et al., 1 995). Again, it is possible that the human breast may proliferate more 
in the follicular phase during early puberty. 
The DNA content of the heifer mammary gland is greatest at oestrus relative to other 
stages of the cycle (Sinha and Tucker, 1 969b). This cyclical variation is accompanied 
by increased secretory activity at oestrus when epithelial cell s  assume a cuboidal 
appearance (Hammond, 1 927) .  Levels of hydroxyproline, a measure of collagen, are 
also elevated in the heifer mammary gland at oestrus (Sinha and Tucker, 1 969b). 
1.1.5 Gestational de velopment 
The majority of postnatal mammogenesis occurs during pregnancy, although the relative 
contribution of such growth is species-dependent (reviewed by Cowie et al., 1 980) . 
Likewise, there are substantial species differences in the relative contribution of 
maternal and foetal influences during this development (Thordarson and Tal amantes , 
1 987). Gestational mammary development for a given species is� DNA 
doubling time remains relatively constant and is primarily a function of gestation length 
(Sheffield and Anderson, 1 985). 
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Gestational mammogenesis in rodents accounts for between 60 and 80% of mammary 
gland growth that occurs during pregnancy and early lactation (Munford, 1 964). One 
exception is the hamster, in which the mammary gland is essentially fully developed at 
term (Sinha et al., 1 970) . In the mouse, approximately 30% of total development occurs 
between days 6 and 1 2  of pregnancy, and approximately 50% occurs between day 1 2  
and parturition (Brookreson and Turner, 1 959). The first phase of gestational 
mammogenesis in rodents involves extensive side-branching of ducts and the budding 
of alveoli into the interductal spaces of the mammary fat pad. The autoradiographic 
studies of Traurig ( 1 967) show peaks in DNA synthesis at days 4 and 1 2  of gestation, 
with similar findings for mitotic index reported by Grahame and Bertalanffy ( 1 972). It 
is probable that the first peak is stimulated by maternal influences such as progesterone 
and prolactin, and that the second is due to the onset of placental stimulation. Studies 
with pseudopregnant rodents indicate that maternal factors are indeed the primary 
impetus for mammogenesis until days 1 0- 1 2  of pregnancy, after which a placental 
influence is required to achieve the full development typical of a normal pregnancy 
(Wrenn et al. , 1 966; Desjardins et al., 1 968). Associated with epithelial growth during 
pregnancy is an increased accumulation of collagen within the mammary parenchyma, 
while the number of cells within the mammary fat pad remains unchanged (Paape and 
Sinha, 1 97 1 ) . Another factor that may account for up to 50% of pregnancy-associated 
mammary growth in rats is self-licking (Roth and Rosenblatt, 1 968), although the 
mechanism responsible for this dramatic effect remains unknown. 
The changing hormonal environment during pregnancy also induces mammary epithelial 
cel ls to differentiate and assume their capacity to synthesise milk constituents. A small 
rise in mRNA levels for certain milk proteins can be detected in the mouse mammary 
gland as early as day 5 (reviewed by Rosen, 1 987) although more substantial increases 
in the level of milk constituents such as a-lactalbumin occur around day 1 5 .  This 
corresponds to a time when epithelial cells also demonstrate a marked increase in cell 
volume (Foster, 1 977). It is during the periparturient and early lactation periods, 
however, that maximal milk synthesis is initiated. 
As for rodents, epithelial growth during pregnancy in the ruminant mammary gland is 
exponential, and in cows equates to a cell doubling time of 87 days (Sheffield and 
Anderson, 1 985). However, development of the ruminant mammary gland differs from 
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that of rodents in that the ruminant gland is almost completely developed at term. It has 
been consistently reported that under normal conditions total mammary DNA content 
does not change after parturition in goats (Anderson et al., 1 98 1 ), heifers (Swanson and 
Poffenbarger, 1 979; Baldwin, 1 966), and sheep (Anderson, 1 975b). 
The mammary parenchyma of ruminants gradually replaces the interspersed adipose 
tissue as it undergoes extensive alveolar development during gestation (Tucker, 1 969). 
This process involves extensive tissue remodelling and reduces the stromal connective 
tissue to narrow bands (Cowie et al., 1 980; Smith et al., 1 989a). As emphasised by 
Swanson and Poffenbarger ( 1 979), these changes are unlikely to be reflected in total 
mammary weight. The total amount of mammary parenchyma inflects around 70-80 
days in goats, 80- 1 1 5  days in sheep, and 1 1 0- 140 days in cows; a period when there is 
noticeable formation of alveoli-filled lobules. The highest percentage of epithelial 
tissue and eH]-thymidine-Iabelled epithelial cells in the mammary gland of ewes is 
around day 1 1 5 of gestation (Smith et al., 1 989a). This phase is also associated with an 
increase in epithelial cell size (Feldman, 1 96 1 ), a general appearance of secretory 
activity within the mammary gland, and an elevation in lactose synthesis and the ratio of 
RNA to DNA (Swanson and Poffenbarger, 1 979). 
As in the rodent, development of the ruminant mammary gland is influenced by a 
variety of maternal and foetal factors which are further discussed in respective sections 
of this review. Davis et al. ( 1 993) made the interesting observation that udder growth in 
hemimastectomised ewes remained at 50% of controls until day 1 44 of pregnancy, after 
which the single gland underwent compensatory growth to contain 70% of the DNA in 
control udders at term. Although the mechanisms which promote this compensatory 
growth are unknown, such a response illustrates the substantial growth potential of the 
mammary gland in the periparturient period. 
Development of the human mammary gland during pregnancy has been summarised by 
Russo and Russo ( 1 987). Early gestational mammogenesis involves both the 
proliferation of peripheral ducts and the formation of new lobules, where a range of 
morphologies is generally evident. By the end of the first half of pregnancy the ductal 
tree is essentially established. Thereafter, differentiated acini become increasingly 
apparent within some lobules and demonstrate an accumulation of secretion within the 
lumen. However, the development of individual lobules is quite heterogeneous, as some 
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may be fully differentiated whilst others may undergo extensive proliferation, even 
during lactation. 
1.1.6 Lactational growth 
As indicated earlier, the extent to which the mammary gland develops during lactation is 
largely species-dependent. The mechanisms which promote such growth are essentially 
unknown. A wide range of studies have investigated aspects of mammary growth 
during lactation (reviewed by Knight and Wilde, 1 987). 
A major proportion of mammary development in rats, mice and guinea pigs occurs 
during early lactation in order to yield maximum DNA content by about day 10  of 
lactation (reviewed by Munford, 1 964). This growth corresponds to a peak of epithelial 
DNA synthesis on days 2 and 3 (Traurig, 1 96 1 )  in association with increased cell 
proliferation in the surrounding connective tissue. It is generally assumed that the 
normal ruminant gland does not undergo such development during early lactation 
(Knight and Wilde, 1 987), although one report (Knight and Peaker, 1 984) suggests that 
goats display a small increment of growth in this time. 
� Growth of the mammary gland during lactation may be induced by various means. 
Several studies have demonstrated that increased lactation demand due to 
hemimastectomy (Knight, 1 987) and increased milking frequency can stimulate 
mammary development (Wilde et al. , 1 987). Likewise, increased suckling intensity 
stimulates mammary growth in a variety of species (reviewed by Tucker, 1 987). 
It is not known by what mechanisms lactational growth is regulated. Tucker ( 1 987) 
points out that the results of various experiments indicate an unlikely involvement of 
ovarian hormones or� It also appears that the effect of growth hormone during 
lactation is to promote galactopoiesis more so than mammary development (Gluckman 
et aI. , 1 987). One possibility is that the lactating mammary epithelium requires 
adequate energy before it can proliferate (Goodwill et al., 1 996) . The potential for 
lactational growth and increased milk yield make the underlying mechanisms for such a 
response particularly intriguing. 
Embryonic and postnatal development of the mammary gland is a process which has 
fascinated researchers from a number of fields within the area of developmental biology. 
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The dramatic changes in epithelial proliferation and morphogenesis across several 
reproductive states in themselves provide valuable insight into the factors controlling 
mammary development. Growth within each of these stages is integral to the overall 
development of the gland before it can assume its ultimate role in milk synthesis and 
secretion. These changes also afford an excellent model for investigating the 
physiological mechanisms which regulate specific aspects of mammary gland function. 
Furthermore, an opportunity to study essentially the entire course of organogenesis in 
the postnatal animal is of particular utility to the biologist. 
1.2 MAMMAR Y MORPHOGENESIS AND HISTOGENESIS 
The mammary parenchyma displays a range of morphologies as it ramifies into the 
stromal tissues of the mammary fat pad. These are generally characteristic of different 
reproductive states and frequently represent responses to specific local and systemic 
influences. Such changes result in the mammary gland becoming an elaborate structure 
capable of providing copious quantities of milk to the offspring on demand. Epithelium 
with these various morphologies differs in its risk of progressing to a tumorous 
phenotype. Furthermore, the nature of epithelial histogenesis and morphogenesis differs 
substantially across a range of species. An appreciation of the histology and 
morphology of the mammary gland may enable a better understanding of the 
mechanisms which serve to regulate normal and neoplastic mammogenesis. 
1.2.1 Cell heterogeneity 
Mammary parenchyma comprises a heterogeneous population of epithelial cell types; 10  
different types have been identified in  the adult rat mammary gland (Dulbecco e t  al. 
1 983). Particular attention has focussed on the pluripotency of transplanted mammary 
epithelium and the possible existence of a stem cell popUlation able to undergo complete 
mammary regeneration. Williams and Daniel ( 1 983) proposed that the cap cells of the 
ductal end bud were one such population. A cytologically distinct, pale-staining cell 
type present throughout the developing mouse mammary gland may also represent a 
form of stem cell (Smith and Medina, 1988). The abil ity of the COMMA- I D  mammary 
cell line to repopulate the mammary fat pad (Daniel son et al. , 1 984) led to its 
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subcloning to identify specific lineages that may represent stem cell types (Danielson et 
aI. , 1 989). The recent findings of Smith ( 1 996) indicate that separate stem cell 
populations do exist within the mammary gland and that they serve as separate 
progenitors for ductal and lobular growth. 
1.2.2 The ductal end bud 
The end bud is a bulbous termination of the mammary duct that is found in the pre- and 
pubertal mammary gland of rodents and humans. Intriguingly, such a structure has not 
been identifiable in mammary tissues of ewe lambs and heifers by histological 
examination (Akers, 1 990; Ellis et aI. , 1 995), although a ful l  assessment based on 
several other parameters remains to be conducted. 
The ductal end bud serves to provide a population of differentiated ductal and 
myoepithelial cells for ductal elongation, and to direct the path of ductal progression 
(Daniel and Silberstein, 1 987). These structures range from 0. 1 to 0.5 mm in diameter 
and are largest at the periphery of the ductal tree. The distal, basal layer of the rodent 
end bud is ensheathed by cap cells - cells which lack polarity and an organised 
cytoskeleton, and which are only loosely adherent with one another (Williams and 
Daniel, 1 983;  Figure 1 . 1 ) . As cap cells progress along the periphery of the end bud they 
acquire structural and ultrastructural characteristics of myoepithelial cells . Some cap 
cel ls may also migrate towards the lumen of the end bud to become ductal cells . Hence, 
the cap cells may in fact represent a pluripotent cell type within the mammary gland 
(Dulbecco et al., 1 983). The apparent absence of end buds within the ruminant 
mammary gland raises the question as to how the mammary ducts progress into the 
mammary fat pad and the origin of the myoepithelial cell population in such species. 
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Figure 1.1 Composite drawing of the ductal terminal end bud made from light and 
electron microscope analyses. Adipocytes (a) abut against cap cells at the tip (left) . 
Fibrous components and fibrocytes (f) comprise the connective tissue tunic around the 
neck region. The basal lamina (bl) is represented as a cutaway to expose the underlying 
cap cells (cp). Cap cells are cuboidal but become progressively flattened toward the 
midregion of the end bud, then differentiate into and are continuous with myoepithelial 
cells (mc) in the neck region. The basal lamina overlying myoepithelial cells in the 
midregion is 1 4  times thicker than that at the tip. Mitosis is seen in the cap and body 
cells (bd). Reproduced from Williams and Daniel ( 1 983) with permission. 
1.2.3 The mammary duct 
The outer layer of the mammary duct subtending the terminal end bud consists of 
myoepithelial cells positioned on the basal lamina. These cells  are arranged 
longitudinally along the ductal axis and form a collar of cells around the inner ductal 
epithelium (Warburton et aI., 1 982; Emerman and Vogl, 1 986). These inner layers of 
ductal cells may comprise several populations which are responsive to different stimuli 
(Sapino et al., 1 990). While primary and secondary ducts are l ined with several layers 
of epithelium, terminal ducts are generally lined with a single layer of epithelial cells  
(Williams and Daniel, 1 983). Luminal epithelial cells possess well developed 
intercellular junctions and have short, blunted microvil l i .  
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1.2.4 Al veolar and lobuloal veolar de velopment 
Pregestational development of the mouse mammary gland involves the establishment of 
a sparse ductal tree within the confines of the mammary fat pad. In some strains, small 
amounts of alveolar budding may arise from ducts in response to hormonal changes 
during the oestrous cycle; these alveoli comprise a lumen surrounded by a single layer of 
epithelial cells (Vonderhaar, 1 984) and may contain evidence of secretory activity. 
Extensive alveolar budding commences with the onset of pregnancy, and by 6 to 8 days 
post coitus these alveoli have begun to cluster to form true lobuloalveolar structures 
surrounding small lumina (Vonderhaar, 1 988). By the end of pregnancy, the gland 
consists of lobules composed of many acini. As alveolar formation proceeds, 
myoepithelial cells alter their orientation to form a basket arrangement around each 
acinus (Emerman and Vogl , 1 986). 
The extent of alveolar development within the pubertal mammary gland varies across 
species. Mayer and Klein ( 1 96 1 )  attributed this variation to the relative length of the 
luteal phase during the oestrous cycle. This  association is not surprising given the well 
established influence of progesterone on alveolar growth (Haslam, 1 988a; Lydon et al., 
1 996). Consequently, in species such as rats and mice where the fol licular phase 
predominates, only ductal morphogenesis is typically evident prior to the onset of 
pregnancy. In contrast, the mammary gland of species that have a long luteal phase 
(such as the bitch) may display lobuloalveolar development during puberty which is 
similar to that seen in pregnancy (Mayer and Klein, 1 96 1 ) . 
The pubertal human breast displays several parenchymal morphologies which are 
distinct from those in the widely studied mouse mammary gland. These features have 
been previously classified in detail (Russo and Russo, 1 987). As the ductal tree 
continues to elongate, the terminal end buds undergo lateral and dichotomous branching 
after the first menses, leading to the formation of small ductules or alveolar buds. These 
buds are arranged around a terminal duct to form a type 1 lobule composed of 
approximately 1 1  alveolar buds (Figure 1 .2). With recurrent oestrous cycles, these type 
1 lobules progress to type 2 lobules, and then to type 3 .  This progression is  
heterogeneous within the gland and involves ongoing alveolar budding such that type 2 
and type 3 lobules contain approximately 47 and 80 alveolar buds, respectively. 
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Figure 1.2 Schematic representation of breast development. (A) At puberty or during 
its onset, the ducts grow and divide in a dichotomous and sympodial basis ending in 
terminal end buds. (B) After the first menstruation, the first lobular structures appear 
(lobules type 1 ) ; they are composed of alveolar buds (AB). Some branches end in 
terminal end buds or terminal ducts. (C) The number of lobules increases with age and 
in the adult nulliparous female breast, three types of lobule may be found (lobules types 
1 ,  2, and 3); n, nipple; lob, lobule. Reproduced from Russo and Russo ( 1 987) with 
permission. 
In studying the local regulation of mammary gland growth, it is important that species 
differences in parenchymal morphogenesis is acknowledged. This recognition may be 
of particular relevance when evaluating the regulation of processes such as branching 
morphogenesis, where it is conceivable that different factors influence the virgin human 
breast and the mouse mammary gland. There is essentially no information regarding 
parenchymal morphogenesis and histogenesis within the ruminant mammary gland, 
1 6  
although a realisation i s  slowly emerging that i t  differs substantially from that i n  the 
widely studied rodent gland (Sheffield, 1 988b; Akers, 1 990) 
1.3 THE STROMAL EN VIRONMENT 
Mammary epithelial cells within the embryonic and postnatal mammary gland 
demonstrate an extensive interaction with the constituents of the surrounding stroma. 
While early investigations considered this environment to be a relatively inert matrix in 
which epithelial cells grow, numerous lines of evidence now indicate that this is far 
from the case. There are also substantial differences in the relative proportions of 
various stromal tissues within the mammary gland across species, a fact which may 
warrant particular consideration in studies of human breast disease and ruminant 
mammogenesls. 
1.3.1 The embryonic mesenchyme 
Several studies have utilised tissue recombination strategies to demonstrate that the 
mesenchyme of the embryonic mammary gland exerts strong influence on the adjacent 
epithelium. Cunha et al. ( 1995) showed that mouse mammary mesenchyme induces the 
epidermis to adopt a mammary epithelial phenotype. Studies by Sakakura et al. ( 1 976; 
1 982) also showed that the development of mammary epithelium depends on the type of 
mammary mesenchyme in which it grows. Various mesenchymes can induce mammary 
epithelium to assume a morphogenesis which is dependent upon the origin of the 
mesenchyme, while mammary epithelium stil l  retains its milk synthetic potential . The 
precursor mammary fat pad best supports organotypic development of several foetal 
epithelial tissues at day 14  of embryogenesis (Sakakura et al. , 1 987). Mammary fat pad 
precursor tissue transplanted into the adult mouse mammary gland or co-transplanted 
with epithelium under the renal capsule facil itates normal morphogenesis while the 
fibroblastic mesenchyme induces a nodular hyperplasia. 
1.3.2 The mammary fat pad 
The mammary fat pad is a vernacular term that refers to the subcutaneous depot of 
adipose tissue in which the mammary gland develops. This fat pad develops from a 
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specific population of precursor mesenchyme which i s  evident in the embryonic mouse 
mammary gland from day 1 4  (Sakakura, 1 987) . Transplantation of this precursor tissue 
to the kidney capsule of mature hosts results in its differentiation into adipose tissue 
after 2 weeks (Sakakura et al., 1 982). This tissue becomes less compact on days 1 5- 1 6  
of embryonic development, and on days 1 6- 1 7  the preadipocytes proliferate, form 
lobular structures with a capillary network, and begin to accumulate lipid (Sakakura, 
1 987). The mammary fat pad in neonatal rodents is readily evident as a depot of white 
adipose tissue. The first sign of a definitive mammary fat pad in the bovine foetus is 
around day 80 of gestation (Sheffield, 1 988b) . 
The mature mammary fat pad consists of several stromal elements including adipocytes, 
connective tissues, blood vessels, nerves and the lymphatic components. There are, 
however, species differences in the relative proportions of these tissues within the 
mammary fat pad, the pattern of development that they undergo, and the extent to which 
the stroma interacts with the developing epithelium. 
As is evidenced histologically, the major proportion of the rodent mammary fat pad is 
comprised of adipocytes, with a thin sheath of connective tissue enveloping the 
established ducts. The mouse mammary fat pad is also serviced by a defined vascular 
network (Soemarwoto and Bern, 1 958), and it is drained by lymphatics to one or more 
lymph nodes. The rat mammary gland demonstrates a net increase in the collagen 
content of both the fat pad and parenchymal fractions during puberty, while ovariectomy 
induces an increase in collagen and the total DNA content of the mammary fat pad 
(Paape and Sinha, 1 97 1 ) . The protein content of the mouse mammary fat pad remains 
relatively constant across mature virgin, pregnant and lactation stages, although it is 
unclear as to why the mammary fat pad demonstrates an increase in its total DNA 
content into lactation (Bandyopadhyay et al., 1 995). 
The mammary fat pad of the human breast is somewhat different. At birth there is an 
already well developed network of connective and vascular tissue, and by prepuberty the 
developing glandular epithelium l ies in veins of connective tissue that form conductive 
pathways for pubertal growth of the eventual duct system (Mayer and Klein ,  1 96 1 ; 
Anbazhagan et al., 1 99 1 ). After the onset of puberty, the human breast demonstrates a 
considerable increase in size due to deposition of substantial amounts of fat and the 
initiation of stromal proliferation (Knight and Peaker, 1 982). Volume of the breast is 
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greatest around the time of menses (Cowie et al., 1 980) and can change by as much as 
20% during the oestrous cycle due to changes in stromal volume (R�nnov-Jessen et al. , 
1 996). Epithelial growth is preceded by stromal proliferation and the deposition of 
inter- and intralobular fibroblastic connective tissue (R�nnov-Jessen et al. , 1 996). As a 
result, and in contrast to the mouse mammary gland, human mammary epithelium 
develops while surrounded by a collagenous intralobular stroma (R�nnov-Jessen et al. , 
1 996) . A similar although less pronounced tissue architecture is seen in the rat 
(Sakakura, 199 1 ) . There also exists a substantial proportion of interlobular collagenous 
stroma which consists of fibroblasts dispersed at a low density. The ratio of stroma to 
parenchyma during the course of development of the human mammary gland was 
reported by Russo and Russo ( 1 987). During puberty only 1 0% of the breast is 
parenchyma; the remaining 90% is comprised of stroma, of which 1 7% is intralobular 
stroma. With age, the breast of nulliparous women comprises 30% parenchyma, and 
28% intralobular stroma. By late pregnancy, parenchyma occupies 73% of gland area 
with concomitant declines in area of both the inter- and intralobular stroma. 
Only subjective observations have been made regarding the nature of the mammary fat 
pad in ruminants. Mayer and KJein ( 1 96 1 )  state that in the neonatal calf, "the non­
glandular structures are almost mature in form, with already-established vascular and 
lymphatic systems. The adipose and connective tissues are also well organised. The 
early partitioning of the adipose tissue by the connective tissue system is remarkable, 
and the connective septa serve as paths for the future extension of the epithelial 
structures". Fat is deposited within the mammary fat pad during prepuberty and 
puberty, although the extent to which this occurs may be influenced by the animal ' s  
plane of nutrition. As the parenchymal elements progress into the mammary fat pad 
during prepuberty and puberty they apparently replace the adipose tissue and 
subsequently become enveloped by a zone of fibroblastic connective tissue similar to 
that seen in the human breast (Sheffield, 1 988b). 
1.3.3 Mammary transplantation studies 
The ability to transplant normal and neoplastic mammary epithelium to various sites has 
facilitated investigations into several aspects of mammary biology (reviewed by 
Hoshino, 1 978; Sheffield, 1 988b; Medina, 1 996), especially the interrelationships 
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between different tissue types within the gland. A large proportion of these studies in 
mice and rats have been aided by the cleared fat pad technique, a procedure described by 
DeOme et al. ( 1 959) that involves ablating the mammary epithelial rudiment at around 3 
weeks of age. This manipulation yields a mammary fat pad devoid of epithelium which 
can subsequently serve as a transplantation site. Several modifications of this  original 
procedure have also been described (Hoshino, 1 962). 
A number of important observations have been made from transplantation studies in 
rodents. Firstly, repopulation experiments indicate that the amount of parenchyma 
which ultimately develops within the mammary gland reflects the volume of the 
mammary fat pad in which it grows rather than a characteristic of the epithelium itself 
(Hoshino, 1 978). 
Results from several transplantation studies also show that the mammary epithelial cel l  
population possesses a great deal of pluripotency. Grafts from various sites of the 
mammary ductal tree, including the terminal end buds, can re-establish a normal ductal 
network when transplanted to a virgin host (Hoshino, 1 964; Sakakura et al., 1 979; 
Ormerod and Rudland, 1 986). The only region incapable of such growth is the nipple. 
Similar potential for regrowth is possessed by foetal (Sakakura et aI., 1 979), neonatal 
(Currie et al., 1 977) and male (Blair and Moretti, 1 970) mammary tissue. These 
recombinants undergo morphogenetic and functional differentiation when hosts are 
mated or hormonally treated (Sekhri et al. , 1 967; Hoshino, 1 983). Immediately after its 
transplantation, mammary tissue undergoes extensive remodelling and proliferation 
within the new stromal environment (Hoshino, 1 978). Other recombination strategies 
have also been developed. One approach involves the isolation and in vitro genetic 
manipulation of mammary epithelial cells which are then inoculated into a cleared 
mammary fat pad or other sites, enabling the resultant phenotype to be examined 
(Edwards et al., 1 995; Edwards et aI. , 1 996) . Other studies have used the mammary fat 
pad to demonstrate that mammary epithelial cell lines such as COMMA- I D  (Daniel son 
et al., 1 984) can undergo a complete and normal morphogenesis in vivo. 
Transplantation studies have also revealed that normal parenchymal elements locally 
regulate their growth and spacing within the mammary gland (Faulkin and DeOme, 
1 960). Other experiments have shown that hyperplastic alveolar nodules are similar to 
normal epithelium in that they only grow within a depot of adipose tissue and, 
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furthermore, that their growth is inhibited by the presence of endogenous mammary 
epithelium relative to their growth in a cleared mammary fat pad (Miller et al. , 1 98 1 ) .  
Transplantation approaches have also enabled investigation into the lifespan of 
mammary epithel ium. The work of Daniel and co-workers (reviewed by Daniel and 
Silberstein, 1 987) demonstrated that serially transplanted epithelium had a finite 
lifespan, and that growth rate declined by approximately 1 5% with each generation. 
This lifespan was a function of the number of cell divisions rather than actual cell age. 
Senescent epithelium did, however, retain an ability to respond to cholera toxin, leading 
to the suggestion that epithelial cells become refractory to in vivo mitogenic stimulation. 
On the other hand, cells from hyperplastic alveolar nodules were immortalised and did 
not demonstrate senescent tendencies (Daniel et aI., 1 968). In contrast, the reports of 
Hoshino (reviewed by Hoshino, 1 978) suggested that serially transplanted mammary 
epithelium does not suffer any reduction in its survival potential. A likely reason for 
these conflicting results is that the measurements made by Hoshino related to the 
success of transplant recovery, whereas a more valid parameter would be the outgrowth 
potential of epithelial transplants as measured by Daniel and co-workers. 
The stromal requirements for normal mammary gland development have been 
investigated in the extensive studies of Hoshino (reviewed by Hoshino, 1 978). When 
transplanted to subcutaneous sites, mammary grafts were maintained, but did not 
demonstrate any outgrowth beyond the adipose tissue associated with the original 
transplant. This limited outgrowth also occurred in transplants to the peritoneal cavity 
and the anterior chamber of the eye. In contrast, grafts to the cleared mammary fat pad, 
the perirenal fat pad or the mesometrial fat pad demonstrated extensive ductal outgrowth 
into the transplanted and host stroma. The extent of outgrowth was generally greatest in 
the cleared mammary fat pad, although substantial amounts of growth were also 
observed in the perirenal fat pad. A high rate of mammary graft recovery was also 
achieved in transplants to the interscapular depot of brown adipose tissue (Hoshino, 
1 967), although no measure was given as to the extent of the outgrowth. Nevertheless, 
the results of these studies indicate that mammary epithelium has an inherent 
requirement for a depot of adipose tissue in order for it to undergo normal growth and 
morphogenesis. The locality of the recipient fat pad also influences where metastatic 
tumours will arise; metastases from the mammary fat pad primarily arise in the lung 
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whilst metastases from ovarian and mesenteric adipose tissues generally occur i n  the 
liver, spleen and diaphragm (Elliott et al. , 1 992) . 
The mammary fat pad of the immunologic ally-deficient athymic nude mouse and rat has 
been widely utilised as a site for heterologous mammary transplants (reviewed by 
Sheffield, 1 988b). Interestingly, Welsch et al. ( 1 987) showed that normal, but not 
carcinomatous, rat mammary epithelium can survive and grow within the mouse 
mammary fat pad. Attempts to transplant human mammary tissue have met with l imited 
success. Although Outzen and Custer ( 1 975) reported outgrowths from transplanted 
human mammary heterografts, the epithelium which they used was from abnormal 
mammary tissue. Transplantations conducted by Jensen and Wellings ( 1 976) did not 
show any outgrowth of human epithelium into the host mammary fat pad; instead 
transplants appeared as rounded grey structures encapsulated by a glistening sheath of 
connective tissue. Similar results were reported by Sheffield and Welsch ( 1 988) and 
Yang et al. ( 1 995). DNA synthesis in these epithelial spheroids could be stimulated by 
hormones, yet their morphology remained unaltered. Such studies have been extended 
to the transplantation of bovine mammary tissue into the mammary fat pads of nude 
mice (Sheffield and Welsch, 1 986). Similar to transplanted human cells, bovine cells do 
not outgrow but instead form hollow spheroid structures ensheathed by connective 
tissue. The same observations were reported by Ellis and Akers ( 1 995) using the MAC­
T bovine mammary cell line. Both studies reported increased DNA synthesis of 
spheroids in response to exogenous hormones without morphological change. 
The reason for species differences in the ability of transplanted epithelium to outgrow 
into the mouse mammary fat pad is intriguing. It is unlikely that it reflects different 
hormonal conditions in host mice, as tissue slices of human and bovine mammary tissue 
are maintained, grow and differentiate when transplanted subcutaneously in nude mice 
(Welsch et aI., 1 979; Sheffield and Welsch, 1 986). One likely explanation is that the 
mouse mammary fat pad does not provide a stromal environment suitable for the 
outgrowth of human and bovine mammary epithelium. Sheffield ( 1 988b) reported that 
the composition of the extracellular matrix that surrounds spheroids of heterografted 
bovine epithelium differs to that in normal bovine mammary tissue. Human and bovine 
epithelium normally grows within a matrix of connective tissue enriched with matrix 
components such as collagen and glycosaminoglycans. Furthermore, the mammary fat 
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pad in both of these species has an extensive, pre-established mesh of connective tissue. 
In contrast, the mouse mammary fat pad comprises predominantly adipocytes, and 
proliferating ductal epithelium abuts onto adipocytes rather than being enveloped by a 
fibroblastic connective tissue. 
Transplantation studies have also shown that both intrinsic epithelial properties and the 
host environment can influence mammogenesis and tumorigenesis. For example, 
Alston-Mills and Rivera ( 1 985) and Ethier and Cundiff ( 1 987) have shown that the 
growth of transplanted DMBA-induced tumours is affected by properties such as growth 
factor independence. Others indicate that host factors such as age (Daniel et ai. , 1 968) 
and dietary fat (Jp and Sinha, 1 98 1 ) can influence the growth of transplanted epithelium. 
1.3.4 The epithelial-stromal reaction 
The encroachment of parenchyma into the adjacent mammary fat pad leads to the 
formation of an intimate association between the mammary epithelium and the 
surrounding stromal elements. Within the mouse mammary gland, cap cells and the 
basal lamina of the advancing terminal end bud are in direct contact with adipocytes of 
the mammary fat pad (Daniel and Silberstein, 1 987). This association induces DNA 
synthesis in stromal cells within 250 �m of the end bud, where eH]-thymidine labelling 
of stromal cells is greatest adjacent to the epithelium and decreases with distance 
(Berger and Daniel, 1 983; Dulbecco et ai., 1 982). Interestingly, this response distance 
of 250 �m is the same as that which separates ducts of the virgin mammary gland 
(Faulkin and DeOme, 1 960). This DNA synthetic response by stromal cells can only be 
induced by epithelium that is undergoing proliferation, for senescent ductal transplants 
do not evoke this effect (Daniel and Silberstein, 1 987). Proliferating epithelium in the 
ductal end bud also induces a local upregulation of stromal epidermal growth factor 
(EGF) receptors (Daniel and Si lberstein, 1 987). Furthermore, mammary parenchyma 
can locally influence lipolysis and lipogenesis in nearby adipocytes of the mammary fat 
pad (Elias et al., 1 973; Kidwell et al. , 1 982; Bartley et al., 1 98 1 )  by liberating diffusible, 
soluble factors (Lucas et al., 1 976). This epithelial influence on adipocyte metabol ism 
might also be mediated by local immune mast cells (Kidwell and Shaffer, 1 984; 
Haslam, 1 988b). It is not known to what extent this local influence on adipocyte 
metabolism subsequently regulates the growth of the mammary epithelium. 
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The constricted flank of the ductal end bud also demonstrates extensive stromal 
reaction. This region, encased by proliferating fibrocytes synthesising interstitial 
collagen (Williams and Daniel, 1 983), is enriched with sulfated glycosaminoglycans 
such as chondroiton sulfate (Silberstein and Daniel, 1 982). Fibrosis within this  zone 
may be induced by the newly differentiated myoepithelium and/or the synthesis of the 
basal lamina (Wicha et al. , 1 980). One question that does arise is whether this 
fibroblastic stroma originates from cells of the mammary fat pad, or from mesenchymal 
cells that have co-migrated with the advancing ductal epithelium. In the case of 
mammary epithelial heterografts which overexpress the Wnt- l on co gene and induce 
extensive stromal fibrosis (Cunha and Horn, 1 996), the resultant fibroblastic stroma has 
been shown to originate from constituents of the host' s mammary fat pad (G.R. Cunha, 
personal communication). It remains to be determined whether the extensive fibrosis 
that occurs around parenchyma in the human and ruminant mammary gland similarly 
arises from the stromal cells of the mammary fat pad proper. 
The myoepithelial cell population is closely associated with epithelial cells and forms a 
collar of longitudinally-oriented cells around the ductal epithelium in the nonpregnant 
female (Haslam, 1 988b). The myoepithelium may therefore act to regulate exposure of 
epithelial cells to the underlying basement membrane. 
The most pronounced example of stromal reaction is seen in the vicinity of breast 
tumours, where desmoplasia may account for greater than 90% of cells in tumours such 
as infiltrating ductal carcinomas (R�nnov-Jessen et aI . ,  1 996). This response may 
involve the upregulated expression of genes for certain mitogens such as IGF-II (Singer 
et al., 1 995). The importance of this stromal reaction may be emphasised by the finding 
that human adenocarcinoma cells transplanted to athymic nude mice have an increased 
tumour take and growth rate when they are co-inoculated with human fibroblasts (Noel 
et al., 1 994). In addition to markedly altering the composition of the extracellular 
matrix,  desmoplasia may encourage the appearance of a modified fibroblast cell type, 
the myofibroblast, which is positive for a-smooth muscle actin. The stromal revelation 
of this cell type during tumour progression may further alter the composition of the 
extracellular matrix, or may allow contractile forces to be exerted during the growth of 
tumorous epithelium (R�nnov-Jessen et al. , 1 996) . 
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1.3.5 Modelling epithelial -stromal associations 
With an increasing recognition that local influences play an important role during 
mammary development and tumorigenesis, numerous attempts have been made to 
model the interactions that take place between the epithelium and the adjacent stroma 
(reviewed by Ip and Darcy, 1996). 
One such approach has been to "condition" cel l  culture medium by' incubating it with 
different constituents of the mammary gland stroma. This conditioned medium can then 
be added to cultures of mammary epithelial cells to determine their response to soluble 
factors liberated by the stromal tissue or cells .  Numerous studies have prepared 
conditioned medium from cultured monolayers of foetal mammary stroma (Grey et al. , 
1 989), and stroma of adult rodent (Sasaki et aI., 1 994), human (Van Roozendaal et al. , 
1 996) and bovine (Woodward et al . ,  1 992) mammary tissue, as well as mammary 
tumour cel ls (Cappelletti et aI. , 1 993). Other studies have conditioned medium using 
differentiated 3T3-L l preadipocytes (Levine and Stockdale, 1 984; Rahimi et al., 1 994), 
isolated mammary adipocytes, or explants of mammary fat pad tissue (Beck and Hosick, 
1 988). Almost al l of these studies have demonstrated that the stromal constituents 
produce some form of biological activity (particularly polypeptide growth factors) 
capable of modifying such characteristics as anchorage-dependence, morphogenesis, 
proliferation, and milk protein synthesis. 
Other studies have investigated physical and physico-chemical influences on epithelial 
growth and morphogenesis by co-culturing epithelial and stromal cells . These co­
cultures may incorporate live cell populations (Wang and Haslam, 1 994), stromal cells 
inhibited by glutaraldehyde or killed by irradiation (Levine and Stockdale, 1 985; 
Haslam, 1 986), or the matrix synthesised by stromal cel ls. Such conditions have been 
shown to stimulate epithelial DNA synthesis; likewise, stromal DNA synthesis is 
stimulated in live mixed cultures. Other characteristics such as epithel ial morphology, 
milk protein expression (Wiens et al., 1 987) and progesterone receptor levels may also 
be altered. A major disadvantage of such an approach is that in many cases it is difficult 
to segregate the epithelial and stromal cell types for routine assay. A third, similar 
approach has been to culture epithelial and stromal populations that are physically 
separated from each other while stil l  allowing bidirectional diffusion of soluble factors. 
This approach has included the use of culture well inserts and the co-casting of 
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mammary fat pad explants in collagen along with epithelial organoids (Carrington and 
Hosick, 1 985). 
1.3.6 The extracellular matrix 
Literature concerning the role of the extracellular matrix in mammary development, 
differentiation, and lactogenesis is extensive and will not be reviewed in detail here. For 
comprehensive reviews of this subject the reader is referred to the reviews of Bissell and 
Hall ( 1 987); Aggeler et al. ( 1 988); Barcellos-Hoff and Bissell ( 1 989) and Blaschke et al. 
( 1 994). It is pertinent, however, to briefly consider the involvement of the extracellular 
matrix in mammary gland development and morphogenesis, and the likely importance 
of the mammary fat pad in providing such a substratum. 
The extracellular matrix on which the mammary epithelium is positioned consists of 
three different strata (Sakakura, 1 99 1 ) . Basal to the epithelial cells i s  a thin sheet 
referred to as the lamina densa that is separated from the epithelium by a narrow 
translucent space known as the lamina lucida. The lamina densa and the lamina lucida 
are collectively referred to as the basal lamina. Adjacent to the basal lamina and 
associated with the stromal components is a layer of variable thickness known as the 
reticular lamina. Epithelial cells in the virgin rodent mammary gland are actually 
separated from the basal lamina by a continuous collar of myoepithelial cells, whereas 
during pregnancy, epithelial cells become directly exposed to the basal lamina as the 
myoepithelial cells assume a basket-like arrangement (Haslam, 1 988b). The basal 
lamina that ensheaths the distal region of the end bud and the subtending ducts in the 
virgin mammary gland is approximately 1 00 nm thick, whilst that along the constricted 
neck region of the end bud may be 1 3-20 times this thickness (Daniel and Silberstein, 
1 987). This latter region is a site of considerable sulfated glycosaminoglycan synthesis 
(Silberstein and Daniel, 1 982). 
Until recently it has been accepted that the epithelium produces components of the basal 
lamina such as laminin, type IV collagen and heparan sulfate proteoglycans (including 
nidogen and entactin), while cells of the stroma synthesise constituents of the reticular 
lamina such as type I and III collagens, fibronectin, and tenascin (Sakakura, 1 99 1 ) . 
These assumptions have been based on the results of immunolocalisation studies and in 
vitro experiments showing the presence of various matrix components in epithelial 
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cultures. However, more recent in situ hybridisation results indicate that only the 
stromal connective tissue cells and adipocytes, and not the epithelium, express mRNA 
for collagen I, collagen IV, and larninin in the mouse mammary gland (Keely et al., 
1 995). Furthermore, this expression is developmentally regulated; collagen I mRNA 
levels are highest in prepuberty and early pregnancy and precede an upregulation of 
collagen IV and laminin expression. These findings emphasise the critical requirement 
for the mammary fat pad stroma during development and the importance of the 
epithelial-stromal reaction in regulating epithelial progression and morphogenesis. It 
remains unclear as to whether the detection of these matrix proteins in epithelial cultures 
in vitro is a function of cell adaptation to an artificial environment, or if it simply 
reflects contamination of cultures with stromal cells or their remnants. 
While the extracellular matrix plays an integral role in regulating the development and 
function of mammary epithelium, the extent of its involvement and the specific roles of 
its numerous constituents remain to be fully characterised. In vitro studies frequently 
adopt the technique of embedding primary epithelial cells within collagen gels to 
achieve sustained growth and hormonal responsiveness (Yang et al., 1 980). However, 
collagen I alone does not fulfil the matrix requirements for normal morphogenesis as 
shown in an experiment conducted by Daniel and co-workers (Daniel et aI., 1 984), 
where epithelium transplanted into collagen gel inside the mammary fat pad grew as 
radial spikes within the gel and only formed end buds when it reached the stroma of the 
mammary fat pad. 
It is possible that specific components of the extracellular matrix are prerequisite for 
certain stages of mammogenesis. For example, tenascin is only expressed by the foetal 
mesenchyme in response to epithelial induction (Sakakura, 1 99 1 )  while the stroma of 
the postnatal gland differentially expresses collagen I, collagen IV and larninin during 
virgin and gestational development (Keely et al. , 1 995). Other studies have shown that 
the synthesis of extracellular matrix components is regulated by various hormones and 
growth factors (Blum et al., 1 989a), further supporting suggestions for their stage­
specific roles. Furthermore, cell-surface receptors for these extracellular matrix 
proteins, the integrin subunits, are expressed by epithelial cells during specific stages of 
development (Anbazhagan et al. , 1 995) and are markedly repressed during lactation 
(Keely et aI., 1 995). Likewise, inhibition of type IV collagen synthesis in vivo using cis-
27 
hydroxyproline leads to a reduction in epithelial growth and encourages the regression 
of epithelium to an involuted-like state (Wicha et al., 1 980) . The most pronounced 
requirement of epithelium for an extracellular matrix is seen in studies of milk protein 
synthesis where epithelial differentiation and hormonal responsiveness is only achieved 
when cells are cultured on substratum such as col lagen or a reconstituted membrane 
matrix such as Matrigel. Aside from having marked effects on epithelial characteristics 
such as morphogenesis and differentiation, the extracellular matrix can also regulate 
other cellular responses including the expression of hormone and growth factor 
receptors (Mohanam et al., 1 988;  Haslam, 1 986) and cell proliferation (Salomon et al., 
1 98 1 ;  Wicha et al., 1 982). 
Taken together, this information strongly implicates the stroma as fulfilling a major role 
in regulating development of the mammary gland. This regulation may be effected both 
chemically and physically, and also likely depends upon the local reaction between 
epithelial cells and the surrounding stroma. Such information is of fundamental 
importance to our understanding of mammary gland biology. However, a great deal 
remains to be understood about the full extent of this regulation and its role during the 
course of normal and neoplastic mammogenesis. Furthermore, species differences 
remain to be explored, where it appears that there are several major distinctions between 
the stromal environment of the rodent mammary gland and that in other species such as 
humans and ruminants. 
1.4 FACTORS IN FLUENCING MAMMAR Y DE VELOPMENT 
The postnatal proliferation of epithelial cells within the mammary fat pad is influenced 
by an array of systemically and locally derived factors. While it is well established 
which hormones primari ly control mammogenesis, in several cases their mechanism of 
action on the mammary gland is unknown. Furthermore, an increasing body of 
information suggests that the local synthesis of other factors within the mammary gland 
may be critical to the growth and morphogenesis of mammary epithelium. A role for 
these factors has been studied in the normal mammary gland of various species as well  
as in the tumorous mammary gland of rodents and humans. 
1.4.1 The ovarian steroids 
1.4.1.1 Oestrogen 
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Numerous studies have demonstrated the important role of oestrogen during postnatal 
mammogenesis (reviewed by Haslam, 1 987). Oestrogen is a potent stimulator of DNA 
synthesis in the mouse mammary gland (Traurig and Morgan, 1 964), particularly within 
the terminal end buds (Bresciani, 1 968). A requirement for the mammogenic effect of 
oestrogen is  exemplified in prepubertal mice where ovariectomy-abrogated ductal 
growth can be restored by exogenous oestrogen (FlUX, 1 954) . While development of the 
rat mammary gland is unaffected by prepubertal ovariectomy, administration of 
oestrogen to ovariectomised female rats promotes both ductal and lobuloalveolar 
development (reviewed by Nandi et al., 1 995). Oestrogen also stimulates DNA 
synthesis in human breast tissue transplanted to athymic nude mice (Laidlaw et al. , 
1 995). 
Short-term administration of supraphysiological doses of oestrogen to prepubertal ewe 
lambs (Ellis et al., 1 996a) and heifers (Woodward et al., 1 993) increases DNA synthesis 
in the mammary epithelium. This oestrogen-induced proliferation in the mammary 
gland of heifers was followed by a phase of stromal DNA synthesis. It is also well 
established that heifers and ewes grazing pastures with a high phyto-oestrogen content 
frequently demonstrate precocious mammary gland development (Adams, 1 995). 
Although ovariectomy abrogates prepubertal mammary development in heifers (Purup et 
al.� 1 993b), the involvement of oestrogen in this effect is somewhat unclear as the serum 
oestrogen concentration was only reduced by 30% (0. 1 pg/ml) fol lowing ovariectomy. 
In contrast, prepubertal mammary growth of ewe lambs is unaffected by ovariectomy 
(Wall ace, 1 953 ;  Ellis et al., 1 996a). Others have shown that oestrogen, in combination 
with progesterone, can facilitate normal growth in ovariectomised heifers (Sud et al., 
1 968); the combination of these two steroids is an essential requirement to adequately 
develop the mammary gland during hormonal induction of lactation (Sawyer et al., 
1 986). 
Responsiveness of the mouse mammary gland to oestrogen-induced proliferation also 
varies during postnatal development (Haslam, 1 989). Specifically, oestrogen does not 
induce DNA synthesis in the mammary gland of 3- 14  day old female mice, while by 3-4 
weeks of age both stroma and epithelium proliferate in response to oestrogen. Along 
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these l ines, it is unlikely that oestrogen serves a role during normal embryonic and 
perinatal mammary development given that the growth of the mammary rudiment is 
unaltered in female mice lacking a functional oestrogen receptor (Korach, 1 994). On 
the other hand, administration of exogenous oestrogen to embryonic mice does result in 
malformed mammary gland (Raynaud, 1 96 1 ). 
The finding that ductal elongation in hypophysectomised mice was not promoted by 
exogenous oestrogen indicated that pituitary hormones were also required to elicit the 
mammogenic effect of oestrogen (Lyons et ai., 1 958;  Nandi, 1 958). Subsequent studies 
in triply-operated mice and rats showed that the combination of oestrogen + corticoid + 
growth hormone could fully restore mammary development (reviewed by Imagawa, 
1 990). A synergistic response by ductal epithelium to oestrogen + prolactin has also 
been reported (Stoudemire et al., 1 975). However, it stil l  remained unclear as to 
whether oestrogen initiated its effect by a direct action on the mammary gland, or via an 
indirect action through the pituitary. Using slow-release implants positioned within the 
immature mammary gland, Daniel et al. ( 1987) and Haslam ( 1 988d) demonstrated that 
oestrogen acts directly on the mammary gland to stimulate ductal growth. This mode of 
action is further supported by the fact that ductal growth is suppressed in the presence of 
implants containing antiestrogens (Silberstein et al., 1 994). In contrast, oestrogen­
stimulated proliferation in the mature gland is systemically mediated, while local 
oestrogen release can sti l l  induce an upregulation of epithelial progesterone receptors 
(Haslam, 1 988d). 
Even though a local action of oestrogen had been shown, there remained the paradox 
that cultured epithelial cells from various species were not stimulated to proliferate by 
oestrogen in vitro (Yang et al. , 1 980; Richards et ai., 1 988). Only occasional reports 
have demonstrated oestrogen responsiveness of cultured mammary epithelium (Gompel 
et ai., 1 986). The establishment of an oestrogen-responsive breast cancer cell line 
(MCF-7) has led to its widespread adoption (Lippman et al., 1 976) as a model for 
hormone-dependent breast cancer. Yet while cultures of mammary epithelial cells do 
not proliferate in response to oestrogen, they do possess functional and prolactin­
inducible oestrogen receptors (Haslam and Levely, 1 985) and upregulate progesterone 
receptor levels in response to oestrogen (Edery et al. , 1 984) . 
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These findings have led several groups to propose that the mammogenic effect of 
oestrogen is  mediated by the adjacent constituents of the mammary fat pad. In support 
of this proposal is the finding that a single injection of oestrogen stimulates DNA 
synthesis in mammary adipocytes and stromal cells prior to a phase of DNA synthesis in 
the adjacent epithelium (Shyamala and Ferenczy, 1 984). McGrath ( 1 983) also showed 
that oestrogen could only stimulate DNA synthesis in cultured epithelial cells after they 
came into contact with mammary fibroblasts. This effect requires live fibroblasts, and is 
associated with oestrogen-dependent stimulation of fibroblast proliferation (Haslam, 
1 986). An indirect action of oestrogen is further suggested by studies showing that 
explants of sheep (Forsyth, 1 989) and heifer (Purup et al., 1 993a) mammary tissue 
demonstrate increased DNA synthesis in response to oestrogen in vitro, while cultured 
bovine mammary epithelial cells are unresponsive to oestrogen (Woodward et al., 
1 994). This may reflect the local, oestrogen-induced synthesis of mitogens by stromal 
cells (Woodward et aI. , 1 992) . That oestrogen stimulates the stromal expression of 
certain paracrine growth factors (Sirbasku, 1 978) is considered in respective sections of 
this review. 
Estrogen also increases progesterone receptor levels on epithelial cells when they are co­
cultured with mammary fibroblasts, an effect that may be mediated by stromal synthesis 
of type I collagen (Haslam and Levely, 1 985). This concurs with the findings of 
Sheffield and Anderson ( 1 984a, 1 984b) who showed that oestrogen stimulates the 
synthesis of collagen, DNA, and RNA by mammary fibroblasts. Such observations may 
be of direct physiological relevance to the developing mammary gland. Specifically, 
immature mammary epithelium which does not upregulate its progesterone receptor 
levels in response to oestrogen can prematurely acquire this type of oestrogen 
responsiveness upon transplantation to the mammary fat pad of a mature host (Haslam 
and Counterman, 1 99 1 ). It is not known, however, by what mechanism(s) the mammary 
fat pad initiates this effect. 
1.4.1.2 Local oestrogen biosynthesis 
In evaluating the mammogenic effects of oestrogen, it must also be recognised that 
mammary stromal cells can synthesise oestrogens from C19  steroids via an aromatase 
enzyme complex (reviewed by Simpson et al., 1 989). This likely accounts for the 
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higher levels of oestrogen measured around breast tumours (Bulun et al. , 1 993). Breast 
tumours may also exert a positive local feedback on stromal cell s  to induce an 
upregulation of aromatase activity (Schmidt and Laffler, 1 994a,b). However, the ful l  
extent to which locally synthesised oestrogens contribute to tumorous and normal 
mammary gland growth remains to be shown. 
1.4.1.3 The oestrogen receptor (ER) 
The pronounced effects of oestrogen on mammary cells are initiated via the ER. 
Synthesised in the cytoplasm, the ER resides in the nucleus where it forms a receptor­
ligand complex capable of interacting with oestrogen response elements in the vicinity 
of target gene promoters (Ciocca and Vargas Roig, 1 995) . The role of this receptor 
during mammary development is indicated by the fact that the mammary glands of mice 
lacking functional ERs are undeveloped except for the presence of vestigial ducts 
around the nipple (Korach, 1 994). Meanwhile, the finding that mammary glands from 
these mice develop upon transplantation to normal hosts in the presence of isografted 
pituitaries (S. Nandi, personal communication) suggests that deficiencies in such 
mechanisms may be compensated for by other hormones such as prolactin. 
By measuring l igand binding to cytoplasmic extracts, Haslam and Shyamala ( 1 98 1 ) 
determined that approximately 50% of the high affinity ERs within the mouse mammary 
gland are present in stromal cells .  Further investigations used steroid autoradiography 
(Daniel et al. 1 987; Haslam, 1 989) and immunocytochemistry (Haslam and Nummy, 
1 992) to localise the cellular expression of ERs within the mouse mammary gland. 
Only mesenchymal cells express ER within the foetal mammary gland. Within the 
virgin gland, cap cells, adipocytes and myoepithelial cells are consistently negative for 
ER while adjacent undifferentiated stromal fibroblasts are frequently positive. Luminal 
epithelium of the end bud and subtending ducts is ER positive. Within the ductal tree 
there is a gradient of ER level/binding capacity, where it is greatest in the nipple region 
and declines towards the end bud zones (Daniel et aI., 1 987). The proportion of ER 
positive epithelial and stromal cells is least at 3 days of age (7.8  and 4.4%, respectively) 
and increases during puberty to be the highest in the epithelium at 7- 1 0  weeks (20%), 
and at 6-7 weeks in the stroma ( 1 6.5%). However, further mechanisms must regulate 
the action of oestrogen as it only induces progesterone receptors in the mature gland 
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(Haslam, 1 988c); this may be achieved at the local level of the mammary fat pad 
(Haslam and Counterman, 1 99 1 ) .  
Multiple factors may regulate ER expression within the mammary gland. Treatment of 
ovariectomised mice with oestrogen generally results in down regulation of the number 
of ER positive epithelial and stromal cells, as does sialoadenectomy (Sheffield and 
Kotolski, 1 993). Levels of ER within the dog mammary gland are increased with age 
and during the luteal phase of the oestrous cycle (Donnay et al., 1 995). In vitro studies 
have demonstrated that dissociated epithelial cells possess functional ER that can be 
upregulated by prolactin (Edery et al., 1 984; Edery et al., 1 985). ER status is also 
widely used as a determinant for breast cancer therapy. Approximately 7% of cells are 
ER positive in normal breast tissue while approximately 70% of primary breast cancers 
are ER positive (Nicholson et aI., 1 995). Positive ER status favours a far greater 
response to therapeutic treatment. The involvement of variant forms of the ER 
(McGuire et al., 1 99 1 )  in normal and neoplastic mammary growth remains to be 
characterised. 
Although a requirement for oestrogen during mammogenesis is unequivocal, a great 
deal remains to be understood about the specific nature of its effects on the mammary 
gland, and the means by which these are exerted. Several l ines of strong, though 
indirect, evidence indicate that stromal constituents within the mammary fat pad may be 
important mediators of oestrogen action. Recent studies have shown that the mammary 
fat pad of ER negative mice does not support the growth of wild-type epithelium (G.R. 
Cunha, personal communication). This may be the first direct evidence that the 
mammary fat pad mediates oestrogen action on the mammary gland. Even once this 
requirement is confirmed, the downstream mode of action and the physiological 
implications of oestrogenic action on the mammary fat pad remain to be established. 
1.4. 1.4 Progesterone 
Although progesterone exerts a major influence on mammary gland development, the 
means by which it elicits its effects at the level of the mammary gland are not fully 
defined. The primary response to progesterone during recurrent oestrous cycles and 
pregnancy is the initiation of ductal branching and lobuloalveolar morphogenesis. 
Exogenous progesterone stimulates DNA synthesis in the ductal epithelium of mature, 
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but not immature, ovariectomised mice to promote ductal side-branch formation and the 
differentiation of terminal buds into alveoli (Bresciani, 1 968 ; Haslam, 1 988a; Haslam, 
1 989). Associated with this growth is an increase in stromal DNA synthesis (Haslam, 
1 989). Although the immature gland is unresponsive to acute progesterone treatment, 
Vonderhaar and Plaut ( 1 992) were able to increase DNA synthesis in the mammary 
epithelium of 4-week old mice after a prolonged 9-day treatment. The minimum 
requirement for ful l lobuloalveolar development in triply operated rodents is oestrogen + 
progesterone + adrenal corticoid + prolactin or growth hormone (Lyons et al., 1 958;  
reviewed by Imagawa et  al., 1 994), where the presence of both pituitary hormones 
facilitates greater development than either alone. 
Administration of progesterone to prepubertal heifers for 4 days did not stimulate DNA 
synthesis within mammary tissue (Woodward et al. , 1 993) .  Similarly, treatment of 
nulliparous, post-pubertal ewes with progesterone had no apparent effect on mammary 
development or morphogenesis, where progression to lobuloalveolar development 
required oestrogen + progesterone in the presence of endogenous prolactin (Schams et 
al. , 1 984). While the human breast displays maximal DNA synthesis during the luteal 
phase, it is unclear why breast tissue heterografted to mice is unresponsive to 
progesterone either alone or in the presence of oestrogen (Laidlaw et al. , 1 995). 
Moreover, the growth of mammary cancer cells is inhibited by progesterone; the reasons 
for this distinction are also unclear (Lippman and Dickson, 1 989; Elliott et al. , 1 992). 
The role of progesterone in branching morphogenesis has recently been confirmed by 
the fact that the mammary glands of mice lacking functional progesterone receptors only 
develop a ductal tree (Lydon et al. , 1 996). However, the ful l  extent of the response by 
the mammary fat pad to progesterone and progesterone-stimulated epithelial growth 
remain to be examined. 
What is clear from studies both in vivo and in vitro is that progesterone may largely act 
in concert with other mammogenic hormones. A primary example of this  is the 
synergistic effect of oestrogen + progesterone on epithelial proliferation in the mature 
mouse mammary gland (Traurig and Morgan, 1 964; Haslam, 1 988c). It has been 
proposed that this effect is due to an upregulation of epithelial progesterone receptors by 
oestrogen. Such a response is not inducible in the immature gland where progesterone 
actually suppresses the DNA synthetic effect of oestrogen. Of various combinations of 
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oestrogen + progesterone administered to nulliparous heifers, a 1 :250 combination 
induces mammary development equivalent to that seen at the 5th month of pregnancy 
(Sud et al., 1 968). 
This interactive effect is  also required to faci litate ful l  lobuloalveolar development in 
mammary gland organ culture. Specifically, immature mice must be primed with 
oestrogen + progesterone for a minimum of 6 days before their mammary glands are 
cultured in medium supplemented with EGF, or for 9 days when EGF is absent from the 
medium (Vonderhaar, 1 984). No development occurs in vitro when mice are primed 
with either oestrogen or progesterone alone, or when oestrogen and/or progesterone are 
instead added to the culture medium. This priming regimen may induce an upregulation 
of progesterone and EGF receptors and promote the local synthesis of transforming 
growth factor-a (Vonderhaar, 1 988). In contrast to immature mice, older mice and 
immature rats may not need priming before their glands are cultured (Forsyth, 1 97 1 ) . 
Progesterone also interacts with the mammogenic effect of prolactin to promote 
mammogenesis. Several reports have indicated that progesterone stimulates the growth 
(Edery et aI., 1 984; Imagawa et al., 1 985) and morphogenesis (Darcy et al., 1 995) of 
primary mammary epithelial cells in vitro, where in all cases this responsiveness 
required the combined presence of prolactin. These hormones synergise to increase 
epithelial progesterone receptor levels (Edery et al., 1 985) and epithelial proliferation in 
vitro (Edery et al. , 1 984) and in vivo (Stoudemire et al., 1 975). This co-stimulation by 
progesterone in the presence of other hormones is likely manifest within the oestrous 
cycle and during pregnancy when there are marked changes in the systemic temporal 
profi les of progesterone, oestrogen and prolactin. 
1.4.1.5 The progesterone receptor (PgR) 
The PgR is an intracellular receptor which can be transactivated by the ER, and consists 
of two ligand binding subunits which are rapidly translocated to the nucleus upon l igand 
binding (Haslam, 1987). Numerous studies have demonstrated that mammary epithelial 
cells express functional PgR both in vitro and in vivo (Edery et al., 1 985;  Haslam and 
Shyamala, 1 98 1 ), the levels of which can be substantially upregulated by oestrogen or 
the interactive effect of progesterone + prolactin (Edery et al., 1 985;  Haslam and 
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Shyamala, 1 979). In contrast, sialoadenectomy of mice suppresses the extent to which 
oestrogen induces the PgR (Sheffield and Kotolski, 1 993) . 
By measuring cytoplasmic binding, Haslam and Shyamala ( 1 98 1 )  found that 
approximately 20% of mammary PgR were present within the mammary fat pad and 
that, in contrast to epithelial PgR, levels of these receptors were unaffected by 
developmental state or exogenous oestrogen. Further studies demonstrated that the level 
of oestrogen-inducible PgR within the mouse mammary gland is age-dependent and 
increases markedly between 6 and 7 weeks of age (Haslam, 1 988c). Acquisition of this 
oestrogen responsiveness corresponds to an increase in mammary gland growth. 
Autoradiographic receptor studies demonstrated a heterogeneous presence of PgR in 
epithelial cells at this time, where prior to this age only stromal cel ls bound ligand 
(Haslam, 1 989). The significance of a distinct population of PgR in the mammary fat 
pad is not known, nor is their function during hormone-induced mammogenesis. There 
is also a subsequent decline in PgR levels in the mouse mammary gland with lactation 
(Haslam and Shyamala, 1 98 1 ). The level of mammary PgR in pregnant ewes increases 
to a maximum at day 1 1 5 and declines by day 140 (Smith et al. , 1 987). 
The ability of the mammary stroma to modulate epithelial expression of PgR has been 
investigated by Haslam in several studies. Using a monolayer co-culture system, she 
demonstrated that mammary fibroblasts facilitate oestrogenic induction of PgR by 
fulfill ing a physical requirement, possibly in the form of type I collagen (Haslam, 
1 988b). Further evidence for stromal regulation of PgR was provided by the finding 
that epithelium from immature donors acquired oestrogen-inducible PgR on 
transplantation to mammary fat pad tissue of mature hosts (Haslam and Counterman, 
1 99 1 ) . 
While it is likely that the mammogenic effect of progesterone is at least partly achieved 
by its direct action on the epithelial cel l ,  it is also possible that progesterone acts on the 
mammary fat pad to el icit several other effects. A role for this type of pathway is 
suggested by findings from studies in other tissues which indicate that the expression of 
certain stroma-derived growth factors is promoted by progesterone (Koji  et al. , 1 994). 
Likewise, the local environment of the mammary fat pad can alter PgR status of 
epithelial cel ls and, potentially, their progesterone responsiveness (Haslam and 
36 
Counterman, 1 99 1 ) .  The ful l  physiological implications of this mechanism during the 
course of mammary gland development remains to be determined. 
1.4.2 The pituitary hormones 
1.4.2.1 Prolactin (Prl) 
A wide body of evidence indicates a role for Prl during normal mammogenesis. 
Although a requirement for Prl during ductal development is unlikely, its involvement 
cannot be discounted. For example, ductal regression induced by hypophysectomy and 
ovariectomy of rats can be restricted by daily injections of Prl (Cole and Hopkins, 
1 962) . When administered to doubly-operated mature virgin rats, Prl stimulates a small 
increase in ductal and alveolar DNA synthesis and markedly synergises with the effects 
of oestrogen or progesterone (Stoudemire et al., 1 975). The parenchymal morphology 
associated with these responses was not described. The results of more recent studies 
have been unable to clarify the importance of Prl during ductal development. 
Silberstein and Daniel ( 1 987) reported that locally implanted homologous Prl stimulated 
end bud formation, whereas Kleinberg et al. ( 1 990) reported only minimal growth 
stimulation by Prl . 
The period of positive allometric mammary growth in prepubertal and pubertal heifers 
corresponds to increased pituitary Prl levels (Sinha and Tucker, 1 969b). In contrast, 
other studies which have investigated the influence of liveweight gain on mammary 
gland development of prepubertal lambs (Johnsson et aI., 1 985) and heifers (Sejrsen et 
al., 1 983) have reported a strong negative correlation between levels of serum Pr! and 
parenchymal growth during this period. Reasons for this negative association are 
intriguing and unknown. Furthermore, administration of bromocriptine to prepubertal 
ewe lambs had no effect on their mammary development (Johnsson et al., 1 986). 
Although unresolved, it is likely that there is only a limited role for Prl during ductal 
development, particularly compared to the stimulatory effects of growth hormone. 
A requirement for Pr! during lobuloalveolar growth is well  documented. Using triply­
operated rats and local hormone implants, Lyons et al. ( 1 958) established that the 
minimum requirement to initiate lobuloalveolar growth was oestrogen + progesterone + 
Pr! ; the inclusion of growth hormone facilitated maximum lobuloalveolar development. 
Prl alone cannot induce such growth, although Talwalker and Meites ( 1 96 1 )  did 
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demonstrate some ductal branching in response to Pr! in doubly-operated rats. Similar 
findings have been reported in mice, where Pr! alone does not induce substantial 
development, but promotes development to at least the extent seen in mid-pregnancy 
when administered with oestrogen + progesterone (Nandi, 1 958;  Vonderhaar, 1 984). It 
is also likely that the cyclic pattern of systemic Pr! levels that occurs during the oestrous 
cycle is reflected in the development of the virgin mammary gland (Lotz and Krause, 
1 978). However, it has not been determined to what extent the interactive effect of Prl, 
oestrogen and progesterone is initiated at the local level of the mammary gland, and 
what proportion of this combined effect is due to feedback pathways between the 
pituitary gland and the ovary. Although the function of Pr! in mammary cancer remains 
unknown, suppression of systemic Pr! levels in mice markedly reduces tumorigenic risk 
(Welsch and Gribler, 1 973) while the administration of Pr! increases the incidence of 
mammary tumours. A further aspect that will require careful consideration is the 
recently demonstrated local synthesis of Pr! by normal and tumorous mammary 
epithelium (Kurtz et al. , 1 993; Fields et al., 1 993 ; Mershon et al. , 1 995; Clevenger et 
al., 1 995). The physiological implications of this potentially important observation in 
the normal and cancerous mammary gland are yet to be detailed. 
A variety of in vitro studies have demonstrated that Pr! is required for the growth and 
morphogenesis of cultured epithelial cells (Ip and Darcy, 1 996), and that its effects 
interact with those of progesterone (Imagawa et al., 1 985). In contrast, the growth of 
cultured guinea pig mammary fibroblasts is inhibited by Pr! (Sheffield and Anderson, 
1 986). In vitro studies using whole gland organ culture have further indicated the 
requirement for Pr! during mammogenesis. Such studies have shown that ful l  
lobuloalveolar development of mammary glands from steroid primed donors requires 
the presence of insulin + aldosterone + Pr! either with or without growth hormone 
(Rivera, 1 964; Ichinose and Nandi, 1 966; Wood et aI., 1 975). Neither ovarian or 
pituitary hormones can induce this response alone, and their combination requires 
medium supplemented with insulin. The essentiality of Pr! for this development is 
indicated by the fact that if Prl is removed after the establishment of lobuloalveolar 
development, this lobuloalveolar development will fully regress (Banerjee et al. , 1 983 
cited by Vonderhaar, 1 987). 
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The primary physiological function of Prl appears to be its role in promoting 
lobuloalveolar development during pregnancy. Coitus in rodents initiates twice-daily 
surges of systemic Prl, the levels of which remain elevated for 8- 1 0  days (Forsyth, 
1 986), during which time the mammary gland undergoes extensive alveolar branching. 
Similar mammary development occurs in pseudopregnant rats during this period (Wrenn 
et al. , 1 966) . The importance of Prl in combination with oestrogen + progesterone is 
demonstrated by the fact that oestrogen + progesterone does not promote lobuloalveolar 
development when endogenous Prl is suppressed by bromocriptine (Delouis et al. , 1 980; 
Schams et al., 1 984). In most species there is a mid-gestational increase in the level of 
systemic placental lactogens which may suppress Prl levels. Mammary development 
that occurs after this hormonal switching can be maintained by placental lactogens in 
these species, and to a lesser extent by Pr! (Byatt et al., 1 994). The reduced importance 
of Prl for mammary growth in late pregnancy is indicated by the fact that the mammary 
gland of rats (Anderson, 1 975a), goats (Buttle et al., 1 979), and sheep (Schams et al., 
1 984) undergoes extensive development in the absence of Prl during this period, 
although a periparturient surge of Prl is required for full mammary differentiation and 
optimal milk synthesis (Akers et al., 1 98 1 a, 1 98 1 b) .  Prl may play a more important role 
during this latter phase of gestational mammogenesis in those species which apparently 
lack a placental lactogen (Forsyth, 1 986), except in pigs, where oestrogens may be of 
greater importance (DeHoff et al. , 1 986). 
1.4.2.2 The prolactin receptor 
Prl initiates its mammogenic and lactogenic effects by binding to cell-surface Prl 
receptors . It is assumed that Prl receptors only exist on epithelial cells within the 
mammary gland as Prl does not bind to membrane preparations from cleared mammary 
fat pads (Bhattacharya and Vonderhaar, 1 979), but does bind to isolated mammary 
epithelial cells (Sakai et al., 1 978). In another study, however, the growth of mammary 
fibroblasts in vitro was inhibited by Pr! (Sheffield and Anderson, 1 986), indicating that 
stromal cells may in fact possess Prl receptors. 
The Prl receptor exists in mouse mammary tissue as two distinct forms. One is 
classified as the short form, a 29 1 amino acid protein (approximate Mr 36 kDa) having a 
57 amino acid cytoplasmic domain. The second is the long form, a 592 amino acid 
39 
structure (approximate Mr 87 kDa) with extracellular and transmembrane regions very 
similar to the short form, but having a larger 358 amino acid cytoplasmic domain 
(Ormandy and Sutherland, 1 993). Rat mammary tissue contains approximately 70% 
short and 30% long forms of the Prl receptor (Kelly et al., 1 99 1 ) . Smith et al. ( 1 993) 
indicated that the short form was predominant in the ruminant mammary gland. A 
recent report has confirmed and extended previous studies concerning the biological 
signalling from these different Prl receptors. Using NllI 3T3 cell s  containing a Prl­
responsive casein-reporter construct that were transfected with either the long or short 
form of the Prl receptor, Das and Vonderhaar ( 1 995) demonstrated that both receptor 
types transmitted the mitogenic signal of Prl, while only the long form transmitted the 
lactogenic signal . This latter pathway may act to increase the transcription of milk 
protein genes via the family of ST AT transcription factors . 
A number of factors have been shown to regulate Prl receptor levels within the 
mammary gland. Of several developmental states, Sakai et al. ( 1 978) recorded the 
highest number of Prl receptor sites on mature virgin mouse epithelial cells; these also 
possessed the highest ligand affinity. Levels remained relatively low during pregnancy 
and increased in the first week of lactation. Similar findings have been reported in the 
rat (Jahn et aI., 1 99 1 ). Characterisation of mRNA levels for the short and long forms of 
the Prl receptor in the rat mammary gland indicated that the relative proportions of the 
two receptors did not change during this time (Jahn et al., 1 99 1 ) . In contrast to these 
findings in rodents, several studies in ewes (Akers, 1 985; N'Guema Emane et al., 1 986; 
Smith et al., 1 989a) have shown that mammary Prl receptor levels are markedly 
increased around 100- 1 1 5  days of gestation. Other factors may also regulate Prl 
receptor levels in mammary tissue (reviewed by Vonderhaar, 1 987b). For example, Prl 
induces upregulation of its receptor in mammary tissue while its levels are suppressed 
by bromocriptine. Progesterone and EGF have also been shown to decrease the number 
of Prl binding sites while ovariectomy increases the number of Prl receptors. 
Although recognised as a critical influence during mammary gland development and 
lactogenesis, a great deal remains to be understood about the mechanisms by which Prl 
evokes its effects. For example, it has been proposed that Prl indirectly promotes the 
release of fatty acids from adipocytes (Kid well and Shaffer, 1 984); these fatty acids may 
in turn enhance the growth of mammary epithelium. Along these l ines, it has been 
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shown that Prl upregulates levels of lipid-dependent protein kinase C within mammary 
epithelial cells (Banerjee and Vonderhaar, 1 992), a signalling molecule which can 
enhance the responsiveness of epithelial cells to mitogens such as EGF (Bandyopadhyay 
et al. , 1 993). The physiological relevance of these local growth regulatory pathways and 
the specific involvement of Prl remains to be elucidated. Extensive interest is also being 
directed towards the mechanism by which Prl elicits marked alterations in milk protein 
transcription within mammary epithelial cells. 
1.4.2.3 Growth hormone (GB) 
In addition to its wel1 established galactopoietic properties which have been exploited in 
dairy production (reviewed by Burton et al. , 1 994), GH is an important regulator of 
mammary gland development. Studies by Flux ( 1 957) showed that ovariectomised mice 
treated with daily injections of GH had increased ductal development, and that this 
effect could be further potentiated by oestrogen. Using triply-operated rats, Lyons et al. 
( 1 958) demonstrated that the duct-promoting effects of GH required the presence of 
either oestrogen or adrenal corticoid, and that maximum ductal growth only occurred in 
the combined presence of GH + oestrogen + adrenal corticoid. More recently, 
Kleinberg et al. ( 1 990) and Feldman et al. ( 1 993) showed that the stimulation of ductal 
development by GH involved its direct, local action via the GH receptor. These 
findings, together with the demonstration that GH upregulates local IGF-I rnRNA (Ruan 
et al., 1 995), and that 10cal1y released IGF-I can mimic the mammogenic effect of GH 
(Ruan et al. , 1 992), have led to the proposal that GH stimulated mammogenesis is 
mediated by local IGF-I synthesis. However, the full physiological contribution of such 
a mechanism during the course of mammogenesis remains to be characterised. 
Administration of GH to prepubertal and pubertal ewe lambs (Johnsson et al., 1 986; 
McFadden et aI., 1 990a) and heifers (Sejrsen et aI., 1 986; Purup et al., 1 993b) results in 
substantial stimulation of mammary parenchymal development, although the resultant 
parenchymal morphology has not been described. A report by Sandles et al. ( 1 987) 
showed that this enhanced development did not translate to increased milk yield, 
although other trials have shown that prepubertal heifers treated with GH have increased 
liveweight gain and milk production (RJ. Collier, personal communication). Systemic 
levels of IGF-I in ruminants are elevated by the administration of GH, as well as by a 
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high plane of nutrition. This latter treatment frequently corresponds to a reduction in 
mammary gland development, suggesting that the mammogenic effect of GH in 
ruminants is realised via mechanisms other than systemic IGF-I. Likewise, a direct 
action of GH on mammary epithelium would appear unlikely as ruminant mammary 
epithelial cells apparently do not bind GH (Akers, 1 985;  McFadden et al., 1 990). The 
local synthesis of IGF-I in response to GH is unknown, although the expression of IGF-I 
mRNA in mammary parenchyma after GH treatment depends upon the rate of 
liveweight gain (Weber et al., 1 996) . Further studies are needed to fully determine the 
local expression of IGF-I (insulin-like growth factor-I) within the mammary gland and 
its response to GH treatment. 
The role of GH in lobuloalveolar development is not fully defined. Lyons et al. ( 1 958) 
reported that the combination of oestrogen + progesterone + Prl promoted 
lobuloalveolar growth in rats, although maximal development was realised only when 
GH was also administered. An involvement of GH in regulating lobuloalveolar growth 
is also suggested by the finding that the mammary glands of mature virgin mice which 
overexpress hGH are developed to an extent typical of that seen at days 1 4- 1 5  of 
pregnancy (Bchini et al., 1 99 1 ). In whole gland organ culture, Plaut et al. ( 1 993) 
demonstrated that GH was able to substitute for Prl as a promoter of lobuloalveolar 
development, although at a somewhat higher concentration ( 1  Jlg/ml). Taken together, 
these findings suggest that GH is involved in promoting lobuloalveolar development. 
This may be further supported by the fact that the administration of GH to pregnant rats 
(Kumaresan and Turner, 1 966) and prepartum ewes and heifers (Stelwagen et al. , 1 992; 
Stelwagen et al., 1 993) increases mammary development. The relative importance of 
GH during gestational mammogenesis has not been widely investigated, probably 
because GH levels in the maternal circulation remain relatively constant until they 
increase in the periparturient period. 
A further finding is that progesterone, also known to promote lobuloalveolar growth, 
induces a dramatic upregulation of GH expression in the mammary epithelium of dogs 
(Selman et al., 1 994; Mol et al., 1 995). It will be interesting to elucidate the 
physiological significance of such a finding. 
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1.4.2.4 The growth hormone receptor 
The mechanism by which GH initiates its effect on the developing and lactating 
mammary gland and the role for a GH receptor has been the subject of extensive debate. 
Prompting this has been the inability of several groups to demonstrate the binding of 
radiolabelled GH to mammary parenchyma from cows (Akers, 1 985) and sheep 
(McFadden et al., 1 990b). However, other studies util ising approaches such as 
immunocytochemistry, in situ hybridisation, and Northern analysis have indicated that 
rat (Lincoln et al., 1 990; Lincoln et al., 1 995), bovine (Glimm et al., 1 990; Hauser et al., 
1 990), rabbit, ovine and porcine (J ammes et al. , 1 99 1 )  mammary tissue does express 
GH receptor protein or mRNA which localises to mammary epithelial and stromal cells. 
Although these findings suggest the presence of GH receptors within the mammary 
gland, evidence to support their physiological function is lacking. The only evidence 
along these lines is that GH implants can locally stimulate mammogenesis via a 
mechanism independent of the Pr! receptor (Feldman et al., 1 993). The likely cellular 
target for GH within the mammary gland is not known. Even if epithelial cells do not 
possess functional GH receptors, other cell types present within the mammary gland 
such as fibroblasts and adipocytes can bind GH (Kelly et al., 1 99 1 ) . Hence, these 
constituents may mediate the actions of GH by the local synthesis of paracrine factors 
such as IGF-I (Ruan et aI., 1 995). Along these lines, the proliferation of mammary 
fibroblasts is stimulated by GH in vitro (Sheffield and Anderson, 1 986). Obviously 
further investigation needs to be conducted before the mechanism by which GH acts on 
the mammary gland is resolved. 
1.4.3 The placental lactogens (PLs) 
The mammogenic and lactogenic effects of the placenta by its synthesis of PLs has been 
the subject of considerable interest. Emerging evidence indicates that there may be 
substantial across-species variation in both the structure and physiological role of the 
PLs. For comprehensive reviews of this topic the reader is referred to articles by Bremel 
and Schuler ( 1 987), Thordarson and Talamantes ( 1 987), and Forsyth ( 1 994). 
A placental influence on gestational mammogenesis was suggested by the results of 
several early studies. Pregnant and pseudopregnant female rats displayed similar 
mammary development to day 1 2  of pregnancy, after which only pregnant females 
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demonstrated continued mammary growth (Wrenn et al. , 1 966). Furthermore, 
mammary development in the latter part of pregnancy was dependant upon the presence 
of the placenta, but not the foetal units (Desjardins et al. , 1 968). Anderson ( 1 975a) 
made a similar observation in hypophysectomised rats and demonstrated that the 
placenta, but not the pituitary, was required for maximal mammogenesis in the second 
half of pregnancy. Similarly, mammogenesis in goats (Buttle et al. , 1 979), ewes and 
heifers (Schams et al., 1 984) during the latter half of pregnancy is largely independent 
of Prl or pituitary hormones. Additional evidence for placental regulation of 
mammogenesis is provided by the fact that a positive relationship exists between the 
number of offspring and milk yield in goats and sheep (Forsyth, 1 986). Furthermore, 
several different assay systems indicated that placental extracts contained substantial 
lactogenic activity (Forsyth, 1 967) .  
The PLs are members of the GH/Prl family which were initially characterised by their 
ability to bind to both GH and Prl receptors. It has been shown more recently that there 
is species diversity within this family of hormones, where PL in humans bears a high 
homology to GH (85%) and a low homology to Prl (27%), while PL in ruminants has 
higher homology to Prl (49%) than GH (28%) (Forsyth, 1 994). Furthermore, whereas 
bovine PL is a glycosylated protein of 32 kDa Mr, the primary PL in other species is a 
non-glycosylated molecule of approximately 22 kDa Mr. 
Two distinctive PL activities have been recorded in rodents during pregnancy. The level 
of a larger glycosylated PL-I (29 to 42 kDa Mr) increases from day 6 to a maximum on 
day 1 0, and rapidly declines to remain at a basal level after day 1 3 . In contrast, the level 
of the smaller non-glycosylated PL-ll increases on day 9 and remains elevated 
throughout the remainder of gestation (Thordarson and Talamantes, 1 987). Levels of 
PL-ll are also increased in response to hypophysectomy in late gestation. Plasma PL 
levels in sheep begin to increase around day 50 of gestation and reach maximum levels 
just prior to parturition (Handwerger et al., 1 977). In contrast, only extremely low 
levels of bPL are found in the maternal serum of cows across the course of gestation 
(Bremel and Schuler, 1 987). Across a range of species, maternal serum PL levels are 
correlated with the number of foetuses in utero (Thordarson and Tal amantes , 1 987; 
Byatt and Forsyth, 1 983) 
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Although there is convincing evidence to support a role for PL during mammogenesis 
and lactogenesis, the extent of its effects and the means by which it initiates these are 
largely unknown. Administration of recombinant bPL to steroid-treated heifers 
stimulated substantial increases in mammary gland development (Byatt et al. , 1 994). 
Collier et al. ( 1 995) suggest that bPL stimulates mammary growth via an indirect 
mechanism given their finding that bPL does not stimulate the growth of cultured 
bovine mammary epithelial cells (Collier et al. , 1 993). PL may initiate its mammogenic 
effect by a mechanism similar to GH, for oPL binds with high affinity to a somatogenic 
site in ovine mammary tissue that is competed for by various GHs but not Pr! (N' guema 
Emane et aI., 1 986). One potential mechanism may involve the local synthesis of IGFs 
by the stromal constituents of the mammary gland. It is obvious that a great deal more 
needs to be understood about the specific targets of PL within the mammary gland 
before its mechanism of action can receive thorough investigation. Likewise, several 
studies have shown that PL has lactogenic effects in vitro (Thordarson et al. , 1 986; 
Forsyth, 1 994) and in vivo (Byatt et al. , 1 994), although once again ,  the mechanism by 
which this response is effected remains to be fully determined. 
1.4.4 Plane of nutrition 
1.4.4.1 Rodents 
In contrast to that in ruminants, rodent mammogenesis is positively correlated with 
caloric intake. Female mice fed high calorie diets to 8 and 1 8  weeks of age 
demonstrated larger mammary fat pads and increased ductal development compared to 
controls, while mice fed a low calorie diet had smaller fat pads and less mammary 
development (McFadden et aI. , 1 988). Engelman et al. ( 1 993 ; 1 994) showed that 
caloric restriction suppressed the proliferation of mammary epithelium in virgin mice. 
Furthermore, 8 weeks of peripubertal caloric restriction afforded significant protection 
from spontaneous tumorigenesis while tumour risk was further reduced by sustained 
caloric restriction. Similar findings relating tumorigenic risk to caloric intake have also 
shown a positive correlation between caloric intake and serum Pr! levels (Sarkar et al., 
1 982; Engelman et al., 1 993). Further studies indicated that total caloric intake had a 
greater influence on mammary tumorigenesis than the proportion of fat which 
contributed to dietary energy (Engelman et al., 1 990) . 
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1.4.4.2 Ruminants 
Rearing heifers for dairy production seeks to develop a female capable of yielding large 
volumes of milk; economic considerations generally make it desirable for these animals 
to enter the herd at the earliest possible age. An early conception may be realised by 
promoting high rates of prepubertal and pubertal Iiveweight gain. However, such gains 
may impair mammogenesis and subsequent milk yield potential (reviewed by Sejrsen, 
1 994). 
Using identical twins, Swanson ( 1 960) demonstrated that the reduced lactational 
performance of heifers fed a high level of concentrate was associated with an 
impairment of mammogenesis. Since this study, numerous reports have shown that 
accelerated liveweight gain during prepuberty and puberty has a detrimental effect on 
the subsequent milk yield from dairy heifers (Plum and Harris, 1 968; Little and 
Harrison, 1 98 1 ;  Valentine et ai., 1 987; Peri et al., 1 993). This effect is essentially non­
reversible and remains in subsequent lactations (Swanson, 1 960; Little and Kay, 1 979). 
The milk production potential of ewes (Gould and Whiteman, 1 975; Umberger et al., 
1 985; McCann et ai., 1 989) and beef heifers (Johnsson and Obst, 1 984) is similarly 
compromised by high rates of l iveweight gain. 
The resultant effect on mammogenesis is a reduced amount of total mammary 
parenchyma and parenchymal DNA in heifers (Sejrsen et al. , 1 982; Harrison et al., 
1 983;  Petitclerc et al., 1 984; Capuco et ai. , 1 995), ewes (Johnsson and Hart, 1 985) and 
goats (Bowden et ai., 1 995). The mammary gland is larger and heavier due to extensive 
fat deposition in the mammary fat pad which leads to a far greater volume of the gland 
being occupied by adipocytes. Whether these dramatic changes within the mammary fat 
pad directly impair the growth of the mammary parenchyma is unknown. Some recent 
studies have been unable to demonstrate a negative effect of excessive nutrition on 
mammary development in heifers (Stelwagen and Grieve, 1 990; Capuco et al. , 1 996) . 
Reasons for the absence of such an effect are not always obvious but may reflect the 
experimental design, or that heifers selected for high growth rates and milk production 
become refractory to the negative effects of high Iiveweight gain on mammary 
development. 
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The exact timing at which a high plane of nutrition affects mammary gland development 
remains uncertain.  The findings of several studies strongly suggest that these negative 
effects are exerted during a phase of allometric growth prior to and during the first 
oestrous cycles; this concurs with results from other studies showing no effect of rapid 
gain during isometric mammary growth in puberty (Sejrsen et al., 1 982; Lacasse et al., 
1 993) or during gestation (Valentine et al., 1 987). Emerging evidence indicates that this 
effect may actually be realised much earlier than puberty at a period around weaning (S. 
Purup, personal communication). This suggestion is not surprising as the mammary 
gland is l ikely to become sensitive to any adverse effects of excess nutrition at the same 
time that it commences positive allometric growth at around 2-3 months of age. 
The actual rate of liveweight gain and the composition of the diet may also determine 
the impact that the plane of nutrition has on mammogenesis. Based on the results from 
a wide range of studies, Sejrsen ( 1994) concluded that virgin heifers fed to an average 
l iveweight gain in excess of 600-700 g/day are susceptible to impaired mammary 
development. It is suggested that the primary cause of this effect is in fact excess energy 
intake, and that an adequate energy to protein ratio can permit higher gains without 
negative effects on the mammary gland (Capuco et al., 1 995). Such a relationship 
remains to be fully assessed. Recent studies indicate that a diet high in protein does not 
affect mammary development (Mantysaari et al., 1 995; Zhang et al., 1 995). At a 
restricted rate of gain there is no effect of dietary energy concentration on subsequent 
mammary growth (Sejrsen and Foldager, 1 992) . 
The mechanism(s) underlying the adverse effect of a high plane of nutrition on 
mammogenesis is unknown. The most likely explanation appears to be a suppression of 
the somatotrophic axis by a high liveweight gain, where the amount of parenchyma in 
the mammary gland is positively correlated to GH levels (Sejrsen et al., 1 983 ;  Sejrsen 
and Foldager, 1 992) . However, the mechanisms by which GH initiates its actions are 
not yet known. The proposal that GH acts via systemic IGF-I is disproven by the fact 
that plasma IGF-I levels are elevated in heifers with a high rate of liveweight gain (Peri 
et al., 1 993 ; Capuco et al., 1 995). However, this increase may be offset by the fact that 
mammary epithelium from heifers fed a high plane of nutrition is less responsive to the 
mitogenic effect of IGF-I (Wbeatley et al. , 1 988;  Purup et al., 1 996) . Likewise, the 
local synthesis of IGF-I and IGF-BPs may be important considerations in this  effect 
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(Weber et al., 1 996) although the actual levels of IGF-I within the mammary gland have 
not been reported. Furthermore, the involvement of other mammogens such as Prl and 
insulin, the profiles of which are also altered by plane of nutrition (Johnsson et al., 
1 985;  Sejrsen et al., 1 983), and growth factors locally synthesised within the mammary 
gland, remains to be investigated. 
1.4.5 Dietary fat 
1.4.S.1 1n vivo studies 
Dietary fat can substantially influence mammary gland development, where both the 
level and composition of dietary fat is reflected in the lipid composition of the 
mammary gland. A requirement for essential fatty acids (EF A) during mammogenesis 
was indicated by the results of Knazek et al. ( 1 980) and Miyamoto-Tiaven et al. ( 1 98 1 ) . 
Mice fed an EFA-deficient diet from birth had impaired ductal and alveolar 
development, while already-established alveolar growth underwent regression if this 
treatment was initiated after weaning. This effect could be prevented if mice were 
administered S.c. injections of linoleic acid. Using epithelium transplanted to hosts fed 
EF A deficient diets, Faulkin et al. ( 1 986) indicated that mammary growth was only 
suppressed when the EFA-deficient diet was initiated prepubertally and that this 
negative effect may be at least partly due to an impairment of ovarian function. 
The level of dietary fat influences mammary development and tumorigenesis in 
laboratory rodents (reviewed by Welsch, 1 985; 1 992), and is positively correlated with 
the incidence of human breast cancer. Numerous studies have shown that the growth of 
spontaneous, chemical ly-induced, transplantable and metastatic mammary tumours is 
increased with the quantity of fat ingested and the length of time that a high fat diet is 
consumed. The stimulatory effect of excess dietary fat is most apparent after tumour 
induction, suggesting that this response is initiated at the promotional stage of 
tumorigenesis (Jp and Sinha, 1 98 1 ). There does not appear to be a particular age 
relative to puberty at which the cancer-promoting effect of high fat diets is increased 
(Silverman et al., 1 989). In contrast, the response of tumours to the suppressive effect 
of dietary fat restriction differs in pubertal and mature mice (lp and lp, 1 980) . In mice, 
Welsch and Q'Connor ( 1989) showed that normal mammary development in vivo and in 
vitro was increased as the fat content of the diet increased from 0 to 5 to 20%. This did 
48 
not, however, correspond to any appreciable effect of dietary fat concentration on 
epithelial responsiveness to the mammogenic effects of oestrogen + progesterone. 
Dietary fat composition also substantially alters mammary development. Immature 
mice fed a diet supplemented with menhaden oil (rich in long chain n-3 fatty acids) have 
suppressed ductal development while a diet supplemented with corn oil (high levels of 
1 8 : 1  and 1 8 :2) promotes mammary gland growth (Welsch and O'Connor, 1 989). 
Similar findings have been reported in studies of experimental tumorigenesis, where 
high levels of polyunsaturated fats enhance, and long chain n-3 fatty acids restrict, 
mammary tumour development (Karmali et al. , 1 984; Abou-El-Ala- et al. , 1 988). 
Similar results have been recorded in sheep, where high levels of protected 
polyunsaturated fats fed to prepubertal ewe lambs increases the amount of mammary 
parenchymal tissue (McFadden et al., 1 990a). 
1.4.5.2 Mechanisms of dietary fat influence 
The means by which dietary fat influences mammary cell proliferation has been the 
subject of extensive investigation and has led to the proposed involvement of several 
different pathways at the cellular level (reviewed by Welsch, 1 985; Welsch, 1 987). In 
addition, high fat diets may act systemically to stimulate the secretion of thyroid 
hormone and Prl which might subsequently promote mammogenesis. 
Several studies have demonstrated that the in vitro proliferation of normal and 
neoplastic mammary epithelial cells is stimulated by unsaturated fatty acids while 
saturated fats are inhibitory or without effect (Kidwell et al., 1 978; Wicha et al., 1 979; 
Beck et al., 1 989). Epithel ial cells within the mouse mammary gland are able to utilise 
fatty acids sequestered from adipocytes of the mammary fat pad (Bandyopadhyay et al., 
1 995). This corresponds to the finding that the proportions of unsaturated fatty acids in 
the rat mammary gland correspond to the concentration optimums required for these 
fatty acids to induce epithelial growth in vitro (Wicha et al., 1 979; Kidwell et al. , 1 982). 
Furthermore, the proliferative effect of medium conditioned by mammary fat pad tissue 
on mammary epithelial cells can be simulated by unsaturated fatty acids (Beck and 
Hosick, 1 988; Beck et al. , 1 989). In addition, epithelial cells can influence l ipid 
metabol ism within mammary adipocytes (Elias et al., 1 973; Lucas et al., 1 976; Bartley 
et al., 1 98 1 ). Kidwell and Shaffer ( 1984) proposed a mechanism whereby Prl-
49 
stimulated epithelial cells could induce the release of histamine from adjacent mast cells 
to act on mammary adipocytes and stimulate their liberation of free fatty acids. This is 
consistent with the recent immunocytochemical demonstration of histamine expression 
by mast cells within the mammary gland (Maslinski et al., 1 993). While these 
suggestions propose that unsaturated fatty acids from mammary adipocytes can 
influence the growth of the adjacent mammary epithelium, no direct evidence exists in 
support of such involvement within the mammary gland. Likewise, the relative 
importance of such a mechanism during various stages of development and its 
interrelationship with other growth regulatory pathways has not been widely 
investigated. 
There are several possible mechanisms by which fatty acids may influence cell growth. 
One such pathway involves local prostaglandin synthesis. It has been demonstrated that 
mammary prostaglandin levels are elevated in rodents fed high fat diets, and that 
prostaglandin levels and tumour growth can be reduced by feeding the cyclooxygenase 
inhibitor, indomethacin (Carter et al., 1 983; Kollmorgen et aI., 1 983). Likewise, rats 
fed diets high in n-3 fatty acids, which competitively inhibit cyclooxygenase, have lower 
tumour prostaglandin levels and tumorigenic risk (Karmali et aI., 1 984) . Furthermore, it 
has been shown that cultured rat mammary preadipocytes synthesise high levels of PGE2 
which is mitogenic for cultured mammary epithelial cells (Rudland et al. , 1 984). 
Mammary epithelial cells can also process 1 8 :2 and 20:4 fatty acids into prostaglandins 
(mainly PGE2) and other eicosanoid derivatives such as hydroxyeicosatetraenoic acids. 
These products can enhance the proliferation of mammary cells in response to EGF in 
vitro, possibly by upregulating the cAMP-dependent protein kinase A (Bandyopadhyay 
et al., 1 987; Bandyopadhyay et aI., 1 988;  Imagawa et aI., 1 988). 
Another mechanism by which unsaturated fatty acids may promote cell proliferation is 
by upregulating levels of protein kinase C, a lipid dependent second messenger involved 
in growth factor receptor signalling (Bandyopadhyay et al., 1 993 ; Sylvester et al., 1 994). 
Along these lines, it has been demonstrated that levels of protein kinase C within the 
mammary gland are developmentally and hormonally regulated (Caulfield and Bolander, 
1 986; Holladay and Bolander, 1 986). As well as stimulating mitogenesis, unsaturated 
fatty acids can also modulate other aspects of mammary cel l  function including cell 
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migration (Connolly and Rose, 1 993), ER function (Borras and Leclercq, 1 992) and 
casein synthesis (Levay-Young et al., 1 987). 
Obviously there exists the potential for adipocytes of the mammary fat pad to modulate 
the function of the neighbouring epithelial cells by modifying their l ipid environment. 
The means by which lipid metabolism in the mammary fat pad is regulated, and the 
extent to which this subsequently modifies the response of epithelial cells to other 
growth regulatory influences, remains to be determined. 
1.4.6 Peptide growth factors 
1.4. 6.1  The insulin-like growth factors (lGFs) 
Structurally related to insulin, the insulin-like growth factors IGF-I and -IT are single 
chain, 70 and 67 amino acid polypeptides of Mr 7650 and 7470 Da, respectively (Sara 
and Hall ,  1 990). While the liver is the primary source of circulating IGFs, a wide range 
of studies indicate that local IGF synthesis may be particularly important for the growth 
and differentiation of a variety of tissues (Cohick and Clemmons, 1 993 ; Jones and 
Clemmons, 1 995). That the expression and synthesis of IGF-I in both hepatic and local 
sites is upregulated by GH has led to the general belief that the actions of GH are 
mediated by IGF-I (Jones and Clemmons, 1 995). 
1 .4.6. 1 . 1 IGF-I 
Numerous in vitro studies have demonstrated that IGF-I is a potent mitogen for primary 
and cell line epithelial cells derived from normal rodent (Imagawa et al., 1 986), ovine 
(Winder et al., 1 989) and bovine (Baumrucker and Stemberger, 1 989) mammary tissue, 
as well as for human mammary tumour cells (Ell is et al., 1 994). Also, it is likely that 
the mitogenic effect of supraphysiological concentrations of insulin is initiated via the 
IGF-I receptor (Imagawa et al. , 1 986). The ability of IGF-I to stimulate epithelial 
growth in vivo is indicated by the fact that infusions and local implants of IGF-I and des­
IGF-I promote extensive ductal and alveolar development in hypophysectomised, 
castrated, oestradiol-treated prepubertal male rats (Ruan et al., 1 992) while 
intramammary infusion of IGF-I stimulates mammary development in pregnant cows 
(Collier et al., 1 995). 
5 1  
Only a limited number of reports provide information regarding the physiological role of 
IGF-I during mammogenesis. In situ hybridisation and immunocytochemistry studies 
have revealed that stromal cells express IGF-I in the human breast (Ell is et al., 1 994) 
and in the foetal ovine (Morgan et al., 1 996) and lactating bovine (Glimm et al., 1 988) 
mammary gland. These findings correspond to demonstrations that stromal cell s  
isolated from human breast (Singer et  aI. , 1 995) and pregnant bovine mammary gland 
(Hauser et al., 1 990) express IGF-I mRNA. Intriguingly, Marcotty et al. ( 1 994) 
immunolocalised IGF-I to myoepithelial cells of pregnant and lactating rat mammary 
tissue. Whereas rat (Lavandero et al., 1 99 1 )  and bovine mammary explants synthesise 
and secrete IGF-I, isolated acini cultures only secrete IGF-I (Campbell et al. , 1 99 1 ), a 
difference that may represent the stromal synthesis of IGF-I. Stromal IGF-I mRNA 
expression within the human breast is locally upregulated by normal epithelium and 
downregulated by tumorous epithelium (Singer et al., 1 995; Ellis et al., 1 994). 
Levels of IGF-I mRNA in the rat mammary gland decrease during gestation (Marcotty et 
al., 1 994). This decline may partly reflect RNA dilution by milk protein and epithelial 
RNA, as IGF-I secretion by mammary explants is elevated in late pregnancy and 
lactation (Lavandero et al., 1 99 1 ). A similar pattern of IGF-I mRNA and protein 
expression has been shown in the pregnant pig mammary gland (Lee et al. , 1 993). 
There have been no detailed reports of IGF-I rnRNA or protein levels in the virgin 
mammary gland during the course of development. 
Studies of impaired mammogenesis in ruminants fed a high plane of nutrition have 
found no correlation between mammary development and circulating levels of IGF-I 
(Capuco et aI. , 1 995). This effect may instead represent a reduced sensitivity of 
mammary tissue to the mitogenic effect of IGF-I (Wheatley et al., 1 988 ;  Purup et al., 
1 996). Abundance of IGF-I rnRNA within the mammary parenchyma is reduced by a 
high plane of nutrition, an effect which interacts with that of exogenous GH (Weber et 
al., 1 996) . The associated expression of IGF-I rnRNA within the adjacent mammary fat 
pad remains to be determined. Likewise, it is not known whether the responsiveness of 
mammary epithelial cells to IGF-I is modulated by other locally- or systemically-derived 
factors. 
Evidence does exist to support the proposal that locally synthesised IGF-I mediates the 
mammogenic effect of GH. Kleinberg et al. ( 1 990) demonstrated that GH, but not Prl, 
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increases local IGF-I mRNA expression and mammary development In 
hypophysectomised, castrate male rats. In a further study using hypophysectomised, 
ovariectomised prepubertal female rats, Ruan et al. ( 1 995) showed that oestrogen 
upregulates GH induced IGF-I mRNA expression within the mammary gland, and also 
enhances the mammogenic effects of IGF-I and des-IGF-1. This latter effect may 
coincide with oestrogen-induced upregulation of the IGF-I receptor (Daws et al. , 1 996) . 
In contrast, IGF-I mRNA expression in lactating bovine mammary parenchyma is either 
unaltered (Sharma et al., 1 994) or decreased (Glimm et al. , 1 992) in response to 
exogenous GH. GH induces the expression of an immunoreactive IGF-I within the 
alveolar cells of lactating tissue (Glimm et al. , 1 988), although the full nature of this 
response has not been examined. Overexpression of a des-hIGF-I construct in the 
mammary glands of lactating mice led to ductal hypertrophy, increased collagen 
deposition and impaired involution in the mammary gland (Hadsell et al., 1 996) . In 
another study, overexpression of oIGF-I driven by the MMTV promoter stimulated 
mouse mammary gland development and IGF-I expression in milk (Weber et aI., 1 996). 
The findings of such overexpression studies need to be carefully evaluated, however, as 
the mammary gland consequently becomes exposed to an extremely high level of IGF-I 
which is being atypically expressed by the mammary epithelium. 
1.4.6. 1 .2 The IGF-I receptor 
The IGF-I receptor is a heterotetramer which consists of two ligand-binding a subunits 
and two � subunits with a tyrosine kinase activity which stimulates receptor 
autophosphorylation (Pessin, 1 994). The IGF-I receptor bears structural similarity to the 
insulin receptor. Post-receptor signalling may utilise several pathways including MAP 
kinases and the formation of phosphatidylinositol-3 phosphate (lones and Clemmons, 
1 995). IGF-I has a 2- to 1 5-fold greater affinity for the IGF-I receptor than does IGF-IT. 
While a truncated form of IGF-I, des-IGF-I, has a reduced affinity for the IGF-I receptor, 
it stimulates a greater proliferative response by mammary epithelial cells (Collier et al. , 
1 989) . 
Studies investigating the role of the IGF-I receptor within the mammary gland of various 
species show that normal and tumorous mammary epithelial cells express mRNA for the 
IGF-I receptor (Cullen et al., 1 990; Glimm et aI., 1 992) and possess high affinity ligand 
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binding sites (Lavandero et al. , 1 99 1 ;  Zhao et al. , 1 992; Collier et al. , 1 989). A positive 
correlation exists between the levels of receptors for IGF-I, oestrogen and progesterone 
in cancerous breast tissue (Pekonen et al. , 1 988). IGF-I receptor mRNA localises to 
epithelial cells in the foetal and prepubertal ovine mammary gland, its expression being 
greatest at 4 weeks of postnatal age (Morgan et al. , 1 996). Specific binding of IGF-I to 
mammary parenchymal tissue of heifers is unaltered by exogenous GH and is slightly 
increased by ovariectomy (Purup et al., 1 995). In the rat (Collier et al., 1 989), ovine 
(Disenhaus et al., 1 988; Winder et al., 1 993) and bovine (DeHoff et aI., 1 988) 
mammary gland there is an overall decrease in the number of IGF-I binding sites across 
pregnancy and into lactation along with a concomitant rise in IGF-I binding affinity .  
1 .4.6. 1 .3 IGF-II 
The role of IGF-ll during postnatal mammogenesis is even less well-defined than that of 
IGF-I. The primary mitogenic effect of IGF-ll is likely initiated through the IGF-I 
receptor. Although an initial report by Imagawa et al. ( 1 986) indicated that IGF-ll did 
not stimulate the growth of cultured mouse mammary epithelial cells, subsequent 
studies have shown that IGF-ll does, to a lesser extent than IGF-I, promote the 
proliferation of mouse (Riss and Sirbasku, 1 987), ovine (Winder et al., 1 989) and 
bovine (McGrath et al., 1 99 1 )  mammary epithelium and human breast cancer cell s  (Ellis 
et al., 1 996b). Overexpression of IGF-ll in MCF-7 cells results in an altered growth 
morphology, a loss of contact inhibition and their attainment of an anchorage­
independent growth characteristic (Cullen et al. , 1 992). This may correspond to the 
recent demonstration that overexpression of IGF-ll in the mouse mammary gland 
induces the formation of mammary tumours (Bates et al., 1 995). 
It is likely that IGF-ll locally synthesised within the mammary gland exerts its effects 
via paracrine/autocrine action. Morgan et al. ( 1 996) localised IGF-ll mRNA to the 
stroma of foetal and postnatal ovine mammary tissue. A Iow level of IGF-ll mRNA is 
expressed in the stroma of the human breast, where its expression is markedly 
upregulated in the presence of invasive breast tumours (EIIis et aI., 1 994). This 
response is probably elicited by soluble factors secreted by the cancer cells (Singer et 
al., 1 995). IGF-ll may also be expressed at Iow levels by the neoplastic breast 
epithelium itself (Osbome et aI., 1 989). 
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Essentially nothing is known about the influence of IGF-ll on the developing mammary 
gland. IGF-ll mRNA expression in NMU-induced rat mammary tumours is reduced by 
ovariectomy and can be restored by hormone repletion (Manni et al., 1 994). Oestrogen 
also increases the expression of IGF-ll by breast cancer cells (Westley and May, 1 994). 
The abundance of IGF-ll mRNA in foetal ovine mammary tissue increases with 
embryonic age and is reduced in 4-week postnatal and adult mammary tissue (Morgan et 
al. , 1 996) . The level of IGF-ll mRNA in the pig mammary gland generally declines 
during gestation (Lee et al. , 1 993) . 
While l ittle is known about the function of locally expressed IGF-ll during 
mammogenesis, it is tempting to speculate from these few reports that the local 
synthesis of IGF-ll by the mammary stroma may be an important factor in controlling 
normal and neoplastic mammary development. 
1 .4.6. 1 .4 The IGF-l/ receptor 
The IGF-ll receptor is the mannose-6-phosphate receptor which is also involved in 
lysosomal transport (Braulke et al., 1 994). This receptor has a high affinity for IGF-ll, a 
500-fold lower affinity for IGF-I, and does not bind insulin (Jones and Clemmons, 
1 995) . The full  physiological role of the IGF-ll receptor is not known although it may 
serve an important function in the uptake and degradation of IGF-ll. This function may 
represent a local regulatory mechanism in breast cancer whereby the availability of 
extracellular IGF-ll to the IGF-I receptor is controlled (Ellis et al., 1 996b). Expression 
of the IGF-ll receptor in mammary tissue has only been investigated during pregnancy 
and lactation. Level of the IGF-ll receptor within rat mammary tissue is markedly 
increased with pregnancy (Collier et aI., 1 989) and is elevated in the pig mammary 
gland during early- and mid-pregnancy (Lee et al., 1 993). The number of IGF-ll 
receptors in the pregnant bovine mammary gland is greater than for IGF-I (DeHoff et 
al. , 1 988 ;  Collier et al. , 1 989), where the level of IGF-ll receptors declines into lactation 
(Disenhaus et al., 1 988 ;  Collier et al., 1 989) . 
1.4.6. 1 .5  The IGF binding proteins (IGF-BPs) 
An extensive body of literature exists regarding the nature and candidate roles of the 
IGF-BPs (for reviews see Sara and Hall ,  1 990; Jones and Clemmons, 1 995). Several 
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functions have been proposed for the IGF-BPs which include the transport of IGFs, the 
regulation of IGF half-life, induction of tissue specificity, and alteration of cell 
responsiveness to the IGFs. Given the potent mitogenic effect of the IGFs on mammary 
epithelial cells and the ability of the IGF-BPs to modulate this (Blum et al., 1 989; 
McCusker et al. , 1 99 1 ), the IGF-BPs may have a role in regulating mammary gland 
development. 
Experiments using the MCF-7 breast carcinoma cell l ine showed that IGF-BP2 and -3 
enhanced their mitogenic response to IGF-I, an effect also evident when these cells 
overexpressed IGF-BP3 (Chen et al. , 1 994). In contrast, IGF-BP4 and -5 were without 
effect. Manni et al. ( 1 992) demonstrated that chemical ly-induced mammary tumours 
expressed mRNA for IGF-BP2, -3 and -4. In situ hybridisation revealed that IGF-BP2 
mRNA was expressed by epithelial cel ls whereas IGF-BP5 and -6 was expressed in the 
stroma (Manni et al. , 1 994). Expression of these IGF-BPs was also differentially 
regulated by ovariectomy and hormonal treatment. Oestrogen upregulates the 
expression of IGF-BP2, -4 and -5 by breast cancer cells while their expression of IGF­
BP3 is concomitantly downregulated (Lee and Yee, 1 995). 
Studies by Campbell et al. ( 1 99 1 )  and McGrath et al. ( 1 99 1 )  demonstrated that bovine 
mammary epithelial cel ls express several IGF-BPs, two of which were identified as IGF­
BP2 and -3. Furthermore, the expression of IGF-BP2 and -3 is upregulated in the 
presence of IGF-I (McGrath et al., 1 99 1 ) . Upregulation of a 32 kDa IGF-BP in milk has 
also been reported in mice which overexpress des-IGF-I in the mammary gland (Hadsell 
et al., 1 996). The level of IGF-BP2 mRNA in the pig mammary gland doubles in late 
pregnancy whereas IGF-BP3 levels are depressed from early pregnancy (Lee et aI . ,  
1 993). 
To date, the very function of the IGF-BPs remams largely unknown. Differential 
expression of the various IGF-BPs by epithelial and stromal constituents suggests they 
may serve an important role in modulating IGF action on the mammary gland during 
growth and lactogenesis. 
1.4.6.2 Epidermal growth factor (EGF)-like polypeptides 
Epidermal growth factor (EGF) is a 53-amino acid polypeptide with a Mr of 6045 Da. 
This mature form is proteolytically cleaved from a 9 kDa pro-EGF derived originally from 
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a 1 2 1 7-amino acid prepro-EGF molecule of Mr 1 30 kDa. Structurally related to EGF is 
transforming growth factor-a (TGF-a), a 5.6 kDa, 50-amino acid polypeptide that is 
derived from a 1 60-amino acid precursor. Both EGF and TGF-a initiate their biological 
effects through the EGF receptor (reviewed by Plaut, 1 993). Two recently identified 
members of the EGF family that are also mitogenic for normal and neoplastic mammary 
cells are CRlPTO-I (Brandt et al., 1 994) and amphiregulin (Li et al., 1 992; Kenney et aI. ,  
1 993; Normanno et al. , 1 994). 
The highest levels of prepro-EGF mRNA in mice are found in the submandibular glands. 
Relatively high levels of prepro-EGF are also expressed in the kidney and lactating 
mammary gland, although the translated product in these tissues either remains as a cell 
membrane component (Rall et al., 1 985), or is enzymatically degraded and excreted into 
the urine or milk (Brown et al., 1 986). 
The circulating concentration of EGF derived from the submandibular gland is influenced 
by a variety of factors. Concentrations in the rat increase from 4 to 8 weeks of age, 
increasing markedly thereafter to plateau by 1 2  weeks (Hiramatsu et al. , 1 994). 
Submandibular and plasma levels of EGF in the female mouse increase approximately 
fivefold during pregnancy and remain high throughout lactation (Oka et al. , 1 99 1 ) .  The 
concentration of EGF in the submandibular gland of female mice is increased after 
ovariectomy and is suppressed by exogenous oestrogen. Several progestins also induce an 
increase in the glandular concentration of EGF. Hypophysectomised, hypothyroid and 
diabetic mice all possess reduced levels of submandibular EGF which can be reversed by 
hormonal repletion (Oka et al., 1 99 1 ;  Hiramatsu et al. , 1 994). 
1.4.6.2. 1  In vitro studies 
Since their discovery, EGF and TGF-a have been widely adopted as mitogens for cultured 
rodent mammary epithelial cells. EGF enhances the growth of primary cells and cell lines 
cultured in collagen or on plastic (Imagawa et al. , 1 985; Riss and Sirbasku, 1 987) and can 
induce an altered cell morphology (McGrath et al. , 1 985). The mitogenic effect also 
applies to neoplastic mammary epithelial cells (Stoker et al. , 1 976) and mammary stromal 
cells (Smith et al., 1 984). 
Taketani and Oka ( 1983) found that while EGF increased DNA synthesis by lactating 
mammary epithelial cells, it also induced a concomitant decrease in casein and a-
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lactalbumin synthesis. This likely represents a suppressed lactogenic response to Prl 
(Vonderhaar and Nakhasi, 1986). On the other hand, EGF may be a specific requirement 
for lobuloalveolar morphogenesis, as mammary glands in organ culture can only undergo a 
second round of development in the presence of EGF (Tonelli and Sorof, 1 980). This may 
represent an association of EGF action with the mammogenic effect of Prl (Plaut, 1993 ; 
Darcy et al. , 1 995), where Prl upregulates epithelial EGF rnRNA expression (Fenton and 
Sheffield, 1994). The requirement for female mice to be steroid primed before their 
mammary glands are cultured in vitro may serve to increase the level of TGF-a within the 
mammary gland for transferral to the culture environment (Vonderhaar, 1 988). 
1.4.6.2.2 in vivo studies 
Numerous findings indicate a role for EGF during growth of the normal and neoplastic 
mammary gland (Plaut, 1993). Sialoadenectomised female mice exhibit less pregnancy­
associated mammary development and have lower subsequent milk yields; effects which 
can be recovered by the daily administration of exogenous EGF (Okamoto and aka, 
1 984). Sheffield and co-workers (Sheffield and Welsch, 1 987; Sheffield and Kotolski, 
1993) extended these observations and demonstrated that sialoadenectomy of virgin 
female mice abrogated ductal development and epithelial responsiveness to oestrogen + 
progesterone, and oestrogen + progesterone + cholera toxin. The former effect could be 
partially overcome by subcutaneous salivary grafts or treatment with EGF. 
Sialoadenectomy of females from a tumour-susceptible strain of mice markedly reduces 
mammary tumour incidence and increases the latency period of tumour development 
(Kurachi et al. , 1985). A recent report also indicates that neonatal administration of TGF­
a has extended effects on mammary development (Hilakivi-Clarke et al. , 1 995). Mice 
overexpressing TGF-a (Sakai et al. , 1 994) or lacking a functional EGF receptor (van 
Haaster et ai. , 1 995) have apparently normal development, while a subsequent inability to 
lactate may represent a disruption in signalling from mammary Prl receptors (Sakai et al. , 
1 994). 
The local effect of EGF and TGF-a within the mammary gland has been examined using 
slow release implants. Vonderhaar ( 1 987a) found TGF-a to be a more potent stimulator 
of lobuloalveolar development than EGF in virgin mice treated with oestrogen + 
progesterone. In contrast to EGF, the effects of TGF-a were independent of a requirement 
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for ovarian steroids. A similar response to an EGF-like growth factor derived from 
mammary tissue of steroid-primed mice was also l ikely due to TGF-a (Vonderhaar, 1 988). 
EGF implants stimulated DNA synthesis in ducts and end buds of ovariectomised females 
and restored their morphology (Coleman et al. , 1 988). Similar studies by Haslam et al . 
( 1 993) demonstrated EGF-induced DNA synthesis in epithelial and stromal cells of 
immature glands that was independent of a requirement for ovarian steroids. In mature 
glands, EGF further promoted ductal side-branching compared to that stimulated by 
oestrogen + progesterone. In contrast, the proliferation of actively growing ducts can be 
directly inhibited by locally-released EGF (Coleman and Daniel, 1990). 
The expression of EGF and TGF-a within the mammary gland has been examined in 
several studies. Messenger RNA for both EGF and TGF-a is expressed in the virgin and 
pregnant mammary gland, whereas only EGF mRNA is expressed in lactating tissue 
(Snedeker et al. , 199 1 ). EGF immunolocalises to the epithelium of the inner terminal end 
bud and ducts, while TGF-a mRNA is expressed by the cap cells of the ductal end bud 
and the stromal fibroblasts around the flank of the end bud (Snedeker et al., 1 99 1 ;  
Harigaya et aI., 1 994a). In situ hybridisation revealed that the expression of TGF-a 
mRNA in ductal and alveolar mammary epithelium in rat and human mammary tissue is 
increased during pregnancy and that TGF-a mRNA is also expressed by the mammary 
gland stroma (Liscia et al. , 1990). Amphiregulin and CRIPTO-J are also developmentally 
expressed by the stroma and epithelium of the normal mouse mammary gland (Kenney et 
al., 1 995), where higher levels in breast carcinomas localise to the tumour epithelium 
(Kenney et al. , 1 996). TGF-a in tumorous breast tissue localises to both the neoplastic 
epithelium and the surrounding stromal tissue (Castellani et aI., 1 994; Harigaya et al., 
1 994b). This coincides with the demonstration that mammary epithelial, myoepithelial 
and tumour cells all express TGF-a in vitro (Smith et al. , 1 989b; Salomon et aI., 1 989; 
Cappelletti et al. , 1 993). Both the in vivo and in vitro expression of TGF-a by mammary 
tumour cel ls is upregulated by oestrogen (Dickson et aI., 1986; Liu et aI., 1 987; Bates et 
al., 1 988), indicating that TGF-a may function as an oestrogen-inducible paracrine or 
autocrine growth factor in the mammary gland. Lactating mammary tissue and milk also 
contain significant levels of EGF and TGF-a (Brown et aI. , 1 989; Smith et aI. , 1 989b); 
their appearance in milk is associated with the processing of EGF precursor molecules in 
alveolar epithelium (Jahnke et aI., 1 994). 
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Only limited evidence exists concerning a role for EGF and TGF-a in ruminant 
rnammogenesis. Several reports have demonstrated mild proliferative effects of EGF and 
TGF-a on bovine and ovine mammary epithelial cells in vitro, where TGF-a is more 
potent than EGF (Tou et ai., 1990; Winder et al., 1 989; Woodward et al. , 1 994; Moorby et 
ai., 1 995; Collier et al., 1 993). A role for these growth factors in vivo is suggested by the 
fact that intramammary infusion of EGF into heifers and ewes increases mammary gland 
development (McGrath and Collier, 1988; Collier et al. , 1993). TGF-a mRNA has been 
detected by RT-PCR in bovine mammary tissue (Collier et aI., 1 993), and exists as several 
developmentally-regulated mRNA transcripts (Paquin Platts et ai. , 1 993 ; Koff and Plaut, 
1 995). In contrast, EGF mRNA was undetectable by Northern analysis. Correspondingly, 
whereas TGF-a is detectable in bovine serum by RIA, EGF is not (Paquin Platts et al., 
1 993). Eckert et al. ( 1 985) detected an EGF-like factor in extracts of bovine mammary 
tissue that may be distinct from TGF-a (Byatt et al., 1990). Taken together, these results 
suggest that TGF-a and other EGF-like molecules, but not EGF, may be involved in the 
regulation of ruminant mammary gland development. The site of TGF-a synthesis within 
the ruminant mammary gland remains to be determined. A recent report by Forsyth 
( 1 996) indicates that locally synthesised amphiregulin may also play a role in regulating 
ruminant mammogenesis, although further studies are required to fully establish the role of 
this mitogen. 
1.4. 6.2.3 The EGF receptor (EGFR) 
The mitogenic effects of both EGF and TGF-a are initiated via the transmembrane 
tyrosine-kinase EGFR (Kienhaus et al., 1 993). This receptor undergoes ligand-induced 
autophosphorylation; the extent to which this occurs is influenced by the proliferative state 
of the epithelial cell (McIntyre et al., 1 995). EGFRs within the virgin mouse mammary 
gland are present on the end bud cap cells, the ductal myoepithelium, and stromal cells 
adjacent to end bud and ductal epithelium (Coleman et al. , 1 988). The EGFR is also 
expressed by a variety of mammary tumours and serves as a prognostic marker in breast 
cancer (Sainsbury et al., 1 987). 
Expression of the EGFR and its capacity to bind EGF is regulated by a number of factors. 
EGFR are present on ovine and bovine mammary epithelial cells, the expression of which 
is elevated in pregnancy, reduced during lactation and down-regulated by GH treatment 
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(Spitzer and Grosse, 1 987; Moorby et al., 1995; Glimm et al. , 1 992). During the course of 
murine development, mammary EGFR levels are greatest in mid-pregnancy and decline to 
low levels throughout lactation (Edery et al. , 1 985b). Oestrogen increases the number of 
EGFR levels on mammary cells in vitro (Vanderboom and Sheffield, 1 993) while 
oestrogen + progesterone interact to increase EGFR levels in mammary epithelium, but 
not stroma, derived from mature, but not immature, female mice (Haslam et al. , 1 992; 
Vonderhaar, 1 984; Sheffield, 1988a). Hypothyroidism is associated with a reduction in 
mammary EGFR levels (Vonderhaar et al. , 1 986) while local cholesterol implants induce 
an upregulation of EGFR sites (Vonderhaar, 1993). Bandyopadhyay et al. ( 1 993) 
demonstrated that cells cultured in the presence of linoleic acid had a 1 5% reduction in 
EGFR number and affinity. Furthermore, the extracellular matrix can alter the abi lity of 
EGF to down-regulate its own receptor on mammary epithelium (Mohanam et al. , 1 988; 
Coleman and Daniel , 1 990). Daniel and Silberstein ( 1987) reported that EGFR number is 
increased 5-fold in stromal cells adjacent to end buds compared to distal stromal cells. 
The progression of mammary tumours to hormone independence is associated with an 
increase in EGFR levels (Kienhuis et al., 1993). Hence there appears a strong association 
between stromal influences and the local expression of EGFR. How this translates to 
mammary gland development in different states and in different stromal environments 
remains to be shown. 
A substantial body of evidence indicates that EGF-like molecules are potent stimulators of 
mammary gland development, at least in rodent species. Their ful l  biological function in 
the ruminant mammary gland remains to be characterised. It also remains to be 
established how EGF-like polypeptides interact with other hormonal and local influences 
during the course of mammogenesis. In particular, recent in vitro studies show that 
unsaturated fatty acids can substantially modulate the mitogenic actions of EGF. The 
relationship of this finding to mammary gland growth and the responsiveness of mammary 
epithelial cells to EGF at different dietary fat levels and compositions has not been 
investigated. 
1.4.6.3 Hepatocyte growth/actor (HGF) 
HGF was originally purified from serum and rat platelets as a mitogen for isolated 
hepatocytes (Nakamura et al., 1 987). Identical to HGF is scatter factor which was first 
6 1  
identified as a mesenchymal cell-derived mitogen able to dissociate epithelial colonies 
(Gherardi et al, 1 989; Rubin et al., 1 99 1 ). HGF is an 82 kDa heparin-binding, 
heterodimeric glycoprotein consisting of a 69 kDa a-subunit and a 34-kDa �-subunit 
(Nakamura et al., 1 987); it shares a 38% amino acid sequence identity to plasminogen, 
but lacks proteolytic activity (Nakamura et aI. , 1 989). This growth factor has 
subsequently been shown to increase the motility and proliferation of several epithelial 
cell types and is primari ly synthesised by mesenchymal cells in vitro (Rosen et al., 
1 994b). HGF has a potent tubulogenic effect on kidney epithelial cells (Barros et al., 
1 995), and mRNA for HGF has been detected in a number of tissues including liver, 
kidney, lung, brain, and ovarian theca (Tashiro et aI. , 1 990; Maher, 1 993; Parrott et al., 
1 994). The receptor for HGF is the c-met oncogene product which is a transmembrane 
tyrosine kinase primarily expressed by epithelial cells (Rosen et al., 1 994a). 
Unknowingly, Enami et al. ( 1 983) first showed HGF to be a paracrine mitogen for 
mammary epithelium when they demonstrated epithel ial proliferation in response to 
medium conditioned by mammary fibroblasts. This mitogenic activity was recently 
identified as HGF (Sasaki et al, 1 994). In a further study, increasing concentrations of 
fibroblast CM suppressed casein synthesis by epithelial cells concomitant with increased 
DNA synthesis (Taga et al., 1989). It was recently demonstrated that 3T3-Ll adipocytes 
secrete HGF which can stimulate the growth of SPl mammary carcinoma cells (Rahimi 
et ai, 1 994), whereas 10hnston et al. ( 1 992) reported that the growth of MCF-7 cells was 
inhibited by a similar factor. 
Several findings indicate that HGF may serve to promote mammary ductal 
morphogenesis. Subcloned NMuMG mammary cells grown in collagen gels formed 
elaborate branched ductal structures with a lumen fol lowing exposure to HGF (Soriano 
et al, 1 995). HGF-induced ductal development and lumen formation was further 
enhanced by dexamethasone in association with increased expression of the c-metlHGF 
receptor (Soriano et aI., 1 995). Brinkmann et al. ( 1 995) found that only some of several 
mammary epithelial cell lines surveyed were responsive to the potent morphogenic 
effects of HGF. This finding may correspond to the demonstration that HGF is 
morphogenic for myoepithelial cells, yet only stimulates the proliferation of luminal 
epithelial cel ls (Niranjan et al. , 1 995). 
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Messenger RNA for HGF is expressed as 3, 3.6 and 6 kb transcripts by mammary 
fibroblasts (Sasaki et al., 1 994) and is present in mouse mammary tissue (Soriano et al. , 
1 995). In a separate study, Northern analysis showed HGF gene expression as a single 
mRNA in the virgin mouse mammary fat pad, with the highest expression levels in 
mammary tissue of mature virgin and early pregnant females (Niranjan et al., 1 995). 
HGF mRNA has also been detected in samples of normal and tumorous human breast 
and is expressed by cultures of human mammary stroma (Wilson et al., 1 994). In 
further support of a paracrine action of HGF is its presence in human breast cancer 
tissue extracts, but not in medium conditioned by human breast cancer cel ls (Yamashita 
et al. , 1993). Compared to other factors, the level of HGF in breast tumour extracts is 
the single best predictor of relapse-free breast cancer and overal l patient survival 
(Yamashita et al. , 1 994). Recent findings suggest, however, that HGF may not solely 
function as a stroma-derived paracrine rnitogen/morphogen. Two separate studies have 
reported that in addition to its expression by the stroma, HGF mRNA also localises to 
tumorous epithelium in the human breast, and occurs at a higher intensity around 
regions of ductal hyperplasia (Wang et al., 1 994; Tuck et al. , 1 996) . 
Messenger RNA for the HGF receptor has been detected in both stromal and epithelial 
cell cultures of human mammary tissue (Wilson et al., 1 994), while in a separate study 
HGF receptors were only localised to ductal epithelium of human mammary tissue, 
especially in cells bordering the lumen (Tsarfaty et al., 1 992). In situ hybridisation by 
Tuck et al. ( 1 996) confirmed that HGF receptor mRNA only localises to mammary 
epithelial cel ls. The level of mRNA for the HGF receptor within the rodent mammary 
gland is highest in mature virgin and early pregnant females (Niranjan et al. , 1 995; 
Soriano et al. , 1 995). 
Although the physiological regulation of mammary HGF expression has not been 
described, there is strong evidence to suggest that such regulation occurs. Direct and 
indirect co-culture with epithel ial cells  down regulates fibroblast HGF expreSSIOn 
(Seslar et al. , 1 993). Furthermore, tumour cells and fibroblasts both produce soluble 
factors capable of either stimulating (Rosen et al., 1 994b) or suppressing fibroblast HGF 
production (Seslar et al., 1 995). Other peptide growth factors such as TGF-a and EGF 
have been shown to downregulate stromal HGF mRNA levels, but not protein synthesis 
(Seslar et al. , 1 993). Expression of HGF is also upregulated by the direct interaction of 
63 
the ER complex with oestrogen response elements in the HGF gene (Liu et al., 1 994). 
Induction of kidney epithelial tubulogenesis by HGF can also be influenced by the 
composition of the extracellular matrix (Santos and Nigam, 1 993). 
Compelling evidence therefore suggests an important physiological role for HGF as a 
stroma-derived polypeptide able to influence normal and neoplastic mammary 
development. The extent to which this growth factor regulates growth and ductal 
morphogenesis remains to be fully understood, as does the involvement of HGF in 
mediating the effects of specific mammogenic hormones such as oestrogen, and the 
local influences of epithelial-stromal associations. 
1.4.6.4 Thefibroblast growth/actors (FGFs) 
The fibroblast growth factor family contains at least 9 identified polypeptides that are 
classified as members on the basis of a conserved coding sequence. The FGFs bind and 
interact to various degrees with high affinity tyrosine kinase receptors encoded by four 
separate genes; they also bind with a lower affinity to heparan sulfate receptors 
(reviewed by 10hnson and Wil l iams, 1993). This section will outline knowledge 
relating to three FGFs which have been studied within the normal mammary gland: 
acidic FGF, basic FGF, and keratinocyte growth factor. Other members such as FGF-3 
(int-2) and FGF-4 will not be considered here, although their activation by viral 
insertion into some mouse mammary tumours has demonstrated their ability to induce 
substantial proliferation. 
1.4.6.4.1 acidicfibroblast growth /actor (aFGF) 
Bovine aFGF has a molecular mass of 1 6  kDa and shares a 53% amino acid homology 
with bovine bFGF (Esch et al., 1 985), and a 27% amino acid homology with 
interleukin- l (Gimenez-Gallego et al. , 1 985). Like bFGF, aFGF lacks a classic signal 
peptide sequence typically required for secretion, leading to suggestions for an as yet 
unknown secretion pathway (Abraham et al., 1 986). 
Acidic FGF stimulates the growth of collagen-embedded mouse primary epithelial cells 
(Imagawa et al., 1 994b) and cell l ine cultures (Riss and Sirbasku, 1 987; Kotolski and 
Sheffield, 1 992), an effect which is enhanced by supplementing cultures with heparin 
(Imagawa et al. , 1 994b). No data exists regarding the mitogenic effect of aFGF on 
mammary epithelial cells from ruminants. 
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Only a few studies have investigated the regulation of aFGF expression within the 
rodent mammary gland. Barraclough et al. ( 1 990) detected a 3.9 kb mRNA transcript 
for aFGF in cultured rat mammary fibroblasts and lesser expression in epithelial and 
myoepithelial cells. Evaluation of aFGF mRNA and protein in mouse mammary tissue 
revealed that levels were similar in both epithelium-free and intact mammary fat pad 
tissue (Chakravorti and Sheffield, 1 996a), indicating that aFGF is probably stroma­
derived. The abundance of aFGF mRNA increases during postnatal development and is 
associated with 4 immunoreactive proteins of 30, 48, 52 and 55 kDa which are 
differentially expressed across these states. In addition, aFGF mRNA expression in 
ovariectomised female mice is upregulated by treatment with oestradiol + progesterone 
(Chakravorti and Sheffield, 1 996b). In another study, .however, Coleman-Krnacik and 
Rosen ( 1 994) reported highest abundance of aFGF mRNA in the immature mouse 
mammary gland and decreased levels in mature and pregnant tissues. The reason for 
these conflicting results is unclear, although the developmental pattern of aFGF 
expression needs to be clarified before a physiological role can be ascribed to this 
growth factor. The demonstration that aFGF is stroma-derived and hormonally 
regulated prompts the suggestion that this FGF may function as a local mediator of 
hormonal action within the mammary gland. Although messenger RNA for aFGF is 
present at high levels in cancerous breast tissues (Penault-Llorca et al. , 1 995), there are 
also contrasting reports as to how this level compares to the normal state (Renaud et al., 
1 996). 
1 .4. 6.4.2 basicfibroblast growthfactor (bFGF) 
Basic FGF stimulates the growth of mammary epithelial cells from virgin and 
midpregnant mice within collagen gels, although they subsequently have a reduced 
ability to synthesise casein (Levay-Young et al., 1 989). The growth of bovine 
mammary epithelium can also be stimulated by bFGF (Sandowski et al., 1 993). In 
contrast, Smith et al. ( 1 984) used an array of rat mammary cell types to demonstrate that 
bFGF is mitogenic for mammary fibroblasts and myoepithelial cells, but not epithelial 
cel ls . This cel l-specificity correlated with the expression of cell surface receptors for 
bFGF (Fernig et al. , 1 990). The cellular target for bFGF within the mammary gland is 
therefore not immediately obvious. In situ hybridisation in normal and tumorous breast 
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tissue has localised the FGF type 1 receptor (which binds bFGF with high affinity) to 
the epithelial compartment (Jacquemier et al., 1 994), although no distinction was made 
between epithelial and myoepithelial cells. 
It is myoepithelial cel ls from rat mammary tissue that express the greatest abundance of 
a 5 .7 kb bFGF mRNA in vitro; this expression was 2.5 times that in fibroblasts, and 4 to 
7 times that in epithel ial cells. A large proportion of the secreted bFGF was found to be 
associated with the extracellular matrix (Barraclough et aI., 1990). Gomm et al. ( 1 99 1 )  
immunolocalised bFGF to the myoepithelial cells of the benign human breast and to the 
perimeter of enlarged hyperplastic ducts, but did not detect bFGF in malignant tissue. A 
more extensive study in the rat by Rudland et al. ( 1 993) showed that bFGF is primarily 
associated with myoepithelial cel ls and the extracellular matrix of the basement 
membrane in resting states, whereas in growing end buds and alveolar buds bFGF 
becomes associated with the epithelial cells . Basic FGF in the lactating bovine 
mammary gland immunolocalises to the myoepithelium and endothelium (Schams et al. , 
1 995). 
Expression of bFGF mRNA in both the intact mouse mammary gland and the 
epithelium-free mammary fat pad is elevated during pregnancy and decl ines after 
parturition (Chakravorti and Sheffield, 1 994a). This expression is associated with 
immunoreactive proteins of 30 and 55 kDa, the levels of which decline during late 
pregnancy. As for aFGF, Coleman-Krnacik and Rosen ( 1 994) reported a different 
ontogenic pattern of bFGF mRNA expression within the mammary gland, where highest 
levels were recorded in immature virgins but with levels decreased during pregnancy. 
Expression of bFGF mRNA is also increased in response to treatment of ovariectomised 
mice with oestrogen, or oestrogen + progesterone + Prl + GH (Chakravorti and 
Sheffield, 1 994b). 
Taken together, these results suggest that the stroma and myoepithelium are principle 
sites of bFGF synthesis within the mammary gland, while the cellular targets of this 
mitogen are uncertain. Likewise, components of the extracellular matrix may be 
particularly important in modulating the local availability of bFGF within the vicinity of 
proliferating epithel ium. Whether this availability is influenced by the association of 
epithelial cel ls with the surrounding stroma is unknown. 
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1 .4.6.4.3 Keratinocyte growthfactor (KGF) 
KGF is a 28 kDa FGF originally isolated from embryonic lung fibroblast conditioned 
medium as a mitogen for keratinocytes (Rubin et al., 1 989). The KGF cDNA exhibits a 
37 and 39% sequence identity to aFGF and bFGF cDNA, respectively (Finch et al. , 
1 989). KGF acts as a true paracrine mitogen in that it is only synthesised by 
mesenchymal cells (Aaronson et aI., 1 99 1 )  and stimulates the proliferation of epithelial 
cel ls, but not fibroblasts or endothelium (Finch et al. , 1 989). The KGF receptor (KGFR) 
is an alternative transcript of the FGF type 2 receptor (Miki et aI. , 1 99 1 )  that binds 
aFGF with high affinity, and to a lesser extent, bFGF (Bottaro et al. , 1 990). 
KGF may function as a paracrine mitogen for mammary epithelium during normal and 
neoplastic mammogenesis. Mouse mammary epithelial organoids and terminal end 
buds are responsive to the mitogenic effects of KGF in vitro (Imagawa et aI. , 1 994b), as 
are cultures of human mammary epithelium (Wilson et aI. , 1 994). Tesfayohannes et al. 
( 1 992) reported that KGF was mitogenic for bovine mammary epithelial cells ;  these 
results, however, must be disregarded as the cell line used in these experiments (PS­
BME) was later demonstrated to be of murine origin (Woodward et al. , 1 994). In 
contrast to aFGF, heparin does not modulate the mitogenic effect of KGF (lmagawa et 
al. , 1 994b). KGF-induced proliferation is also negatively regulated by the lipid­
activated signalling molecule, protein kinase C (LePanse et al. , 1 994). This finding may 
be particularly relevant to the role for l ipids in modulating epithelial responsiveness to 
certain mitogens within the mammary gland. 
Intravenous administration of KGF to female rats induces mammary ductal neogenesis, 
intraductal hyperplasia and alveolar hyperplasia (Ulich et al. , 1 994). This effect was 
developmentally specific as KGF did not affect the epithelium of lactating rats. KGF 
administered to intact and ovariectomised mice had similar hyperplastic effects (Yi et 
al., 1 994). Furthermore, KGF administered with oestrogen and progesterone induces a 
dilated ductal hyperplasia and produces a hyperplastic fibrosis in the periductal adipose 
tissue. The epithelial hyperplasia is reversed following cessation of KGF treatment 
while the stromal fibrosis remains (Yi et al., 1 994). 
Finch et al. ( 1 995) localised KGF mRNA expression to mesenchymal cells within the 
foetal mammary gland and correspondingly showed expression of KGFR mRNA in the 
epithelial anlage. Messenger RNA for KGF and the KGFR has also been detected in 
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samples of normal and tumorous human breast stroma and epithelium, respectively 
(Wilson et al. , 1 994; Penault-Llorca et aI. , 1 995). 
There is l ittle information regarding the physiological regulation of KGF within the 
developing mammary gland. Within the rat mammary gland, expression of KGF mRNA 
was elevated at 6 days postpartum compared to day 20 of gestation while there was no 
difference in the level of KGF receptor mRNA between these states (Ulich et al. , 1 994). 
Examination of mouse mammary tissues revealed that KGF mRNA was present as 
different transcripts across the course of postnatal development (Coleman-Krnacik and 
Rosen, 1 994). Surprisingly these researchers did not detect any KGF mRNA in the 
mammary fat pad itself. Recombinant mammary glands containing KGF receptor­
negative epithelium have sparse ductal outgrowths with an extremely fine architecture 
(G.R. Cunha, personal communication). 
From the evidence at hand it appears that KGF may be an important stroma-derived 
paracrine mitogen involved in the regulation of mammogenesis, although the ful l  extent 
of its involvement and the physiological regulation of its expression await investigation. 
In particular, it wil l  be interesting to evaluate whether this growth factor is of greater 
relevance in the human or ruminant mammary gland where there is an increased 
presence of fibroblastic stroma. Along these l ines, findings from studies in other tissues 
such as skin (Guo et aI., 1 993; Werner et al., 1 994), ovary (Parrott et aI., 1 994), seminal 
vesicle (Alarid et al. , 1994) and uterus (Koji  et aI., 1 994) indicate that KGF expression 
is altered in response to epithelial-stromal interaction. Furthermore, KGF is markedly 
up-regulated by cytokines such as interleukin- I a, and to a lesser extent by PDGF, 
interleukin-6 and TGF-a (Chedid et al., 1 994), all of which may influence mammary 
gland growth. Expression of KGF in the endometrial stroma of the uterus is markedly 
increased by progesterone, but not oestrogen (Koji et al., 1 994), indicating that KGF 
may serve as a paracrine mediator of progesterone action. 
An expanse of information indicates that the growth and morphogenesis of mammary 
epithelium is influenced by a range of systemically- and locally-derived factors. These 
factors may also act together to potentiate their mammogenic effects. However, in many 
cases the mechanism(s) of their individual actions remains unknown. In other cases 
their physiological function(s) remains to be fully established before the relative 
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importance of their effect on the mammary gland can be assessed. Another aspect to 
emerge is the ability of the mammary fat pad to provide factors which either directly 
stimulate epithelial growth or modulate the actions of other mammogenic agents . The 
ful l  implications of these actions have received limited attention. 
1.5 PURPOSE AND SCOPE O F  THE IN VESTIGATION 
The mammary gland is rather unique in that the majority of its development occurs 
postnatally as a process which spans several physiological states, each state being 
characterised by a specific pattern of cel l  proliferation and morphogenesis. Cell types 
within the mammary gland of species including humans may also be at risk of 
progressing to a tumorigenic phenotype during this development. 
On reviewing the present understanding of mammary gland biology it becomes obvious 
that the mammogenic process is directed by an array of growth regulators. Historical 
studies identified that several key endocrine hormones were required to facilitate ful l  
development of the mammary gland. Subsequent investigations have shown that in 
many cases these hormones do not act directly on the epithelial cel l  but that their effects 
are instead mediated by other factors within the mammary gland. 
Central to this local mediation is the matrix of the mammary gland fat pad. Even 
following the revelations of Hoshino that such an environment was prerequisite for 
epithelial development, little attention was directed to its growth regulating capacity. 
More recently it has been recognised that the constituents of the mammary fat pad may 
be key components of several different mechanisms involved in regulating normal and 
neoplastic mammogenesis. Such mechanisms include the mediation of systemic 
hormone action, the local synthesis of growth-regulating polypeptides, provision of a 
suitable physical matrix and modification of the lipid environment of the epithelial cel l .  
These processes might also be influenced by the interaction between the developing 
epithelium and the adjacent stromal cells .  The relative contributions of these 
mechanisms may vary across species which have a different mammary gland anatomy. 
Although the integral role of the mammary fat pad is now widely appreciated, the 
biological significance of the aforementioned pathways is largely unknown, and has, in 
many cases, been difficult to elucidate. An understanding of these is of fundamental 
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importance to the quest to modify certain aspects of mammary gland function; a quest 
which may result in practical applications ranging from increased milk production by 
dairy animals to the prevention of breast disease in humans. 
The objective of the research reported herein was to investigate the means by which the 
mammary fat pad regulates the process of postnatal development in the normal 
mammary gland. These investigations have been conducted in rodents and ruminants 
which differ substantially in their mammary tissue composition and parenchymal 
architecture, and in which the mammary fat pad may utilise different mechanisms to 
regulate mammary development. Common to these studies has been an examination of 
the mitogenic effects of the mammary fat pad in different developmental states. 
Analysis of these effects in relation to ontogenic state, ovarian steroid hormones and the 
epithelial-stromal interaction has al lowed a biological significance to be ascribed to the 
findings of this research. 
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CHAPTER 2 
MAMMARY FAT PAD MODULATES THE 
PRO LIFE RA TIVE RESPONSE OF MOUSE MAMMARY 
EPITHELIAL CELLS TO SPECIFIC MITOGENS 
IN VITRO 
7 1  
2.1 ABSTRACT 
The ability of the murine mammary fat pad to directly stimulate the growth of mammary 
epithelial cell s  and to modulate the effects of various mammogenic agents has been 
investigated in a newly described, hormone- and serum-free co-culture system. 
COMMA- I D  mouse mammary epithelial cells were cultured for 5 or 7 days with 
various supplements in the absence or presence of explants of epithelium-free mammary 
fat pad from virgin female BALB/c mice. Co-cultured fat pad stimulated a 2- to 3-fold, 
and 6- to 8-fold increase in the amount of DNA in COMMA- I D  cultures after 5 and 7 
days, respectively. This effect was additive to that of 10% foetal calf serum (FCS). The 
effect of co-cultured mammary fat pad could not be attributed to the release of 
prostaglandin E2 (PGE2) or the synthesis of prostaglandins by epithelial cells . In 
addition, bovine serum albumin (BSA) attenuated (P<0.05) the mitogenic effect of co­
cultured mammary fat pad. Added alone, insulin-like growth factor-I (IGF-I), epidermal 
growth factor (EGF) and insulin increased (P<0.05) total DNA of COMMA- I D  cultures 
by 2.5-, 3 .7-, and 2.3-fold, respectively. Co-cultured mammary fat pad markedly 
interacted (P<0.0 1 )  with these mitogens to yield final DNA values that were 2 1 .2-, 1 3 .3-
, and 22. 1 -fold greater than in basal medium only. Associated with this proliferation 
was the formation of numerous domes above the COMMA- I D  cell monolayer. There 
was no proliferative response to growth hormone or prolactin in the absence or presence 
of co-cultured fat pad (P>0.05). Whereas hydrocortisone alone did not alter cell 
number, it attenuated (P<0.05) the mitogenic effect of co-cultured mammary fat pad. 
These results indicate that the murine mammary fat pad is not only a direct source of 
mitogenic activity, but that a factor(s) from the mammary fat pad modulates the 
response of mammary epithelial cells to certain mammogens. 
2.2 INTRODUCTION 
Normal mammary gland development encompasses several distinct phases of epithelial 
cell proliferation which occur within the confines of the adipose and connective tissue 
matrix which comprises the mammary fat pad. Prior to and during puberty, epithelial 
cells advance from the mammary rudiment and ramify into the fat pad to establish a 
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ductal network (Imagawa et aI. , 1 994). The onset of gestation initiates the formation of 
lobuloalveolar structures so that by parturition the mammary fat pad is occupied by 
epithelial cells  able to synthesise and secrete milk. This course of development is 
regulated by several key hormones (Topper and Freeman, 1 980). 
Increasing evidence suggests that the local environment of the mammary fat pad plays 
an integral role in controlling the proliferation of both normal and neoplastic mammary 
epithelial cell s  in vivo. Transplantation experiments have demonstrated that a depot of 
white adipose tissue such as the mammary fat pad is essential for normal mammary 
development (Hoshino, 1 978). However, the relative importance of local growth 
regulatory mechanisms during mammogenesis is not well defined. 
Stromal cel ls within the mammary gland synthesise components of the extracel lular 
matrix to provide a physical environment for epithelial proliferation and morphogenesis 
(Levine and Stockdale, 1984; Keely et aI., 1 995). The mammary fat pad is also the 
source of paracrine mitogens including fibroblast growth factors (Wilson et aI., 1 994; 
Chakravorti and Sheffield, 1996a), hepatocyte growth factor (Sasaki et al. , 1 994; 
Rahimi et al., 1 994), transforming growth factor-a (Snedeker et al. , 1 99 1 ), insulin-like 
growth factors (Singer et al., 1 995), Wnt proteins (Weber-Hall et aI. , 1 994), and 
unsaturated fatty acids (Wicha et aI., 1 979). Furthermore, the results of both in vivo 
(Shyamala and Ferenczy, 1 984) and in vitro (Haslam, 1 986) studies indicate that the 
proliferative effect of oestrogen on mammary epithelium may be mediated by the 
stromal cells of the mammary gland. 
Attempts to unravel these local growth regulatory mechanisms and their biological 
function are hindered by the intimate association of epithelial cel ls with constituents of 
the mammary fat pad. Several investigators have utilised in vitro co-culture and 
conditioned medium approaches to recombine these components, and have 
demonstrated a mitogenic response by mammary epithel ium to diffusible factors from 
the mammary fat pad (Carrington and Hosick, 1 985; Beck and Hosick, 1 988). These 
studies, however, utilised a medium that included additives such as serum, EGF and 
supraphysiological levels of insulin, all of which can stimulate cel lular proliferation 
under appropriate conditions. Consequently, it is not possible to delineate whether the 
observed mitogenic response was directly attributable to factors from the mammary fat 
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pad, or whether such factors modified the responsiveness of epithelial cell s  to mitogens 
already present in the medium. 
As mammary epithelial cell s  are less responsive to mammogenic agents in vitro than in 
vivo (Yang et al. , 1 980), it was hypothesised that a diffusible factor(s) from the 
mammary fat pad modulates the responsiveness of epithelial cells to various mitogenic 
stimuli . To test this hypothesis a system of co-culturing COMMA- I D  normal mouse 
mammary epithelial cells with mammary fat pad tissue in a hormone- and serum-free 
basal medium (BM) was developed. Findings indicate not only that the mammary fat 
pad is directly mitogenic for mammary epithelial cells ,  but that it also markedly 
potentiates the effects of specific mammogenic agents. 
2.3 MATERIALS AND METHODS 
2.3.1 Reagents and chemicals 
Dulbecco' s  Modified Eagle' s  Medium (DMEM), Dulbecco' s  Modified Eagle' s/Ham's 
nutrient mixture FI2 (DMEIF1 2, 1 : 1 ) and FCS were purchased from Gibco (Grand 
Island, NY and Auckland, New Zealand); Dispase and EGF were from Boehringer 
Mannheim (Germany). Aquasil was from Pierce (Rockford, ll..,). Recombinant human 
IGF-I was from Genentech (San Francisco, CA) and recombinant bovine growth 
hormone (rbGH) was from Elanco (Indianapolis, IN). All other reagents were from 
Sigma (St Louis, MO). Bovine serum albumin was Fraction V, fatty acid content 
0.003%. 
2.3.2 Cell culture 
COMMA- I D  mouse mammary epithelial cell s  were used in these experiments 
(Danielson et al. , 1 984; passages 28-34). Stock cultures were propagated in growth 
medium comprising DMEIF1 2  with phenol red and supplemented with sodium 
bicarbonate (44 mM), FCS (2%), insulin (6 Ilg/ml), EGF (5 ng/ml) , BSA (0.3 mg/ml) , 
penicillin ( 1 00 IU/ml) and streptomycin (0. 1 mg/ml). All cultures were maintained at 
37°C in a humidified 5% CO2:95% air atmosphere. 
COMMA- I D  cells  for proliferation experiments were harvested using Dispase and 
plated into 24-wel l  culture plates (Falcon) in growth medium at either 5x 1 04 or 6x 1 04 
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cells/well .  After 24 h for attachment, monolayers were rinsed with PBS and quiesced 
for 48 h in 0.5 ml defined, hormone-free BM which comprised DMEM supplemented 
with sodium bicarbonate (44 mM), penicillin ( 1 00 ID/ml) and streptomycin (0. 1 mg/ml). 
Preliminary studies indicated that DNA synthesis (as measured by eH]-thymidine 
incorporation) reached a baseline level after this period (Appendix 1 ). 
Hydrocortisone, PGE2 and indomethacin were prepared as ethanolic stocks. All 
treatments within an experiment contained the same concentration of ethanol which 
never exceeded 0. 1 5%. 
2.3.3 Co-cultures 
All animal procedures and manipUlations described in this thesis were conducted in 
accordance with the guidelines of the Ruakura Animal Ethics Committee. Virgin 
female BALB/c mice were from the Ruakura small animal colony and were maintained 
under standard housing and l ighting conditions with ad libitum access to food (Diet 86, 
1 7 .8% protein, 4. 1 % oil ,  NRM New Zealand Ltd) and water. Mice were weaned at 2 1 -
2 3  days of age and sacrificed by cervical dislocation. The 4th abdominal mammary 
glands were exposed and the mammary fat pad dorsal to the supramammary lymph node 
aseptically excised to provide an epithelium-free mammary fat pad (DeOme et al., 
1 959). Mammary fat pad tissue was then sectioned into 5- 10  mg explants 
(approximately 8 mm3) which were rinsed briefly in BM. 
Co-cultures of COMMA- I D  cells  with epithelium-free mammary fat pad were prepared 
by placing an explant of fat pad tissue on a l cm2 raft of sterile, siliconised lens paper 
(Topper et al., 1 975). Loaded rafts were then floated on 0.5 ml of the appropriate 
treatment medium added to quiescent monolayers of COMMA- I D  cell s  (time 0). A 
further 0.5 ml of treatment medium was added on day 3 for both 5 and 7 day cultures. 
For 7 day cultures, 0.5 ml medium was replaced with 0.5 ml fresh treatment medium on 
day 5. Within an experiment, each replicate well represented a separate mouse, and 
tissue from each mouse was assigned across all co-culture treatments. 
At the end of the culture period, monolayers were rinsed with PBS, trypsinised and 
sonicated (3 x 6 sec, Sonic Instruments). Final cel l  number was quantified as total DNA 
by a fluorometric assay (Labarca and Paigen, 1 980) using calf thymus DNA as a 
standard. 
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2.3.4 Statistical analyses 
Multiple treatment comparisons were conducted using the one-way ANOV A and GLM 
procedures of SAS (SAS, 1 994). Interactions between main effects in factorial 
experiments were tested using the GLM procedure of SAS. Comparison of individual 
treatment means to time 0 values was by Student' s t-test. 
2.4 RESULTS 
In developing this co-culture model, certain culture conditions were initially optimised. 
When cultured in the hormone-free BM for 5 to 7 days, COMMA- I D  cells remained 
quiescent and did not alter in DNA yield (P>O.05) relative to time 0 (Figures 2. 1 and 
2.2). Substantial growth of COMMA- I D  cells resulted (P<O.05) when cells were co­
cultured with an explant of mammary fat pad (Figures 2. 1 and 2.2). Preliminary 
experiments indicated that a 5- 10  mg explant of mammary fat pad elicited a maximal 
growth response by COMMA- I D  cells (Appendix 2). 
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The growth of COMMA- I D  cel ls in response to co-cultured fat pad was also influenced 
by the medium changing routine (Figure 2. 1 ). Maximal growth resulted after 5 days 
when explants were initially added to 0.5 rnl BM and a further 0.5 ml BM was added on 
day 3. Cell  growth was relatively less when fat pad explants were initially added to 1 rnl 
BM, or when the medium conditioned by the fat pad tissue was fully replaced after 3 
days. The medium changing routine adopted in subsequent experiments was as 
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Figure 2.1 Effect of medium changing routine on the growth response of COMMA- I D  
cel ls to co-cultured mammary fat pad. The treatments were initiated at t=O (n=4). Cel ls  
were cultured for 5 days, and medium changed as follows: 1 )  BM only, 0 .5 rnl BM with 
a further 0.5 ml BM added at day 3 (n=5); 2) co-culture with fat pad, 1 rnl BM replaced 
completely on day 3 (n=4); 3) co-culture with fat pad in 1 ml BM, 0.5 ml of which was 
replaced at day 3 (n=3);  4) co-culture with fat pad, medium changed as per treatment 1 
(n=4). Data are means ± SEM. Final DNA yield for treatment 1 was not significantly 
different to t=O (P>0.05). a,b,c,d Means with different superscripts are significantly 
different (P<0.05). 
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The growth-promoting effect of co-cultured fat pad was compared to that of FCS, a 
supplement frequently used to maximise cel l  growth. DNA yield fol lowing 7 days co­
culture with mammary fat pad was 6. l -fold greater than that in BM alone (P<0.05), and 
57% of that in 1 0% FCS (Figure 2.2). The mitogenic effect of co-cultured fat pad was 
additive to, and not masked by, that of 10% FCS. 
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Figure 2.2 Growth of COMMA- I D  cell s  in response to co-cultured mammary fat pad 
and FCS.  Cells were cultured in BM or 1 0% FCS for 7 days in the absence or presence 
of an explant of mammary fat pad. t=O represents cel l  number at the commencement of 
treatments. Data are means ± SEM (n=6). a,b,c Means with different superscripts are 
significantly different (P<0.05). Similar responses were obtained in 3 separate 
experiments. 
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As the growth promoting effect of mammary fat pad in vitro may be due to the release 
of unsaturated fatty acids (Beck et al., 1 989), an attempt was made to enhance this effect 
by including BSA as a lipid carrier. Added alone, BSA at concentrations of 50 and 1 00 
�g/ml induced a small but non-significant (P>0.05) increase in DNA yield (Figure 2.3). 
In contrast, the growth promoting effect of co-cultured mammary fat pad was 
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Figure 2.3 Effect of BSA and co-cultured mammary fat pad on COMMA- I D  cel l  
proliferation. Cells were cultured i n  the absence (0) or presence (. )  of mammary fat 
pad tissue with various concentrations of BSA for 5 days. Data points are means ± SEM 
(n=3 without fat pad, n=4 with fat pad). Similar responses were obtained in 2 separate 
experiments. a,h,c Means with different superscripts are significantly different (P<0.05). 
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It was tested whether the proliferative effect of co-cultured fat pad could be attributed to 
the presence or synthesis of prostaglandins. Addition of 0.5 Ilg/ml PGE2 did not mimic 
the effect of co-cultured mammary fat pad, nor was there a response to PGE2 in the 
presence of co-cultured fat pad (Figure 2.4) . Indomethacin (5 Ilg/ml), an inhibitor of the 
cyclooxygenase pathway of prostaglandin synthesis, did not attenuate (P>0.05) the 
growth promoting effect of mammary fat pad. 
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Figure 2.4 Effect of PGE2 (0.5 Ilg/ml)  and indomethacin (Indo; 5 Ilg/ml) on the growth 
of COMMA- I D  cells. Cells were cultured for 7 days in the absence or presence of 
mammary fat pad explants. Data are means ± SEM (n=6). a,b Means with different 
superscripts are significantly different (P<0.05). 
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Having demonstrated a mitogenic effect of co-cultured fat pad on COMMA- I D  cells ,  
the abil ity of this activity to modulate the effects of several other mitogens was 
investigated. Supplementation of BM with insulin ( 1 0  Jlg/ml) increased (P<0.05) cell 
number by 2.3-fold while there was no response (P>0.05) to either prolactin or 
hydrocortisone (Figure 2.5). There was a significant interaction (P<O.OOI )  between the 
effects of co-cultured fat pad and insulin, increasing final DNA yield to 22. I -fold that in 
BM only. There was no effect (P>0.05) of prolactin in the presence of co-cultured 
mammary fat pad in any treatment combination. In contrast, hydrocortisone 
significantly (P<0.05) attenuated the growth of COMMA- I D  cells  in response to co­
cultured mammary fat pad in all treatments. 
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Figure 2.5 Response of COMMA- I D  cells  to mammogenic hormones and co-cultured 
mammary fat pad. Cells were cultured for 7 days in various combinations of insulin 
(Ins; 1 0  Jlg/ml), prolactin (Prl ; 2.5 Jlg/ml), and hydrocortisone (HC; 2.5 Jlg/ml)  in the 
absence or presence of mammary fat pad. Data are means ± SEM (n=5). *P<0.05 
compared to the respective BM treatment. 
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Although growth hormone is a potent mammogen in vivo and in organ culture in vitro 
(Plaut et aI . ,  1 993), the final DNA level in COMMA- I D  cultures was unaltered 
(P>0.05) by rbGH ( l  Ilg/rnl)  in either the absence or presence of co-cultured mouse 
mammary fat pad (Figure 2.6). This concentration of rbGH has been previously shown 
to stimulate the proliferation of murine mammary epithelium in organ culture (Plaut et 
al. , 1 993) . 
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Figure 2.6 Effect of rbGH ( l  Ilg/ml) on COMMA- I D  cel l  growth in the absence or 
presence of co-cultured mammary fat pad. Cells were cultured for 5 days in BM alone 
or BM supplemented with rbGH. Data are means ± SEM (n=5). Results are 
representative of those obtained in 2 separate experiments. t=O represents cel l  number 
at the initiation of treatments (n=4). a,b Means with different superscripts are 
significantly different (P<0.05). 
A number of reports have demonstrated that the in vivo and in vitro proliferation of 
mammary epithel ial cells is stimulated by IGF-I and EGF. Supplementation of BM with 
IGF-I, EGF, or IGF-I + EGF increased (P<0.05) final cel l  number by 2.5-, 3 .7-, and 4.6-
fold, respectively (Figure 2.7). Co-culture of COMMA- I D  cells with mammary fat pad 
increased DNA yield by 6.8-fold. There was a significant interaction (P<O.OO I )  between 
the effects of mammary fat pad and both IGF-I and EGF whereby final DNA yields were 
2 1 .2- and 1 3 .3-fold that in BM alone. Final cell number in the combined presence of 
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IGF-I + EGF and mammary fat pad was the additive response to the individual growth 
factor interactions. 
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Figure 2.7 Response of COMMA- I D  cells to growth factors and co-cultured mammary 
fat pad. Cells were cultured for 7 days in BM, IGF-I (75 ng/ml) and/or EGF (25 ng/ml) 
in the absence or presence of mammary fat pad. Data are means ± SEM (n=5). Results 
are representative of those obtained in 4 separate experiments. a,b,c Means with different 
superscripts are significantly different (P<0.05). 
Figure 2.8 depicts photomicrographs of COMMA- I D  cells cultured for 5 days in these 
treatments. Cells  cultured in BM either alone or supplemented with IGF-I + EGF 
displayed similar morphology at their respective final density (Figures 2.8a and 2.8b). 
Co-culture with mammary fat pad alone induced subconfluent cells to assume a more 
diffuse morphology (Figure 2.8c). The marked proliferative response to IGF-I + EGF in 
co-culture was associated with a high final density of cells  with a typical, cobblestone­
l ike morphology (Figures 2.8d and 2.8e). These cultures were also characterised by the 
formation of numerous multicellular domes above the confluent monolayer (Figures 
2.8d and 2.8e). The growth of cell s  in this treatment may not be contact-inhibited as it  
has been observed that cells overgrow onto zones of already confluent cells after longer 
culture periods. The raised domes were not evident on monolayers cultured in 1 0% FCS 
for the same period (Figure 2.8f) . 
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Figure 2.8 Phase contrast photomicrographs of COMMA- I D  cells  after 5 days culture in 
various treatments. Cells were cultured in BM alone (A, 250x); BM supplemented with 
IGF-I (75 ng/ml) + EGF (25 ng/ml) (B, 250x) ; BM in the presence of co-cultured fat pad 
(C, 250x); BM plus IGF-I + EGF in the presence of co-cultured fat pad (D, 250x and E, 
500x); or BM supplemented with 10% FCS (F, 250x). Arrows indicate domes in co­
cultures supplemented with IGF-I + EGF (D and E). 
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2.5 DISCUSSION 
Previous in vitro studies using explants of mammary fat pad embedded in collagen 
(Carrington and Hosick, 1 985) and medium conditioned by mammary adipose tissue 
(Beck et aI., 1 989) have demonstrated that the mouse mammary fat pad is the source of 
a diffusible mitogenic factor(s). However, the requirement for the medium used in 
those studies to be supplemented with either serum or EGF and high concentrations of 
insulin left the question as to whether the mammary fat pad was the source of a direct­
acting mitogen, or whether a factor(s) from the mammary fat pad was modulating the 
action of other mitogenic supplements. Here it has been demonstrated that a factor(s) 
from the mammary fat pad is both directly mitogenic for mammary epithelial cells and 
also markedly enhances the proliferative effect of specific mammogens. 
The nature of the mitogenic activity derived from the murine mammary fat pad, and of 
that which modulates the effect of other specific mitogens, remains to be elucidated. 
Beck et al. ( 1 989) ascribed the growth promoting effect of mammary adipose 
conditioned medium to adipocyte-derived unsaturated fatty acids. Unsaturated fatty 
acids have been shown to stimulate the proliferation of mammary epithelial cell s  in 
vitro, while saturated fatty acids inhibit cell growth (Wicha et aI., 1 979). In these 
experiments a 2- to 8-fold increase in cel l  number in response to co-cultured mammary 
fat pad was consistently recorded. The additivity of this effect and that of FCS suggests 
that the mitogenic activity from the mammary fat pad is either absent from FCS or that 
it is only present in FCS at suboptimal concentrations. That the effect of co-cultured fat 
pad may be due to its l iberation of unsaturated fatty acids coincides with the finding that 
relative to rat serum, FCS-supplemented medium does not support the growth of 
mammary tumour cel ls  in vitro due to a deficiency of linoleic acid (Kidwell et al. , 
1 978). 
In an attempt to increase the mitogenic effect of mammary fat pad, co-cultures were 
supplemented with BSA as a carrier of free fatty acids (Nilausen, 1 978). Surprisingly, 
increasing concentrations of BSA attenuated the response to co-cultured fat pad in a 
dose-dependent manner. One explanation for this response may be that excess BSA 
competed for free unsaturated fatty acids to make them unavailable for cellular 
util isation (Spector, 1 986). Likewise, there may be discrete differences in the way that 
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BSA modulates the effects of certain mitogens, as the growth of COMMA- I D  cells  in 
response to EGF differs in the presence of ovalbumin and BSA (Riss and Sirbasku, 
1 987). 
Unsaturated fatty acids may be further processed into eicosanoid derivatives such as 
prostaglandins to subsequently stimulate mammary cel l  proliferation (Rudland et al. , 
1 984). As PGE2 did not simulate the effect of co-cultured mammary fat pad, and the 
cyc100xygenase inhibitor indomethacin did not abolish the effect of mammary fat pad in 
these experiments, the influence of prostaglandin derivatives in this response is unlikely. 
The growth of COMMA- I D  ce]]s in response to BM supplemented with IGF-I, EGF and 
insulin was similar to that previously reported for both primary and cell l ine mammary 
epithelial cell s  in vitro (Imagawa et al., 1 982; Riss and Sirbasku, 1 987). It is likely that 
the concentration of insulin used here mimicked the effects of IGF-I (Imagawa et aI., 
1 986). Of specific interest, however, was the marked interaction that occurred between 
the proliferative effects of these mitogens and a factor(s) from co-cultured mammary fat 
pad. 
Recent findings indicate that unsaturated fatty acids and their hydroxy fatty acid 
derivatives enhance the mitogenic effect of EGF on mammary epithelial cells 
(Bandyopadhyay et al. ,  1 987; Bandyopadhyay et aI. ,  1 988) and 3T3 fibroblasts (Eling 
and Glasgow, 1 994), an effect which involves increased intracellular signalling through 
an upregulation of protein kinase C (Bandyopadhyay et al., 1 993 ; Sylvester et aI., 1 994). 
It has not been reported whether unsaturated fatty acids can amplify the intracellular 
signals initiated by IGF-I in mammary epithelial cells .  Given that the insulin and IGF-I 
receptors, similar to the EGFR, possess protein-tyrosine kinase activity (Pessin, 1 994), it 
is possible that exogenous unsaturated fatty acids incorporated by the mammary 
epithelial cell could also enhance the mitogenic actions of other growth factors . The 
observation that hydrocortisone suppressed the effect of mammary fat pad and its 
interaction with insulin may further implicate unsaturated fatty acids in these responses 
as another glucocorticoid, dexamethasone, suppresses cel lular protein kinase C activity 
(Zor et al., 1 990) and also inhibits EGF-induced proliferation and prostaglandin 
formation in BALB/c 3T3 fibroblasts (Nolan et aI. , 1 988). 
In contrast, co-culture with mammary fat pad did not facilitate a response to other 
recognised mammogenic factors such as prolactin, rbGH or PGE2• The reason 
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underlying this specificity is unclear. It may be that the modulatory effect of the 
mammary fat pad is restricted to certain mitogenic pathways, or that response to the 
latter agents in co-culture requires additional influences such as an appropriate 
extracellular matrix (Salomon et ai., 1 98 1 ) .  
However, it is also possible that the stimulatory effect of co-cultured mammary fat pad 
recorded in these experiments is due to other paracrine mitogens derived from the 
mammary fat pad. Hepatocyte growth factor is mitogenic for mammary epithelial cells 
and is secreted by cultured mammary fibroblasts (Sasaki et al. ,  1 994) and adipocytes 
(Rahimi et al. , 1 994). The mouse mammary fat pad is also a source of acidic- and 
basic-fibroblast growth factor (Chakravorti and Sheffield, 1 996), both of which are 
mitogenic for COMMA- ID  cells (Riss and Sirbasku, 1 987). The stimulatory effect of 
these mitogens, however, is typically additive to, and not interactive with, the effects of 
IGF-I and EGF (Rahimi et al., 1 994; Enami et aI. , 1 987; Riss and Sirbasku, 1 987). 
This investigation of the mitogenic capacity of the mammary fat pad has been facilitated 
by the use of the COMMA- ID  cell line cultured in a hormone- and serum-free medium. 
COMMA- I D  cel ls cultured under similar conditions have been used to bioassay the 
mitogenic effect of tissue extracts as well as that of various hormones and growth 
factors (Riss and Sirbasku, 1987). This cell l ine exhibits characteristics of normal 
mammary epithelium including an ability to synthesise casein in vitro (Eisenstein and 
Rosen, 1 988) and to form both ductal and alveolar structures when inoculated into 
cleared mouse mammary fat pads (Danielson et aI. , 1 984). It has also been observed 
that NMuMG mammary epithelial cells demonstrate similar synergistic responses to co­
cultured mammary fat pad and growth factors (Chapter 3). 
Util ising COMMA- ID  cel ls, a simple and inexpensive co-culture system has been 
developed for studying epithelial-stromal interactions whereby explants of tissue such as 
mammary fat pad are floated at the gas:medium interface above a cell monolayer 
cultured on plastic or other substrata. Siliconised lens paper has been widely used in 
whole mammary gland organ culture (Plaut et al. , 1 993) to permit the bi-directional 
diffusion of soluble factors between culture medium and the floated tissue. An 
alternative system incorporates a wire grid to support explants at the gas:medium 
interface (Levay-Young et al., 1987). However, the potential sedimentation of non­
adherent cel ls from tissue explants onto the monolayer under study would likely 
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confound cell growth assays. No such sedimentation onto bare plastic has been 
observed when using siliconised lens paper. This approach also allows the cellular 
components of the mammary fat pad to remain arranged in an in situ form and may 
more accurately represent intercellular associations that occur within the mammary fat 
pad in vivo. This contrasts to other systems where isolated epithelial and fibroblast cells 
are co-cultured directly together (Wang and Haslam, 1 994) or in compartments 
separated by a permeable membrane (Ip and Darcy, 1 996) . 
The present findings demonstrate that the murine mammary fat pad is the source of a 
diffusible mitogenic activity which markedly enhances the proliferation of mammary 
epithelial cells in response to certain mitogens. Given that growth factors such as IGF-I 
and EGF have been implicated in stimulating both normal mammary development and 
mammary tumorigenesis (Ruan et al. , 1 995; Coleman et ai. , 1 988 ;  Dickson and 
Lippman, 1 995), the regulation of their mitogenic effect by the mammary fat pad may 
represent an important local growth regulatory mechanism within the mammary gland. 
The nature of this activity and the role it serves during mammogenesis will be the focus 
of future investigation. 
CHAPTER 3 
MOUSE MAMMARY FAT PAD SPECIFICALLY 
REGULATES GROWTH FACTOR-INDUCED 
PROLIFERATION OF MAMMARY EPITHELIAL 




The objective of this study was to characterise the abi l ity of the mouse mammary fat 
pad to stimulate the growth of mammary epithelial cells and to modulate their 
responsiveness to polypeptide growth factors. Treatment of COMMA-ID cells with 
various concentrations of insulin-like growth factor (IGF)-I, epidermal growth factor 
(EGF) or insulin in a defined, hormone-free basal medium (BM) stimulated small 
increments of growth. In contrast, these mitogens stimulated marked proliferation in the 
presence of co-cultured mammary fat pad. Final DNA levels increased asymptotically 
in response to increasing concentrations of lGF-I, EGF and insulin to realise maximum 
values that were 45-, 29-, and 24-fold that in BM only, respectively. Using medium 
conditioned by mammary fat pad tissue (conditioned medium; CM) it was shown that 
the mitogenic and growth factor-modulating effects of the mammary fat pad were due to 
a diffusible factor(s), the mitogenic effect of which was additive to that of 1 0% FCS. 
The enhanced growth of COMMA-ID cells in response to IGF-I and EGF in CM could 
not be ascribed to an increase in the number of cell-surface receptors for these ligands; 
cells cultured in CM plus various mitogens consistently bound less IGF-I while EGF 
binding was unaltered or reduced by CM in these same treatments. Furthermore, 
potentiation of mitogenic stimulation by the mammary fat pad is  apparently specific for 
certain growth factors as COMMA-ID responsiveness to fibroblast growth factors 
(FGFs) and IGF-II was essentially unaltered in  the presence of mammary fat pad­
derived activity. Whereas several different cell types grew in response to co-cultured 
mammary fat pad alone, only some cell lines, in particular normal mammary epithelial 
cell l ines, demonstrated additional interactive growth responses to IGF-I and EGF. 
These findings indicate that the mammary fat pad may be an important regulator of 
mammary epithelial cell growth, particularly by its provision of a diffusible activity that 
markedly enhances the mitogenic effects of certain growth factors. 
3.2 INTRODUCTION 
The postnatal proliferation of mammary epithelial cells within the stromal matrix of the 
mammary fat pad is influenced by a variety of systemic and local factors (Imagawa et 
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al., 1 994). Classical experiments finnly established that several key honnones are 
required to achieve nonnal and fully functional mammary gland development (Nandi, 
1 958). More recent findings suggest that polypeptide growth factors, particularly those 
of local derivation, may also function to regulate this  development (Imagawa et al., 
1 994). Specific attention has been given to the role that these growth factors may serve 
in locally mediating the actions of systemic honnones during normal and neoplastic 
mammary gland growth (Dickson and Lippman, 1 995). 
Growth factors from several families have been implicated as paracrine and/or autocrine 
mitogens for mammary epithelial cells in vivo. The IGFs (lGF-I and -11) are potent 
mitogens for normal and neoplastic mammary epithelial cell s  in vitro (Lee and Yee, 
1 995) and are expressed by constituents of the mammary stroma (Ell is et al., 1 994; 
Chapter 9). Furthermore, the mammogenic effect of both growth hormone and 
oestrogen may be locally mediated by IGF-I (Ruan et al., 1 995), while the stromal 
expression of IGF-II may be particularly responsive to local epithelial influence (Singer 
et al., 1 995). 
Members of the EGF family such as EGF and transforming growth factor-a (TGF-a), 
have a recognised mitogenic effect on mammary epithelium in vitro (Plaut, 1 993) and 
exert pronounced effects on the nonnal and tumorous mammary gland in vivo (Kurachi 
et al., 1 985; Vonderhaar, 1 987). The cel lular expression of EGF and EGF-like factors 
within the mammary gland (Liscia et al., 1 990; Snedeker et al., 1 99 1 )  suggests they 
may act via both paracrine and autocrine pathways. Furthermore, an upregulation of 
TGF -a within the mammary gland may account for the combined mammogenic effect 
of the ovarian steroids, oestrogen and progesterone (V onderhaar and Plaut, 1 992). 
Several reports have demonstrated that the FGFs are mitogens for mammary epithelial 
cells in vitro (Levay-Young et al., 1 989; Imagawa et ai. , 1 994b) and are expressed 
within the mammary gland (Rudland et al., 1 993; Chakravorti and Sheffield, 1 996a). 
Although their precise physiological role has not been established, FGF expression 
within the mammary gland is regulated by several mammogenic hormones (Chakravorti 
and Sheffield, 1 996b; Chapters 1 0  and 1 1 ) and is  altered during mammary 
tumorigenesis (Penault-Llorca et al., 1 995). 
While these growth factors are potent mitogens for mammary epithelial cells in vitro, 
evidence suggests that their effects in vivo may be modulated by other soluble and 
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physical factors within the mammary gland. For example, the mitogenic effect o f  basic 
FGF is regulated by heparan sulfate proteoglycans that form part of the extracellular 
matrix (Blum et al. , 1 989a; Barraclough et al., 1 990). Furthermore, mouse mammary 
epithelial cells grow in close association with adipocytes of the mammary fat pad and 
are exposed to a local enrichment of fatty acids (Bandyopadhyay et al., 1 995) which 
may increase the responsiveness of mammary epithelial cells to the proliferative effect 
ofEGF (Bandyopadhyay et al., 1 988; Sylvester et ai., 1 994). 
Further evidence for such growth modulation within the mammary gland was recently 
obtained whereby the proliferation of mouse mammary epithelial cell s  in response to 
insulin, IGF-I and EGF was markedly enhanced in the presence of co-cultured 
mammary fat pad (Chapter 2). Given this fmding and the likely role for these and other 
growth factors during mammogenesis, the objective of this study was to further 
characterise the specificity and mechanisms of this in vitro effect of the mammary fat 
pad. Here it is reported that the mammary fat pad enhances the responsiveness of 
mammary epithelial cells to specific growth factors via a diffusible factor, and that this 
mechanism of growth regulation may be particularly relevant to epithelial proliferation 
within the mammary gland. 
3.3 MATERIALS AND METHODS 
3.3.1 Materials 
Dulbecco' s  Modified Eagle's Medium (DMEM) , Dulbecco's  Modified Eagle's/Ham's 
F 1 2  (DMEIF 1 2, 1 : 1 ) and foetal calf serum (FCS) were from Gibco (Grand Island, NY). 
Dispase was from Boehringer Mannheim (Germany). Na_ 1
25I was obtained from NEN 
(Wilmington, DE). Aquasi l  and Iodo-Gen were from Pierce (Rockford, IL). 
Recombinant human IGF-I was from Genentech (San Francisco, CA), recombinant 
human IGF-II was from Eli Lilly (Indianapolis, IN) and recombinant human 
keratinocyte growth factor (KGF) was from R and D Systems (Minneapolis, MN). All 
other reagents were purchased from Sigma (St Louis, MO). Acidic- and basic-FGF 
were from bovine brain and mouse EGF was tissue culture grade. 
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3.3.2 Cell culture 
COMMA- I D  nonnal mouse mammary epithelial cells used in these experiments have 
been characterised previously (Danielson et aI. , 1 984). Cells were routinely maintained 
in growth medium comprising DMEIF1 2  supplemented with FCS (2%), EGF (5 ng/ml), 
insulin (6 �g/ml), bovine serum albumin (BSA; 0.3 mg/ml), penicil l in ( 1 00 ID/ml) and 
streptomycin (0. 1 mg/ml). Other cell lines used were L6 myoblasts, HeLa human 
cervical carcinoma, Wi-38 human embryonic lung fibroblasts, C 1 27 mouse mammary 
tumour, NLFK feline kidney epithelium, and NMuMG nonnal murine mammary 
epithelial cells. All cell lines were maintained in the same growth medium as 
COMMA-I D  cell s  and were passaged weekly. 
Cells for proliferation experiments were seeded into 24-well plates (Falcon) for 24 h 
after which they were rinsed with PBS and quiesced for a further 48 h in 0.5 ml of 
defined, honnone-free BM comprised of DMEM supplemented with sodium 
bicarbonate (44 mM), penicillin ( 1 00 ID/ml) and streptomycin (0. 1 mg/ml). Treatments 
were then applied to the appropriate cultures. At the end of the culture period cell 
mono layers were rinsed with PBS and trypsinised. Cell suspensions were sonicated and 
DNA content measured by fluorimetry (Labarca and Paigen, 1 980) using calf thymus 
DNA as a standard. 
3.3.3 Co-cultures and conditioned medium 
Virgin female BALB/c mice were weaned at 2 1  days of age and then sacrificed by 
cervical dislocation. Mammary fat pad tissue devoid of endogenous epithelium 
(DeOme et aI., 1 959) was excised from the fourth abdominal mammary glands and 
diced into 5 - 10  mg explants (approximately 8mm3). COMMA-ID cell s  were co­
cultured with mammary fat pad tissue by floating an explant on lens paper above 
COMMA- I D  monolayers as described (Chapter 2). Co-cultures were incubated in 0.5 
ml of treatment medium for the first 3 days with a further 0.5 ml treatment medium 
added for the final 2 days. 
To prepare CM, mammary fat pad tissue was sectioned into explants (5- 1 0  mg) which 
were rinsed in BM and then incubated in BM (7.5 mg tissue/m!) for 48 h. Control BM 
was incubated for 48 h in the absence of mammary fat pad tissue. CM and BM were 
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collected, fi ltered (0.2 IJ.m) and added to cultures ( 1  mllwell) for 3 days. All 
supplements were added to CM and BM immediately prior to their use in  cultures. 
3.3.4 Ligand binding assays 
IGF-I (2 IJ.g) and EGF (2 IJ.g) were radiolabelled with 500 IJ.Ci Na_1
251 using the lodo­
Gen procedure (Fraker and Speck, 1 978). COMMA-I D  cells which had been plated ( 1  
x 1 05 cells/well) and quiesced as above were cultured for 3 days i n  either CM or BM ( 1  
ml) supplemented with various treatments. Treatment media were then aspirated and 
mono layers rinsed 3 times with ice-cold assay buffer (0. 1 M HEPES, 0. 1 2  M NaCI, 5 
mM KCI, 1 .2 mM MgS04, 8 mM glucose, 1 0  mg/ml BSA). Monolayers were 
incubated with radiolabelled IGF-I (7.2 x 1 04 cpmlwell for 20 h at 4°C) or EGF ( 1 .25 x 
1 05 cpmlwell for 8 h at 4°C) in  1 ml assay buffer. These conditions had been previously 
established to yield maximal binding (Appendices 3 and 4). Non-specific binding was 
determined in the presence of unlabelled ligand (500 ng/ml). Monolayers were then 
rinsed 3 times with ice-cold assay buffer and trypsinised. The cell suspension was 
sonicated and the bound radioactivity measured in a y-counter (Wallac, Finland). 
Binding of radiolabelled ligand in each well was adjusted for the respective DNA level. 
3.3.5 Statistical analyses 
Data were analysed by one- and two-way ANOV A using the GLM procedure of SAS, where 
individual means comparisons were performed by LSD. DNA yields of the various cell 
lines were transformed (log 1 0 + 1 )  prior to analysis. 
3.4 RESULTS 
3.4.1 Co-cultured mammary fat pad potentiates mitogenic stimulation 
Given previous results showing that the mouse mammary fat pad markedly potentiates the in 
vitro mitogenic effect of insulin, IGF-I and EGF (Chapter 2), the response of COMMA-I D  
cells to various concentrations of these mitogens in the absence and presence of co-cultured 
mammary fat pad was determined. The greatest response to IGF-I alone was a 1 .9-fold 
increase in final DNA yield at an IGF-I concentration of 1 50 ng/ml (Figure 3 . l a). 
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Figure 3.1 Concentration-response curves for mitogens added to cultures of COMMA-I D  
cells i n  the absence (0) or presence (_) of co-cultured mammary fat pad. Cells were 
cultured for 5 days with various concentrations of (A) IGF-I, (B) EGF, or (C) insulin. 
Data are means ± SEM (n=5). a,b,c Means with different superscripts are significantly 
different (P<O.05). 
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Co-cultured mammary fat pad in BM stimulated a l O. l -fold increase (P<0.05) in total DNA. 
Increasing concentrations of IGF-I in the presence of co-cultured mammary fat pad 
asymptotically raised final DNA levels to a maximum response at an IGF-I concentration of 
1 50 ng/ml that was 45-fold that in BM alone. 
Supplementation of BM with EGF induced small increases in total DNA, where the 
maximum response was realised at an EGF concentration of 10  ng/rnl (Figure 3. l b). This 
mitogenic effect was markedly potentiated by co-culture with mammary fat pad whereby 
final DNA yield increased asymptotically to a maximum 29.2-fold elevation at an EGF 
concentration of 100 ng/rnl. 
Insulin added alone at concentrations up to 20 �g/rnl induced small, but non-significant 
(p>0.05), amounts of cell growth (Figure 3 . 1c). When added in combination with co­
cultured fat pad, insulin initiated substantial growth responses by cultures of COMMA-I D  
cells. The maximum response to insulin in co-culture was a 24.2-fold increase in DNA yield 
at an insulin concentration of I �g/rnl. 
3.4.2 In vitro effects of the mammary fat pad are due to a diffusible activity 
The co-culture approach demonstrated not only that the mammary fat pad promotes a 
mitogenic response by mammary epithelial cells, but that it also enhances their 
proliferative response to growth factors. Within this system, however, it was not 
possible to determine whether these growth factors elicited their effect by acting directly 
on epithelial cells, or if they induced co-cultured mammary fat pad to release a 
secondary mitogenic stimulus. To resolve this issue CM was prepared to which specific 
mitogens were subsequently added. 
Increasing proportions of CM induced a linear increase in [mal DNA yield after 3 days 
culture (Figure 3 .2a). When medium supplemented with 1 0% FCS was similarly 
conditioned, an asymptotic response to the mitogenic stimulation from the mammary fat 
pad was evident (Figure 3.2a). The growth of mammary epithelial cells  in response to 
growth factors added to increasing levels of CM was then examined. EGF -stimulated 
growth was increased with the proportion of CM, where a maximal 2-fold increase in 
total DNA was realised in 1 00% CM plus EGF (Figure 3 .2b). Increasing levels of CM 
produced an asymptotic growth response up to 100 ng/ml IGF-I; the maximum response 
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Figure 3.2 Response of COMMA- I D  cells to increasing concentrations of CM 
supplemented with mitogens. (A) COMMA-I D  cells were cultured for 3 days in  1 ml of 
medium containing various proportions of CM (0) or 10% FCS similarly conditioned by 
mammary fat pad tissue (.). Dilutions were made using BM and 10% FCS, respectively. 
a,h,c Means with different superscripts are significantly different (P<0.05). (B) COMMA­
I D  cells were cultured for 3 days in various proportions of CM (final volume 1 ml) without 
supplement (0), or in the presence of25 ng/ml EGF (.), 1 00 ng/ml IGF-I (D) or IGF-I + 
EGF (T). Data are means ± SEM (n=3). 
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COMMA-I D  cells in response to IGF-I + EGF was also increased asymptotically to 
reach a maximum 6. 1 -fold increase in final DNA in 1 00% CM. 
3.4.3 Mitogenic potentiation by the mammary fat pad is growth factor-specific 
It was of interest to determine whether a diffusible activity from the mammary fat pad 
could enhance the responsiveness of COMMA-I D  cells to other growth factors. Acidic 
FGF added to BM induced a small but non-significant (P>0.05) increase in final DNA 
after 3 days (Figure 3 .3a), a tendency which was also evident in the presence of lGF-I or 
EGF. Whereas the mitogenic effect of CM interacted with that of both IGF-I and EGF, 
no such interaction occurred between CM and aFGF. Acidic FGF enhanced the 
mitogenic effect of IGF-I in both BM and CM but attenuated the response to EGF and 
IGF-I + EGF in CM. 
While the supplementation of BM with bFGF did not alter the final amount of DNA, it 
tended (P<O. I )  to attenuate the mitogenic effects of IGF-I and IGF-I + EGF in BM 
(Figure 3 .3b). Similar to aFGF, bFGF did not interact (P>0.05) with the effect of CM. 
Furthermore, addition of bFGF to CM suppressed the interaction between CM and IGF­
I or EGF, and reduced cell proliferation induced by their combination. 
The effect of KGF on COMMA-I D  cell growth was tested in a separate experiment. 
Supplementation of BM with KGF did not effect an increase in final DNA yield (Figure 
3 .3c). KGF stimulated increased growth in the presence of IGF-I (P<0.05), but not in 
the presence of EGF or IGF-I + EGF. There was no additional growth in response to 
KGF in the presence of co-cultured fat pad either alone or with the various combinations 
of lGF-I and EGF. 
The growth of COMMA-I D  cells in response to IGF-II in the absence and presence of 
co-cultured mammary fat pad was also assessed. Addition of lGF-II to BM stimulated a 
small increase (P<0.05) in final DNA yield at an IGF-II concentration of 250 ng/ml 
(Figure 3 .3d). Co-cultured mammary fat pad alone increased (P<0.05) final DNA levels 
and facilitated a small increment of growth in the presence of increasing concentrations 
of lGF-II, but not to the extent of that promoted by IGF-1. 
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Figure 3.3 Growth of COMMA- I D  cells in response to growth factors in CM or in co­
cultures. (A and B) Cells were cultured for 3 days in BM or CM supplemented with 
various combinations of IGF-I ( 1 00 ng/ml), EGF (25 ng/ml) and either (A) acidic-FGF 
(5 ng/ml) or (B) basic FGF (5 ng/ml). (C) COMMA-I D  cells were cultured for 5 days 
in combinations of IGF-I, EGF and KGF (25 ng/ml) in the presence or absence of co­
cultured mammary fat pad. *P<0.05 vs the respective mean without FGF. (D) In a 
separate experiment, COMMA-I D  cells were cultured for 4 days in various 
concentrations of IGF-II in the absence (0) or presence (-) of co-cultured mammary fat 
pad. Bars indicate cell growth responses to IGF-I ( 1 00 ng/ml) in the absence or 
presence of co-cultured mammary fat pad. Data are means ± SEM (n=3). a,h,c Means 
with different superscripts are significantly different (P<0.05). 
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3.4.4 Effect of mammary fat pad on IGF-I and EGF receptors 
To begin investigating how the mitogenic effect of IGF-I and EGF might be modulated 
by an activity from the mammary fat pad, binding of these ligands to COMMA-I D  cells 
was examined. Relative to that in BM, IGF-I binding was reduced (P<0.06) after 3 days 
culture in CM, and CM tended (P<0. 1 5) to exert a similar effect in the presence of EGF 
(Figure 3 .4a). Cells cultured in the presence of IGF-I or IGF-I + EGF alone 
demonstrated marked reductions in IGF-I binding; in the latter treatment binding was 
further suppressed (P<O.OI )  in the presence of CM. Whereas IGF-I binding was 
unaltered (P>O.4) by insulin alone, the amount of IGF-I bound was reduced by 70% 
when cells were cultured in CM plus insulin. IGF-I binding was also reduced (P<O.OI )  
when cells were cultured in 1 0% FCS, and was further reduced when it was added to 
CM (P<O. l ) . 
Binding of EGF to COMMA- I D  cells was unaltered after 3 days culture in CM alone 
(Figure 3 .4b). When cells were cultured in BM plus IGF-I, the level of EGF bound 
doubled, although this response was partly suppressed (P<O.O I )  in CM. Similar 
responses were recorded for cultures supplemented with insulin. EGF binding was 
substantially downregulated (P<O.OO I )  when cells were cultured in medium 
supplemented with EGF. The reduction in EGF binding to cells after culture in 1 0% 
FCS was unchanged by culture in CM. 
3.4.5 Responses to mammary fat pad are cell type-specific 
It was examined whether the mitogenic and modulatory effects of co-cultured fat pad were 
specific to mammary epithelial cells. For all of the cell lines tested, co-cultured mammary 
fat pad increased final DNA levels to between 1 .8- and 5.2-fold that in BM alone (Table 
3 . 1) .  The normal mammary epithelial cell lines, COMMA-ID and NMuMG, demonstrated a 
marked proliferative response to the various mitogenic supplements in the presence of co­
cultured fat pad. HeLa epithelioid carcinoma cells, and to a lesser extent Wi-38 foetal lung 
fibroblasts, also displayed increased growth in response to certain mitogens when co­
cultured with mammary fat pad, while other cell types did not respond further. The various 
cell lines also differed in their ability to undergo further growth in response to the mammary 
fat pad above that stimulated by 1 0% FCS. 
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Figure 3.4 Specific binding of (A) IGF-I and (B) EGF to COMMA- I D  cells cultured in 
BM or CM supplemented with various treatments. Cultures which had been grown for 
3 days in 1 ml of BM or CM supplemented with IGF-I ( 1 00 ng/ml), EGF (25 ng/ml), 
IGF-I + EGF, insulin ( 1 0  J.lg/ml) or 1 0% FCS were then incubated with radiolabelled 
ligand. Non-specific binding was determined in the presence of 500 ng/ml unlabelled 
ligand. Specific binding values are adjusted for the DNA content of cultures. Data are 
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Cells seeded at 5 x 1 04 (COMMA- I D  and NMuMg) or 1 x 1 04 cells/well were quiesced and then cultured for 5 days in BM alone or in the 
presence of either IGF-I ( l OO ng/rnl), EGF (25 ng/rnl), IGF-I + EGF, insulin ( l 0  �g/rnl) or 1 0% FCS in the absence or presence of co-cultured 
mammary fat pad. * Final DNA values (n=3) are expressed as a proportion of that in the respective BM only treatment. a,b,c Means within a 






It was demonstrated in a previous study (Chapter 2) that co-cultured mammary fat pad 
markedly enhances the growth of mouse mammary epithelial cells in response to IGF-I, 
EGF, and a supraphysiological concentration of insulin. Given the magnitude of this 
response and the likely roles of these polypeptide mitogens during mammary 
development and tumorigenesis (Plaut, 1 993; Lee and Yee, 1 995 ; Panico et al., 1 996), 
the ability of the mammary fat pad to regulate the in vitro growth of mammary epithelial 
cells was further evaluated. 
As reported by others (lmagawa et a!., 1 982; Riss and Sirbasku, 1 987), mammary 
epithelial cells in the hormone-free BM displayed small increments of growth in 
response to a range of IGF-I and EGF concentrations. Over this same range, epithelial 
responsiveness to these mitogens was markedly upregulated by the presence of co­
cultured mammary fat pad. From their respective concentration-response curves, the 
EDso for IGF-I and EGF in the presence of co-cultured mammary fat pad was 
approximately 20 and 5 ng/ml, respectively. Similar low levels of IGF-I (Ruan et a!. , 
1 992; M. Weber, personal communication) and EGF (Vonderhaar, 1 984) within the 
mammary gland are associated with extensive epithelial proliferation. This leads to the 
suggestion that diffusible factors released from the mammary fat pad are an important 
component of IGF-I- and EGF-induced mitogenesis in vivo. Substantial mitogenic 
stimulation by supraphysiological levels of insulin was also recorded in co-culture. This 
effect was likely initiated via the type I IGF receptor (lmagawa et al., 1 986), consistent 
with results showing that the responses to IGF-I and insulin in the presence of co­
cultured mammary fat pad are not additive (Appendix 5). 
It was considered that the effect of IGF-I and EGF on COMMA-I D  cell growth in co­
cultures may have occurred indirectly through IGF-I and EGF receptors present in the 
mammary stroma (Edery et al., 1 985b; Daniel and Silberstein, 1 987; Hodgkinson et aI., 
1 99 1 ). Likewise, COMMA- I D  cells may have liberated soluble factors to induce the 
synthesis of para cri ne growth factors by the co-cultured mammary fat pad (Singer et al., 
1 995 ; Coleman-Krnacik and Rosen, 1 994). Using CM it was established that the 
observed effects of the mammary fat pad are due to a diffusible activity liberated 
independent of any influence by IGF-I, EGF or COMMA-I D  cells. This activity 
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initiated its effects in a dose-dependent manner, and its mitogenic effect was additive to 
that of 1 0% FCS as observed previously (Chapter 2). 
Subsequent experiments indicated that potentiation of IGF-I- and EGF-stimulated 
growth by a diffusible factor(s) from the mammary fat pad could not be ascribed to an 
increase in the number of cell-surface receptors for these ligands. In fact, culture in CM 
suppressed IGF-I binding in all treatments and reduced EGF binding in the presence of 
IGF-I and insulin. That IGF-I and EGF substantially down-regulated the number of 
their own receptors is consistent with the findings of others (Carpenter and Cohen, 
1 979; De Vroede et aI., 1 984). One possibility is that the mitogen-potentiating effect of 
CM was associated with a corresponding increase in receptor affinity for these ligands. 
However, it is also conceivable that CM amplified intracellular signalling after 
formation of the ligand-receptor complex. This notion is supported by the finding that 
the synergistic response to CM and IGF-I + EGF is abrogated upon inhibition of the 
lipid-activated signalling molecule, protein kinase C (Chapter 4). 
While a mitogenic factor(s) from the mammary fat pad enhanced the proliferative 
response to both IGF-I and EGF, this effect was specific in that no substantial 
interaction was observed with other growth factors including three FGFs (aFGF, bFGF 
and KGF), and IGF-II. That there was no increase in cell growth in response to these 
FGFs may reflect the culture conditions of these experiments, for separate experiments 
(Appendix 6) and others (Riss and Sirbasku, 1 987) have shown that they do induce 
COMMA-I D  cells to increase their DNA synthesis (as eH]-thymidine incorporation). 
Likewise, others have shown that these FGFs are mitogenic for mammary epithelial 
cells in vitro (Levay-Young et al., 1 989; Imagawa et al. , 1 994) and in vivo (Ulich et al. , 
1 994). 
The ability of the mammary fat pad to potentiate the mitogenic effect of specific growth 
factors may represent a local growth regulatory mechanism within the mammary gland. 
Specifically, the release of a diffusible activity by the mammary fat pad might allow 
maximum epithelial responsiveness to mitogens such as IGF-I and EGF at certain stages 
of development (plaut, 1 993; Chapter 9), even when other growth factors may be 
present (Niranjan et al., 1 995; Chakravorti and Sheffield, 1 996a). The specificity of 
growth factor potentiation by CM also corresponds to results which suggest that CM 
achieves its effect via protein kinase C (Chapter 4) for, whereas EGF and IGF-I 
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stimulate mitogenesis VIa protein kinase C dependent pathways, FGF-induced 
proliferation occurs independently of protein kinase C (Neri et al., 1 994). It will be of 
interest to determine whether the proliferation of mammary epithelial cells in response 
to other growth factors involved in mammary development such as hepatocyte growth 
factor (Niranjan et al., 1 995) and the transforming growth factors-a and -p (plaut, 1 993; 
Pierce et a!. , 1 993) can also be modulated by the mammary fat pad in vitro. 
Although the various cell types differed in their responsiveness to mitogens in BM, co­
cultured mammary fat pad stimulated the growth of all lines to DNA yields that were 2 
to 5-fold that in BM alone. This finding suggests that the mitogenic activity liberated 
by the mammary fat pad is either a broad spectrum mitogen or a generic requirement for 
cell growth. In contrast, only certain cell types, in particular normal mammary 
epithelial cells, utilised this activity to markedly enhance their proliferative response to 
IGF-I, EGF, and high concentrations of insulin. This may reflect the fact that mammary 
epithelium is rather unique in its requirement for a fatty stroma in which to develop 
(Ho shino , 1 978), and that its development is markedly influenced by IGF-I and EGF 
(Ruan et al., 1 992; Plaut, 1 993). Similar cell-specific growth regulation by the 
mammary fat pad has also been recorded in vivo, where only mammary and hair follicle 
epithelium develops when transplanted into the mammary fat pad (Sakakura et a!., 
1 979). It is likely that adipocytes of the mammary fat pad play an important role in this 
effect as the growth of transplanted mammary epithelium is supported in several adipose 
depots but not in other sites (reviewed by Hoshino, 1 978). Therefore, the mammary fat 
pad, particularly the mammary adipocytes, may liberate a diffusible factor(s) that meets 
specific and important requirements for the growth of mammary epithelium, particularly 
by increasing its responsiveness to certain growth factors. 
In conclusion, these findings demonstrate that a diffusible activity from the mouse 
mammary fat pad markedly potentiates the mitogenic actions of certain growth factors, 
an effect that may be particularly relevant to the proliferation of mammary epithelium. 
Current studies are focussed on identifying the nature of this factor(s) and the 
physiological implications of this potentially important growth regulatory mechanism. 
CHAPTER 4 
ROLE FOR MAMMARY FAT PAD-DERIVED 
UNSATURATED FATTY ACIDS IN POTENTIATING 
GROWTH FACTOR-STIMULATED GROWTH OF 




The stromal environment of the mammary fat pad plays a pivotal role in regulating the 
growth and morphogenesis of mammary epithelium. Mouse mammary fat pad tissue 
liberates an activity in vitro that stimulates the growth of mammary epithelial cells and 
markedly enhances their proliferative response to insulin-like growth factor-I (IGF-I) 
and epidermal growth factor (EGF). The present studies were undertaken to identify 
this activity and the mechanism by which its effects are achieved. The growth­
stimulating effects of medium conditioned by mouse mammary fat pad (CM) were not 
trypsin-labile but were heat-sensitive and were reduced by pH-dependent charcoal 
stripping. That these effects may be due to a bioactive lipid constituent coincides with 
the presence of unsaturated fatty acids in CM. Of several unsaturated fatty acids tested, 
linoleic acid and, to a lesser extent, arachidonic acid stimulated the growth of COMMA­
I D  cells and enhanced their proliferative response to the mitogenic effects of IGF-I + 
EGF. Furthermore, linoleic acid, similar to CM, potentiated the individual mitogenic 
effects of IGF-I and EGF, and was maxim ally effective at a concentration of 5 - 10  
Ilglml. Consistent with a ability to stimulate cell growth via enhanced intracellular 
signalling, CM, both alone and in the presence of IGF-I or EGF, stimulated tyrosine 
phosphorylation on several proteins in COMMA-I D  cells. The mitogenic response to 
CM either alone or in the combined presence of IGF-I + EGF was abolished by 
inhibiting the lipid-activated signalling mediator, protein kinase C (PKC). Taken 
together, these findings indicate that the mammary fat pad may fulfil an important role 
during mammogenesis by liberating unsaturated fatty acids to stimulate the growth of 
mammary epithelial cells and their responsiveness to specific growth factors via PKC. 
4.2 INTRODUCTION 
Postnatal development of the rodent mammary gland involves the ramification of 
mammary epithelium into the fatty stroma of the mammary fat pad (Imagawa et al., 
1 994). During this proliferation, epithelial cells are continually in close proximity to 
adipocytes (Imagawa et ai. , 1 994) with rapidly dividing cells in the terminal end bud 
abutting onto adjacent adipocytes (Williams and Daniel, 1 983). The importance of this 
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adipose environment is emphasised by the fact that mammary epithelium can only 
undergo normal growth and morphogenesis when transplanted to a depot of adipose 
tissue (reviewed by Hoshino, 1 978). 
What is unclear is the precise role that this fatty stroma serves in the local regulation of 
epithelial growth. Several studies have shown that the mammary fat pad is a source of 
paracrine growth factors (Chakravorti and Sheffield, 1 996a; Niranjan et al., 1 995; 
Chapters 9-1 1 )  which may mediate the actions of several hormones on the mammary 
gland (Chakravorti and Sheffield, 1 996b; Chapters 9- 1 1 ) .  Fatty acids released from 
mammary adipocytes and transported across the basement membrane may also 
influence epithelial proliferation (Bandyopadhyay et a/., 1 995). Specifically, 
unsaturated, but not saturated, fatty acids stimulate the in vitro growth of normal (Wicha 
et al., 1 979) and neoplastic (Kidwell et al. , 1 978; Wicha et a/. , 1 979) mammary 
epithelial cells. Other investigations have demonstrated that unsaturated fatty acids 
such as linoleic and arachidonic acid enhance the mitogenic effect of epidermal growth 
factor (EGF) on mammary epithelial cells (Bandyopadhyay et a/. , 1 987; Sylvester et al. , 
1 994), possibly by amplifying post-receptor signalling through PKC (Bandyopadhyay et 
a/. , 1 993 ; Sylvester et a/., 1 994). However, it has not been determined whether the 
mammary fat pad liberates unsaturated fatty acids to induce similar effects. 
It was shown in previous studies that the mouse mammary fat pad liberates a diffusible 
mitogenic factor(s) that markedly and specifically enhances the growth of mammary 
epithelial cells in response to IGF-I and EGF (Chapters 2 and 3). The objective of this 
study was to determine the nature of this mammary fat pad-derived stimulation and its 
mechanism of action. The results suggest that the mammary fat pad releases 
unsaturated fatty acids to markedly enhance the proliferative effects of both IGF-I and 
EGF on mammary epithelium. This response is likely associated with enhanced post­
receptor signalling via PKC. 
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4.3 MATERIALS AND METHODS 
4.3.1 Cell cultures 
The COMMA-I D  mouse mammary epithelial cell line (Danielson et al. , 1 984) used in 
these experiments was maintained under previously described conditions (Chapter 2). 
The defined, hormone-free basal medium (BM) comprised DMEM supplemented with 
sodium bicarbonate (44 mM), penicillin ( 1 00 ill/ml) and streptomycin (0. 1 mg/ml). 
4.3.2 Conditioned medium 
Medium conditioned by mouse mammary fat pad tissue (CM) was prepared as described 
(Chapter 3). Briefly, abdominal mammary fat pads devoid of endogenous epithelium 
were aseptically excised from weanling female BALB/c mice and then diced into 5- 1 0  
mg explants. CM was prepared by incubating mammary fat pad explants in B M  (7.5 
mg/ml) for 48 h and collecting the resultant CM. Control BM was similarly prepared in 
the absence of mammary fat pad tissue. All supplements were added to CM and BM 
immediately prior to their use in culture. 
4.3.3 Conditioned medium analyses 
Proteolysis was performed by incubating CM with trypsin (50 Jlg/ml, type XI, Sigma) 
for 4 h at 37°C. Trypsin was subsequently inactivated by adding a combination of 
soybean trypsin inhibitor (500 Jlg/ml; Sigma), leupeptin (1 Jlg/ml; Boehringer 
Mannheim) and aprotinin (2 Jlg/ml; Boehringer Mannheim) for a further 2 h. Trypsin 
that had been pre-neutralised with the same mixture of inhibitors served as a negative 
control. Proteolysis was confirmed by the ability of trypsin to abolish the mitogenic 
effect of lGF-I + EGF in the presence of CM (Appendix 7). 
Charcoal stripping of media was performed according to the method of Chen ( 1967). 
Briefly, CM and BM were incubated with activated charcoal (BDH; 2 mg/ml) for 1 h at 
4°C with continual swirling. Suspensions were centrifuged at 20 000 g for 20 mins, the 
supematant was then collected, filtered (0.2 Jlm) and added to cultures. Stripping was 
conducted at both pH 7.4 and 2 .5 ;  the latter pH increases the efficiency of fatty acid 
removal (Chen, 1 967). Acidified media was readjusted to pH 7.4 with 3 M NaOH 
before its addition to cultures. 
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CM and BM were also heated for 5 minutes at either 60°C or 1 00°C, filtered (0.2 �m), 
and added to COMMA- ID cultures. 
4.3.4 Cell growth experiments 
COMMA-I D  cells were plated into 24-well plates at 1 x 1 05 and 5 x 1 04 cells/well for 3 
and 5 day cultures, respectively. Treatments were added in 0.5 ml BM for the first 3 
days with treatment media for 5 day cultures replaced on day 3 .  Prostaglandin E2 
(PGE2; Sigma) and unsaturated fatty acids as sodium salts (Sigma) were prepared as 
ethanolic stocks; all medium treatments within an experiment contained the same 
concentration of ethanol. Linoleic acid-BSA (Sigma; 0.5 to 1 .0% linoleic acid) was 
dissolved in BM prior to use. Recombinant human IGF-I was from Genentech, and 
mouse EGF was from Sigma. At the end of the culture period cell mono layers were 
trypsinised and the amount of DNA determined by a fluorometric assay (Labarca and 
Paigen, 1 980). 
4.3.5 Western blotting 
Monolayers of COMMA-I D  cells which had been cultured in vanous medium 
treatments were rinsed with PBS plus orthovanadate and scraped in 1 00 ).11 loading 
buffer (Laemmli, 1 970). Samples were electrophoresed through a 1 0% polyacrylamide 
gel and transferred to nitrocellulose. Membranes were blocked for 1 h with 4% BSA in 
TBS-tween (0. 1 %) and then incubated overnight with a rabbit polyclonal anti­
phosphotyrosine antibody (Transduction Laboratories) in TBS-tween at a dilution of 
1 :500. Membranes were incubated with an anti-rabbit secondary antibody (Sigma, 1 :  1 0  
000), washed 4 times in TBS-tween, and immunocomplexes detected using an ECL kit 
(Amersham). 
4.3.6 Fatty acid analyses 
Total lipids were extracted from CM ( 135  mls) according to the method of Bligh and 
Dyer ( 1 959). The chloroform extract was evaporated under vacuum and the sample was 
then similarly re-extracted. Esterified and free fatty acids were derivatised to 
nitrophenylhydrazides as described by Miwa and Yamamoto ( 1 990) and separated 
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through a C-8 column by reversed-phase HPLC. Blank values were determined for BM 
that had been similarly extracted. 
4.3.7 Statistical analyses 
Data was analysed by one- and two-way analysis of variance using the GLM procedure 
of SAS, where individual means comparisons were by LSD. 
4.4 RESULTS 
4.4.1 Analysis of the mitogenic activity in CM 
The first experiments sought to identify the mitogenic and growth factor-potentiating 
activity present in mammary fat pad CM. An initial experiment revealed that these 
responses were unaffected by preincubating CM with trypsin (Table 4. 1 ) .  In a second 
experiment, cell growth induced by CM alone was reduced after CM was incubated with 
activated charcoal at pH 2.5 (Table 4. 1 ) .  The growth of COMMA-I D  cells in response 
to CM supplemented with IGF-I + EGF was reduced by preincubating CM with 
activated charcoal at pH 7.4, and was essentially abolished when it was similarly 
incubated at a pH of 2.5 (Table 4. 1 ) .  These mitogenic responses were also suppressed 
when CM was heated at 60°C, and were further reduced on heating to 1 00°C (Table 
4. 1 ). Other experiments have demonstrated that the mitogenic activity in CM is not 
depleted by incubating CM with heparin sepharose (Appendix 8), a treatment which 
removes a variety of heparin-binding polypeptide growth factors (Gospodarowicz et al., 
1 984). 
1 1 1  
Table 4.1 Effects of treatments applied to CM on the subsequent growth of COMMA­
I D  cells. 
Medium treatment alone + IGF-I + EGFt 
(I!g DNA/well) (I!g DNA/well) 
Expt. 1 BM+ 1 .8 ± 0. 1 a 4. 1 ± 0.5a 
CM+ 2.7 ± 0.2a 1 3 04 ± 0.8b 
CM + trypsin 2.4 ± O.3a 1 5 .7 ± 0.7c 
Expt. 2 BM 3.0 ± 0. l a 6 .5 ± OAa 
CM 4. 1 ± 0. 1 c 1 8 .9 ± OA
d 
CM + charcoal, pH 7 A 4. 1 ± O. lc 1 1 .8 ± 0.2c 
CM + charcoal, pH 2.5 3.6 ± 0. 1 b 7.5 ± 0.3b 
Expt. 3 BM 3.6 ± 0.2a 8 .2 ± 0.2b 
CM 6 . 1  ± 0.2d 22.5 ± OAd 
CM, 60aC 5.2 ± O. l c 1 8 .2 ± OAc 
CM, 1 00aC 4. 1 ± 0. 1 b 4.5 ± 0.2a 
COMMA- I D  cells ( 1  x 1 05 cells/well) were cultured for 3 days in 1 ml of treatment 
media. Data are means ± SEM (n=3) for final DNA yields. Each experiment was 
performed 3 times and the data is from one representative experiment. 
t Media were supplemented with IGF-I ( 1 00 nglml) and EGF (25 nglml). 
t Included pre-neutralised trypsin. 
a,b,c Within an experiment, means in a column with different superscripts are 
significantly different (P<0.05). 
That the effects of CM were insensitive to trypsin and could be removed by pH­
dependent charcoal stripping suggested that the mitogenic factor(s) present in CM was 
lipid in nature. Analysis of fatty acids in CM revealed that approximately two thirds of 
those present were in the free form, predominantly as palmitic and stearic acids (Table 
4.2). Relative to free fatty acids, triglycerides contained a much lower proportion of 
stearic acid and a far greater level of oleic acid. 
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a Concentrations of fatty acids as free fatty acids and as triglycerides were determined 
from an internal standard after HPLC analysis as described in Methods. 
4.4.2 Fatty acid effects on COMMA-ID cell growth 
Given that unsaturated fatty acids can stimulate the growth of mammary epithelial cells 
(Wicha et al. , 1 979) and enhance their proliferative response to EGF (Bandyopadhyay et 
al., 1 987;  Sylvester et aI., 1 994), the growth of COMMA-I D  cells in response to several 
unsaturated fatty acids was determined. When added to BM, linoleic acid and, to a 
lesser extent, arachidonic acid stimulated the growth of COMMA-I D  cells (Table 4.3). 
Prostaglandin E2, which may account for the effect of linoleic acid on mammary 
epithelial cell growth (Bandyopadhyay et aI., 1 988), induced an increase in the final 
yield of DNA. Linoleic acid also potentiated the mitogenic response to IGF-I + EGF, an 
effect achieved to a lesser extent by arachidonic acid. In contrast, the response to these 
growth factors was unaltered in the presence of PGE2• 
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Table 4.3 Effect of unsaturated fatty acids and prostaglandin E2 on the growth of 















alone + IGF-I + 
(I!g DNNwell) EGF
t 
2.8 ± O. lb 5.7 ± 0.2b 
2.5 ± O. l a 4.3 ± O.2a 
3 .2  ± O. l c 9 . 1  ± 0.7d 
3 .8 ± 0. l
d 9.9 ± O.2d 
3 .2  ± O. l c 7.3 ± O.4c 
3 .6 ± O. l
d 5 .2 ± 0.5ab 
COMMA- I D  cells ( 1  x 1 05 cells/well) were cultured for 3 days in 1 ml of BM 
supplemented with various treatments. Data are means ± SEM (n=3) for final DNA 
yields. 
a,b,c Means within a column with different superscripts are significantly different 
(P<0.05). 
t Medium was supplemented with IGF-I ( l OO ng/ml) and EGF (25 ng/ml). 
:\: Added as the sodium salt. 
¥ Linoleic-BSA at 1 mg/ml provides approximately 5- 1 0  �g linoleic acid/ml. 
The mitogenic effects of various concentrations of CM and linoleic acid-BSA were 
compared both alone and in the presence of IGF-I + EGF. As observed previously 
(Chapter 3), CM stimulated COMMA- I D  cell growth in a dose-dependent manner 
(Figure 4. 1 a). The maximum growth response was in 1 00% CM where the final DNA 
yield in the absence and presence of IGF-I + EGF was increased by 2.3- and 1 l .2-fold, 
respectively. Supplementation of BM with linoleic acid also increased final DNA levels 
in a dose-dependent fashion (Figure 4. 1 b); the maximum response in both the absence 
and presence of IGF-I + EGF was realised at a linoleic-acid BSA concentration of 1 
mg/ml (equivalent to 5-1  0 �g/ml linoleic acid). The respective DNA yields were 2. 1 -
and 7.4- times that in BM alone. Separate experiments demonstrated that BSA alone 
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Figur e 4.1 Growth of COMMA-ID cells in response to various concentrations of (A) 
CM and (B) linoleic acid-BSA added to cultures either alone (0) or in the presence of 
IGF-I + EGF (.) . CM dilutions were made using control BM. Linoleic acid-BSA 
contained between 0.5 and I % linoleic acid. Cultures were for 5 days and were 
incubated in 1 m! treatment medium which was replaced on day 3 .  Data are means ± 
SEM (n=3). 
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The ability of CM and linoleic acid-BSA to enhance the response of COMMA-ID  cells 
to the individual mitogenic effects of IGF-I and EGF was also assessed. Cultures 
supplemented with IGF-I andlor EGF demonstrated small increases in their final DNA 
yield (Figure 4.2). Both CM and linoleic acid-BSA stimulated cell growth alone and 
similarly potentiated the individual mitogenic effects of lGF-I and EGF. 
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Figure 4.2 Comparison of the mitogenic effects of CM and linoleic acid-BSA alone 
and in the presence of IGF-I andlor EGF. Cultures were grown for 3 days in 1 ml of 
CM or BM plus 1 mg/ml linoleic acid-BSA (0.5-1 % linoleic acid) either alone or in the 
presence of IGF-I ( l OO ng/ml) andlor EGF (25 ng/ml). Data are means ± SEM (n=3). 
4.4.3 Effects of CM on intracellular signalling 
The phosphorylation of tyrosine residues on COMMA-ID cell proteins was assessed to 
begin evaluating the intracellular responses to CM (Figure 4.3). Cells cultured for 30 
mins in CM + IGF-I demonstrated a pattern of tyrosine phosphorylation similar to that 
for cells cultured in BM supplemented with phorbol 1 2-myristate 1 3-acetate (PMA; 
Sigma), a tumour promoter and inducer of PKC in mammary epithelial cells (Wada et 
al., 1 994). After 6 h culture in CM either alone or plus IGF-I or EGF, several proteins 
with sizes of approximately 47, 42, 39, 34-36, 25 and 1 8  kDa demonstrated increased 
tyrosine phosphorylation compared to those in cells exposed to these treatments in BM. 
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Figure 4.3 Western blotting of protein tyrosine phosphorylation in COMMA- I D  cells 
following their incubation for 30 mins or 6 h in various medium treatments. Cells (2 x 
1 05/well) were cultured for the indicated time in BM or CM supplemented with IGF-I 
( 1 00 ng/ml), EGF (25 ng/ml) or PMA ( 1 00 ng/ml). The approximate molecular size of 
several tyrosine-phosphorylated proteins is indicated. 
Given that unsaturated fatty acids may enhance EGF-induced growth Via PKC 
(Bandyopadhyay et al., 1 993; Sylvester et al., 1 994), it was examined whether CM­
induced growth was influenced by 1 -0-hexadecyl-2-0-methyl glycerol (OHMG; 
Sapphire Biosciences), a specific inhibitor of PKC (Daniel et al. , 1 988;  Kramer et al. , 
1 989). While OHMG at concentrations above 1 IlM suppressed cell growth in BM and 
in the presence of IGF-I + EGF (Figure 4.4a), lower concentrations of OHMG 
substantially reduced the growth responses that were induced by CM alone or by the 
combined presence of CM and IGF-I + EGF (Figure 4.4b). 
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Figure 4.4 Effect of various concentrations of the PKC inhibitor, OHMG, on the 
growth of COMMA-I D  cells in (A) BM or (B) CM, either alone (0) or in the presence 
of IGF-I ( 1 00 ng/ml) + EGF (25 ng/ml) (.). Cells were cultured for 3 days in 1 ml of 
treatment medium. Data are means ± SEM (n=3). 
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4.5 DISCUSSION 
In previous studies it was identified that the mouse mammary fat pad releases a 
diffusible factor(s) in vitro that markedly stimulates the growth of mammary epithelial 
cells (Chapters 2 and 3). Several treatments within the present study, including 
proteolysis and charcoal stripping, strongly suggested that these effects were due to the 
presence of a bioactive lipid fraction. This suggestion was supported by the fact that 
cultured mammary fat pad tissue released unsaturated fatty acids into the incubation 
medium. The proportions of the various fatty acids in CM were similar to those 
reported by Beck et al. ( 1 989), although the total level of non-esterified fatty acids was 
somewhat lower than that recorded by others under similar conditions (Kidwell et al., 
1 982; Beck et al. , 1 989). This discrepancy is probably due to an inefficiency of the 
lipid extraction procedure used and it is likely that CM did in fact contain higher levels 
of the various fatty acids. 
The results of subsequent experiments indicated that linoleic acid, one of the 
unsaturated fatty acids in CM and the rodent mammary gland (Wicha et aI. , 1 979), 
likely accounts for a large proportion of the mitogenic effects induced by CM. This 
finding is consistent with an earlier report suggesting that the increased growth of 
preneoplastic mammary epithelial cells in response to a diffusible activity from the 
mammary fat pad was effected by unsaturated fatty acids (Beck et al., 1989). Likewise, 
several other studies have demonstrated that unsaturated fatty acids can directly 
stimulate the in vitro growth of normal (Wicha et al. , 1 979; Sylvester et al., 1 994) and 
neoplastic (Kidwell et al., 1 978; Beck et al., 1 989) mammary epithelial cells, while 
saturated fatty acids are generally inhibitory (Wicha et aI., 1 979; Sylvester et al., 1 994). 
Of the various unsaturated fatty acids, linoleic acid typically promotes the greatest 
independent stimulation of mammary epithelial cell growth (Kidwell et al. , 1 978;  Wicha 
et al., 1 979; Beck et al., 1 989). 
As well as its direct mitogenic effect, the diffusible factor from the mammary fat pad 
enhances the responsiveness of mammary epithelial cells to mitogenic stimulation by 
IGF-I, EGF and supraphysiological concentrations of insulin (Chapters 2 and 3) .  It was 
conceivable that these effects were also due to unsaturated fatty acids present in CM, 
given that EGF-induced proliferation of mammary epithelial cells is potentiated by 
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linoleic (Bandyopadhyay et al., 1 987; Bandyopadhyay et aI., 1 993) and arachidonic 
(Sylvester et aI., 1 994) acids. No link to date, however, has been established between 
this effect of unsaturated fatty acids and that due to the mammary fat pad; nor has the 
modulation of lGF-I induced mitogenesis by unsaturated fatty acids been demonstrated. 
These results indicate that linoleic acid, similar to an activity released from the 
mammary fat pad, potentiates the mitogenic effect of both IGF-I and EGF on mammary 
epithelial cells. This, to my knowledge, is the first demonstration that polyunsaturated 
fatty acids can enhance the responsiveness of mammary epithelial cells to the 
established proliferative effect of IGF-I (Imagawa et aI., 1 994). This has probably not 
been identified previously because of the intrinsic requirement for primary mammary 
epithelial cells to be maintained in a basal medium supplemented with a high 
concentration of insulin (Imagawa et al. , 1 982) which simulates IGF-I (Imagawa et al. , 
1 986). 
As well as showing that linoleic acid mimics the effects of CM, several other findings 
further the notion that unsaturated fatty acids from the mammary fat pad account for its 
in vitro effects on mammary epithelial cell growth. For example, COMMA- I D  cells co­
cultured with mammary fat pad in the presence of IGF-I + EGF form numerous dome 
structures (Chapter 2), as occurs in medium supplemented with linoleic acid and IGF-I 
+ EGF (personal observation). Furthermore, supplementation of mammary epithelial 
cultures with either linoleic acid (Bandyopadhyay et al., 1 993) or CM (Chapter 3) in the 
presence of insulin similarly reduces the binding of EGF to cell surface receptors. Also, 
the finding that BSA suppressed the mitogenic effect of co-cultured mammary fat pad 
on mammary epithelial cells (Chapter 2) may reflect a reduced availability of free 
unsaturated fatty acids (Spector, 1 986). COMMA-I D  cells co-cultured with ovarian 
adipose tissue demonstrate responses similar to those seen in co-culture with mammary 
fat pad (Appendix 1 0), strongly suggesting that this activity is liberated by adipocytes, 
and strengthening the likelihood that these effects are due to unsaturated fatty acids. 
The potentiation of ' IGF-I and EGF-induced mitogenesis by CM prompted an 
investigation into the mechanism( s) underlying this response. As this effect is not 
associated with increased ligand binding to the cell-surface receptor (Chapter 3), it was 
investigated whether it is achieved through enhanced intracellular signalling. Consistent 
with this suggestion, CM upregulated tyrosine phosphorylation of numerous proteins, 
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several of which may correspond to those phosphorylated in pnmary mammary 
epithelial cells grown in the presence of linoleic acid (Bandyopadhyay et aI. , 1 993). A 
similar pattern of protein tyrosine phosphorylation was observed in COMMA-I D  cells 
treated with the tumour promoter and PKC activator, PMA. Furthermore, the ability of 
OHMG to suppress the effects of CM suggests that a diffusible activity from the 
mammary fat pad potentiates IGF-I- and EGF-induced mitogenesis via the lipid 
activated signalling molecule, PKC. This coincides with the fact that both of these 
growth factors induce specific, rapid translocation of PKC-a to the nucleus (Neri et al. , 
1 994), where PKC-a is the major PKC isoform present in mouse mammary epithelial 
cells (Sylvester et al. , 1 994). 
Further consistent with this suggestion is the demonstration that unsaturated fatty acids 
enhance the mitogenic effect of EGF on mammary epithelial cells in association with an 
increased activity of PKC (Bandyopadhyay et al., 1 993 ; Sylvester et al. , 1 994). In 
contrast, the mitogenic effect of several fibroblast growth factors is not potentiated by 
CM (Chapter 3), corresponding to the fact that FGF stimulates cell proliferation through 
a PKC-independent pathway (Magnaldo et aI. , 1 986; Mohammadi et al. , 1 992; Virdee 
et al. , 1 994) and does not induce the nuclear translocation of PKC (Neri et al. , 1 994). It 
will be interesting to determine whether unsaturated fatty acids can enhance the 
proliferation of mammary epithelial cells in response to platelet-derived growth factor, a 
mitogen for mammary tumour cells (Miller and Bukowski, 1 994) that also induces the 
nuclear translocation of PKC (Neri et aI., 1 994). 
These findings lead to a suggestion that adipocytes within the mammary fat pad liberate 
unsaturated fatty acids, particularly linoleic acid, which subsequently modify the fatty 
acid composition of mammary epithelial cell membranes (Sylvester et al., 1 994). This 
may elevate PKC levels and allow maximal cell proliferation in response to IGF-I and 
EGF. Such a mechanism is of potential physiological importance given that both IGF-I 
and EGF are potent mitogens for normal and tumorous mammary epithelium in vivo 
(lmagawa et al., 1 994; Dickson and Lippman, 1 995). Furthermore, the expression of 
IGF-I and EGF-like factors within the mammary gland is upregulated by oestrogen 
and/or growth hormone (Liu et al., 1 987; Vonderhaar, 1 988; Ruan et al., 1 995), 
hormones which also stimulate lipolysis in adipocytes (Hansen et al. , 1 980; Rebuffe­
Scrive, 1 987). Therefore, these hormones may realise their mammogenic effect by 
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inducing the local synthesis o f  polypeptide growth factors and potentiating the growth 
factor-induced proliferation of mammary epithelial cells via a local release of 
unsaturated fatty acids. Mammary epithelium may also use this combinatory 
mechanism to regulate its growth given it can stimulate lipolysis in mammary 
adipocytes (Bartley et aI., 1 98 1 )  and growth factor expression in the adjacent stroma 
(Coleman-Krnacik and Rosen, 1 994; Kenney et al., 1 995; Singer et aI. , 1 995). 
Likewise, the mammogenic effect of prolactin may involve its action through the 
mammary epithelium (Kidwell and Shaffer, 1 984) to initiate the local release of 
unsaturated fatty acids from mammary adipocytes (Kidwell et al. , 1 982). 
Along these lines, the in vitro mitogenic capacity of the mammary fat pad is altered with 
hormonal changes during the oestrous cycle, and by the presence of endogenous 
mammary epithelium (Chapter 5). This mitogenic capacity also varies throughout the 
course of mammary gland development (Chapter 6) when there are substantial changes 
in lipid metabolism within the mammary gland (Bandyopadhyay et al., 1 995). 
Furthermore, it is well established that rodents fed a diet containing a high proportion of 
fat or unsaturated fatty acids have increased mammary gland growth and tumorigenic 
risk (Welsch and O'Connor, 1 989) whereas normal and neoplastic mammogenesis is 
impaired by a diet deficient in essential fatty acids (Knazek et al. , 1 980; Miyamoto­
Tiaven et al., 1 98 1 ), or which contains a high proportion of saturated fats (Karmali et 
al., 1 984). Given that the fatty acid composition of mammary epithelial cell membranes 
reflects that of the diet and the surrounding mammary fat pad (Welsch, 1 987), it is 
conceivable that dietary fat composition may regulate the development of normal and 
neoplastic mammary epithelium, at least in part, by influencing its ability to proliferate 
in response to specific growth factors. 
In conclusion, these results show that unsaturated fatty acids are liberated from the 
mammary fat pad and may subsequently enhance the proliferation of mammary 
epithelial cells in response to IGF-I and EGF. This growth potentiating effect and the 
potential for its hormonal and dietary regulation warrants further investigation as it may 
fulfil an important role in the developing normal and neoplastic mammary gland. 
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CHAPTER S 
MODULATION OF STEROID- AND GROWTH FACTOR­
STIMULATED GROWTH OF MAMMARY EPITHELIAL 
CELLS BY THE MAMMARY FAT PAD AND 




Ovarian steroid hormones exert pronounced effects on mammary epithelial growth and 
morphogenesis which may be mediated by the mammary gland stroma and its 
interaction with the mammary epithelium. COMMA- I D  mouse mammary epithelial 
cel ls have been used in a co-culture system to determine whether the mitogenic capacity 
of the mouse mammary fat pad is altered during the oestrous cycle. The influence of 
epithelial-stromal interaction was evaluated by comparing cel l  growth responses to 
mammary fat pad cleared of endogenous epithelium (CFP) and intact mammary tissue 
(MFP). When co-cultured in the presence of either oestrogen, progesterone, epidermal 
growth factor (EGF) , or insulin-like growth factor-I (IGF-D + EGF, there was a 
significantly (P<O.05) greater in vitro mitogenic response to mammary tissue removed at 
oestrus relative to the other stages of the oestrous cycle. In addition to this systemic 
regulation, mitogenic stimulation afforded by the mammary fat pad was influenced by 
the endogenous epithelium. There was a significantly (P<O.OI )  greater effect of MFP 
compared to CFP across the oestrous cycle in medium supplemented with either 
progesterone, IGF-I, EGF, or IGF-I + EGF. In contrast, there was no difference between 
the response to CFP and MFP in the presence of oestrogen either alone or in 
combination with progesterone (P>O.75). Furthermore, the growth of COMMA- I D  
cel ls  in response to oestrogen tended (P<O.08) to be increased by co-cultured mammary 
tissue while progesterone suppressed (P<O.05) the mitogenic effect of CFP. These 
effects were similarly evident in medium conditioned (CM) by CFP. Further 
investigation of the oestrogenic response revealed that CM increased the growth factor­
induced expression of a -55 kDa oestrogen receptor (ER) protein by COMMA- I D  cells. 
Taken together, these findings demonstrate that a growth-stimulatory activity is released 
from the mammary fat pad under hormonal and local regulation during the oestrous 
cycle; an activity that also differentially modulates the responsiveness of mammary 
epithelial cel l s  to oestrogen, progesterone and growth factors. Such findings are 
discussed in terms of the diverse roles proposed for mammary adipocyte-derived 
unsaturated fatty acids. 
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5.2 INTRODUCTION 
Accumulating evidence indicates that the growth and morphogenesis of normal and 
neoplastic mammary epithelium may be substantially influenced by its associations with 
the surrounding adipose and connective tissue matrix of the mammary fat pad 
(Sakakura, 1 99 1 ;  Cunha and Horn, 1 996) . The proliferation of epithelial cells within the 
mammary fat pad during this development also initiates an extensive reaction by the 
surrounding stroma (R�nnov-Jessen et al. , 1 996) . This reaction results in an array of 
stromal responses including increased DNA synthesis (Berger and Daniel, 1 983) and 
growth factor expression (Ellis et al., 1 994), altered levels of growth factor receptors 
(Daniel and Silberstein, 1 987) and lipolysis in adjacent adipocytes (Elias et al. , 1 973). 
Interaction between the epithelium and stroma may fulfil a crucial role during ovarian 
steroid-induced mammogenesis (Haslam, 1 988b). While oestrogen stimulates extensive 
proliferation by epithelial cells within the mammary gland and promotes their 
morphogenesis as ducts (reviewed by Haslam, 1987), mammary epithelial cells are 
general ly unresponsive to oestrogen in vitro (Richards et al., 1988). This paradox has 
led several groups to propose that the mammogenic effects of oestrogen are mediated by 
the stromal elements of the mammary gland (McGrath, 1 983;  Shyamala and Ferenczy, 
1 984; Haslam and Counterman, 1 99 1 ). Consistent with this, receptors for oestrogen 
exist within the mammary gland stroma as well as on mammary epithelium (Haslam and 
Shyamala, 1 98 1 ) . Furthermore, oestrogen stimulates DNA synthesis in stromal 
fibroblasts prior to the proliferation of proximal mammary epithelium (Shyamala and 
Ferenczy, 1 984). This response may coincide with the local expression of paracrine and 
autocrine growth factors (Dickson and Lippman, 1 987; Ruan et al. , 1 995; Chakravorti 
and Sheffield, 1 996b). While progesterone directly stimulates the in vitro proliferation 
of primary mammary epithelial cells (Edery et al. , 1 984; Imagawa et al. , 1 985), 
progesterone receptors also exist within the stroma (Haslam and Shyamala, 1 98 1 ), 
raising the possibil ity that progesterone acts on several mammary cell types to initiate a 
variety of responses (Haslam, 1 987; Selman et al. , 1 994). 
Alterations in the systemic profile of ovarian steroid and pituitary hormones during the 
oestrous cycle induce marked developmental changes within the mammary gland 
(Vonderhaar, 1 988). The rodent mammary gland is morphologically most developed at 
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oestrus and least developed at dioestrus (Lotz and Krause, 1 978). This corresponds to 
the formation of ductal end buds during the fol licular phase (Laguchev, 1 962) while the 
formation of alveolar buds may be initiated during the luteal phase (Dulbecco et aI., 
1 982; Vonderhaar, 1 988). DNA synthesis in mammary epithelial cells within ductal end 
buds peaks in pro-oestrus/early oestrus (Sutton and Suhrbier, 1 967; Dulbecco et al., 
1 982) while DNA synthesis and mitotic index in mammary epithelial cells of ductules is 
greatest at late oestrus-metoestrus (Dulbecco et al., 1 982) and dioestrus (Purnell and 
Kopen, 1 976), respectively. These cycles of ductal elongation and side branching in 
recurrent oestrous cycles result in an incremental increase in mammary gland 
development as the female approaches maturity (Lotz and Krause, 1 978; Vonderhaar, 
1 988). The significance of these acute cyclical changes is emphasised by the fact that 
stage of the oestrous cycle modifies the susceptibility of the mammary gland to 
chemically-induced carcinogenesis (Lindsey et al., 1 98 1 ;  Ratko and Beattie, 1 985). 
Recent investigations into the stromal regulation of mammary gland development have 
demonstrated that the mammary fat pad stimulates the in vitro growth of normal 
mammary epithelial cells and markedly enhances their responsiveness to the mitogenic 
effects of insulin, IGF-I and EGF (Chapters 2 and 3). The present study has investigated 
whether the ability of the mammary fat pad to modulate the growth of mammary 
epithelial cells in response to growth factors and ovarian steroid hormones is altered by 
hormonal changes during the oestrous cycle and by the endogenous mammary 
epithelium. Results show that the in vitro modulatory effects of the mammary fat pad 
vary during the oestrous cycle correspondent with marked changes in mammary gland 
development in vivo. Furthermore, these effects are regulated by the interaction of 
epithelium with the surrounding stroma, an association that may modulate epithelial 
responsiveness to ovarian steroid hormones. 
5.3 MATERIALS AND METHODS 
5.3.1 Animals 
BALB/c mice were maintained under standard conditions in the Ruakura Small Animal 
Colony with ad l ibitum access to food and water. Nulliparous females were mated to 
provide mice for the stage-of-oestrous cycle experiment, where the resultant litters were 
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standardised to 8 pups. Around the time of weaning at 2 1 -23 days of age, female pups 
were anaesthetised with Avertin (2.5%, 1 6  , .. dig BWT i .p.) and the epithelial mammary 
rudiment was excised from one abdominal #4 mammary gland to leave a mammary fat 
pad cleared of endogenous epithelium (CFP; Faulkin and DeOme, 1 960). The 
contralateral mammary gland remained intact (MFP) to allow normal mammary 
development. Operated females were subsequently housed at four per box. 
On the morning of sacrifice (at approximately 56 days of age), their stage of oestrous 
was determined from vaginal smears (Rugh, 1 967) as confirmed by vaginal appearance 
(Champlin et al. , 1 973). By this age the mammary ductal tree had filled approximately 
80% of the abdominal mammary fat pad. Four mice at each stage of the oestrous cycle 
[dioestrus (DI); pro-oestrus (PRO); oestrus (EST); and metoestrus (MET)] were selected 
to be the source of mammary tissue for in vitro co-culture experiments. 
5.3.2 Cell cultures 
The COMMA- I D  mouse mammary epithelial cell l ine (Danielson et al. , 1 984) was 
maintained under previously described conditions (Chapter 2). Cells were plated into 
24-well plates (5 x 1 04 cel ls/well) in 0.5 rnl hormone-supplemented growth medium. 
After 24 h attachment, monolayers were rinsed with PBS and quiesced in DMEM basal 
medium (BM) for a further 48 h .  
CFP and MFP tissue was aseptically excised from mice after sacrifice by cervical 
dislocation. These tissues were sectioned into explants (-8mm3, -7.5 mg) which were 
rinsed in BM prior to use in co-culture. Co-cultures of COMMA- I D  cells and 
mammary tissue were prepared as previously described (Chapter 2). Briefly, an explant 
of CFP or MFP was placed on a raft of siliconised lens paper and floated at the 
gas :medium interface of appropriate cultures. Explants were added to an initial 0.5 ml 
treatment medium, with a further 0.5 ml treatment medium added on day 3 .  Cultures 
were terminated after 5 days. Monolayers were trypsinised and their DNA content 
measured using a fluorometric assay (Labarca and Paigen, 1980). 
Conditioned medium (CM) was prepared by incubating epithelium-free mammary fat 
pad tissue in BM as described (Chapter 3) and was stored at -80DC without any adverse 
affect on its activity (Appendix 1 1 ) .  
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5.3.3 Assessment of mammary development 
Mammary gland development during the oestrous cycle was determined for mice which 
provided mammary tissues for co-cultures. Thoracic mammary glands were removed 
and spread on slides, fixed in Camoy's  fixative and defatted in acetone. Preparations 
were then stained with alum carmine, dehydrated through graded alcohols, clarified in 
toluene and photographed using a dissecting microscope. Photomicrographs were 
subjectively scored on a scale of 0 to 5 for both end bud development (0 = no end buds, 
5 = numerous large end buds) and alveolar development (0 = no alveolar ductules, 5 = 
numerous alveolar ductules) . Whole mounts were then embedded in paraffin and 
sectioned (5 �m) for histological examination. 
5.3.4 Estrogen receptor (ER) immunoblotting 
COMMA- I D  cells plated at 2 x 1 05 cells/well  were cultured for 48 h in either BM or 
CM treated with various supplements. Monolayers were rinsed with PBS and scraped in 
50 �l loading buffer (Laemm]j, 1 970). Samples of cel l  lysate (2 �g DNA) were 
electrophoresed through a 10% polyacrylamide gel under reducing conditions and 
transferred to nitrocellulose. After blocking in 4% BSA in TBS-tween, the membrane 
was incubated with a rabbit anti-rat ER antibody (FurIow et al. , 1 990) diluted 1 :  1000 in 
TBS-tween-O. l % BSA. The membrane was then washed in TBS-tween-O. l % BSA and 
incubated with horseradish peroxidase-conjugated anti-rabbit IgG (Sigma, 1 :  1 0 000 
dilution in TBS-tween-O. l % BSA). After the membranes had been washed four times 
in TBS-tween-O. l % BSA, immunoreactive proteins were detected using enhanced 
chemiluminesence (Amersham). 
5.3.5 Statistical analyses 
All statistical analyses were performed using SAS. Scores for mammary gland 
development during the oestrous cycle were analysed by one way ANOV A. Final co­
culture DNA levels in each medium treatment were analysed for effects of stage-of­
cycle and mammary tissue type and their interaction using the GLM procedure. 
Response to the individual medium treatments added to BM was analysed by Student' s  
t-test. Cell growth responses to CM, oestrogen, progesterone and their interactions were 
compared by the GLM procedure. 
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5.4 RESULTS 
5.4.1 Mammary gland development 
Morphology of the mammary gland parenchyma was markedly altered during the 
oestrous cycle. At dioestrus, mammary ducts demonstrated moderate amounts of side­
branching and alveolar budding (Figures 5 . l a  and 5 . l b). The regression of alveolar 
structures at pro-oestrus coincided with the formation of end bud structures at the tips of 
ma�ary ducts (Figures 5 . l c  and 5 . l d) .  By oestrus, bulbous end buds were evident at 
the tips of most ducts along with a general absence of alveolar budding (Figures 5 . l e  
and 5. 1 f). End buds had begun to regress at metoestrus coincident with some signs of 
alveolar branching (Figures 5 . l g  and 5 . l h) .  These substantial changes were also 
evidenced histologically, where the ductal end bud structures observed at oestrus (Figure 
5.2a) differed substantially from the ductal alveolar buds seen at dioestrus (Figure 5 .2b). 
Parenchymal morphology during the oestrous cycle was subjectively scored for end bud­
and alveolar development. Mean end bud score increased to a maximum at oestrus and 
was least at metoestrus (Table 5 . 1 ) . Conversely, the degree of alveolar budding peaked 
at dioestrus and declined to a minimum at oestrus. 
5.4.2 Co-cultures 
The growth of COMMA- I D  cells in response to co-cultured mammary tissue in various 
medium treatments was used as a measure of the mitogenic and modulatory capacity of 
the mouse mammary fat pad during the oestrous cycle. Comparison of the response to 
CFP and MFP allowed an evaluation of whether epithelial-stromal interactions 
influenced these effects. 
Co-cultured mammary fat pad stimulated substantial growth by COMMA- I D  cells in 
the hormone-free BM (Figure 5 .3a) as recorded previously (Chapters 2 and 3) .  MFP 
obtained at oestrus stimulated the greatest mitogenic response by COMMA- I D  cells .  In 
contrast, the ability of CFP to stimulate cell growth was significantly (P<O.05) increased 
at metoestrus relative to other stages. 
Figur e 5.1 Mammary gland morphology in virgin female BALB/c mice during the 
oestrous cycle. Thoracic mammary glands were from females at dioestrus CA and B), pro­
oestrus CC and D), oestrus CE and F), and metoestrus CG and H) were prepared as whole 
mounts and stained with alum carmine. N, nipple; ab, alveolar buds; eb, end buds. 
Magnifications: A, E and G, l lx; B and F, 55x; C, 17x; D and H, 33x. 
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Figure 5.2 Histomorphology of mammary parenchyma at (A) oestrus, and (B) 
dioestrus. Mammary tissues were sectioned (5 Jlm) and stained with Gomori ' s  
trichrome. At oestrus, epithelial cells at the tips of ducts form into bulbous end buds 
(eb). At dioestrus, ductal epithelium is organised into clusters of alveolar buds (ab). cp, 
cap cells; a, adipocytes; me, myoepithelial cells; f, fibroblasts. Scale bar = 1 0  Jlm. 
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Table 5.1 Assessment of mammary gland development in virgin female BALB/C mice 
during the oestrous cycle. 
Stage of cycle End bud score Alveolar score 
Dioestrus 0.9 ± 0.7a 3.4 ± LOb 
Pro-oestrus 2.4 ± 0.7ab 1 .9 ± 0.8ab 
Oestrus 3 .6 ± 1 .0b 0.6 ± O.4a 
Metoestrus 0.8 ± 0.3a 1 .8 ± 0.8ab 
Mammary gland whole mounts from mice at each stage of the oestrous cycle were 
subjectively scored on a scale of 0 to S for end bud development (0 = no end buds, S = 
numerous, large end buds) and alveolar development (0 = no alveolar ductules, S = 
numerous alveolar ductules). Data are means ± SEM (n=4). 
a,b Means within a column with different superscripts are significantly different 
(P<O.OS) .  
Supplementation of BM with 1 7p-oestradiol at 1 ng/ml did not alter final DNA levels in 
cultures of COMMA- I D  cells (P>O.OS; Figure S .3b). The overall effects of MFP and 
CFP throughout the oestrous cycle in the presence of oestrogen were not different 
(P>O.OS). There was a highly significant stage-of-cycle effect (P<O.OO l )  whereby both 
MFP and CFP induced greater (P<O.OS) cell growth at oestrus relative to other stages of 
the cycle. 
Supplementation of BM with progesterone had no effect on the final DNA level in 
cultures of COMMA- I D  cells (P>O.OS ; Figure S.3c). There was a highly significant 
effect of tissue type (P<O.OOI )  in the presence of progesterone where the mitogenic 
effect of MFP was greater than that of CFP across the oestrous cycle. Furthermore, 
there was a highly significant stage-of-cycle effect (P<O.OO I )  whereby cell growth 
stimulated by co-cultured CFP and MFP was greatest at oestrus and had subsequently 
decreased (P<O.OS) at metoestrus. 
Addition of oestrogen and progesterone to BM had no effect on final DNA yield 
(P>O.OS ; Figure S .3d). In this medium there was no difference (P>O.OS) between the 
effects of MFP and CFP during the oestrous cycle. Response to MFP was unaltered 
during the cycle (P>O.OS) while there was more (P<O.OS) growth in response to CFP at 
dioestrus and oestrus. 
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Figure 5.3 In vitro mitogenic stimulation by virgin mouse CFP and MFP during the 
oestrous cycle in (A) hormone-free BM, or BM supplemented with (B) 1 7p-oestradiol 
(E; 1 ng/ml); (C) progesterone (P; 1 �g/ml); or (D) 1 7p-oestradiol + progesterone. 
COMMA- I D  cells were co-cultured for S days with mammary tissues from females at 
the indicated stages of the oestrous cycle and the resultant DNA yields measured. 
Values are means ± SEM (n=4). The significance of main effects and their interaction 
are indicated. 
Analysis of the overall responses to co-cultured mammary tissue in media supplemented 
with oestrogen and/or progesterone revealed that growth stimulated by CFP was 
suppressed (P<O.OS) in the presence of progesterone and was increased (P<O.OS) by 
oestrogen, while it remained unchanged in their combination (Table S .2) . DNA levels 
in response to MFP tended (P<O.08) to be increased in the presence of oestrogen while 
responses were unaltered by including progesterone either alone or with oestrogen 
(P>O.OS). 
1 33 
Table 5.2 Least squares mean COMMA- I D  growth responses
' 
to co-cultured mammary 
tissue in medium supplemented with ovarian steroid hormones. 
Medium treatment CFPt MFPt 
BM 4.32b 4.63a 
I7�-oestradiol 5 . I 6c 5 .27b 
progesterone 3 .29a 4.54a 
I 7� oestradiol + progesterone 4.57b 4.69a 
a,b,c Least squares means within a column with different superscripts are significantly 
different by LSD. +(P<0.05) t (P<0.08). Pooled SE = 0.25 
Previous investigations have shown that co-cultured fat pad markedly potentiates the 
mitogenic effect of IGF-I and EGF on COMMA- I D  cells (Chapters 2 and 3) .  Cultures 
showed a slight but non-significant (P>0. 1 5) response to IGF-I added to BM (Figure 
5 .4a). In the presence of IGF-I there was a significantly (P<O.O I )  greater response to 
MFP than CFP. There was no change (P>0.05) in the proliferative effect of MFP during 
the oestrous cycle while there was a significantly greater response to CFP at metoestrus 
(P<0.05). 
EGF added to BM increased (P<0.05) the final DNA level in COMMA- I D  cultures by 
2 1  % (Figure 5 .4b). The mean response to CFP across the oestrous cycle in the presence 
of EGF was 58% of that stimulated by MFP (P<O.OO I ) . There was a significant stage­
of-cycle effect (P<0.05) whereby the mean response to co-cultured mammary tissue was 
maximal at oestrus and subsequently declined (P<0.05) at metoestrus. The maximal 
response to MFP was recorded at pro-oestrus while CFP stimulation was greatest at 
oestrus and least at pro-oestrus and metoestrus. 
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Figure 5.4 In vitro mitogenic stimulation by virgin mouse CFP and MFP during the 
oestrous cycle in BM supplemented with (A) IGF-I ( l OO ng/ml); (B) EGF (25 ng/ml);  or 
(C) IGF-I + EGF. COMMA- ID cells were co-cultured for 5 days with mammary tissues 
from females at the indicated stages of the oestrous cycle and the resultant DNA yields 
measured. Values are means ± SEM (n=4). *P<0.05 compared to BM only. The 
significance of main effects and their interaction are indicated. 
Cell growth was significantly (P<0.05) increased by supplementing BM with IGF-I + 
EGF (Figure S.4c). There was a greater (P<O.OOI )  overall effect of MFP compared to 
CFP in the presence of IGF-I + EGF. In this medium treatment there was a significant 
(P<0.05) stage-of-cycle effect whereby cel l growth in response to co-cultured tissue was 
greater at oestrus compared to other stages of the cycle. 
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5.4.3 CM modulation of steroid action 
The finding that co-cultured mammary fat pad facilitated the growth of COMMA- I D  
cel ls in response to oestrogen while its mitogenic effect was suppressed by progesterone 
was further investigated. CM was utilised to delineate whether these effects involved 
hormonal action on the mammary tissue, or if an activity was liberated independently 
from MFP and CFP to subsequently modulate epithelial responsiveness to these 
steroids. Cultures grown in CM alone showed a small but non-significant increase in 
final DNA yield. Supplementation of BM with oestrogen stimulated an increase in cell 
growth (P<O.05) which was further increased in CM (P<O.05). This effect did not occur 
in the presence of progesterone. Furthermore, progesterone suppressed the CM­















Figure 5.5 In vitro proliferation of COMMA- I D  cells in BM or CM supplemented with 
ovarian steroid hormones. COMMA- ID cells were cultured for 3 days in the presence 
of I 7�-oestradiol (E; I ng/rnl) and/or progesterone (P; 1 Ilg/ml). Data are means ± SEM 
(n=3) .  a,b,c Means with different superscripts are significantly different. 
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The ability of CM to modulate the responsiveness of COMMA- 1 D  cells to oestrogen 
was examined at the level of the oestrogen receptor (ER). Western blotting detected the 
-66 kDa ER in an extract of mouse uterus but not in cultures of COMMA- 1 D  cells. 
However, an immunoreactive ER protein of -55 kDa was expressed by cells cultured 
for 2 days in BM supplemented with IGF-I + EGF, but not oestrogen or progesterone. 
This protein was not detected in COMMA- 1 D  cells cultured in CM alone or with 
oestrogen or progesterone, but CM markedly increased the level of its expression 
induced by IGF-I + EGF. 
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Figure 5.6 Western blotting of ER proteins in COMMA- 1 D  cells after their culture in 
various medium treatments. COMMA- 1D cells were cultured for 2 days in either BM 
or CM alone or supplemented with IGF-I ( l OO ng/ml) + EGF (25 ng/ml), 17�-oestradiol 
(E2; 1 ng/ml), progesterone (P4; 1 Ilg/rnl) or E2 + P4. Each lane contained an equivalent 
amount of DNA (2 Ilg). An extract of virgin mouse uterus (80 Ilg protein) served as a 
positive control . The position of molecular weight markers is indicated. 
5.5 DISCUSSION 
Mammary parenchyma responded to the changing hormonal profiles of the oestrous 
cycle by demonstrating marked differences in its morphology as described by others 
(Dulbecco et aI. , 1 982; Vonderhaar, 1 988). The appearance of highly mitotic end buds 
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at oestrus is presumably in response to an increased circulating oestrogen concentration 
(Daniel et ai. , 1 987; Haslam, 1 988). As these hormonally-induced responses may be 
mediated by the mammary gland stroma (Shyamala and Ferenczy, 1 984; Haslam and 
Counterman, 1 99 1 ), a co-culture system (Chapter 2) was utilised to determine whether 
the in vitro mitogenic stimulation afforded by the mammary fat pad was concomitantly 
altered during the oestrous cycle. 
The present findings show that the mitogenic effect of the mammary fat pad is increased 
at oestrus relative to other stages of the cycle in the presence of certain medium 
supplements, particularly oestrogen and progesterone. That this stage-of-cycle effect 
occurred in response to both CFP and MFP indicates that it was initiated by a stroma­
derived activity. Results of previous studies (Chapter 4) and those of others (Beck et 
aI., 1 989) suggest that the mouse mammary fat pad stimulates the growth of mammary 
epithelial cells in vitro by its liberation of unsaturated fatty acids. Given the present 
findings, hormonal changes during the oestrous cycle may modulate the release of 
unsaturated fatty acids from adipocytes within the mammary fat pad. Consistent with 
this notion are reports that oestrogen stimulates lipolysis (Rebuffe-Scrive, 1 987 ; 
Steingrimsdottir et aI., 1 980) and inhibits lipogenesis in adipocytes (Steingrimsdottir et 
aI. , 1 980; Ramirez, 1 98 1 ), while progesterone promotes lipogenesis (Krotkiewski and 
Bjorntorp, 1 976; Shirling et al. , 1 98 1 ). Furthermore, lipolysis in rat adipocytes is least 
at dioestrus and increases to a maximum at oestrus (Hansen et al., 1 980), a pattern 
which parallels the mitogenic stimulation afforded by the co-cultured mammary tissues 
during the oestrous cycle in this study. The level of systemic prolactin also peaks at pro­
oestrus-oestrus (Lotz and Krause, 1 978), during which time it may indirectly stimulate 
lipolysis within mammary adipocytes (Kidwell and Shaffer, 1 984). However, it is 
unlikely that prolactin is involved in the present results as receptors for prolactin do not 
occur within the CFP (Bhattacharya and Vonderhaar, 1 979). 
This stage-specific pattern of mitogenic stimulation also aligns with the proliferation of 
mammary epithelium in vivo, where DNA synthesis in ductal epithelium increases to a 
maximum at oestrus (Sutton and Suhrbier, 1 967) coincident with the formation of ductal 
end buds (Dulbecco et al., 1 982). The growth of ductal end buds in vivo is also 
stimulated by locally implanted IGF-I (Ruan et aI., 1 992) and EGF (Coleman et al. , 
1 988) .  While it has not been reported, i t  is conceivable that the local expression of 
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these growth factors within the mammary gland is elevated at oestrus in response to 
oestrogen (Carlsson et al. , 1 989; Stevenson et aI., 1 994; Dickson and Lippman, 1 987). 
It was shown in Chapter 4 and by others (Bandyopadhyay et aI., 1 993 ; Sylvester et aI., 
1 994) that unsaturated fatty acids potentiate the mitogenic effects of these growth 
factors on mammary epithelial cells. Together, these findings raise the possibility that 
ductal proliferation at oestrus is stimulated by oestrogen-inducible growth factors whose 
mitogenic effects are enhanced by a concomitant local release of unsaturated fatty acids. 
Consistent with this suggestion is the fact that ductal growth in immature mice is 
impaired by a diet deficient in essential fatty acids (Miyamoto-Tiaven et al., 1 98 1 ). 
Furthermore, unsaturated fatty acids may enhance growth factor-induced mitogenesis 
via the lipid-inducible signalling messenger, protein kinase C (PKC; Bandyopadhyay et 
al., 1 993 ; Sylvester et aI., 1 994; Chapter 4), where oestrogen elevates, and progesterone 
suppresses, mammary epithelial PKC levels within the developing mammary gland 
(Holladay and Bolander, 1 986). These changes may reflect alterations in the local 
availability of lipids. Hormonal regulation of mammary lipid metabolism may also 
account for the fact that the growth of mammary tumour cells within various adipose 
depots is stimulated by oestrogen and suppressed by progesterone (Elliott et al., 1 992). 
Such results may be manifest in the demonstration that mammary glands of rats treated 
with carcinogen at pro-oestrus and oestrus have a higher tumour incidence and a shorter 
latency period compared to rats treated at dioestrus (Lindsey et aI., 1 98 1 ;  Ratko and 
Beattie, 1 985). 
As well as its potential for endocrine regulation, mitogenic stimulation afforded by the 
mammary fat pad may be locally influenced by the mammary epithelium. Such an 
influence has been implicated in various aspects of stromal activity including lipid 
metabolism (Bartley et aI. , 1 98 1 )  and growth factor expression (Singer et al., 1 995). 
Comparison of the response to co-cultured epithelium-free CFP and MFP which 
contains endogenous epithelium suggests that mammary epithelium can promote the 
release of a growth-promoting factor(s) from the mammary fat pad. This effect was 
specific to medium supplemented with progesterone or growth factors and was 
antagonised by the presence of oestrogen. 
The mechanisms underlying these responses remain to be established. Epithelial 
upregulation of stromal stimulation may reflect its ability to induce the expression of 
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stroma-derived growth factors (Singer et al., 1 995 ; Chapters 9- 1 1 ) . In keeping with an 
earl ier suggestion however, it is proposed that this effect more likely represents 
epithelial modulation of lipid metabolism within proximal mammary adipocytes. CFP 
from prepubertal mice markedly potentiates the mitogenic effects of IGF-I and EGF on 
COMMA- I D  cells, as in the present study, by liberating unsaturated fatty acids into the 
culture medium (Chapter 4). The finding that MFP was more stimulatory than CFP in 
combination with these growth factors may represent epithelial-induced liberation of 
fatty acids, particularly unsaturated fatty acids, from mammary adipocytes. This 
concurs with other reports showing that mammary epithelium induces lipolysis in 
adjacent mammary adipocytes (Elias et al., 1 973), perhaps via the local synthesis of 
histamine (Kidwell and Shaffer, 1 984) or prostaglandin F2a (Kidwell et al., 1 982). 
Furthermore, co-cultured MFP stimulates higher levels of casein synthesis by mammary 
epithelium in vitro than CFP, possibly by liberating more unsaturated fatty acids such as 
linoleic acid (Levay-Young et al., 1 987). Kidwell et al. ( 1 982) reported, however, that 
MFP released less linoleic acid than CFP tissue in vitro, an inconsistency probably 
associated with increased sequestration of unsaturated fatty acids by endogenous 
epithelium in the presence of prolactin (Kidwell et al., 1 982). 
Differential modulation of the mitogenic effects of CFP and MFP in vitro by 
progesterone and oestrogen is intriguing, particularly given the pivotal roles of these 
steroids during mammogenesis. It is presently unclear as to whether this difference 
involved epithelial modulation of hormone action on the co-cultured mammary stroma, 
or whether CFP and MFP differentially liberated certain factors to regulate COMMA­
I D  responsiveness to oestrogen and progesterone. Such results do indicate, however, 
that there may be an important relationship between the local interaction of mammary 
epithelial and stromal cells and the actions of ovarian steroid hormones on epithelial 
proliferation. 
Co-cultured mammary fat pad also promoted the stimulation of COMMA- I D  cell 
growth by oestrogen. This oestrogenic stimulation, as well as a corresponding negative 
effect of progesterone, was similarly evident in CM, a finding which suggests that these 
effects were independent of steroid action on the co-cultured mammary tissue. A 
possible effector of such responses are unsaturated fatty acids which likely account for 
the growth-promoting effects of CM (Beck et al., 1 989; Chapter 4). That unsaturated 
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fatty acids modulate ovarian steroid-induced mammary growth may relate to the fact 
that both tumour growth within adipose tissue (Elliott et al., 1 992) and mammary 
epithelial levels of lipid-activated PKC (HoUaday and Bolander, 1 986) are increased by 
oestrogen and decreased by progesterone. 
The ability of CM to facilitate oestrogen-induced growth was examined at the level of 
the ER. Although the mature -66 kDa ER was not expressed by COMMA- I D  cells, 
treatment with IGF-I + EGF did induce the expression of a -55 kDa ER protein. This 
form of the ER is a proteolytic cleavage product (Horigome et al. , 1 988) which binds 
oestrogen with the same affinity as the mature ER (Horigome et al., 1 987), and which 
has an increased affinity for DNA (Baskevitch and Rochefort, 1 985). A physiological 
role for this ER is suggested by the fact that its expression in the uterus is increased at 
oestrus (paye et al., 1 986) and by treatment with exogenous oestrogen (Horigome et al., 
1 988). Upregulation of its expression in response to these growth factors in the present 
study may correspond to the finding that EGF increases levels of both the -66 kDa and 
-55 kDa ER in the uterus (Ignar-Trowbridge et al., 1 992) . The abundance of the -55 
kDa protein as induced by IGF-I + EGF was further increased by CM. This may be in 
response to unsaturated fatty acids present in CM as supplementation of MCF-7 cells 
with unsaturated, but not saturated, fatty acids leads to cleavage of the mature ER 
protein (Borras and Leclercq, 1 992). Such an effect may involve ER mRNA 
destabilisation via PKC (Saceda et al. , 1 99 1 ) .  While the mechanisms underlying these 
responses are unclear, such findings could relate to the interrelationship between steroid 
receptor- and growth factor-signalling through PKC (Cho and Katzenellenbogen, 1 993 ; 
Katzenellenbogen, 1 996; Martfnez-Lacaci and Dickson, 1 996). 
In conclusion, these results indicate an important role for the mammary fat pad in 
mediating the mammogenic effects of the ovarian steroids during the oestrous cycle. 
Systemic hormonal changes may alter the liberation of mitogenic activity from the 
mammary stroma to subsequently modulate the responsiveness of mammary epithelium 
to growth factors and ovarian steroids. Such effects are also likely regulated at the local 
level of the mammary gland by the interaction of epithelial cells with the surrounding 
stroma. 
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CHAPTER 6 
INFLUENCE OF ONTOGENIC STATE, OVARIECTOMY, 
AND OV ARIAN STEROID HORMONES ON THE IN 




The present experiments were conducted to investigate whether the in vitro mitogenic 
effects of the mouse mammary fat pad are modulated by stage of postnatal development, 
ovarian steroids and epithelial-stromal interaction. These effects were bioassayed using 
COMMA- I D  mouse mammary epithelial cells co-cultured with mammary fat pad tissue 
cleared of epithelium (CFP) or intact mammary tissue (MFP) from females at various 
stages of postnatal development, and from 8-week old intact and ovariectomised 
females treated for 5 days with oestrogen and/or progesterone. 
Mitogenic stimulation by CFP and MFP was substantial at 3 weeks of age coincident 
with a period of rapid ductal growth in vivo. This stimulation subsequently declined 
(P<O.05) to lowest levels in mature virgin and mid-pregnant mice. During this period 
MFP was more mitogenic than CFP in specific medium treatments, possibly reflecting a 
local influence of endogenous epithelium. MFP-induced cell growth in various growth 
factor and steroid medium treatments was increased (P<O.05) by 2-3 fold during 
lactation. This effect in the basal medium (BM) either alone or in the presence of 
ovarian steroids subsequently declined (P<O.05) after weaning. Stimulation of cell 
growth by CFP during this period was dependant upon the medium treatment; it 
remained low in the basal medium (BM) or in the presence of ovarian steroids but 
increased (P<O.05) in late lactation and post-weaning in the presence of IGF-I and/or 
EGF. 
Prepubertal ovariectomy abrogated mammary development but did not reduce (P>O.05) 
the mitogenic effect of co-cultured MFP or CFP on COMMA- I D  cells. Conversely, 
ovarian function was necessary for progesterone treatment to increase (P<O.05) the 
mitogenic effect of both MFP and CFP. Furthermore, co-cultured MFP from saline­
treated mice was more stimulatory than contralateral CFP tissue (P<O.05), indicating 
that endogenous epithelium may promote the release of a mitogenic activity from the 
mammary fat pad. Oestrogen modulated this response in that the mitogenic effect of 
CFP was increased (P<O.05) when mice were treated with oestrogen while that of the 
contralateral MFP was suppressed. Taken together, these findings indicate that 
mitogenic stimulation afforded by the mammary fat pad may be involved in regulating 
postnatal development of the mammary gland. This stimulation may be locally induced 
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by the mammary epithelium, an influence which specifically modulates honnonal 
effects on the mammary fat pad. 
6.2 INTRODUCTION 
Epithelium within the rodent mammary gland demonstrates marked changes in its 
proliferation and morphology as the female passes through a series of postnatal 
reproductive states (reviewed by Imagawa et al., 1 994). Parenchyma of the neonatal 
gland constitutes little more than a branched ductal rudiment around the nipple. 
Epithelial cel ls within the pre- and peripubertal mammary gland then undergo rapid 
proliferation to establish a ductal network within the bounds of the mammary fat pad. 
Alveolar growth commences with the onset of pregnancy so that by parturition the 
mammary gland is comprised of lobuloalveolar structures capable of active milk 
secretion. Stage of development also influences the tumorigenic susceptibil ity of the 
mammary gland (Grubbs et al., 1 983) with age being one of the main risk factors in 
human breast cancer (Kelsey and Berkowitz, 1 988). 
This course of postnatal mammogenesis is directed by the actions of several endocrine 
honnones (Topper and Freeman, 1 980). Of these, the ovarian steroids oestrogen and 
progesterone fulfil pivotal roles (Lyons et al., 1 958; Nandi, 1 958). While oestrogen 
stimulates epithelial proliferation and its ductal morphogenesis, progesterone promotes 
tertiary branching and alveolar budding (Bresciani, 1 968). 
Emerging evidence also suggests that the adipose and connective tissue of the mammary 
fat pad mediates the mammogenic effects of ovarian steroids. While oestrogen acts 
directly on the mammary gland (Daniel et al., 1 987; Haslam, 1 988d), mammary 
epithelial cells are unresponsive to oestrogen in vitro (Yang et al., 1 980; Richards et al., 
1 988), leading to suggestions of an indirect action via the mammary stroma (Shyamala 
and Ferenczy, 1 984) . Consistent with such proposals, receptors for both oestrogen and 
progesterone are present within the mammary fat pad as well as on mammary epithelial 
cells (Haslam and Shyamala, 1 98 1 ;  Haslam, 1 989; Haslam and Nummy, 1 992). 
Developmental changes in the effects of oestrogen and progesterone on the mammary 
epithelium (Haslam, 1 989) may reflect an altered stromal expression of steroid receptors 
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(Haslam, 1 988c; Haslam and Nummy, 1 992), or a differing ability of the stroma to 
modulate epithelial responsiveness to ovarian steroids (Haslam and Counterman, 1 99 1 ) . 
What remains unclear is how these developmental changes and the local effects of 
ovarian steroids relate to the requirement of mammary epithelium for a depot of adipose 
tissue in which to develop in vivo (reviewed by Hoshino, 1 978). Adipose tissue 
stimulates the metastatic growth of mammary tumour cells and facilitates their 
oestrogen-responsiveness while progesterone suppresses their growth (Elliott et ai., 
1 992). It was recently shown that the in vitro mitogenic effect of the mammary fat pad 
is altered during the oestrous cycle and that this activity can modulate the 
responsiveness of mammary epithelial cells to ovarian steroids in vitro (Chapter 5). 
These results suggest that adipocyte-derived factors, under the influence of endocrine 
signals, may directly or indirectly control mammary epithelial cell proliferation. Such 
effects may also be regulated at the local level of the mammary gland by the epithelium 
(Cunha and Horn, 1 996) which can influence various aspects of lipid metabolism 
(Bartley et al., 1 98 1 )  and growth factor expression (Coleman-Krnacik and Rosen, 1 994). 
Given the marked effects of developmental state and ovarian hormones on epithelial 
growth and the candidate role for the mammary fat pad in modulating these, the 
objective of these experiments was to investigate whether such responses reflect 
changes in the mitogenic capacity of the mammary fat pad. A co-culture system was 
used to bioassay this capacity at various stages of development and after ovariectomy 
and ovarian steroid treatment. The ability of endogenous epithelium to modulate these 
effects was examined by comparing the responses to epithelium-free and intact 
mammary tissue. Results indicate that the mitogenic capacity of the mammary fat pad 
and its ability to modulate epithelial responsiveness to other factors are altered during 
ontogeny and are influenced by the effects of ovariectomy, oestrogen and progesterone. 
Importantly, these effects may be locally regulated by the endogenous epithelium. 
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6.3 MATERIALS AND METHODS 
6.3.1 Animals 
BALB/c mice were housed in the Ruakura Small Animal Colony under standard 
conditions with free access to food (Diet 86, NRM Stockfeeds, NZ) and water. 
The effect of ontogenic state on the mitogenic capacity of the mammary fat pad was 
studied in a group of virgin females weaned together from standardised litters. The 
epithelial component of one abdominal mammary gland of these mice was surgically 
excised at 2 1 -23 days of age according to the procedure of DeOme et al. ( 1 959) to leave 
a mammary fat pad cleared of endogenous epithelium (CFP). The contralateral gland 
was left intact to allow normal epithelial development within the mammary fat pad 
(MFP). Mice were subsequently housed in groups of 4. 
Females were subsequently sacrificed at the fol lowing stages of development to provide 
mammary tissues for co-culture experiments (n=4 per group) : virgins at 2 1 ,  35 and 80 
days of age; day 9 of pregnancy (80 days of age); early (days 1 -2) and late (day 1 8) 
lactation; and 2 days post-weaning ( 1 8  days post-partum). For those females sacrificed 
in pregnancy, day of vaginal plug detection was deemed day 0 of gestation; pregnancy 
was confirmed at sacrifice. Litters of lactating females were standardised to 8 pups 
within 24 hours of parturition. 
In a separate study a group of virgin females was used to investigate the influence of 
ovariectomy and ovarian steroids on the mitogenic capacity of the mammary fat pad. At 
the time that one abdominal mammary fat pad was surgically cleared of epithelium as 
described above, half of the females were bi-Iaterally ovariectomised while the 
remainder were sham-operated. From 50 days of age, groups of ovariectomised and 
sham-operated mice were treated for 5 days with daily injections (0. 1 ml, s.c.) of saline, 
1 7�-oestradiol (Sigma; 1 /lg), progesterone (Sigma; 1 mg), or 1 7�-oestradiol + 
progesterone (n=5 per group). Steroids were prepared as ethanolic stocks diluted into 
sal ine; all treatments contained an ethanol concentration of 6%. The final injection was 
given on the morning of sacrifice. Stage of oestrous for saline-treated sham-operated 
females was determined on the morning of sacrifice by vaginal lavage (Rugh, 1 967) and 
confirmed by vaginal appearance (Champlin et al., 1 973), and 4 females in pro-oestrus 
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were selected to represent this group. Completeness of ovariectomy was determined at 
sacrifice. 
6.3.2 Co-cultures 
An in vitro co-culture system (Chapter 2) was used to measure the mitogenic and 
growth modulatory effects of mammary tissues from mice in the various treatment 
groups. COMMA- I D  cells seeded into 24-well plates (5 x 1 04 cells/well) were then 
quiesced for 48 h in hormone-free DMEM basal medium (BM). CFP tissue or the 
epithelial region of MFP was sectioned into explants (5- 1 0  mg) which were weighed 
and rinsed in BM. Explants were placed on rafts of siliconised lens paper and floated at 
the gas:medium interface of appropriate cultures. All cultures were incubated in 0.5 rnl 
treatment medium for the first 3 days, with a further 0.5 rnl of fresh treatment medium 
added on day 3 .  Cultures were terminated after 5 days and the final level of DNA in the 
trypsinised monolayers was measured using a fluorometric assay (Labarca and Paigen, 
1 980). CFP and MFP explants were blotted and weighed at the end of the co-culture 
period. 
1 7�-oestradiol and progesterone were added to BM from ethanolic stocks and all media 
contained the same concentration of ethanol. Recombinant human IGF-I was from 
Genentech (San Francisco, CA), and mouse EGF was from Sigma. 
6.3.3 Mammary gland whole mounts 
Thoracic mammary glands were spread on slides and fixed in Camoy' s  fixative for 24 h. 
Preparations were defatted in acetone and stained with alum carmine as described 
(Chapter 5) .  Whole mounts were photographed using a dissecting microscope. 
6.3.4 Statistical analyses 
Groups of females within the ontogeny experiment were sacrificed on separate 
occasions, except the mature virgin and day 9 pregnancy groups which were sacrificed 
together at 80 days of age, and the late lactation and post-weaning groups which were 
sacrificed together at 1 1 0 days of age. To directly compare the in vitro responses to co­
cultured mammary tissues at these different times, culture DNA yields on each occasion 
were normalised against DNA values in the respective BM only and 1 0% FCS 
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treatments using the formula (X-BM)/(FCS_BM), where the final DNA level in BM and 1 0% 
FCS treatments equalled 0 and 1 ,  respectively. Data expressed in this way were 
analysed using REML analysis and the MIXED procedure of SAS to test the main 
effects of stage of development, in vitro medium treatment and fat pad type and their 
interactions, where mouse was included as a random term within stage of development. 
Results from the ovariectomy and steroid priming experiment were subjected to analysis 
of variance using the GLM procedure of SAS to test the main effects and interactions of 
in vivo oestrogen treatment, in vivo progesterone treatment, ovariectomy, fat pad type 
and the in vitro medium. Mammary tissue weights and change in the weight of. co­
cultured mammary tissues were compared by the GLM procedure. These data were 
expressed as the net change in weight, where similar results were obtained when weight 
change was expressed as a percentage of their initial weight. 
6.4 RESULTS 
6.4.1 Effect of ontogenic state 
6.4.1.1 Mammary gland development 
The marked changes in parenchymal growth and morphogenesis which occurred during 
postnatal development are depicted in Figure 6. 1 (a-g). The mammary parenchyma of 
3-week old females comprised a simple rudiment about the nipple. This subsequently 
underwent extensive proliferation prior to and during puberty to establish a ductal tree 
within the bounds of the mammary fat pad in mature virgin females. Ductal alveolar 
budding was evident by day 9 of pregnancy and lobules of alveoli occupied virtually the 
entire gland during lactation. Post-weaning involution was associated with parenchymal 
regression and a concomitant repletion of adipocyte lipids. The CFP comprised a depot 
of adipose tissue devoid of mammary parenchyma (Figure 6. 1 h) .  
This development was reflected by changes in the weight of the mammary tissues 
(Figure 6.2). Change in the weight of CFP up until mid-pregnancy closely paralleled 
that recorded for MFP. CFP weight during lactation was significantly (P<O.05) reduced 
relative to that in mid-pregnancy. In contrast, MFP weight was markedly increased 
(P<O.05) with the onset of lactation and declined abruptly after weaning. 
Figure 6.1 Ontogeny of postnatal mammary gland development and morphogenesis in 
female BALB/c mice. Thoracic mammary glands were from females at various stages of 
postnatal development (A) 2 1  days; (B) 35 days; (C) 80 days; (D) day 9 of pregnancy; (E) 
early lactation; and (F and G) involution. (H) #4 abdominal CFP devoid of endogenous 
epithelium from a 90-day old virgin female. N, nipple. Magnifications: A, 70x; B, 1 9x;  
C-H, 1 0x. 
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Figure 6.2 Body and mammary tissue weights of female BALBIc mice during postnatal 
development. Females were sacrificed at the stages indicated and the weights of the 
epithelium-free CFP and contralateral MFP were determined prior to their use in co­
culture experiments. Each point is mean ± SEM (n=5). 
6.4.1.2 Co-cultures 
The growth of COMMA- ID  cells in several medium treatments was used to bioassay 
the mitogenic effects of CFP and MFP from mice across various physiological states 
and stages of mammary gland development. 
Cell growth in the hormone-free BM was markedly stimulated by CFP or MFP taken at 
3 weeks of age; this then declined (P<O.05) to low levels for tissue from mature virgin 
(day 80) and mid-pregnant females (Figure 6.3a). The mitogenic effect of CFP did not 
differ (P>0.05) across the remaining developmental states. In contrast, cell growth in 
response to MFP was significantly (P<O.OO l )  increased in early and late lactation 
relative to mid-pregnancy, a response which subsequently declined (P<0.05) after 
weaning. 
As reported previously (Chapter 5), co-cultured virgin MFP and CFP markedly 
potentiated the mitogenic effect of IGF-I on COMMA- I D  cells. As in BM, growth 
stimulated by both CFP and MFP in the presence of IGF-I declined (P<0.05) from 3 
weeks of age to lowest levels in mature virgin and mid-pregnancy states (Figure 6.3b) . 
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In contrast to the responses in BM, mitogenic stimulation afforded by CFP increased 
(P<O.OOI )  in late lactation and remained elevated post-weaning in a pattern similar to 
that induced by MFP . The response to MFP at 5 weeks of age, in early and late 
lactation, and post-weaning was significantly greater (P<0.05) than that to CFP. 
The mitogenic effect of EGF was also potentiated by co-cultured mammary tissue. Cell 
growth stimulated by MFP and CFP declined to lowest levels in mature virgin, mid­
pregnancy, and early lactation states; the response to CFP increased (P<0.05) in late 
lactation in parallel with that to MFP (Figure 6.3c). There was a consistently greater 
(P<O.O l )  overall effect of MFP compared to CFP in the presence of EGF. 
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Figure 6.3 Ontogeny of mitogenic stimulation by mouse CFP and MFP in (A) 
hormone-free BM, or BM supplemented with (B) IGF-I ( l OO ng/ml); (C) EGF (25 
ng/ml); or (D) IGF-I + EGF. COMMA- I D  cells were co-cultured for 5 days with 
mammary tissues from female mice at the indicated stages of postnatal development and 
the resultant DNA yields measured. Data are corrected for DNA values in BM alone 
(equals 0) and are expressed as a proportion of the response to I O% FCS (equals I )  as 
detai led in the Methods. Values are means ± SEM (n=4). 
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Responses to co-cultured mammary tissue in the combined presence of IGF-I and EGF 
generally represented the additive result of the individual growth factor interactions. 
Both MFP and CFP were least (P<O.05) stimulatory in mature virgin, mid-pregnant, and 
early lactation states, while mitogenic stimulation afforded by MFP and CFP was 
increased (P<O.OOl )  in late lactation and involution relative to that in early lactation 
(Figure 6.3d). There was no difference between the overall effect of MFP and CFP 
across development in this growth factor combination (P>O.5). 
The ontogeny of growth stimulation by MFP and CFP in the presence of BM 
supplemented with 1 7�-oestradiol (Figure 6.4a) was similar to that in BM alone (refer 
Figure 6.3a) . The presence of oestrogen tended to reduce the mitogenic effect of both 
MFP and CFP at 3 weeks of age, and that of MFP during lactation. Furthermore, the 
different growth stimulation by MFP and CFP observed in the presence of progesterone 
at 35 days of age and in mid-pregnancy (Figure 6.4b) was not evident in medium 
supplemented with oestrogen. 
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Figure 6.4 Ontogeny of mitogenic stimulation by mouse CFP and MFP in BM 
supplemented with (A) I7p-oestradiol ( 1  ng/rnl); (B) progesterone ( 1  J.lg/ml); or (C) 
1 7p-oestradiol + progesterone. COMMA- I D  cells were co-cultured for 5 days with 
mammary tissues from females at the indicated stages of postnatal development and the 
resultant DNA yields measured. Data are corrected for DNA values in BM alone 
(equals 0) and are expressed as a proportion of the response to 10% FCS (equals 1 )  as 
detai led in the Methods. Values are means ± SEM (n=4). 
The patterns of response to MFP and CFP in the presence of progesterone (Figure 6.4b) 
were similar to those observed in BM (refer Figure 6.3a) . Supplementation of medium 
with progesterone tended to reduce the proliferative responses to MFP and CFP relative 
to those in BM. 
The combination of 17p-oestradiol and progesterone in BM restored the mitogenic 
effect of MFP and CFP at 3 weeks while the response to MFP at 35 days was stil l  
reduced relative to that in BM alone (compare Figure 6.4c and Figure 6.3a). 
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Change in the weight of co-cultured CFP and MFP explants was recorded as a possible 
indicator of metabolic differences in these tissues (Figure 6.5). The weight of CFP and 
MFP explants from 3-week females decreased by 35 and 30% during the co-culture 
period. Weight reductions were generally much less in subsequent states. However, 
from mid-pregnancy onwards MFP explants lost significantly (P<O.OO I )  more weight 
than CFP. Part of the increased weight loss from MFP in early lactation presumably 
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Figure 6.5 Change in the weight of co-cultured MFP and CFP explants from mice at 
various stages of development. Explants of tissue were weighed prior to co-culture and 
then re-weighed at the end of the culture period 5 days later. Values are means ± SEM 
for explants co-cultured in the 7 different medium treatments (n=28). 
6.4.2 Effects of ovariectomy and ovarian steroids 
6.4.2.1  Mammary development 
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Whole mounts i llustrate the response of mammary parenchyma to ovariectomy and 
exogenous ovarian steroids (Figure 6.6, a-h). Sham-operated females developed an 
expansive ductal tree within the mammary fat pad by 55 days of age. In contrast, 
prepubertal ovariectomy completely abrogated ductal elongation to leave a quiescent, 
simply branched rudiment. Short-term treatment of sham-operated and ovariectomised 
females with oestrogen promoted end bud formation at the tips of ducts both within the 
ductal tree and at its periphery. Progesterone had little obvious effect on the 
parenchyma of ovariectomised females while it induced the formation of numerous 
alveolar buds on the ductal epithelium of sham-operated mice. Administration of 
oestrogen plus progesterone to ovariectomised females resulted in small ,  variable 
degrees of end bud and alveolar formation, where similar but more pronounced effects 
were observed in sham-operated mice. 
Whereas mean bodyweight tended (P<O. l )  to be increased across all ovariectomised 
groups relative to sham-operated females, it was unaffected (P>O.05) by the different 
steroid treatments (Table 6. 1 ) .  Weight of the MFP and CFP from saline-treated mice 
was unaltered (P>O.05) by ovariectomy. Relative to the saline group, weight of the 
MFP and CFP was significantly increased by administering oestrogen and/or 
progesterone to ovariectomised mice, while oestrogen tended to increase the weight of 
MFP and CFP from intact females. 
Figure 6.6 Mammary gland development in sham-operated (A-D) and ovariectomised (E­
H) female mice treated for 5 days with excipient (A and E), 17�-oestradiol (B and F), 
progesterone (C and G) or 1 7�-oestradiol + progesterone (D and H). Females were 
ovariectomised or sham-operated at 3 weeks of age and were administered the various 
treatments from 50 days of age. N, nipple. Magnifications: A-D, 13x; E, 66x; F-H, 50x. 
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Table 6.1 Mean (± SEM) body and mammary tissue weights of sham-operated and 
ovariectomised (ovex) female mice treated for 5 days with saline, progesterone, 





















1 9.6 ± O.4ab 
19.3 ± 0.6a 
1 9.6 ± 1 .0·b 
20.3 ± 0.2ab 
20.0 ± 0.3ab 
2 1 .7 ± 1 .5b 
20.4 ± 1 .0ab 
20.7 ± 0.6ab 
CFP wt 
(mg) 




70.4 ± 7ab 
7 1 .5 ± 4·b 
6 1 .6 ± 5a 
95.6 ± l Oc 
83.6 ± 7be 
82.8 ± 5be 
MFP wt 
(m g) 
1 25.8  ± 1 3ab 
1 46.9 ± 7 be 
1 33.8  ± 1 2abe 
1 28.2 ± n ab 
1 1 3.0 ± 6 a 
1 8 1 .4 ± l O
d 
1 62.4 ± 1 5c
d 
1 63.0 ± 5 c
d 
Body weights and weights of MFP and CFP of female mice which had been 
ovariectomised or sham-operated at approximately 2 1  days of age and were then treated 
for 5 days from 50 days of age. 
t Saline-treated, sham-operated females were at pro-oestrus. 
a,h,c Means within a column with different superscripts are significantly different 
(P<0.05). 
6.4.2.2 Co-cultures 
COMMA- I D  cells did not demonstrate any increase (P>0.05) in final DNA yields when 
BM was supplemented with IGF-I, EGF, IGF-I + EGF, oestrogen, progesterone or 
oestrogen + progesterone (Figure 6.7) . In contrast, 1 0% FCS stimulated a 4.6-fold 
increase (P<O.OOl )  in final DNA yield. Consistent with results presented in Chapters 2 
and 5 ,  co-cultured mouse mammary fat pad directly stimulated the growth of COMMA­
I D  cells and potentiated the mitogenic effects of IGF-I and EGF. Figure 6.7 depicts an 
example of these responses when COMMA- I D  cells were co-cultured with CFP and 
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Figure 6.7 Growth of COMMA- I D  cell s  in response to various medium supplements 
either alone, or when co-cultured with explants of CFP or MFP. Cells were cultured for 
5 days in BM either alone, or supplemented with IGF-I ( l OO ng/ml), EGF (25 ng/rnl) , 
IGF-I + EGF, progesterone (P; 1 Ilg/ml), 1 7�-oestradiol (E; 1 ng/ml), P + E, or 1 0% 
FCS.  Co-cultures were with explants of either CFP or MFP from saline-treated, sham­
operated female mice. Data are means ± SEM (n=5). 
Analysis of growth responses by COMMA- I D  cells indicated that there were no 
interactions between the various in vitro medium treatments and those in vivo 
(ovariectomy, oestrogen, progesterone and fat pad type). Results in Table 6.2 are least 
squares means for the various in vivo treatments averaged across the seven in vitro 
medium treatments. 
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Table 6.2 Least squares means of COMMA- ID cell growth responses to co-cultured 
CFP and MFP tissue from sham-operated or ovariectomised (ovex) female mice treated 
for 5 days with saline, progesterone, oestrogen, or progesterone + oestrogen. 
Treatment sham ovex 
CFP MFP CFP vs MFP CFP MFP CFP vs MFP 
(/lg DNA) (/lg DNA) (P<) (/lg DNA) (/lg DNA) (P<) 
saline 9.44' 1 1 .27b 0.001 1 0. 1 6' 1 1 .24b 0.02 
oestrogen 1 O.78b 1 0.33' 0.33 1 1 .48b 1 0. 1 '  0.003 
progesterone 1 1 .46b 1 2.6c 0.02 1 0.05' 1 O.9 1 ,b 0.06 
prog. + oestrogen 1 1 .67b 1 1 .2b 0.32 1 1 .55b 1 O.53,b 0.03 
Data are least squares means for DNA yield/well averaged across 7 different in vitro 
treatments (n=5 replicates per treatment except for saline-treated, sham-operated 
females where n=4). 
Pooled SE = 0.33 except for saline-treated, sham-operated CFP and MFP LS means 
where pooled SE = 0.37. 
a,h,c Least squares means within a column with different superscripts are significantly 
different (P<0.05). 
There was a significantly (P<O.OO I) greater mitogenic effect of MFP compared to the 
contralateral CFP from saline-treated, sham-operated mice. These effects were 
unaffected by ovariectomy (P>O. I) .  Progesterone treatment for 5 days significantly 
increased the mitogenic effect of both the CFP and MFP from intact (P<O.O l ) , but not 
ovariectomised (P>O.4) females. In contrast, administration of oestrogen increased 
(P<O.O I )  the mitogenic effect of the CFP from both intact and ovariectomised females 
while that of the contralateral MFP from both groups was correspondingly decreased 
(P<0.06). The response to CFP and MFP from females treated with oestrogen and 
progesterone generally represented the combined effect of the individual hormones. 
Measurement of weight changes in co-cultured explants indicated that MFP from all 
groups decreased in weight while that of CFP explants from saline-treated 
ovariectomised and intact females was increased (Table 6.3). Progesterone treatment 
tended (P<O. I)  to reduce the weight of MFP and CFP explants from intact, but not 
ovariectomised, females. Exogenous oestrogen reduced (P<0.05) the weight of MFP 
explants from both groups, but only the weight of CFP from ovariectomised females. 
The combination of oestrogen + progesterone stimulated a significant (P<0.05) decrease 
in the weight of explants from all groups. 
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Table 6.3 Change in the weight of co-cultured CFP and MFP explants from sham­
operated and ovariectomised (ovex) female mice treated for 5 days with saline, 





prog. + oestrogen 
sham 
(mg) 














-0. 1 8a 
-0.95b 
- 1 .22b 




- 1 .24c 
_0.46ab 
- 1 . 1  bc 
Data are least squares means for changes in explant weight across 7 different in vitro 
treatments (n=5 replicates per treatment except for saline-treated, sham-operated 
females where n=4). 
Pooled SE = 0.22 except for saline-treated, sham-operated CFP and MFP least squares 
means where pooled SE = 0.25 . 
a,b,c Least squares means within a column with different superscripts are significantly 
different (P<0.06). 
6.5 DISCUSSION 
Postnatal development of the rodent mammary gland is influenced by a variety of 
systemic and local factors . The present findings lend strong support to suggestions that 
the mammary fat pad plays a pivotal role in promoting the growth of the mammary 
gland epithelium and in mediating the mammogenic actions of ovarian steroids. 
The ontogeny of mitogenic stimulation by co-cultured mouse mammary tissue in vitro 
was such that it declined from 3 weeks of age to reach basal levels in mature virgin and 
mid-gestation females. That similar responses were elicited by CFP and MFP tissue 
indicates that this activity was derived from the stromal constituents of the mammary 
gland. This pattern of fat pad-derived stimulation reflects the ontogeny of ductal 
elongation in vivo, where epithelial growth becomes allometric around 3 weeks of age 
(Silver, 1953) and essentially ceases once ducts reach the bounds of the mammary fat 
pad by around 8-9 weeks of age (Nandi, 1958). DNA synthesis in the terminal end bud 
epithelium concomitantly declines from a maximum at 3 weeks of age (Haslam, 1 989). 
Similarly, mitogenic stimulation by the mammary fat pad during the oestrous cycle is 
greatest at oestrus during a phase of ductal proliferation (Chapter 5) . This 
developmental pattern of mitogenic stimulation by the mammary fat pad parallels the 
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susceptibility of the mammary gland to chemical-induced carcinogenesis (Haslam, 
1 979; Grubbs et al. , 1983). 
Such findings suggest that postnatal change in the mitogenic environment of the 
mammary fat pad regulates ductal proliferation within the mammary gland. Data 
presented in Chapter 4 suggests that the in vitro mitogenic stimulation afforded by the 
prepubertal CFP is due to its liberation of unsaturated fatty acids. These results are 
consistent with the demonstration that a diet deficient in essential fatty acids impairs 
ductal development in immature mice (Miyamoto-Tiaven et al. , 1 98 1 ). While the 
metabolism of lipids by mammary gland adipocytes during this period has not been 
characterised, the substantial changes in the weight of co-cultured mammary tissues in 
vitro suggests that their ability to liberate lipids may progressively decline. In addition, 
ductal proliferation in the virgin mammary gland is promoted by IGF-I (Ruan et al., 
1 992) and EGF (Col em an et aI., 1 988), the mitogenic effects of which are potentiated by 
unsaturated fatty acids (Bandyopadhyay et al., 1 993; Sylvester et aI., 1994; Chapter 4). 
Furthermore, IGF-I mRNA expression is elevated within the mammary fat pad of lambs 
prior to puberty (Chapter 9). It is therefore tenable that prepubertal ductal growth is a 
function of growth factor-induced proliferation which is modulated by locally-derived 
fatty acids. 
While mammary tissues were highly mitogenic during the prepubertal phase of ductal 
proliferation, those from the period of rapid alveolar proliferation in mid-pregnancy 
(Traurig, 1 967) were not. This raises the possibility that in contrast to ductal growth, 
alveolar growth occurs independently of local stimulation from the mammary fat pad. 
Rather, it may be directly governed by the mammogenic effects of systemic hormones 
such as progesterone, prolactin and placental lactogen (Cowie et al. , 1 980; Vonderhaar, 
1987b; Forsyth, 1994). Consistent with this notion and the aforementioned potential 
role for unsaturated fatty acids is the demonstration that alveolar growth is unaffected by 
dietary fat composition (Faulkin et al., 1 986). Furthermore, elevated lipoprotein lipase 
activity within mammary adipocytes during pregnancy (Jensen et al., 199 1 )  may 
suppress the liberation of unsaturated fatty acids from mammary adipocytes for the 
stimulation of epithelial growth. 
These results also indicate that the mitogenic capacity of mammary tissues is 
differentially altered during lactation. While stimulation by CFP remained constant in 
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BM, responses to MFP during this period were markedly increased. This may relate to 
the substantial proliferation of epithelium which occurs within the rodent mammary 
gland during lactation (Traurig, 1 96 1 ;  Munford, 1964). This increased stimulation was 
presumably derived from, or induced by, the epithelium within MFP tissue. 
One possible explanation for the enhanced effect of MFP during lactation is an 
increased contribution of unsaturated fatty acids to co-cultures. Lactating epithelium 
stimulates lipolysis in adjacent mammary adipocytes (Elias et al., 1 973), and MFP has a 
higher lipid content than CFP during lactation (Bandyopadhyay et al., 1 995) in 
association with increased lipoprotein lipase activity (Hamosh et al., 1 970; Jensen et al., 
1 994). Furthermore, lactating MFP contains raised levels of 1 8 :2006 and 20:4006, 
elevation of the latter being associated with an increased activity of epithelial �5 
desaturase (Bandyopadhyay et al. , 1 995). In addition, the effect of MFP declined after 
weaning when the metabolism of lipids by mammary epithelium is markedly decreased 
(Hamosh et al. , 1 970). 
In contrast to the MFP, proportions of individual fatty acids in CFP do not change 
during lactation and the CFP demonstrates relatively low levels of lipolysis during this 
period (Elias et al. , 1 973; Bandyopadhyay et al., 1995). The latter may explain the 
lesser weight change of CFP explants in co-culture at these stages. While the 
stimulatory effect of CFP remained relatively constant during this period in BM and 
steroid treatments, it further potentiated the mitogenic effect of growth factors on 
COMMA- ID  cells. This may have been due to low levels of lipolysis within the CFP 
during lactation (Elias et al., 1973; Bandyopadhyay et al., 1 995), given that only low 
levels of unsaturated fatty acids can markedly potentiate the mitogenic effect of these 
growth factors on COMMA- ID cells (Chapter 4). 
Results from the second experiment, prompted by earlier findings of stage-specific 
regulation of mitogenic stimulation by the mammary fat pad during the oestrous cycle 
(Chapter 5), indicate that the ovary and its steroid hormones have substantial effects on 
both mammary gland development and the mitogenic capacity of the mammary fat pad. 
As anticipated (Imagawa et al. , 1 994), prepubertal ovariectomy completely abrogated 
subsequent mammogenesis. This response was not associated with a reduction in 
mitogenic stimulation from the mammary fat pad, suggesting that its basal mitogenic 
effect in vitro is independent of ovarian function. Such a finding concurs with 
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attribution of the mitogenic effect of co-cultured CFP to unsaturated fatty acids (Chapter 
4) in that lipolysis in subcutaneous adipocytes is unaltered by ovariectomy (Lacasa et 
al., 1 99 1 ), and lipogenesis is maintained at a level similar to that in pro-oestrus (Hansen 
et al., 1980). Also, change in the weight of co-cultured mammary fat pad explants, 
which may reflect a change in lipid mass given other findings in vitro (Shirling et al. , 
1 98 1 ;  Benoit et al., 1982; Rebuffe-Scrive, 1987), was unaffected by ovariectomy. 
Progesterone increased the weight of mammary tissues in ovariectomised, but not intact, 
females. This response contrasts with the effect of progesterone on other adipose depots 
where fat deposition and adipose LPL activity is increased in intact (Steingrimsdottir et 
al., 1 980), but not ovariectomised (Hamosh and Hamosh, 1975; Gray and Wade, 1 98 1 )  
females. This inconsistency may represent differential regulation of lipid metabolism 
within adipocytes from mammary and subcutaneous depots relative to other sites 
(Krotkiewski and Bjomtorp, 1976; Steingrimsdottir et al., 1980; Rebuffe-Scrive et al., 
1986; Bandyopadhyay et al., 1995). 
Progesterone also increased the in vitro mitogenic effect of MFP and CFP from intact 
females, an effect which was dependent on ovarian function. Such a response 
presumably occurred within the stroma of mammary tissue. Consistent with the 
likelihood that progesterone altered lipid metabolism in mammary adipocytes was the 
finding that the weight of CFP and MFP explants from progesterone-treated intact 
females decreased in co-culture while that of explants from ovariectomised females did 
not. This suggests that exogenous progesterone promoted lipolysis in mammary 
adipocytes in vitro. That these responses did not occur in mammary tissues from 
ovariectomised females coincides with the fact that progesterone only influences lipid 
metabolism in adipocytes of intact females (Steingrimsdottir et al. , 1 980; Gray and 
Wade, 198 1 ) , possibly due to a requirement for oestrogen to increase PgR levels (Gray 
and Wade, 198 1 ;  Haslam, 1988c). 
In contrast, oestrogen acted independently of ovarian function and increased mammary 
tissue weight in both intact and ovariectomised females. While oestrogen typically 
decreases adipose tissue weight by increasing lipolysis and suppressing lipogenesis 
(Steingrimsdottir et al., 1 980; Ramirez, 1 98 1 ), the results of Kim and Kalkhoff ( 1 975) 
show, in contrast, that oestrogen induces a specific increase in LPL activity within the 
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mammary gland. Such results further emphasise that ovarian steroids may affect lipid 
metabolism within mammary adipocytes differently to that in adipocytes at other sites. 
Exogenous oestrogen increased the mitogenic effect of CFP, perhaps by increasing 
lipolysis in vitro through elevated levels of hormone sensitive lipase (Benoit et ai. , 
1 982). This corresponds with the earlier finding that mammary tissue is significantly 
more mitogenic at oestrus relative to other stages of the oestrous cycle (Chapter 5). 
However, this effect was reversed by the presence of endogenous epithelium in MFP. 
The reason behind this is presently unclear although it may relate to the observation that 
the increased mitogenic effect of MFP relative to CFP does not occur in medium 
supplemented with oestrogen (Chapter 5). Such a response was also associated with a 
substantial decline in the weight of co-cultured MFP tissue. One possibility along the 
lines of a report by Kidwell et al. ( 1 982) is that oestrogen stimulated mammary 
adipocytes to liberate unsaturated fatty acids which were preferentially sequestered by 
endogenous MFP epithelium to make them unavailable for co-cultured COMMA- ID 
cells. 
As observed previously (Chapter 5), co-cultured MFP was often more stimulatory than 
contralateral CFP devoid of endogenous epithelium. This result suggests that mammary 
epithelium acts on the surrounding mammary fat pad to upregulate its mitogenic effect. 
Consistent with the hypothesis that these responses are induced by unsaturated fatty 
acids from mammary adipocytes are reports that mammary epithelium exerts a lipolytic 
effect on adjacent adipocytes (Elias et al., 1 973;  Kidwell and Shaffer, 1984). Likewise, 
however, it is possible that endogenous epithelium upregulated the stromal expression 
of particular paracrine growth factors (Coleman-Krnacik and Rosen, 1994; Ellis et al., 
1 994). As well as this direct effect, the present results also indicate that this interaction 
may modulate the action of oestrogen on the mammary gland, consistent with the results 
of earlier in vitro studies (McGrath, 1 983; Haslam and Levely, 1 985; Haslam, 1 986). 
While the mechanisms associated with this are presently unknown, such findings 
emphasise the potentially important role of the interaction between epithelial and 
stromal cells within the mammary gland (Cunha and Horn, 1996) . 
In conclusion, the present findings lend strong support to a role for the mammary fat pad 
in regulating postnatal mammogenesis. Such regulation likely represents a complex 
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DIFFERENTIAL MODULATORY EFFECTS OF MURINE 
AND OVINE MAMMARY FAT PAD ON THE 




Several lines of evidence suggest that different mechanisms locally regulate epithelial 
growth within the rodent and ruminant mammary glands. The objective of these 
experiments was to compare the in vitro mitogenic effects of murine and ovine 
mammary fat pad (FP) tissue on murine (COMMA-ID) and bovine (MAC-T) mammary 
epithelial cells. The growth of COMMA-ID cells was increased (P<0.05) by 
approximately 2-fold in the presence of co-cultured FP from prepubertal ewe lambs, 
with a similar response to lamb FP conditioned medium (CM). This stimulation was 
typically additive to the mitogenic effects of 1 0% FCS, insulin-like growth factor-I 
(IGF-I) and epidermal growth factor (EGF). Subsequent comparisons indicated that the 
growth of COMMA-ID cells in a hormone-free basal medium (BM) was equally 
stimulated by co-cultured ovine FP and murine FP, while ovine FP was less stimulatory 
than murine FP for MAC-T cells. Evidence for a local influence of endogenous 
epithelium on the surrounding stroma was provided by the result that ovine mammary 
parenchyma (PAR) was more mitogenic (P<0.05) than ovine FP for both cell lines. 
Comparison of the ability of these tissues to modulate the responsiveness of mammary 
epithelial cells to various medium treatments revealed several distinctions. Murine FP 
substantially potentiated the mitogenic effects of IGF-I, EGF, and insulin for COMMA­
ID cells, more so than ovine FP or PAR. There was no response by COMMA-ID cells 
to other factors such as prolactin, oestrogen or progesterone in co-culture with any of 
these tissues. All co-cultured tissues similarly interacted with IGF-I to stimulate the 
growth of MAC-T cells while only ovine PAR facilitated a response to EGF. MAC-T 
cells were unresponsive to acidic FGF or basic FGF either alone or in the presence of 
murine or ovine FP, while ovine PAR tended to potentiate their effect. MAC-T cells 
were unresponsive to prolactin, oestrogen, or progesterone in any of the conditions 
tested. These results indicate differences in the mitogenic effect of murine and ovine 
mammary fat pads and their ability to modulate the growth responsiveness of murine 
and bovine mammary epithelial cells. Furthermore, interactions between the epithelial 
and stromal constituents in the ovine mammary gland may modulate the effects of 
certain mammogenic factors. 
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7.2 INTRODUCTION 
The mammary fat pad comprises a matrix of adipose and connective tissue which 
supports the extensive proliferation of epithelial cells during development of the female 
mammary gland (Sheffield, 1 988b). The size of the mammary fat pad determines the 
extent of parenchymal growth (Hoshino, 1 978) which in turn dictates the ultimate milk 
yield potential of the mammary gland (Tucker, 1 98 1 ) .  
The mammary fat pad may regulate the growth of mammary epithelial cells by several 
different mechanisms. Various constituents of the mammary stroma express 
polypeptide growth factors (Hauser et al. , 1 990; Niranjan et al. , 1 995; Chakravorti and 
Sheffield, 1 996a) which exert potent mitogenic and morphogenic effects on mammary 
epithelium. These effects may be further modulated by fatty acids locally released from 
mammary adipocytes (Bandyopadhyay et al. , 1 993; Chapter 4). Stromal cells also 
provide a physical substratum (Keely et al. , 1 995) capable of modifying both the 
morphogenesis (Wiens et al. , 1 987) and hormonal responsiveness (Salomon et al., 
1 98 1 )  of mammary epithelium. Such mechanisms might locally mediate the 
mammogenic effects of hormones such as oestrogen (Shyamala and Ferenczy, 1 984) 
and growth hormone (Hauser et aI. , 1 990). Within this cellular interaction, epithelial 
cells can exert reciprocal effects on stromal activities including DNA synthesis 
(Dulbecco et aI. , 1 982; Berger and Daniel, 1 983), lipolysis (Kidwell and Shaffer, 1 984) 
and growth factor expression (Coleman-Krnacik and Rosen, 1 994). 
Earlier observations (Chapter 8) and those of others (Sheffield, 1 988b; Akers, 1 990) 
emphasise that the ruminant mammary gland undergoes a histogenesis and 
morphogenesis distinct from that of the widely studied rodent mammary gland 
(Imagawa et aI., 1 994). As well as being more dichotomously branched, ruminant 
mammary epithelium is continually enveloped by a fibroblastic connective tissue 
(Chapter 8). This connective tissue, which is also interspersed among the adipocytes of 
the ruminant mammary fat pad, is much less abundant within the rodent mammary 
gland. In several of these respects the ruminant gland is similar to the human breast 
which also undergoes a morphogenesis distinct from that of the rodent mammary gland 
(Sakakura, 1 99 1 ;  R0nnov-Jessen et aI., 1 996) . 
Such differences may be manifest in the findings of transplantation experiments, where 
mouse (reviewed by Hoshino, 1 978) and rat (Daniel et aI., 1 983; Welsch et al., 1 987) 
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mammary epithelium develops normally within the mammary fat pads of mice while 
bovine (Sheffield and Welsch, 1 986; Ellis and Akers, 1 995) and human (Sheffield and 
Welsch, 1 988; Yang et aI. , 1 995) mammary epithelium does not outgrow but instead 
forms cystic structures. These findings have prompted the suggestion that regulatory 
influences exerted by the stromal elements of the ruminant and human mammary gland 
are distinct from those within the rodent gland (Sheffield, 1 988b). 
It has been recently shown that murine FP releases an activity in vitro which stimulates 
the growth of mouse mammary epithelial cells and markedly enhances their 
proliferative response to certain mitogens (Chapters 2 and 3). Furthermore, these effects . 
of the mammary fat pad are altered at various physiological stages of mammary 
development (Chapters 5 and 6). It was hypothesised that differences between the 
rodent and ruminant mammary fat pads would be reflected in this co-culture system. 
The experiments herein have compared the ability of murine and ovine FP to modulate 
the response of murine and bovine mammary epithelial cells to various mitogens. The 
influence of epithelial-stromal interactions on the mitogenic effect of ovine mammary 
stroma in vitro has also been investigated. 
7.3 MATERIALS AND METHODS 
7.3.1 Cell cultures 
Stocks of COMMA-ID mouse mammary epithelial cells (Danielson et al. , 1 984) were 
propagated in DMEIF 1 2  (Gibco, New Zealand) supplemented with 2% foetal calf serum 
(FCS; Gibco, New Zealand), 6 �g/ml insulin (Sigma), 5 ng/ml mouse EGF (Sigma) and 
0.3 mg/ml bovine serum albumin (Sigma). MAC-T bovine mammary epithelial cells 
(Huynh et ai., 1 99 1 )  were cultured in DMEM (Gibco, New Zealand) plus 1 0% FCS, 1 
�g/ml hydrocortisone (Sigma) and 5 �g/ml insulin. COMMA-ID and MAC-T stocks 
were passaged weekly using Dispase and trypsinlEDTA, respectively. COMMA-ID 
and MAC-T cells for co-culture experiments were plated in hormone-supplemented 
media at 5 x 1 04 and 3.5 x 1 04 cells/well. COMMA-ID cells for conditioned medium 
experiments were seeded at 1 x 1 05 cells/well. After 24 h for attachment, cultures were 
quiesced for 48 h in DMEM basal medium (BM) before treatments were applied. 
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7.3.2 Animals and tissues 
Coopworth x Dorset ewes maintained under standard grazing conditions in the Ruakura 
flock were the source of mammary tissues for these experiments. Mammary tissues for 
initial experiments conducted on three separate occasions were from one I -week old and 
two 5-week old ewe lambs. These lambs were kept with their dam until they were 
sacrificed. Mammary tissues for the second set of experiments were from two 35-week 
old virgin ewes. Sheep were euthanased by captive bolt and exsanguination. The udder 
was removed and immediately transported to the tissue culture facility. Pieces of 
mammary fat pad (FP) tissue were aseptically sampled from the extra-parenchymal 
region of each gland as delineated by parenchymal pigmentation. In the second series 
of experiments parenchymal tissue (PAR) was also sampled. Tissues were briefly 
rinsed in BM before use in co-culture experiments. 
In the second set of experiments extra-parenchymal FP tissue from the abdominal 
mammary fat pads of 3-week old female BALB/c mice was also used as previously 
described (Chapter 2). 
7.3.3 Co-cultures and conditioned medium 
Mammary tissue was co-cultured with mono layers of mammary epithelial cells as 
described in Chapter 2. Briefly, tissues were sectioned into explants of approximately 
5 - 10  mg which were rinsed in the hormone-free BM. Explants were then placed on rafts 
of siliconised lens paper and floated at the gas:medium interface of appropriate cultures. 
Mammary explants were added to an initial 0.5 ml treatment medium, and a further 0.5 
ml of medium was added on day 3 .  Co-cultures were for 5 days. 
Medium conditioned by mammary fat pad tissue (CM) was prepared as described in 
Chapter 3. Explanted ovine FP was incubated in BM (7.5 mg/ml) for 48 h at 37°C in a 
humidified 5% CO2:95% air atmosphere. The resultant CM and control BM (incubated 
in the absence of FP tissue) were filtered (0.2 /lm) and supplemented with various 
treatments before being added to cultures for 3 days. 
Other medium supplements included recombinant bovine growth hormone (rbGH; 
Elanco, Indianapolis, IN) , acidic and basic FGF (Sigma), prolactin (Sigma) and 
recombinant human IGF-I (Genentech, San Francisco, CA). 1 7p-oestradiol (Sigma), 
progesterone (Sigma) and hydrocortisone (Sigma) were added from ethanolic stocks, 
where all treatments within an experiment contained the same concentration of ethanol. 
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At the end of the culture period mono layers were trypsinised and the final DNA content 
measured by a fluorometric assay (Labarca and Paigen, 1 980) using calf thymus DNA 
as a standard. 
7.3.4 Statistical analyses 
Cell growth results were analysed for the main effects of in vitro culture treatment, co­
cultured mammary tissue and their interactions using the GLM procedure of SAS 
( 1 994). Where appropriate, data were natural log transformed to address heterogeneity 
of variance. Individual means comparisons were by LSD. 
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7.4 RESULTS 
The fIrst set of experiments determined the mitogenic effect of co-cultured ovine FP on 
COMMA-ID mouse mammary epithelial cells, the proliferation of which is markedly 
stimulated by murine FP (Chapter 2). Final DNA yield in the presence of co-cultured 
ovine FP was 2.2-fold that in BM only (P<0.05 ; Figure 7. 1 ). Supplementation of BM 
with 10% FCS increased (P<0.05) the fInal DNA yield by 7.9-fold while ovine FP 
furthered this response to a 10.5-fold increase. 
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Figure 7. 1 Growth response of COMMA-ID cells to co-cultured ovine FP and 10% 
FCS. COMMA-ID cells were cultured for 5 days in either BM alone or BM 
supplemented with 10% FCS in the absence or presence of co-cultured FP from a 5-
week old ewe lamb. Data are means ± SEM (n=4). a,b,c Means with different 
superscripts are signifIcantly different (P<0.05). 
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In Chapters 2 and 3 it was shown that co-cultured murine FP markedly potentiates the 
effect of lGF-I and EGF on COMMA-ID cell growth (Chapters 2 and 3) . It was tested 
whether co-cultured ovine FP could similarly modulate these effects. The final level of 
DNA in the presence of co-cultured ovine FP was 2.S-times that in BM alone (Figure 
7.2; P<O.OOI ). Supplementation of cultures with IGF-I, EGF, or their combination 
increased (P<O.OS) final cell number by 8S, 78, and 1 3S%, respectively. While there 
was a slight (P<O.OS) interactive response between the effects of co-cultured ovine FP 
and IGF-I, the effects of EGF and IGF-I + EGF were additive to that of ovine FP. 
S imilar results were obtained for FP from 1 - and S-week old ewe lambs. 
BM IGF- I  EGF IGF- I  + EGF 
Treatment 
Figure 7.2 Growth of COMMA-ID cells in response to co-cultured ovine FP, IGF-I 
and EGF. COMMA-ID  cells were cultured for S days in BM either alone or 
supplemented with IGF-I ( 1 00 ng/ml) and/or EGF (2S ng/ml) in the absence or presence 
of co-cultured FP from a 5-week old ewe lamb. Data are means ± SEM (n=4). 
a,b,cMeans with different superscripts are significantly different (P<O.OS). 
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Determination of the response to CM prepared using ovine FP revealed that final DNA 
values increased (P<0.05) with the proportion of CM alone, and that parallel responses 
occurred in the presence of IGF-I, EGF, or IGF-I + EGF (Figure 7.3). Final DNA yield 
in 1 00% CM either alone or in the presence of IGF-I, EGF or IGF-I + EGF was 
increased (P<0.05) by 22, 39, 35 and 59%, respectively relative to DNA yield in BM 
only. Inclusion of at least 25% CM in medium supplemented with 1 0% FCS realised 
the maximum additional response to CM (Figure 7.3). 
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Figure 7.3 Response of COMMA-ID cells to a range of concentrations of CM 
prepared using ovine FP, both alone and in the presence of various mitogenic 
supplements. COMMA-ID cells were cultured for 3 days in the indicated 
concentrations of CM ( 1  ml) which was also supplemented with IGF-I ( 1 00 ng/ml) 
and/or EGF (25 ng/ml), or 10% FCS. CM was prepared using FP tissue from a 5-week 
old ewe lamb. Data are means ± SEM (n=3). 
Several groups have proposed that the mammogenic effect of GH in ruminants may be 
mediated by the mammary fat pad (Hauser et al. , 1 990; Chapter 9). While IGF-I 
stimulated the growth of COMMA-ID cells alone and in the presence of ovine FP, 
rbGH had no effect on the growth of COMMA-ID cells either alone or in the presence 
of FP, IGF-I, or their combination (Figure 7.4). 
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Figure 7.4 Effect of co-cultured ovine FP, IGF-I and rbGH on the growth of COMMA­
ID mouse mammary epithelial cells. Cells were cultured for S days in the absence or 
presence of co-cultured ovine FP in BM either alone or supplemented with IGF-I ( 100 
ng/ml) andlor rbGH ( 1  Jlg/ml). FP tissue was from a S-week old ewe lamb. Data are 
means ± SEM (n=4). a,b,c Means with different superscripts are significantly different 
(P<O.OS). 
In a second series of experiments the mitogenic effect of murine FP was compared to 
that of FP from 3S-week old ewes, and the influence of epithelial-stromal interactions 
examined by determining the response to ovine PAR. These tissues were co-cultured 
with COMMA-ID and MAC-T cells in various medium treatments. 
COMMA-ID cells demonstrated similar responses to co-cultured murine and ovine FP 
in that the respective final DNA yields were 2.2- and 2.S-fold that in BM only (Figure 
7.Sa). Ovine PAR stimulated a further (P<O.OS) increment of growth whereby the final 
DNA level was increased by 3 .3-fold. A similar pattern of responses was observed 
above the proliferative effect of 10% FCS. 
Ovine FP was less (P<O.OS) stimulatory for MAC-T cells than either murine FP or ovine 
PAR, where murine FP, ovine FP and ovine PAR stimulated growth to final DNA 
values that were 2.S-, 1 .7- and 3 .2-fold that in BM only (Figure 7.Sb). While murine FP 
did not alter the growth of MAC-T cells in 10% FCS (P>O.OS), ovine FP and PAR 
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Figure 7.5 Growth of (A) COMMA-ID, and (B) MAC-T cells in response to co­
cultured mammary tissues and 1 0% FCS. Cells were cultured for 5 days in BM or 1 0% 
FCS either alone or in the presence of co-cultured murine FP, or ovine FP or PAR from 
a 35-week old ewe. Data are means ± SEM (n=4). *P<0.05 compared to the respective 
no FP response. 
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The relative mitogenic effect of these tissues on COMMA-ID  cells was altered in the 
presence of IGF-I and/or EGF (Figure 7.6a). The most marked interaction was in co­
culture with murine FP where growth responses in all treatments were equal to or 
greater than that due to ovine PAR, which in turn was equal to or greater than the 
response to ovine FP. 
For MAC-T cells there were differential effects of these tissues in the presence of lGF-I 
and/or EGF. All co-cultured tissues interacted (P<O.05) with IGF-I to yield a 
distribution of responses similar to that in BM (Figure 7 .6b). EGF alone did not alter 
the yield of DNA (P>O.05) from MAC-T cultures, and no response was effected by EGF 
in the presence of co-cultured murine FP or ovine FP. In contrast, there was a 
significant (P<O.05) interaction between the effects of EGF and ovine PAR that was 
reduced in the presence of lGF-1. 
Supplementation of COMMA-ID cultures with aFGF and bFGF increased (P<O.05) 
final cell number by 43 and 47%, respectively (Figure 7.7a). While there were modest 
interactions between the effects of co-cultured ovine FP and PAR with aFGF and bFGF, 
the most substantial response was in the presence of murine FP where final cell number 
in the presence of aFGF and bFGF was 3 .3- and 3.8-times that in BM only. 
Acidic FGF and bFGF alone did not stimulate any increase (P>O.05) in the final DNA 
level ofMAC-T cultures (Figure 7.7b). There was no additional effect of these FGFs in 
the presence of murine FP (P>O.05), with slight but non-significant effects in co-culture 
with ovine FP. In the presence of ovine PAR there was a tendency (P<O. I 5) for both 
aFGF and bFGF to evoke an additional response over that due to PAR alone. 
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Figure 7.6 Effect of IGF-I, EGF, and co-cultured mammary tissues on the growth of 
(A) COMMA-ID, and (B) MAC-T cells. Cultures were for 5 days in  BM alone or 
supplemented with IGF-I ( 100 nglml) and/or EGF (25 nglml) in the presence of co­
cultured murine FP, or ovine FP or PAR from a 35-week old ewe. Data are means ± 
SEM (n=4). a,b,c Means with different superscripts within a treatment group are 
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Figure 7.7 Proliferative response of (A) COMMA-ID, and (B) MAC-T cells to aFGF, 
bFGF, and co-cultured mammary tissues. Cells were cultured for 5 days in BM either 
alone or supplemented with aFGF (5 ng/ml) or bFGF (5 ng/ml) in the presence of co­
cultured murine FP, or ovine FP or PAR from a 35-week old ewe. Data are means ± 
SEM (n=4). *P<O.05 compared to respective BM value. 
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Supplementation of BM with prolactin did not alter (P>O.05) the response of either 
COMMA-ID  (Figure 7.8a) or MAC-T (Figure 7.8b) cells to co-cultured mammary 
tissues. Insulin alone stimulated (P<O.05) the growth of COMMA-ID  cells but did not 
affect that ofMAC-T cultures (P>O.05). For COMMA-ID  cells, this effect was additive 
to that of co-cultured ovine FP and PAR while it significantly (P<O.05) interacted with 
that of co-cultured murine FP. For MAC-T cells, insulin promoted small but non­
significant increases in final DNA values above the effects of ovine FP and PAR, while 
it significantly (P<O.05) interacted with the effect of murine FP. Hydrocortisone did not 
alter the response of COMMA-ID  or MAC-T cells to murine FP but suppressed or 
tended to suppress the effect of ovine FP and PAR on both cell lines. 
Oestrogen and progesterone did not affect (P>O.05) final DNA levels in COMMA-ID  
(Figure 7.9a) or MAC-T (Figure 7.9b) cultures, although their combination reduced 
(P<O.05) MAC-T cell growth. Neither cell line demonstrated any additional response to 
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Figure 7.8 Growth of (A) COMMA-ID, and (B) MAC-T cells in response to 
mammogenic honnones and co-cultured mammary tissues. Cells were cultured for 5 
days in BM either alone or supplemented with prolactin (2.5 /lg/ml), insulin ( 1 0  /lg/ml), 
or hydrocortisone (2.5 /lg/ml) in the presence of co-cultured murine FP, or ovine FP or 
PAR from a 35-week old ewe. Data are means ± SEM (n=4). *P<0.05 compared to 
respective BM value. 
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Figure 7.9 Effect of ovarian steroids and co-cultured mammary tissues on the growth 
of (A) COMMA-ID, and (B) MAC-T cells. Cultures were for 5 days in BM either 
alone or supplemented with oestrogen (1 ng/ml) and/or progesterone ( 1  �g/ml) in the 
presence of co-cultured murine FP, or ovine FP or PAR from a 35-week old ewe. Data 
are means ± SEM (n=4). *P<O.05 compared to respective BM value. 
1 82 
7.5 DISCUSSION 
Transplantation studies have demonstrated that COMMA-I D  (Danielson et al., 1 984) 
and primary mouse mammary epithelial cells (DeOme et al., 1 959) undergo normal 
growth and morphogenesis within the murine mammary fat pad whereas MAC-T (Ellis 
and Akers, 1 995) and primary bovine mammary epithelial cells (Sheffield and Welsch, 
1 986) do not. Human mammary epithelium is also unable to outgrow into the murine 
mammary fat pad (Sheffield and Welsch, 1 988; Yang et al., 1 995). One factor which 
may account for these differences is the environment of the endogenous mammary fat 
pad. The present findings indicate that the mouse and ruminant mammary fat pads 
differ in their mitogenic effects in vitro, effects which result in differential growth 
responses by murine COMMA-ID and bovine MAC-T mammary epithelial cells. 
Co-cultured ovine FP consistently stimulated an approximate doubling in DNA yields 
of COMMA-I D  and MAC-T cultures in the hormone-free BM. It was recently shown 
that co-cultured murine FP releases unsaturated fatty acids which can stimulate the 
growth of COMMA-I D  cells (Chapter 3). Unsaturated fatty acids also promote the 
growth of MAC-T cells (Cockrell et aI., 1 992) while saturated fatty acids inhibit the 
growth of rodent (Wicha et al., 1 979) and bovine (Cockrell et al., 1 992) mammary 
epithelial cells. The rodent mammary fat pad contains a high proportion of unsaturated 
fatty acids, particularly linoleic acid (Wicha et al., 1 979; Bandyopadhyay et al., 1 995), 
while ovine mammary tissue contains a high proportion of saturated fatty acids and low 
amounts of linoleic acid (McFadden et al. , 1 990b). 
Consistent with the predicted fatty acid composition of the tissues, co-cultured murine 
FP was more stimulatory for MAC-T cells than ovine FP while, interestingly, co­
cultured ovine FP stimulated COMMA-ID cell growth to an extent similar to murine 
FP. This apparent inconsistency may reflect the demonstration that ovine FP expresses 
a relatively high abundance of mRNA for several growth factors which are mitogenic 
for mammary epithelial cells (Chapters 9- 1 1 ) .  Furthermore, ovine mammary tissue 
contains a high proportion of fibroblasts (Akers, 1 990; Chapter 8) which secrete a 
soluble activity that is mitogenic for COMMA-I D  cells (Chapter 1 1 ) .  Although the 
relative contributions of such factors remain unclear, it is evident that several means 
exist by which the ovine FP may elicit its growth promoting effect; means which may 
exert differential effects on murine and bovine mammary epithelial cells. 
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The ability of murine and ovine FP to modulate the proliferative effect of various factors 
on mammary epithelial cells was also compared. While the mitogenic effect of co­
cultured tissues for COMMA-ID cells was additive to that of 1 0% FCS, the response of 
MAC-T cells to FCS was suppressed by co-cultured ovine mammary tissues. These 
contrasting responses may reflect different sensitivity of murine and bovine mammary 
epithelial cells to the effects of high fatty acid concentrations (Wicha et al., 1 979; 
Cockrell et al., 1992) or growth inhibitory factors such as transforming growth factor-� 
(Woodward et al., 1 995 ; Soriano et al., 1 996). 
A finding that may be of particular significance is the different ability of murine and 
ovine mammary fat pads to modulate the responsiveness of murine and bovine epithelial 
cells to certain mitogens. While murine FP substantially potentiates the effects of IGF­
I, EGF and insulin on COMMA-ID cells, ovine FP only adds to or slightly interacts 
with these effects. In contrast, MAC-T responsiveness to IGF-I and insulin is similarly 
enhanced by murine and ovine FP. 
In these experiments the most pronounced cell growth responses occurred when 
COMMA-ID cells were co-cultured with murine MP. It was recently reported that 
murine FP likely elicits such responses by its liberation of unsaturated fatty acids to 
enhance intracellular signalling via protein kinase C (Chapter 4). Such a mechanism 
may be of increased importance within the developing mouse mammary gland where 
epithelium grows in close association with adipocytes (Daniel and Silberstein, 1 987) 
which can transport free fatty acids directly across the basement membrane 
(Bandyopadhyay et a!. , 1995). While the growth of ruminant mammary epithelial cells 
is stimulated by unsaturated fatty acids in vitro (Cockrell et al., 1 992) and in vivo 
(McFadden et al., 1990a), these cells may have a reduced ability to utilise unsaturated 
fatty acids to enhance their responsiveness to certain growth factors, a suggestion which 
could be reflective of the fatty acid composition of the ruminant mammary fat pad. 
Such findings, however, do not fully resolve the question of why ruminant mammary 
epithelium does not outgrow into the mouse mammary fat pad. It is possible that the 
endogenous mammary fat pad provides other factors to satisfy requirements for such 
growth. Sheffield (1 988b) indicated that the extracellular matrix in the rodent 
mammary gland differs substantially from that in ruminants and humans by virtue of 
differences in the proportion of connective tissue surrounding the mammary epithelium. 
Additionally, the ovine mammary gland stroma expresses a relatively high abundance of 
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mRNA for certain growth factors (Chapters 9-1 1 )  which may fulfil specific 
requirements for the growth and morphogenesis of ruminant mammary epithelium. 
Co-cultured ovine PAR was consistently more mitogenic than ovine FP, suggesting that 
ovine mammary epithelium locally upregulates mitogenic stimulation by the adjacent 
stromal constituents. A similar effect was recently recorded within mouse mammary 
tissue at different stages of postnatal development (Chapter 6) and during the oestrous 
cycle (Chapter 5), an effect which may represent epithelium-induced lipolysis within 
adjacent mammary adipocytes (Levay-Young et ai. , 1 987; Kidwell et al., 1 982). 
However, the mechanism underlying this effect in ovine mammary tissue is unknown. 
It is possible that endogenous epithelium induced the increased or specific release of 
unsaturated fatty acids in co-culture, perhaps through an epithelial desaturase activity 
(Bandyopadhyay et ai. , 1995) or by preferential sequestration of unsaturated fatty acids 
from mammary adipocytes (Kidwell et al., 1 982). It is also possible that epithelium 
increased the mitogenic effect of PAR by increasing the stromal synthesis of paracrine 
growth factors (Chapters 9- 1 1 ) .  While the cause(s) underlying this increased 
stimulation remains to be established, such findings support the concept that mammary 
epithelium can signal the adjacent stroma to locally promote its growth and 
morphogenesis. 
This cellular interaction might also modulate epithelial responsIveness to certain 
mammogemc factors. While intact mouse mammary tissue is significantly more 
mitogenic than murine FP in vitro (Chapter 5), this difference does not exist in the 
presence of oestrogen (Chapters 5 and 6). That this effect was not apparent in co­
culture with ovine FP and PAR may relate to the uncertain role of the ovary during 
ovine mammogenesis (Ellis et al., 1 996a). However, a similar effect was observed 
where MAC-T cells only responded to EGF in the presence of PAR, even though an 
earlier report established that MAC-T cells are unresponsive to the mitogenic effect of 
EGF (Woodward et al. , 1994). One means by which this response may have occurred is 
through an indirect action of EGF via EGF receptors within the parenchyma! stroma, the 
expression of which is induced by the adjacent epithelium (Daniel and Silberstein, 
1 987). Certainly other factors resulting from the epithelial-stromal interaction within 
PAR may have also accounted for, or contributed to, this response. It is possible that 
such effects may be required to elicit a local mammogenic effect of GH, although such a 
mechanism remains to be investigated. 
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In conclusion, these findings demonstrate that the murine and ovine mammary fat pads 
exert distinctive mitogenic effects on murine and bovine mammary epithelial cells and 
differentially modulate their responsiveness to certain mammogenic factors. As in the 
mouse mammary gland, epithelial-stromal interactions within the ovine mammary gland 
may serve to locally regulate epithelial proliferation. 
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CHAPTER S 
PREPARA TION OF A PARENCHYMA-FREE MAMMARY 
FAT PAD AND SUBSEQUENT MAMMARY GLAND 
DEVELOPMENT IN SHEEP 
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8.1 ABSTRACT 
A surgical procedure was developed for the preparation of an epithelium-free mammary 
gland fat pad (cleared mammary fat pad; CFP) in ewes. At 7- 10  days of age, ewe lambs 
(n=43, mean BW 9.2 ± 0.2 kg at 14 days) were sedated, the udder aseptically prepared, 
and one gland locally anaesthetised. Palpation indicated the extent and location of 
epithelial parenchyma to be removed from this gland. An incision was made that 
circumscribed the base of the teat. Blunt dissection was then performed through the 
extraneous mammary fat pad tissue to enable the parenchyma and teat to be wholly 
removed. A preliminary study indicated that any residual epithelium could regenerate 
into the mammary fat pad. Mean diameter of the parenchymal rudiment was 8 .9 ± 0.5 
mm (range 5- 1 6  mm). The site of excision was closed with wound clips, and recovered 
lambs were returned to their dam. The contralateral mammary gland remained intact, 
allowing it to undergo normal development. 
Liveweight gain was unaffected by this surgical procedure. Groups of ewes were 
subsequently slaughtered at various stages of prepuberty, puberty, gestation and 
lactation. Of 39 operated glands recovered, only one demonstrated epithelial growth 
into the mammary fat pad. The contralateral, intact gland underwent phases of rapid 
growth in prepuberty, puberty, and late gestation, and was capable of milk synthesis 
after steroid hormone induction or parturition. Weight change by the CFP paralleled 
that of the intact mammary gland to 1 00 days of pregnancy. Sham CFP surgery was 
performed on an additional 4 ewes wherein parenchyma was fully excised and 
immediately replaced. Sham-operated epithelium populated the mammary fat pad and 
synthesised milk that could be expressed via the teat. A CFP in sheep will be a useful 
model for future investigations into the local growth regulatory mechanisms associated 
with postnatal ruminant mammogenesis. 
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8.2 INTRODUCTION 
The mammary gland undergoes a series of proliferative and morphological changes as it 
develops postnatally (Imagawa et aI., 1994). By far the majority of studies which have 
investigated the processes underlying such development have been conducted in rodents 
as a model for human breast cancer (Nandi et al., 1 995). 
An aspect of mammary biology that has received increased attention is the local growth 
regulatory capacity of the mammary fat pad. This stromal matrix may direct epithelial 
development via the local synthesis of growth factors (Chakravorti and Sheffield, 
1 996a; Chapters 9- 1 1 )  and extracellular matrix components (Keely et al., 1995), and by 
locally mediating hormone action (Shyamala and Ferenczy, 1 984). Investigations of 
such mechanisms in rodents have been greatly facilitated by the "cleared mammary fat 
pad" technique. Originally described by DeOme et al. ( 1 959), this relatively simple 
procedure involves ablating the epithelial rudiment to yield a mammary fat pad devoid 
of endogenous epithelium. A wide range of studies have utilised the CFP to study 
various aspects of mammary fat pad function including lipid metabolism 
(Bandyopadhyay et aI., 1 995) and growth factor expression (Coleman-Krnacik and 
Rosen, 1 994; Chakravorti and Sheffield, 1996a). The CFP has also been extensively 
used as a transplantation site for murine (Hoshino, 1 978), bovine (Sheffield and Welsch, 
1 986), tumorous (Miller et al., 198 1 ), and genetically transformed (Edwards et aI. , 
1 996) mammary epithelium. 
Although the results of some rodent experiments are directly relevant to aspects of 
ruminant mammogenesis, several distinctions between mammary gland development in 
the two orders strongly discourage an extensive extrapolation of results (Akers, 1990). 
For example, whereas mouse mammary epithelium ramifies into the mammary fat pad 
as a sparse network of ducts guided by peripheral end buds (Imagawa et aI., 1994), 
ruminant mammary epithelium progresses into the fat pad as a more dichotomously 
branched parenchyma (Hammond, 1 927) with no apparent end bud structures (Ellis et 
al., 1 995). This latter morphogenesis is associated with the epithelium being 
encompassed by a much greater proportion of connective tissue (Sheffield, 1988b; 
Akers, 1 990), somewhat similar to that seen in the human breast (R�nnov-Jessen et aI. , 
1 996). Additionally, whereas rodents fed a diet high in energy have increased mammary 
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development and tumorigenic risk (Engelman et ai., 1 994), ruminants fed a high plane 
of nutrition have impaired mammogenesis and lactogenic potential (Johnsson and Hart, 
1 985;  Little and Kay, 1 979). Furthermore, adipocytes of the rodent mammary fat pad 
contain a high proportion of unsaturated fatty acids (Bandyopadhyay et al., 1 995) which 
influence mammary epithelial development and tumorigenesis (Wicha et al. , 1 979; 
Welsch, 1 992) whereas ruminant mammary adipocytes contain a high proportion of 
saturated fatty acids (McFadden et al., 1 990a). 
The objective of this study was to prepare a CFP in sheep as a model for studies into the 
local regulation of ruminant mammogenesis. The successful development of such a 
procedure is described herein, and some aspects of subsequent mammary gland 
development in these ewes are reported. 
8.3 MATERIALS AND METHODS 
8.3.1 Animals 
A total of 53 Dorset x Coopworth ewe lambs from the Ruakura flock were used in this 
study. Of these, 40 were singles and the remainder twins. A total of 47 ewe lambs were 
surgically prepared; the remaining six served as unoperated controls. Lambs were 
weaned at 1 1  weeks of age. All sheep grazed ryegrass pastures as a single flock and 
were subjected to standard management practices. 
8.3.2 Surgical procedure 
All manipUlations were approved by the Ruakura Animal Ethics Committee. Surgery 
was conducted over 3 consecutive days on 43 ewe lambs that were 7- 1 0  days of age. 
Lambs were separated from their dam on the morning of surgery and were held in pens. 
The mean bodyweight of these lambs 4 days post-surgery was 9.2 ± 0.2 kg. Each lamb 
was sedated (Rompun, 2%; 0. 1 5  ml i.v.), placed in a dorsally recumbent position, and 
the posterior abdomen, udder region and inside hind legs shaved and aseptically 
prepared. One mammary gland of each lamb was subsequently prepared as a CFP. The 
region at the base of the appropriate teat was palpated to ascertain the size and location 
of the underlying parenchymal tissue to be ablated. The periphery of this gland was 
locally anaesthetised with a field block (Xylocaine, 1 ml) . A concavo-convex incision 
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circumscribing the base of the teat was then made. Blunt dissection was performed 
subcutaneously to beyond the bounds of the parenchymal tissue, and then through 
extraneous adipose tissue of the mammary fat pad such that the teat and associated 
parenchyma could be wholly removed. The site of excision was closed with stainless 
steel clips and topically treated with Terramycin powder. A systemic antibiotic was also 
administered (Depomycin, 0.5 ml, i .m.) . Once fully recovered (approximately 2 h), 
lambs were returned to their dam and the establishment of ewe-lamb bonding 
confirmed. 
On a separate occasion a sham CFP was prepared in four l O-day old lambs. In these 
instances the parenchymal tissue and teat were removed according to the above 
procedure and were then replaced into the excision site which was closed with wound 
clips. 
A total of 6 lambs died throughout the course of this study (5 operated, 1 control), 
although in no case was death attributed to the surgical manipulation. 
8.3.3 Experimental design 
Ewe lambs were weighed weekly to 1 6  weeks of age, fortnightly to 3 1  weeks, and at 
varying intervals thereafter. The onset of oestrus in ewes under similar conditions is 
typically around 30-38 weeks of age (Smith et aI. , 1 993a). At 32 weeks, all ewes were 
administered an intravaginal CIDR™ for 14 days to synchronise oestrus (Paton et al. , 
1 993). Ewes to be mated were pastured with rams fitted with a marking harness for two 
subsequent oestrous cycles, and marked ewes were recorded each morning. Pregnancies 
were confirmed at approximately 40 days post coitus by ultrasound scanning. Standard 
gestation length in these ewes is 145- 1 50 days. 
Ewes with CFPs were sacrificed in groups at various stages of development, specifically 
at 6 weeks (n=4), 1 0  weeks (n=4), 1 5  weeks (n=4), 22 weeks (n=5), 35  weeks (n=4), 53-
57 weeks (n=5), 50 days gestation (n=4), 1 00 days gestation (n=2), 140 days gestation 
(n=2) and 1 day post-partum (n= I) .  One sham CFP ewe was sacrificed at 53 weeks of 
age, and another at 5 days post-partum. One control ewe was sacrificed at 1 00 days 
gestation, and another at 140 days gestation. The remaining virgin ewes were 
hormonally induced into lactation as described below and were sacrificed thereafter at 
65 weeks of age. 
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8.3.4 Mammary sampling 
Ewes were killed by captive bolt and exsanguination. The udder was removed and 
separated along the medial suspensory ligament into the intact and CFP halves which 
were then weighed. Both udder halves were sliced sagitally in the dorso-ventral plane 
into slices of approximately 8 mm thickness. The first cut through the intact gland 
bisected the parenchymal mass. 
To obtain a non-destructive measure of mammary development within the intact gland, 
the face of each slice was traced onto transparency film along the bounds of the skin, 
parenchyma (on the basis of colour) and mammary fat pad. Each tracing was then 
photocopied onto paper, the parenchymal and mammary fat pad regions cut out, and 
their area determined with an LI-3000 portable area meter (Li-Cor, USA). Values 
presented are the maximal parenchymal cross-sectional area measured within each gland 
along with the corresponding area of mammary fat pad. 
A gross inspection was conducted on dissection of the CFP to confirm the absence of 
any epithelium within the CFP. In addition, any sites that possibly contained epithelium 
were collected for histological evaluation. 
8.3.5 Hormonal induction of lactation and milking 
Virgin ewes (3 CFP, 2 sham CFP, 3 controls) were induced into lactation by steroid 
treatment at 64 weeks of age (Smith and Schanbacher, 1 974). Daily s.c. injections of 
17p-oestradiol (0. 1 mg/kg; Sigma) and progesterone (0.25 mg/kg; US Biochemical) 
were administered for 7 days; on days 8 and 9 ewes were treated with 1 mg 
dexamethasone s.c. (Dexadreson, Intervet) . Ewes were hand milked once daily on days 
9, 1 0, and 1 1 , and milk yields recorded. These ewes were sacrificed on day 1 1 . 
For the one parturient sham CFP ewe, the lamb was removed 48 h after birth and the 
hand-milked yields from each gland were recorded twice-daily following oxytocin 
treatment (0.2 ml, i .v.). 
8.3.6 Chemical analyses 
The protein level in milk from hormonally-treated ewes was determined by the BCA 
assay (Pierce, ll...,) and the lipid content measured following chloroform/methanol (2: 1 )  
extraction (Bligh and Dyer, 1 959). Lactose concentration was determined 
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fluorometrically (McFadden et al. , 1 995). Composition of milk (fat, protein, lactose) 
from the sham CFP ewe was determined by Milkoscan analysis. 
8.3.7 Histology and whole mounts 
Tissues for histological examination were fixed in phosphate-buffered 1 0% formalin for 
24-48 h at 4°C. Samples were prepared for paraffin microtomy and sectioned at 5-7 !lm. 
Sections were mounted onto poly-lysine subbed s lides and processed for routine l ight 
microscopy. 
Mammary tissue for whole mounts was cut into 1 -2 mm thick s lices using a Stadie­
Riggs hand microtome. S l ices were spread on s lides and fixed in Carnoy' s  fixative for 
24 h .  Preparations were defatted in acetone, stained with alum carmine, dehydrated 
through graded alcohols, and clarified in xylene. Whole mounts were photographed 
using a dissecting microscope. 
8.3.8 Statistical analyses 
Data were analysed by Student 's  Hest or one-way AN OVA using SAS . 
8.4 RESULTS 
8.4.1 Mammary CFP technique 
In establishing this procedure, a preliminary study was conducted whereby 6 mammary 
glands of four 1 0-day old lambs were surgically  prepared using an approach similar to 
that described in Materials and Methods. On this occasion an attempt was made to 
c losely dissect the denser parenchyma from the surrounding stroma of the mammary fat 
pad. Examination of these glands 3 months later revealed that epithelium had 
extensively populated the mammary fat pad in 3 of the 6 glands. This parenchymal 
regrowth was grossly evident within the mammary fat pad and consisted of terminally­
branched ducts (Figures 8 . 1 a and 8 . 1  b) . Such an outcome emphasised the need to fully 
encapsu late the parenchymal elements while performing blunt dissection for the main 
study. 
Figure 8.1 Histomorphogenesis of parenchymal regrowth within the mammary fat pad 
of virgin ewe lambs. The preliminary CFP procedure was performed at 1 week of age as 
described in 8.4. 1 ,  and ewe lambs were sacrificed at 3 months of age. CA) Whole mount 
of regrown mammary parenchyma. Scale bar = 1 mm. CB) Histology of regrown 
mammary parenchyma depicting ductal epithelium encapsulated by fibroblastic stromal 
tissue. Stained with Gomori' s  trichrome. Scale bar = 100 �m. lb, lobular bud; d, duct; 
f, fibroblasts. 
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Tissue excised from the neonatal mammary gland included a discrete node of 
parenchyma at the base of the teat (Figure 8 .2a) that consisted of numerous branched 
ducts encapsulated by stromal connective tissue (Figure 8 .2b). Where epithelial 
regrowth was subsequently recorded in the preliminary study, the site from where the 
parenchyma had not been completely removed was sometimes evident (Figure 8 .2c) .  In 
the main study the excised tissue was bisected and the diameter of the parenchymal node 
measured. The mean diameter (± SEM) of this region was 8 .9 ± 0.5 mm (n=37) with a 
range of 5- 1 6  mm. 
Of the 39 CFPs that were recovered at slaughter or necropsy in the main study, only one 
displayed epithelial regrowth. Variable evidence of scarring was also recorded within 
the CFPs. This ranged from no detectable scarring to a thin band of scar tissue at the 
site of the excision (Figure 8 .2d). 
Figure 8 .3  i l lustrates the udder of mature ewes which had been prepared as either a CFP 
or a sham-operated CFP. 
Figure 8.2 Mammary tissues from the CFP procedure. (A) Mammary tissue excised from neonatal ewe lambs by the CFP procedure in the main 
experiment was bisected and fixed. T, teat. The dashed line delineates the parenchymal tissue. (B) Mammary tissue excised from neonatal ewe 
lambs in the preliminary CFP procedure described in Section 8.4. 1 was sectioned (7 �) and stained with Gomori ' s  trichrome. T, teat; p, 
parenchyma; s, stroma. Scale bar = 3 mm. (C) Higher magnification of the boxed area in (B) showing the peripheral region of parenchymal 
tissue which had not been completely removed during the CFP procedure. Scale bar = 1 mm. (D) Section of scar tissue within the CFP of a 3-
month old ewe lamb. Scale bar = 3 mm. sc, scar tissue; a, adipocyte. 
Figure 8.3 Photograph of the udder of a ewe in which one gland had been prepared as (A) 
a CFP or CB) a sham-operated CFP. Both ewes had been hormonally-induced to lactate 
and had been hand milked for 3 days. Arrows in CB) indicate the location of the scar 
which resulted from the surgical procedure. 
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8.4.2 Mammary gland development 
Liveweight gain for CFP ewe lambs to 23 weeks of age was not different (P>0.05) to 
that for control lambs ( 1 7 1  vs 1 69 g/day, Figure 8 .4) , reaching a maximum average daily 
gain of 255 g/day. The lower initial bodyweight of the control group reflected that these 
l ambs were from twin sets. 
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-- Control ewes 
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- 30 J: 
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Figure 8.4 Liveweights of virgin CFP (0) and control (.) ewe lambs. Data are means 
± SEM for the entire group at the indicated ages. 
Weights of the CFP and the contralateral intact mammary gland underwent similar 
changes during the course of development, and only diverged after day 1 00 of 
pregnancy (Figure 8 .5) .  The weight of intact glands and CFPs from virgin ewes 
increased significantly (P<0.05) between 6 and 1 0, and 23 and 35 weeks of age. 
Likewise, intact glands increased in weight substantially  during the periparturient period 
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Figure 8.5 Weight of CFP (..&.) and intact (0) mammary glands from ewes sacrificed at 
various stages of postnatal development. Data are means ± SEM. The number of ewes 
in each age group is detai led in Section 8 .3 .3 .  
The cross sectional area of parenchymal tissue within mammary glands was measured as 
an assessment of mammogenesis .  Between 6 and 1 0, and 1 0  and 1 5  weeks of age, the 
rate of parenchymal area increase was 44.3 and 79.4 mm2/week, respectively (Figure 
8 .6a) . Thi s  subsequently declined to 24 mm2/week between 1 5  and 23 weeks of age. 
Rate of parenchymal area change increased to 54 mm2/week between 23 and 35 weeks 
and remained around this level until day 1 00 of pregnancy when it increased 
immediately prior to parturition. 
To evaluate the dynamics of parenchymal growth within the mammary fat pad, 
parenchymal areas were expressed as a percentage of the respective total gland area. 
The pattern of parenchymal occupation was generally similar to that recorded for 
parenchymal area, particularly in relation to the increased growth between 1 0  and 1 5  
weeks, and after 23 weeks of age (Figure 8 .6b). One distinction was that in  contrast to 
parenchymal area, percentage of the gland occupied did not change between days 1 00 
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Figure 8.6 Development of parenchyma within the intact mammary gland of CFP ewes 
sacrificed at various stages of postnatal development. (A) Parenchymal cross-sectional 
area. (B) Proportion of mammary cross-sectional area occupied by parenchyma. Data 
are means ± SEM. The number of ewes in each age group is detailed in Section 8 .3 .3 .  
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The growth and lactogenic responses by mammary glands of CFP and sham CFP ewes 
to hormonal induction of lactation or parturition were also examined. While  there were 
only l imited numbers in each group, glands contralateral to a CFP produced milk yields 
comparable  to those from control glands, and having a similar composition (Table 8 . 1 ) . 
Even after neonatal disruption, parenchyma in sham-operated ewes grew into the 
mammary fat pad and produced milk of a normal composition that could be expressed 
from a ful ly functional teat. The extent of this regeneration and the subsequent milk 
yield varied; parenchyma in sham-operated glands was frequently interspersed with 
various amounts of scar tissue. It was possible, based on the measurement of 
parenchymal area, that the intact gland of udders in hormonally-treated, sham-operated 
ewes demonstrated some degree of compensatory growth. 
8.5 DISCUSSION 
This report describes the novel preparation of a parenchyma-free mammary fat pad in 
sheep, a technique that has been widely util ised in rodents to investigate various aspects 
of mammary gland biology (Sheffield, 1 988b; Medina, 1 996). Such a procedure should 
prove particularly useful for studies into the local regulation of mammary gland 
development in ruminants. Ongoing investigations have uti l ised this approach to 
examine the local expression of growth factors by the mammary fat pad and the growth 
regulatory influence of epithelial-stromal interactions (Chapters 9- 1 1 ) . 
Consistent with findings from rodent studies i s  the demonstration that ovine mammary 
epithelium has a substantial capacity to proliferate and regenerate within the mammary 
fat pad. This was i l lustrated by two separate observations .  First, remnants of mammary 
epithelium that were not ablated grew into the mammary fat pad and assumed an 
apparently normal morphology. A simi lar response has been documented in rodents 
(Hoshino, 1 978) . Furthermore, this regenerative capacity suggests the existence of a 
p luripotent population of epithelial cell s  within the ruminant mammary gland (El l is et 
al. ,  1 995), as may exist within the rodent gland (Smith and Medina, 1 988) .  Second, 
substantial development occurred in sham-operated glands wherein the parenchyma had 
been excised and then immediately replaced, despite the presence of moderate amounts 
of scarring. This epithelium subsequently synthesised and secreted normal milk. Such a 
finding is  consistent with rodent studies showing that ductal segments and dispersed 
Table 8.1 Lactogenic and mammogenic responses in mammary glands of surgical ly modified ewes. 
Induced 
Control ewes CFP ewes Sham ewes 
Gland (n) (6) (3) Control (2) Sham (2) 
Yield (g)t 53 .3  ± 1 2  4 1 . 5 ± 5 70.7 ± 32 46.4 ± 3 
Fat (%)� 6.0 ± 1 .2 7 .9 ± 1 .2 6 .8 ± 2.2 4 .5 ± 1 .0 
Protein (%)¥ 4.4 ± 0 .5 4.5 ± 0.7 3 .9 ± 0.6 3 .9 ± 0 . 8  
Lactose (%)+ 4.0 ± 0 . 1 4.0 ± 0.2 3 .7 ± 0.7 3 .7 ± 0.3 
Parenchymal DNA (mg) 1 27 ± 29 1 58 ± 44 1 6 1 .3 ':' 1 1 1  ± 1 6  
Parenchymal area (mm2) 3 1 66 ± 427 3284 ± 485 7040 ± 1 253 2820 ± 454 
Parenchyma (% gland) 6 1  ± 4  62 ± 7  83 ± 1 3  72 ± 2  
This part of the trial was conducted i n  collaboration with Danielle Auldist, Massey University. 
nd = not determined 
tCumulative milk yield; 3 once-daily milkings for induced ewes, 3 hal f-daily  milkings for parturient ewe. 
:j:Fat and lactose content is average for all mi lkings. 
¥Protein content for induced ewes is average for milkings 2 and 3 .  
':'n= 1 
Parturient 
Control ( 1 )  Sham ( 1 )  
607 .9 90.2 
8 .5  8 . 1 
6 . 1 6.4 
4.7 4. 1 
nd nd 
6740 244 1 




epithelial cells undergo normal morphogenesis ,  differentiation and milk protein 
expression when inoculated into a CFP (Hoshino, 1 983 ;  Ormerod and Rudland, 1 986). 
The ontogeny of mammary gland development in these sheep, as measured by 
parenchymal area and mammary weight, was characterised by phases of rapid 
parenchymal growth prior to and during puberty, and immediately prior to parturition. 
Other studies have similarly reported stage-specific development of the ovine 
(Anderson, 1 975b; Johnsson and Hart, 1 985 ;  Smith et al., 1 989a) and bovine (Sinha and 
Tucker, 1 969b; Tucker, 1 969) mammary gland. The prepubertal phase of positive 
allometric growth is especially critical for subsequent mammogenesis i n  ruminants, as 
indicated by its susceptibil i ty to negative effects due to a h igh plane of nutrition 
(reviewed by Sejrsen, 1 994) . As measured by changes in parenchymal area, mammary 
glands of these ewe lambs underwent the most rapid development between 1 0  and 1 5  
weeks of age. The timing of this rapid growth corresponds to positive allometric growth 
in previous studies (Wall ace, 1 953 ;  Anderson ,  1 975b; Johnsson and Hart, 1 985) .  
Util i sing the ovine CFP, it has been demonstrated that the local expression of paracrine 
mitogens such as the insulin-like growth factors may be particularly important in  
regulating this phase of development (Chapter 9) .  
The ruminant mammary gland also undergoes extensive tissue remodell ing as 
epithelium progresses into the stromal matrix of the mammary fat pad. Specifically, 
parenchyma1 tissue within the virgin mammary gland "replaces" a large volume of the 
mammary fat pad as it progresses en bloc. This development contrasts to that in  the 
virgin rodent mammary gland where epithelium forms a sparse network of elongate 
ducts within an expansive mammary fat pad (Imagawa et al. , 1 994) . Parenchyma in the 
virgin ruminant mammary gland consequently consists of epithelial ducts surrounded by 
an extensive fibroblastic stroma, and only a l imited number of adipocytes (Figure 8 .7a). 
Within thi s  study, parenchymal replacement of the mammary fat pad was evidenced by 
the fact that weight of the intact mammary glands paralleled that of the contralateral 
CFP, even though the amount of parenchymal tissue within the mammary gland 
increased substantially during this time. Furthermore, the proportion of mammary gland 
area occupied by parenchyma closely fol lowed the profi le for parenchymal area during 
development, indicating that the major changes in tissue area occurred within the 
parenchymal compartment. An exception was during late gestation when parenchymal 
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area increased dramatically while the proportion of gland area occupied by parenchyma 
remained unchanged. This difference l ikely reflects epitheli al cell hypertrophy and the 
rapid division of epithelial cells during this period (Foster, 1 977; Smith et al. , 1 989a) . 
Histological examination of ovine mammary tissue emphasises several di stinctions 
between the mammary gland of ruminants and rodents, and reiterates the need for 
separate investigations into their development (Akers, 1 990). Specifically, ruminant 
mammary tissue contains a substantial proportion of fibroblastic connective tissue, both 
in the intralobular and interductal regions of parenchyma (Figure 8 .7a), and as a pre­
established network throughout the mammary fat pad (Figure 8 .7b). The h istology and 
morphology of nulliparous ovine mammary parenchyma and stroma strongly resembles 
that described for the normal , nulliparous human breast (Russo and Russo, 1 987; 
Monaghan et al. , 1 990; Moffat and Going, 1 996; Ry)nnov-Jessen et al. , 1 996). This 
contrasts with the rodent mammary gland in which actively dividing cells ,  particularly 
those within  the ductal end bud, are in close or direct contact with adipocytes of the 
mammary fat pad (Wil l iams and Daniel, 1 983). 
The interspersement of connective tissue throughout the ruminant mammary fat pad and 
parenchyma l ikely provides an essential internal support for the pendulous lactating 
udder. By virtue of its position , the human breast is also supported by such a 
framework. This network of connective tissue might serve to regulate the ultimate 
location and distribution of lobules within the mammary gland (Mayer and Klein ,  1 96 1 ) . 
Species differences in the proportion of connective tissue within the mammary gland 
may be embodied by the findings of xenotransplantation experiments showing that 
whereas rat and mouse mammary epithelium proliferates extensively within the CFP of 
mice (Hoshino, 1 978; Daniel et al. , 1 983), epithel ial cel ls from bovine (Sheffield and 
Welsch, 1 986; E11 is and Akers, 1 995) and human (Sheffield and Welsch, 1 988 ;  Yang et 
al. ,  1 995) mammary tissue do not outgrow, but instead form hollow spheroids 
encapsulated by connective tissue. These species-specific responses may reflect 
epitheli al requirements for particular components of the extracellular matrix as provided 
by the appropriate mammary fat pad (Sheffield, 1 988b). It wil l  be interesting to 
evaluate the abil ity of ruminant, human, and rodent mammary epitheli al cell s  to develop 
within the ruminant CFP once immunological tolerance can be addressed. 
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In conclusion , these present findings emphasise that development of the ruminant 
mammary gland involves dynamic changes in tissue proliferation, morphogenesis and 
remodelling. Preparation of an epithelium-free CFP in sheep should prove particularly 
useful for investigating the mechanisms underlying these changes. Resultant findings 
may not only be relevant to attempts at increasing milk yield of dairy animals, but may 
also be directly applicable to studies of human breast cancer. 
Figure 8.7 Histology of mammary parenchyma CA) and fat pad CB) tissue from a 3-
month old virgin ewe lamb (6 /lm).  Scale bar = 1 00 Ilffi. de, ductal epithelium; f, 
fibroblasts; a, adipocytes. Stained with Gomori ' s  trichrome. 
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CHAPTER 9 
DEVELOPMENTAL EXPRESSION SUGGESTS ROLES 
FOR LOCALLY-DERIVED INSULIN-LIKE GROWTH 
FACTORS-I AND -11 DURING OVINE MAMMOGENESIS 
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9.1 ABSTRACT 
Locally-derived insulin-l ike growth factors (IGF-I and -II) have been implicated in the 
stimulation of mammogenesis although evidence supporting  such a role is l imited. In 
the present study the expression of IGF-I and -II mRNA in the mammary parenchyma 
and supporting mammary fat pad of ewes during postnatal development was assessed. 
A single 7 .5 kb IGF-I mRNA was most abundant in mammary fat pad tissue adjacent to 
parenchyma (MFP) , while its expression was less in the contralateral fat pad that had 
been surgical ly cleared of epithel ium (CFP). The l owest levels of IGF-I mRNA were in 
the mammary parenchyma. Expression of IGF-I mRNA was elevated at 6 and 1 0  weeks 
of age, had decl ined by 1 5  weeks, and remained low unti l it increased in late pregnancy. 
The level of IGF-II mRNA in mammary parenchyma was elevated from I to 23 weeks 
correspondent with the upregulated expression of specific mRNA transcripts .  The 
abundance of IGF-II mRNA in the mammary fat pads was initially low but increased 
with age; between 1 and 23 weeks of age levels were consistently h igher within the 
MFP than in the CFP. IGF-I mRNA expression was unaffected by ovariectomy while 
oestrogen treatment increased the level of IGF-I mRNA in the mammary fat pad of 
ovariectomised ewes and the parenchyma of intact ewes. Ovariectomy increased the 
expression of IGF-II mRNA in mammary parenchyma whereas exogenous oestrogen 
suppressed levels in both the parenchyma and mammary fat pad. These findings 
indicate a role for locally expressed IGF-I and -II during ovine mammary development 
and demonstrate their regulation by stage of ontogeny, ovarian hormones, and epithelial­
stromal interaction. 
9.2 INTRODUCTION 
A number of in vitro studies have demonstrated that IGF-I and -II are potent mitogens 
for normal murine, ovine and bovine mammary epitheli al cells (Imagawa et al. , 1 986; 
Winder et al . ,  1 989; Coll ier et al. , 1 993), as well as for mammary tumours (Lee and 
Yee, 1 995) .  A direct effect of IGF-I on mammary epithelium has been shown in vivo, 
where rats (Ruan et aI. , 1 995) and cows (Coll ier et al. , 1 993) display increased 
parenchymal growth in response to locally administered IGF-I. In addition, 
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overexpression of IGF-I in the mammary glands of mice leads to ductal hypertrophy and 
incomplete involution (Hadsell et al. , 1 996), while overexpression of IGF-II increases 
the incidence of mammary adenocarcinoma (Bates et al. , 1 995). 
IGFs produced within the mammary gland likely function as paracrine mitogens .  
Messenger RNA for IGF-I and -II has been detected in stromal fractions from the human 
(Singer et al. , 1 995) and bovine (Hauser et al. , 1 990) mammary gland. In situ 
hybridisation has confirmed the stromal origin of IGF-I and -II expression in normal and 
neoplastic mammary tissues from rats (Manni et al. , 1 994) and humans (Singer et al. , 
1 995;  Ellis et al. , 1 994) , and in foetal and neonatal ovine mammary tissue (Morgan et 
al. , 1 996). IGF-I also immunolocalises to the stromal cel l s  of the lactating mammary 
gland (Glimm et al. , 1 988) .  
Despite this  information, l ittle is known about the physiological role of IGFs synthesised 
within the mammary gland. Locally-expressed IGF-I may mediate the mammogenic 
effect of growth hormone (GH; Ruan et al. , 1 995) as IGF-I expression is upregulated by 
GH, but not prolactin (Kleinberg et al. , 1 990). Furthermore, oestrogen upregulates GH­
induced IGF-I expression and epithelial responsiveness to IGF-I (Ruan et al . ,  1 995) 
while ovariectomy suppresses IGF-II mRNA levels in mammary tumours (Manni et al. , 
1 994). Expression of IGF-I and -II mRNA in the pig mammary gland i s  highest in early 
pregnancy (Lee et al. , 1 993). Taken together, these findings indicate that several factors 
which regulate mammary gland development may also direct the local expression and 
function of paracrine IGFs. 
Mammary epithelium undergoes extensive proliferation and morphogenesis postnatally 
as it penetrates the adipose and connective tissues of the mammary fat pad. Although 
the above evidence suggests a role for locally-derived IGFs during this development, 
regulation of IGF-I and -II expression within the postnatal mammary gland has not been 
reported. The influence of developmental state, ovarian hormones and epithel ial­
stromal association on IGF-I and -II mRNA expression in the fat pad and parenchyma of 
the ovine mammary gland has been investigated in this study. Candidate roles for these 
IGFs during mammogenesis are discussed. 
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9.3 MATERIALS AND METHODS 
9.3.1 Animals and tissues 
Detail s  of sheep used in the ontogeny study have been reported elsewhere (Chapter 8) .  
Briefly, one mammary gland of ewe lambs was surgical ly cleared of parenchyma at 1 
week of age to leave an epithelium-free mammary fat pad (CFP) . The contralateral 
gland remained intact to allow the normal development of parenchyma into the 
surrounding mammary fat pad (MFP). Virgin ewes were sacrificed at 6, 10, 1 5 , 23, 35 
and 53 weeks of age (n=4/group), or  at days 50 (n=4), 1 00 (n=2), and 1 40 (n=2) of 
pregnancy. One ewe was sacrificed at 1 day post-partum. Ewes were stunned and 
immediately exsanguinated. The udder was removed and tissue samples obtained from 
the parenchyma and extra-parenchymal MFP, and the contralateral CFP. Parenchyma 
surgically excised at 1 week of age was also used. All tissues were immediately frozen 
in l iquid nitrogen and stored at -80°C. 
The effects of ovariectomy and oestrogen were studied using tissues from lambs in a 
separate trial (El l i s  et al. , 1 996a). Lambs were either intact or had been ovariectomised 
at 1 0  days of age; these lambs received daily s .c .  injections of either 1 7�-oestradiol (0. 1 
mg/kg l iveweight) or excipient for 7 days prior to sacrifice at 1 2  weeks of age (n=3 
l ambs/group) . Samples of mammary parenchyma and MFP tissue were col lected at 
s laughter. 
9.3.2 Probes and labelling 
IGF-I and IGF-II cDNA probes (Wong et al., 1 989; Ohl sen et al., 1 994) were labelled 
by random priming (Rediprime, Amersham) with e2p]-dCTP (3000 Ci/mM, 
Amersham). For normalisation of loading, a 26-mer oligonucleotide probe 
corresponding to human 28S rRNA (Barbu and Dautry, 1 989) was l abelled with e2p]­
dCTP (3000 Ci/mM, Amersham) using terminal transferase. 
9.3.3 Northern analysis 
Tissues were homogenised in 4 M guanidinium isothiocyanate and RNA extracted with 
phenol and chloroform (Chomczynski and Sacchi ,  1 987). RNA samples (20 /lg) were 
electrophoresed through 1 % agarose/formaldehyde gels  and transferred to Hybond N+ 
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membrane (Amersham). For ontogeny samples, each of four blots had RNA from the 
three tissues of a single ewe at each stage of development. Membranes were hybridised 
with the IGF-I cDNA probe for 1 6  h at 60 °C in O.5M NaHP04, 1 mM EDTA, 7% SDS 
buffer (Church and Gilbert, 1 984), and were then washed at 60°C to I x  SSC ( 10  minutes 
each with O .S% SDS). After autoradiography, membranes were stripped in O. 1 x  SSC, 
0 .5% SDS for 1 h at 8SoC and rep robed for IGF-II and 28S rRNA. Autoradiograms 
were quantified by scanning densitometry (Image Quant, Molecular Dynamics). Values 
for IGF-II mRNA are reported as the sum total of multiple transcripts. 
9.3.4 Statistical analyses 
Ontogeny data were analysed for the effects of stage of development and tissue type, and 
their interaction, using a mixed model within the REML procedure of SAS. Ewe was 
included as a random term across development and tissue type was analysed within ewe. 
Individual means for the ovariectomy and oestrogen treatments were compared by 
Student' s t -test to address variance heterogeneity and the significance of main effects 
was tested using the GLM procedure of SAS . 
9.4 RESULTS 
Northern analysis revealed a single 7 .S kb IGF-I mRNA transcript in ovine mammary 
tissues which was most abundant in the mammary fat pads (Figures 9 . 1 a and 9. 1 b). 
Lower levels were detected in parenchymal tissue, l ikely reflecting mRNA expression 
by the interspersed stroma (Morgan et al. , 1 996) . Expression in both the extra­
parenchymal MFP and the CFP was h ighest at 1 0  weeks of age, declining (P<O.OS) by 
I S  weeks to low levels through puberty and into early pregnancy (Figure 9. 1 b). Levels 
increased (P<0.05) into l ate pregnancy and remained high in early l actation. Prior to 23 
weeks of age the level of IGF-I mRNA in the extra-parenchymal MFP was greater than 
in the CFP (P<0.08). 
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virgin pregnancy 
Figure 9.1 Northern analysis of mammary IGF-I mRNA in postnatal ovine mammary 
tissues. (A) Total RNA (20 fJg) from the extra-parenchymal MFP, CFP, and mammary 
parenchyma (PAR) at various stages of postnatal development was hybridised with an 
ovine IGF-I cDNA (3 day exposure) . 
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Figure 9.1 Northern analysis of mammary IGF-I mRNA in postnatal ovine mammary 
tissues. (B) Densitometric quantification of IGF-I mRNA in MFP (£.), CFP (D) and 
parenchyma (0), normalised for loading against 28S rRNA levels .  Data points are 
means ± SEM. Number of replicates are n=4 for virgins and 50 days gestation, n=2 for 
100 and 1 40 days gestation, and n= 1 in  lactation. *P<0.08 vs respective CFP value. 
IGF-II mRNA was detected in both mammary fat pads as transcripts of approximately 
5 .7 , 4.7 and 0.9 kb (Figure 9.2a) . Total expression in the extra-parenchymal MFP was 
generally higher than in the CFP to 23 weeks of age, after which levels were simi lar 
(Figure 9 .2b). The total level of IGF-II mRNA in mammary parenchyma was 
significantly (P<0.05) greater than in either of the fat pads between 1 and 23 weeks of 
age (Figure 9 .2b). This corresponded to increased expression of the 5 .7 and 0.9 kb 
mRNAs and the detection of three additional transcripts of estimated sizes 4.0, 3 .2, and 
2 .5 kb (Figure 9.2a). In contrast, parenchymal expression of the 4.7 kb mRNA 
remained relatively constant across development at a level simi lar to that in the 
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Figure 9.2 Northern analysis of IGF-II mRNA expression in ovine mammary tissues 
during postnatal development. (A) Membranes similar to that in  Figure 9 . 1 a were 
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Figure 9.2 Northern analysis of IGF-II mRNA expression i n  ovine mammary tissues 
during postnatal development. (B) Densitometric quantification of IGF-II mRNA in 
MFP (..&.), CFP (D) and parenchyma (0). Data points (means ± SEM) are the sum 
expression of IGF-II mRNA as multiple transcripts which have been normalised for 
loading against 28S rRNA levels. Number of replicates are n=4 for virgins and 50 days 
gestation, n=2 for 1 00 and 1 40 days gestation, and n= 1 in l actation. 
IGF-I mRNA expression in the parenchyma and extra-parenchymal MFP of prepubertal 
ewe l ambs was unaltered by ovariectomy (Table 9. 1 ) . Exogenous oestrogen increased 
IGF-I mRNA levels in the parenchyma of intact ewes and in the extra-parenchymal 
MFP of ovariectomised ewes. Ovariectomy did not alter IGF-II mRNA levels in the 
extra-parenchymal MFP (P>0.6), but significantly increased levels in parenchyma 
(P<0.002) .  Administration of oestrogen suppressed IGF-II expression in all mammary 
tissues ; the overall main effect of this treatment was highly significant (P<O.OO I ) . 
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Table 9.1 Effects of ovariectomy (ovex) and oestrogen on IGF-I and -II mRNA levelsa 
in prepubertal ovine mammary tissues. 
excipient oestrogen pb 
IGF-I fat pad intact 1 1 . 3 ± 3. 1  8 .4 ± 2 .5 n .s .  
ovex 7 .3 ± 0. 2  1 2.3 ± 0.6 0.002 
parenchyma intact 2 .5 ± 0.5 4 . 1 ± 0.7 0. 1 3  
ovex 5 . 1 ± 2 .9 4.5 ± 2 . 1 n . s .  
IGF-II fat pad intact 28.7 ± 6 .0 1 2.4 ± 2.7 0.07 
ovex 25.9 ± 9 .3  1 O.7 ± 4. 1  n . s .  
parenchyma intact 36.4 ± 4 .8  26 .3  ± 3 . 5  n .s .  
ovex 63.4 ± 5 . 1 * 39.8 ± 4 .9
* 0 .03 
<iData are mean densitometric units ± SEM, normalised to 28S rRNA levels (n=3) .  
bComparison of two means by Student' s t-test. 
*P<O. l vs respective intact value. 
9.5 DISCUSSION 
IGF-I and -II are potent mitogens for mammary epithelial cel l s  in vitro although their 
precise role during mammary gland development has not been defined. Our finding that 
mRNA for both IGF-I and -II mRNA is expressed by the mammary fat pads of ewes 
upholds previous suggestions that IGFs produced within the mammary gland function as 
paracrine mitogens for mammary epithelium (Hauser et al. , 1 990; Manni et al. , 1 994; 
El l is  et al . ,  1 994; Glimm et al., 1 988) .  
The interaction of epithelial and stromal constituents within the mammary gland has 
marked effects on cell growth and morphogenesis (Cunha and Horn, 1 996). In this 
study, expression of mRNA for both IGF-I and -II prior to 35 weeks of age was higher 
in the MFP adjacent to rapidly growing parenchyma than in the contralateral CFP 
devoid of endogenous epithelium. It is also l ikely that the increased expression of 
specific IGF-II mRNAs within mammary parenchyma during this period was in the 
interspersed stroma, given that three of these transcripts were detected i n  the mammary 
fat pads, and that IGF-II mRNA local i ses to the stroma of mammary parenchyma in  4-
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week old ewe lambs (Morgan et al., ] 996). Other recent reports have also demonstrated 
epi thel ial induction of stromal IGF expression in normal and malignant mammary tissue 
(Singer et al. , 1 995;  Manni et al., 1 994; Ell is et al., 1 994) . Taken together, these 
findings strongly suggest that proliferating epithel ium exerts a positive feedback on the 
surrounding stroma, possibly via the local release of a diffusible factor (Singer et al., 
1 995), to upregulate the stromal expression of IGF-I and -lI. 
The developmental changes in IGF-I and -II mRNA levels within the ovine mammary 
gland support growth stimulatory roles for locally expressed IGFs during postnatal 
mammogenesis .  Detection of IGF-I mRNA as a single 7 .5 kb transcript may be 
particularly relevant to this proposal , as this unstable message undergoes post­
translational modification (Lund, 1 994), and may encode IGF-I with a paracrine 
function (LeRoith and Roberts, 1 99 ] ) . Similarly, the multiple ovine IGF-II mRNAs 
detected in mammary tissue are transcribed from different promoters (Ohlsen et al. , 
1 994) and may be differentially translated. 
Elevation of IGF-I mRNA within the mammary fat pads at 6 and 1 0  weeks corresponds 
to the onset of prepubertal allometric mammary growth in these (Chapter 8) and other 
lambs (John ss on and Hart, 1 985) .  Parenchymal expression of IGF-II mRNA was also 
markedly increased at these ages. Whereas IGF-I mRNA levels in mammary fat pads 
decl ined by 1 5  weeks, parenchymal expression of IGF-II mRNA remained elevated until 
35  weeks, during which time mammary epithelium continues to proli ferate (Johnsson 
and Hart, 1 985;  Chapter 8). Furthermore, IGF-I mRNA levels in virgin mammary fat 
pads decl ined with age while IGF-II mRNA levels concurrently increased. These results 
indicate that the expression of IGF-I and -II at the local level of the mammary gland is 
differential ly  regulated. Given these findings, i t  i s  tempting to speculate that paracrine 
IGF-I stimulates the onset of rapid epi thelial proliferation, and that this proliferation 
subsequently induces paracrine IGF-II expression to maintain ongoing parenchymal 
growth. As in prepuberty, IGF-I mRNA levels in the mammary fat pads were 
upregulated in late pregnancy when parenchyma undergoes substantial growth (Smith et 
al., 1 989a; Chapter 8) .  The fact that parenchyma} IGF-II expression was not 
subsequently increased may reflect differences in the morphology of epithel ial growth 
between the two states. 
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Previous i nvestigations into prepubertal ruminant mammogenesi s  have shown a positive 
correlation between mammary growth and systemic GH levels (Johnsson et al. , 1 985 ;  
Sejrsen e t  al. , 1 983 ;  Capuco e t  al. , 1 995). Ruminant mammary epithelium, however, 
does not bind GH (McFadden et al. , 1 990b) , and suggestions of an indirect action of GH 
via systemic IGF-I (Purup et al., 1 995) are countered by the fact that GH levels and 
mammary development do not always correlate with serum IGF-I levels (Capuco et al. , 
1 995) .  The present results support the suggestion that GH acts via the mammary fat pad 
and upregulates the paracrine expression of IGF-I (Hauser et al. , 1 990). Adipocytes and 
fibrobl asts, both of which exist within the mammary fat pad, have been shown to bind 
GH (Kelly et al. , 1 99 1 ) , and GH is known to upregulate IGF-I expression in various 
peripheral tissues (lones and Clemmons ,  1 995). The pattern of IGF-I mRNA expression 
in the mammary fat pads during prepuberty was similar to that for serum GH levels 
recorded in prepubertal l ambs (Johnsson et al. , 1 985). In particular, the significant 
decline in IGF-I mRNA level s between 1 0  and 1 5  weeks coincides with a 55% reduction 
in serum GH levels between 1 0  and 1 4  weeks as recorded by Johnsson et al. ( 1 985). 
Furthermore, increased IGF-I expression in the mammary fat pad during l ate pregnancy 
corresponds to a gradual increase in serum GH levels of ewes during this time (Smith et 
al. , 1 989a) .  Thi s  increased expression might also be in response to a more substantial 
rise in placental lactogen (PL) levels (Handwerger et al. , 1 977). This possibil ity is 
supported by the l ikelihood that PL stimulates mammary development via an indirect 
mechanism (Col lier et al. , 1 995), and the knowledge that PL displays a high affinity for 
somatogenic sites (N'Guema Emane et al. , 1 986) and mainly targets adipose tissues 
(Delouis et al. , 1 980). 
Consistent with findings from rodent studies (Ruan et al., 1 995), exogenous oestrogen 
could upregulate IGF-I expression in mammary tissues. In contrast, IGF-II mRNA 
expression was significantly down-regulated by oestrogen and was increased in 
parenchyma by ovariectomy, even though ovariectomy did not effect mammary gland 
development (Ellis et al. , 1 996a). A negative effect of oestrogen on IGF-II expression 
has also been reported in the mammary gland of pseudopregnant pigs (Lee et al. ,  1 993) 
whereas IGF-II expression in rat mammary tumours is reduced by ovariectomy (Manni 
et al. , 1 994) . These results demonstrate ovarian regulation of IGF-II expression within 
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the mammary gland, although the physiological significance of this regul ation remains 
unknown. 
In conclusion, these findings suggest that IGF-I and -IT expressed by the mammary gland 
stroma may fulfi l  an important role i n  the stimulation of postnatal ovine mammogenesis .  
Factors which influence mammary development such as epitheli al -stromal associat ion, 
stage of ontogeny and ovarian hormones also influence expression of IGFs within the 
mammary gland. Several l ines of evidence are consistent with suggestions that the 
mammogenic action of GH is mediated via paracrine IGF-I. 
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CHAPTER 10 
MULTIPLE FACTORS REGULATE THE PARACRINE 
EXPRESSION OF KERATINOCYTE GROWTH FACTOR 




Keratinocyte growth factor (KGF) is a stroma-derived mitogen implicated in the 
mediation of epithelial-stromal interactions. These experiments have investigated the 
role and regulation of KGF in the ruminant mammary gland in which epithelium 
develops within an extensive stromal matrix. The target-cel l  specificity of KGF was 
demonstrated by the finding that KGF stimulated the in vitro prol iferation of mammary 
epitheli al cel l s, but not mammary fibroblasts. Consistent with a paracrine action, 
cultured mammary fibroblasts, but not epitheli al cel l s ,  expressed KGF mRNA as 
transcripts of approximately 4.6, 2.4, 1 .5 and 0.9 kb. Thi s  expression was reduced by 
80% in the presence of dexamethasone. KGF mRNA was present in the ovine 
mammary fat pad as two transcripts of 2.4 and 1 .5 kb while only the 2.4 kb mRNA was 
detected in mammary parenchyma. Levels of KGF mRNA in the extra-parenchyma] 
mammary fat pad were higher than in the contralateral fat pad cleared of endogenous 
epithel ium prior to puberty; levels were lowest in mammary parenchyma throughout 
development. Ovariectomy of prepubertal ewe lambs tended to increase the abundance 
of KGF mRNA within the mammary gland whereas its expression was significantly 
reduced by exogenous oestrogen .  Of several ovine tissues examined, a 2 .4 kb mRNA 
transcript was only detected in mammary parenchyma while adipose tissues expressed a 
single ] .5 kb KGF mRNA. This suggests differential transcription of KGF by 
adipocytes and fibroblasts within the mammary fat pad. These findings support a role 
for paracrine KGF in development of the ruminant mammary gland and indicate that 
local and systemic factors may regulate its tissue-specific expression. 
10.2 INTRODUCTION 
Investigations into the embryonic and postnatal development of numerous tissues, 
including the mammary gland, have demonstrated a vital role for the stromal 
environment in regulating the proliferation and morphogenesis of both normal and 
neoplastic epithelium (Sakakura, 1 99 1 ;  Birchmeier et al., 1 995; Cunha and Horn, 1 996). 
This epi thelial -stromal association may be of particular importance during development 
of the ruminant mammary gland where, in contrast to the rodent mammary gland, there 
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I S a marked abundance of connective tissue III which the glandular epithelium 
proliferates (Sheffield, ] 988b; Chapter 8). 
A recently identified mitogen implicated as a mediator of epithel ial-stromal associations 
is KGF (Rubin et al. , 1 989), a member of the fibroblast growth factor family (Finch et 
al. ,  ] 989). KGF likely functions as a paracrine mitogen for, whereas stromal cell s  
synthesi se and secrete KGF, only epithel ial cell s  are responsive to i ts  mitogenic effect 
(Rubin et al. ,  1 989). Results from other studies suggest that stroma-derived KGF 
stimulates epitheli al development in a wide range of foetal (Finch et al. , 1 995) and 
postnatal (Guo et al. , 1 993 ; Alarid et al. , 1 994; Siddiqi et al. , ] 995) tissues. Several 
l ines of evidence also indicate that KGF may act local ly to effect the mitogenic and 
morphogenic actions of specific steroid hormones (Yan et al., 1 992; Koj i  et al. , 1 994; 
Fasciana et al. , ] 996). 
A role for KGF during mammogenesis is emerging from the results of recent rodent and 
human studies . As in other tissues, it is  the stromal constituents of the mammary gland 
which express KGF mRNA (Wil son et al. , 1 994; Finch et al., 1 995). KGF directly 
stimulates the growth of mouse mammary epithelial cell s  and ductal end buds in vitro 
(Imagawa et al. , 1 994b). This proliferative effect is consistent with the finding that 
systemically administered KGF induces extensive epitheli al hyperplasia within the 
mammary glands of virgin and pregnant mice (Ulich et al. , 1 994; Yi et al. , ] 994). 
Although these results indicate a role for KGF within the mammary gland, l i ttle is 
known of its regulation and physiological function. Information is l imited to 
observations showing that mRNA for KGF is expressed and differentially  transcribed in 
the mouse mammary gland during postnatal development (Coleman-Krnacik and Rosen, 
1 994) ,  and that KGF mRNA is present in a h igh proportion of breast tumour samples 
(Koos et al. , 1 993). 
Given the candidate role for KGF in the developing rodent and human mammary gland, 
and the extensive epithelial -stromal association that occurs within the ruminant 
mammary gland, it was hypothesised that KGF would be mitogenic for ruminant 
mammary epithel ium, and that it would be expressed by the stroma of the mammary fat 
pad. The regulation of local KGF gene expression by factors which influence mammary 
gland development has also been investigated. The findings reported herein 
demonstrate that KGF is a paracrine mitogen for ruminant mammary epithel i al cel l s ,  
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and that constituents of the mammary fat pad differential ly  transcribe KGF mRNA. 
Furthermore, KGF mRNA expression is regulated by several mechanisms that are of 
physiological relevance to normal mammogenesis. 
10.3 MATERIALS AND METHODS 
10.3.1 Ce)) culture 
MAC-T bovine mammary epithelial cells (Huynh et al. ,  1 99 1 )  were maintained in 
DMEM (Gibco) plus 1 0% FCS (Gibco), 5 fJg/ml insulin (Sigma), 1 fJg/ml 
hydrocortisone (Sigma), penicil l in ( l OO IU/ml)  and streptomycin (0. 1 mg/m] ; S igma) . 
Bovine mammary epithelial and fibroblast cel l s  were i solated from parenchymal tissue 
of a non-pregnant Friesian-cross heifer fol lowing a procedure essentially as described 
(McGrath , 1 987). Tissue was digested in HBSS (Gibco) which contained collagenase 
(0.2% type II; S igma), hyaluronidase (0. 1 %; Sigma) and DNAse (0.02%;  Boehringer 
Mannheim) for 3 h at 37°C. The filtered ( 1 50 fJm) cell suspension was then treated with 
trypsin (0. 1 5% ;  Gibco) and type II collagenase in HBSS for 20 min. Epithel i al and 
fibroblast cel l s  were separated using a Percoll gradient (Mc Grath, 1 987) and were 
cultured on plastic in DMEM plus 1 0% FCS .  Epithel ial and fibrobl ast cultures were 
further purified by selective trypsinisation of loosely adherent fibroblasts from the 
firmly attached epithel ial cel l s  (Danielson et al., 1 984). Bovine epithel ial and fibroblast 
cell s  used in these experiments were passage 2. 
Ovine mammary epithel ial organoids were prepared from mammary parenchyma of a 
1 2-week old ewe. Tissue was digested with type V collagenase (0.4%) in medium 1 99 
plus 1 0% FCS for 2 h at 37°C. The resultant cell suspension was pelleted and washed in 
medium ] 99 plus 1 % FCS and the epitheli al organoids collected by differential 
centrifugation (45 g, 2 min). Ovine mammary fibrobJasts were obtained by similarly 
digesting extra-parenchymal mammary fat pad (MFP) tissue from the same ewe and 
plating the pelleted cell fraction . All primary epithel ial and fibroblast cultures were 
maintained in DMEM supplemented with 1 0% FeS.  
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10.3.2 Proliferation studies 
MAC-T cell s  and ovine mammary fibroblasts were seeded into 24-wel l  plates in DMEM 
plus 1 0% FCS at 2 .5 x 1 04 and 5 x 1 04 cell s/well ,  respectively .  After 24 h ,  monolayers 
were rinsed with PBS and quiesced for 48 h in DMEM. Various growth factor 
treatments were then added in fresh DMEM (0.5 ml). Recombinant human KGF was 
from R and D Systems (Minneapolis , MN), recombinant human insul in- like growth 
factor-I (IGF-I) was from Genentech (San Francisco, CA) and recombinant human IGF­
II was from Eli-Li l ly (Indianapolis , IN). Acidic fibroblast growth factor (aFGF; from 
bovine brain) was from Sigma and was added with heparin (Leo Lab, 3 .5 IU/ml) .  
After 24 h treatment, cultures were label led for 2 h with eH]-methyl thymidine ( l  
IlCilml ,  85 Ci/mM, Amersham). Monolayers were then rinsed 3 times with 0.5 ml ice­
cold PBS ,  twice with 0.5 ml ice-cold 1 0% TCA and fixed in 1 00% ethanol .  Monolayers 
were solubil i sed with 3 M NaOH and then neutralised with 1 M HC} to a final volume 
of 1 ml .  Samples were added to Ready-Safe scinti l lation cocktail (Beckman) and 
radioactivity measured in a scintil l ation counter (Wal1ac, Finland) . 
10.3.3 Animals and tissues 
All animal experimentation was conducted with the approval of the Ruakura Animal 
Ethics Committee. Samples of mammary tissue from ewes at various stages of 
development were from a trial reported elsewhere (Chapter 8). Briefly, one mammary 
gland of neonatal ewe lambs was surgically prepared whereby the epithelial component 
was excised to leave a mammary fat pad devoid of endogenous epithelium (cleared fat 
pad, CFP; Chapter 8) .  The contralateral gland remained intact to all ow epithelial 
growth into the surrounding extra-parenchymal mammary fat pad (MFP). Ewes were 
reared under standard grazing practices and groups were sacrificed at the fol lowing 
physiological states and ages: virgins at 6, 1 0, 1 5, 22, 35 and 53 weeks (n=4 per group); 
days 50 (n=4), 1 00 (n=2) and 1 40 (n=2) of pregnancy;  and I day post-partum (n= 1 ) . 
Ewes were euthanased by captive bolt and exsanguination . The udder was removed, 
and tissue samples were col lected from the parenchyma and extra-parenchyma] MFP of 
the intact gland, and from the contralateral CFP. The CFP was always sampled at a site 
free from any scarring resultant from the surgical procedure. Tissue samples were snap 
frozen in l iquid n itrogen and stored at -80°C. 
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The effect of ovariectomy and oestrogen on mammary KGF expression in prepubertal 
ewe l ambs was determined in samples from a separate study (Ellis et al. , 1 996a). 
Ovariectomy was performed at approximately 1 0  days of age. Prior to sacrifice at 1 2  
weeks of age, groups of i ntact and ovariectomised l ambs were treated for 7 days with 
dail y  s .c .  injections of either oestrogen ( 1 7�-oestradiol ; 0. 1 mg/kg bodyweight) or 
vehicle (n=3/group). Samples of mammary parenchyma and extra-parenchymal MFP 
collected at slaughter were immediately frozen in l iquid nitrogen and stored at -80°e. 
10.3.4 Probes and labelling 
A 622 bp cDNA spanning the ovine KGF coding sequence (GenBank accession number 
Z46236) was kindly provided by Dr Jane Mitchell ,  Moredun Research Institute. This 
cDNA was label led with e2P-a]dCTP (3000 Ci/mM, Amersham) by random priming 
(Rediprime, Amersham). RNA loading was standardised using a human 28S ribosomal 
RNA 26-mer oligonucleotide probe (Barbu and Dautry, 1 989) labelled with e2p­
a]dCTP (3000 Ci/mM) using terminal transferase. 
10.3.5 RNA isolation and Northern analysis 
Frozen tissues were homogenised in 4 M guanidinium isothiocyanate; cell monolayers 
in 1 00 mm dishes were scraped in thi s  solution . RNA was extracted with 
phenol/chloroform and precipitated with i sopropanol (Chomczynski and Sacch i ,  1 987). 
Total RNA (20 Ilg) was electrophoresed through 1 %  agarose/formaldehyde gels. 
Integrity of RNA was confirmed by ethidium bromide staining and RNA was then 
transferred to Hybond N\Amersham). For analysis of KGF mRNA expression across 
ontogenic states, each of four repl icate blots carried RNA from the three tissues of one 
ewe at each stage of development. Membranes were prehybridised for 2 h and then 
hybridised with the KGF cDNA probe for 1 6  h at 60°C in 0.5 M NaHP04, 1 mM EDTA, 
7% SDS buffer (Church and Gilbert, 1 984). Post hybridisation washes (to 0.5x SSC, all 
plus 0.5% SDS) were at 60°C. Membranes were exposed to x-ray film  against 
intensifying screens and then stripped and reprobed for 28S rRNA. Autoradiograms 
were quantified by scanning densitometry using Image Quant software (Molecular 
Dynamics). RNA from cultures of bovine embryonic lung fibroblasts (BeLu) served as 
a positive control for KGF mRNA and gave a result similar to that for RNA from Wi-38 
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embryonic fibroblasts (Finch et al. , 1 989; Appendix 1 2). No KGF mRNA was detected 
in several epitheli al cell l ines (C 1 27 mammary carc inoma, NLFK fel ine kidney 
epithel ial cells ; MDCK canine kidney epithelial cells ; COMMA- l D mouse mammary 
epithelial ; Appendix 1 2). 
10.3.6 Statistical analyses 
All statistical analyses were conducted usmg SAS (SAS, 1 994) .  Data were log 
transformed where appropriate. Cell proliferation results were analysed by one-way 
ANOV A. The ontogeny of KGF expression data was analysed using a mixed model 
within the REML procedure to test the effects of stage of development and tissue type, 
and their interaction. Ewe was included as a random term across stage of development 
and tissue type was analysed within ewe. The effects of ovariectomy, oestrogen 
treatment and tissue type were compared using the GLM procedure. 
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10.4 RESULTS 
10.4.1 KGF is specifically mitogenic for mammary epithelium 
When MAC-T bovine mammary epithel ial cel l s  were cultured in medium supplemented 
with human KGF, DNA synthesis was increased by 390% at a KGF concentration of 1 0  
ng/mJ ;  above this level their proliferative response was suppressed (Figure 1 0. 1  a). DNA 
synthesis by MAC-T cel l s  was also stimulated by IGF-I and IGF-II. In contrast, DNA 
synthesis by ovine mammary fibroblasts was unaffected by a range of KGF 
concentrations (P>0.05; Figure 1 0. 1  b). Their proliferation was ,  however, stimulated by 
other fibroblast growth factors, aFGF and bFGF, as well as by IGF-I. 
10.4.2 Mammary stroma expresses KGF mRNA in vitro 
To determine the cellu lar origin of KGF within the mammary gland, epithel ial and 
fibroblast cells isolated from bovine mammary tissue were cultured as a source of RNA 
for Northern analysis. Mammary fibroblasts, but not epitheli al cel ls ,  expressed 
abundant KGF mRNA as transcripts of approximately 4.6, 2.4, 1 .5 ,  and 0.9 kb (Figure 
1 O.2a). No expression of KGF mRNA was detected in virgin mouse mammary tissue 
after this exposure. It was also tested as to whether various treatments known to 
influence mammary growth could regulate KGF gene expression by bovine mammary 
cells in vitro. When bovine mammary fibroblasts were cultured in the presence of 
dexamethasone or dexamethasone plus insul in ,  total KGF mRNA was reduced by 80% 
compared to that in DMEM alone (Figure 1 O.2b). A smaller reduction of approximately 
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Figure 10.1 Effect of various concentrations of recombinant human KGF on the 
proliferation of (A) MAC-T bovine mammary epithel ial cel ls ,  and (B) ovine mammary 
fibroblasts. Cel l s  were cultured in DMEM supplemented with various treatments for 24 
h, after which DNA synthesis was measured as CH]-thymidine incorporation .  Acidic 
FGF was added at 5 ng/ml in the presence of heparin (3 .5  IU/ml) ;  IGF-I and -II were 
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Figure 10.2 (A) Northern analysis of KGF gene expression in primary cultures of 
bovine mammary epithelial and fibroblast cell s  (20 h exposure). Confluent monolayers 
were cultured for 24 h in DMEM supplemented with various treatments prior to RNA 
extraction. Treatments were dexamethasone (Dex; 250 nM), insulin (Ins ;  1 0  Ilg/ml )  , 
IGF-I ( l OO ng/ml), EGF (25 ng/ml), progesterone (P4; 1 Ilg/ml) ,  and 1 7�-oestradiol (E2; 
1 ng/ml) .  Other RNA was from BeLu cell s  (positive control) and mature virgin mouse 
mammary tissue. The position of the 28S and 1 8S rRNA is shown. (B) Densitometric 
quantification of total KGF mRNA expressed by mammary fibroblasts. Levels are 
normalised to 28S rRNA levels  and are a percentage of abundance in DMEM only .  
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10.4.3 The KGF gene is differentially transcribed in the ovine mammary gland 
Northern analysis revealed abundant expression of KGF mRNA in the mammary fat 
pads and parenchyma of the ovine mammary gland during ontogenesis (Figure 1 0.3) .  
Whi le two transcripts of 2 .4 and 1 .5 kb were detected in the extra-parenchymal MFP 
and CFP at all stages, only the 2 .4 kb mRNA was consistently detected in parenchyma. 
Abundance of these transcripts was unaltered by h igh stringency washing to 0. 1 x SSC, 
0. 1 %  SDS .  
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virgin pregnancy 
}""igure 10.3 Northern analysis of KGF mRNA in ovine mammary tissues throughout 
development. Total RNA (20 /Jg) from the extra-parenchyma} MFP, CFP, and 
mammary parenchyma (PAR) at the indicated stages of development was hybridised 
with an ovine KGF cDNA (20 h exposure) . 
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To determine whether absence of the 1 .5 kb mRNA in mammary parenchyma reflected 
epithelial regulation of KGF gene expression by the interspersed stroma, ovine 
mammary fibroblasts were cultured in medium conditioned by ovine mammary 
epithelial cells ,  or were directly co-cultured with epithelial cel ls .  Neither of these 
treatments had any effect on the KGF mRNA transcripts expressed by ovine mammary 
fibroblasts (Figure 1 0.4). The reduced abundance of KGF mRNA in co-cultures was 
attributed to dilution of fibroblast RNA by that from epithelial cells .  





Figure 10.4 KGF gene expression by ovine mammary cel l s  in vitro. RNA for Northern 
analysis was from cultures of ovine mammary fibroblasts (lane 1 ), ovine mammary 
epithelial cel l s  (lane 2), ovine mammary fibroblasts cultured for 24 h in ovine epithelial 
cell conditioned medium (lane 3) ,  and co-cultures of mammary fibroblast and epithelial 
cells (lane 4 ;  plated at 1 :  1 ) .  Lane 5 is  BeLu positive control (3 day exposure). Ethidium 
bromide-stained 28S rRNA is displayed in the lower panel to demonstrate similar 
loading. 
Further experiments examined whether differential transcription of the KGF gene 
occurred in other ovine tissues. Of those tested, the 2.4 kb transcript was detected only 
in mammary parenchyma from virgin ewes, presumably due to expression by the 
interspersed stromal cel l s  (Figure 10.5). No KGF mRNA was detected in mammary 
parenchyma in late pregnancy, l ikely due to mass dilution by epithelial and milk protein 
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RNA. Interestingly, adipose tissue from two separate depots only expressed the smaller 
1 .5 kb KGF mRNA transcript. No KGF mRNA was detected in RNA samples from the 
other tissues after thi s  exposure. 
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Figure 10.5 Expression of KGF mRNA in various ovine tissues. Samples were from 
the indicated tissues of a 35-week old ewe (mammary parenchyma was from 2 different 
ewes) . Mammary parenchyma was also obtained from a ewe sacrificed at day 1 20 of 
gestation. Total RNA (20 Ilg) was analysed for KGF mRNA by Northern analysis ( 1 6  h 
exposure). The lower panel displays corresponding 28S rRNA levels .  
10.4.4 Mammary KGF expression is physiologically regulated 
Quantification of KGF mRNA expression as detected by Northern analysis revealed 
developmental changes in KGF gene expression within the ovine mammary gland 
(Figure 1 0.6) . Parenchymal expression remained relatively low and constant throughout 
development and declined in late pregnancy. KGF mRNA levels in the extra­
parenchymal MFP of prepubertal ewes at 6, 1 0  and 1 5  weeks of age were significantly 
(P<0.06) higher than in the contralateral CFP. The level of KGF mRNA i n  the CFP also 
progressively increased up until 35 weeks of age; thereafter it remained similar to that in  
the extra-parenchymal MFP. 
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Figure 10.6 Quantification of KGF mRNA in ovine mammary tissues throughout 
postnatal development. Total mRNA expression in parenchymal , extra-parenchyma! 
MFP and CFP tissues, detected by Northern analysis, was quantified by scanning 
densitometry and normalised to respective 28S rRNA values . Data are means ± SEM. 
Number of replicates at each stage are n=4 for virgins and day 50 gestation, n=2 for 1 00 
and 1 40 days gestation, and n= 1 for lactation. *P<0.06 vs respective CFP value. 
The effect of ovariectomy and exogenous oestrogen on mammary KGF expression was 
examined in prepubertal ewe lambs. Ovariectomy increased the level of KGF mRNA in 
parenchymal tissue (P<0.05), but not in the extra-parenchymal MFP (Figure 1 0.7). The 
overall effect of ovariectomy tended to increase mammary KGF expression (P=O. l ). 
Exogenous oestrogen suppressed KGF mRNA levels in both the parenchyma and extra­
parenchymal MFP; the effect of oestrogen was highly significant (P<O.OO I ). The 
increased relative expression of KGF mRNA in parenchyma was due, at least in part, to 
the detection of the 1 .5 kb KGF mRNA in association with a high proportion of adipose 
tissue in these samples. 
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Figure 10.7 Effect of ovariectomy (ovex) and oestrogen (E2) on KGF expression in 
mammary parenchyma (PAR) and extra-parenchymal MFP of prepubertal ewe l ambs. 
Total KGF mRNA, detected by Northern analysis, was quantified and normalised to 
respective 28S rRNA levels. Data are means ± SEM (n=3). a,b,c Means with different 
superscripts are significantly different (P<O.05). Main effect of ovariectomy, P=O. l ;  
main effect of oestrogen, P<O.OO 1 .  
10.5 DISCUSSION 
The developing ruminant mammary gland, similar to the human breast and somewhat 
distinct from the rodent mammary gland, is characterised by the proliferation and 
morphogenesis of epitheli um within a matrix of connective tissue interspersed 
throughout the mammary fat pad (Sheffield, 1 988b). Given this  extensive epithelial­
stromal interaction, a role for the stroma-derived paracrine mitogen, KGF, i n  the local 
regulation of ruminant mammogenesis was investigated. 
Increased DNA synthesis by MAC-T cell s  establishes that bovine mammary epithelial 
cel l s  are responsive to the mitogenic effect of KGF. It was necessary to demonstrate 
this effect on ruminant mammary epithelium since another polypeptide growth factor, 
EGF, stimulates the proliferation of mammary cell s  from humans and rodents, but not 
ruminants (Woodward et al. ,  1 994; Moorby et al. ,  1 995). A previous report of KGF-
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induced proliferation in PS BME- I bovine mammary cel ls (Tesfayohannes et al., 1 992) 
must be disregarded as this cell line was subsequently shown to be of murine origin 
(Woodward et al. , 1 994) . 
A paracrine action of KGF within the ruminant mammary gland is strongly suggested by 
several findings of this study. First, bovine and ovine mammary fibroblasts (Figures 
1 O.2a and 1 0.4), but not the respective epithelium, express KGF mRNA in vitro . 
Second, stromal constituents of the ovine mammary fat pad express mRNA for KGF in 
vivo. Thi rd, KGF stimulates the proliferation of ruminant mammary epithel i al cel l s ,  but 
not mammary fibroblasts. The target-cell specificity for the mitogenic effect of KGF is 
emphasised by the fact that the proliferation of mammary fibroblasts is stimulated by 
other fibroblast growth factors such as aFGF and basic FGF (Chapter 1 1 ) . 
Both in vivo and in vitro studies have generally reported KGF mRNA as a predominant 
transcript of 2.4 kb (Finch et al. , 1 989; KelIey et al. , 1 992; Chedid et al. , 1 994; Koji et 
al. , 1 994; Chedid et al. , 1 996). This transcript was present at relatively h igh abundance 
in both the parenchymal and fat pad tissues of the ovine mammary gland. In vitro, the 
KGF gene was transcribed in mammary fibroblasts as four mRNAs of approximately 
0.9, ] .5 ,  2.4, and 4.6 kb. The absence of the 4.6 kb mRNA in vivo may reflect its 
correspondence to an unstable 5 .0 kb transcript (Finch et al., 1 989). Of particular 
interest was a 1 .5 kb KGF transcript that was expressed within the mammary fat pad at a 
level similar to the 2.4 kb mRNA, but that was generally not detected in mammary 
parenchyma. This transcript may correspond to a 2.0 kb splice variant of KGF mRNA 
present in certain cell lines (Kelley et al. ,  1 992). Differential transcription of KGF 
mRNA has also been reported in the mouse mammary gland where the expression of a 
1 . 1  kb KGF mRNA is altered during development (Coleman-Krnacik and Rosen, 1 994). 
Given that epithelial cel l s  can regulate the stromal expression of certain paracrine 
growth factors (Rosen et al . ,  1 994b; Singer et al. , 1 995), including KGF (Smola et al. , 
1 993), it was considered that differential transcription of KGF mRNA in mammary 
parenchyma may reflect a local influence from the epithelium. Subsequent analysis of 
other tissues revealed that the two KGF mRNAs within the mammary fat pad probably 
represent a 1 .5 kb mRNA expressed by adipocytes and a 2.4 kb transcript expressed by 
the interspersed connective tissue fibroblasts. Therefore, transcription of the KGF gene 
within different tissues probably reflects their cellular composition� whereas the 
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mammary fat pad comprises adipocytes with a greater degree of connective tissue 
(Figure 1 0.8a) relative to other adipose depots (Figure 1 0.8b), mammary parenchyma i s  
characterised by epithelium enveloped by a predominantly fibroblastic stroma (Figure 
1 O.8c) . It remains to be established whether the 1 . 5  kb mRNA expressed by adipose 
tissue bears any significance to the finding that KGF increases the level of circulating 
fatty acids in mice and rats (Nonogaki et al. , 1 995). 
These investigations also indicate that KGF expression is regulated by several factors 
which are physiologically relevant to the course of mammogenesis. To date, hormonal 
regulation of KGF expression within the mammary gland has not been investigated. In 
thi s  study, the level of KGF mRNA in mammary tissues of prepubertal l ambs was 
markedly suppressed by exogenous oestrogen . Interestingly, mRNA expression for 
another stroma-derived mitogen, IGF-II, is similarly affected (Chapter 9). This response 
for KGF mRNA contrasts to that for acidic FGF mRNA, the expression of which i s  
increased by oestrogen within the mouse mammary gland (Chakravorti and Sheffield, 
1 996b). Conversely, studies in other tissues indicate that KGF expression is increased 
by another ovarian steroid, progesterone (Koji et al. , 1 994; Taga et al. , 1 996). 
Suggestion for opposing effects of oestrogen and progesterone on mammary KGF 
expression i s  consistent with their distinctive roles during mammogenesis in rodents; 
whereas oestrogen promotes ductal elongation, progesterone stimulates ductal alveolar 
branching (Imagawa et al. , 1 994). KGF has also been implicated as a promoter of 
epitheli al branching morphogenesis (AJarid et al. , 1 994; Peters et al., 1 994; Post et al., 
1 996). Hence, a specific function of KGF within the mammary gland may be to local ly 
mediate progesterone-induced ductal branching, particularly during pregnancy. A 
morphogenic effect of KGF might also be an ongoing requirement for ruminant 
mammary epithelium which demonstrates a dichotomous, branched morphogenesis 
throughout development. This may account for the abundance of KGF mRNA that was 
detected in the ovine mammary fat pad relative to other ovine tissues, and to the mouse 
mammary gland in which there is minimal ductal branching prior to pregnancy 
(Imagawa et al. , 1 994) . 
Dexamethasone acutely suppressed the expressIOn of KGF mRNA by mammary 
fibroblasts in vitro. Glucocorticoids have recently been shown to suppress KGF 
expression by dermal fibroblasts in vitro and in vivo (Brauchle et al. , 1 995 ; Chedid et 
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al. ,  1 996), an effect which i s  associated with reductions in both transcription rate and 
mRNA stability (Chedid et al., 1 996). The negative effect of oestrogen and 
gIucocorticoids on KGF expression in the ruminant mammary gland may be manifest 
together immediately prior to parturition when both hormones display a preparturient 
surge (Cowie et al. , 1 980). Suppression of local KGF expression at this time may 
contribute to the fact that ruminant mammary epithel ium undergoes extensive 
lobuloalveolar proliferation in late pregnancy, but not into lactation (Cowie et al., 1 980). 
The possibi lity that KGF-induced mammary growth ceases at parturition is further 
supported by the finding that mammary epithelium of lactating rats is unresponsive to 
the proliferative effect of KGF (Ulich et al. , 1 994). 
During  a phase of rapid prepubertal mammary growth in these ewes (Chapter 8), the 
level of KGF mRNA in the extra-parenchymal MFP was significantly higher than in the 
contralateral CFP. This difference may represent the local induction of KGF expression 
in the MFP by the adjacent mammary epithelium, for others have shown that epithel ial 
cells can upregulate stromal expression of KGF in vitro (Smola et al. , 1 993). Similarly, 
epithel ial influence has been shown to increase the expression of other stroma-derived 
paracrine growth factors within the mammary gland (Singer et al. , 1 995 ; Chapters 9 and 
1 1 ) .  Such findings emphasise the potentiall y  important role of epithel ial -stromal 
interactions in the local regulation of cell growth. 
In conclusion, these findings support a role for KGF as a paracrine mitogen during the 
course of mammary gland development in ruminants. It is evident that a number of 
local and systemic factors regulate the tissue-specific gene expression of KGF. By 
determining the preci se function of KGF and the mechanisms which underlie its 
regulation, it may be possible to unravel some of the complexities associated with 
epithel ial -stromal interactions and their involvement in mammary gland development 
and tumorigenesis . 
Figure 10.8 Histology of mammary and adipose tissues from a prepubertal ewe lamb. 
(A) mammary fat pad comprised of adipocytes and interspersed connective tissue, CB) 
subcutaneous adipose tissue primarily comprised of adipocytes, and (C) mammary 
parenchyma consisting of ductal epithelium growing within the connective and adipose 
tissues of the mammary fat pad. Gomori 's  trichrome. Scale bar = 100 J..l1ll. 
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CHAPTER 11 
EXPRESSION AND ROLE OF PARACRINE GROWTH 
FACTORS DURING DEVELOPMENT OF THE 
RUMINANT MAMMARY GLAND 
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11.1 ABSTRACT 
The objective of these experiments was to investigate the role of two heparin-binding 
paracrine mitogens, hepatocyte growth factor (HGF) and basic fibroblast growth factor 
(bFGF), during postnatal development of the ruminant mammary gland. Northern 
analysis revealed that bFGF mRNA was expressed in ovine mammary tissues as two 
transcripts of approximately 6.9 and 4.5 kb. The level of bFGF mRNA within the extra­
parenchymal mammary fat pad (MFP) of prepubertal ewe lambs was significantly 
higher than in the contralateral epithelium-free mammary fat pad (cleared fat pad, CFP), 
possibly due to a local influence of the mammary epithelium. Expression of bFGF 
mRNA in these mammary fat pads throughout development was greater than that in 
mammary parenchyma. In contrast, cultured bovine mammary epithelial cells expressed 
a greater abundance of bFGF mRNA than bovine mammary fibroblasts. The level of 
bFGF mRNA in mammary tissues of prepubertal ewe lambs was increased following 
ovariectomy whereas it was decreased within the mammary fat pad by exogenous 
oestrogen. 
Low levels of HGF mRNA were detected in ovme mammary fat pads, but not 
parenchyma, as four transcripts of approximately 5 .7 ,  3 .5 ,  2.0, and 1 .2 kb. The 
developmental pattern of HGF mRNA expression within mammary fat pads was similar 
to that for bFGF mRNA. Only bovine mammary fibroblasts expressed HGF mRNA in 
vitro; the level of this expression was markedly reduced in the presence of 
dexamethasone. 
Medium conditioned by ovine mammary fibroblasts contained a mitogenic activity 
which also induced ovine mammary epithelial organoids to form branched cords within 
collagen gels, responses which may be due to the secretion of HGF by mammary 
fibroblasts. These results suggest that the local synthesis of bFGF and HGF within the 




Interactions between the epithelial and stromal elements of the mammary gland likely 
serve a critical role in regulating the growth, morphogenesis and differentiation of both 
normal and tumorous epithelium (Sakakura, 1 99 1 ;  Cunha and Horn, 1 996). Epithelial 
cells within the rodent mammary gland grow in close proximity to adipocytes of the 
mammary fat pad (Williams and Daniel, 1 983 ;  Rf2jnnov-Jessen et al. , 1 996). The 
importance of this association is demonstrated by the fact that mouse mammary 
epithelium can undergo normal development only when it is transplanted to a depot of 
adipose tissue (reviewed by Hoshino, 1 978). In contrast, epithelium within the ruminant 
and human mammary gland is continually enveloped by a fibroblastic connective tissue 
(Sheffield, 1 988b; Akers, 1 990). Findings from numerous studies suggest that an 
important function of this type of stromal tissue is the synthesis of polypeptide growth 
factors which influence the adjacent epithelium by paracrine action (Birchmeier et al., 
1 995). 
Two heparin-binding growth factors that may fulfil such a role are hepatocyte growth 
factor (HGF) and basic fibroblast growth factor (bFGF). Originally purified from 
platelets as a mitogen for hepatocytes (Nakamura et al., 1 987), HGF stimulates the 
proliferation of epithelial cells from several tissues (Rubin et al., 1 99 1 ) .  The synthesis 
of HGF by mouse mammary fibroblasts (Sasaki et al., 1 994) and its mitogenic effect on 
mammary epithelial cells (Niranjan et al., 1 995) strongly implicate HGF as a paracrine 
mitogen within the mammary gland. HGF may also fulfil an important morphogenic 
role as it induces mammary epithelial cells within collagen gels to form extensively 
branched cords with a central lumen (Brinkmann et al. , 1 995; Niranjan et al. , 1 995; 
Soriano et al. , 1 995). These findings coincide with the presence of the HGF receptor, c­
met, on luminal epithelial cells in human breast tissue (Tsarfaty et al., 1 992). In terms 
of its physiological role, the expression of mRNA for HGF and c-met in the mouse 
mammary gland is altered with stage of development (Niranjan et al., 1 995) while the 
level of immunoreactive HGF in breast tumour extracts is the single best predictor of 
relapse-free breast cancer and overall patient survival (Yamashita et al. , 1 994). Stromal 
HGF expression is also influenced by the mammary epithelium which can exert both a 
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positive (Rosen et al., 1 994b) and negative influence (Johnston et al., 1 992; Seslar et 
al. , 1 993). 
Basic FGF belongs to the family of fibroblast growth factors, members of which have 
been widely implicated as mediators of epithelial-stromal interactions (Gospodarowicz, 
1 99 1 ). Basic FGF stimulates the proliferation of rodent (Levay-Young et al., 1 989) and 
ruminant (Sandowski et al., 1993) mammary epithelial cells in vitro. Findings from 
several studies indicate that multiple cell types may express bFGF within the mammary 
gland. Two reports show that the majority of bFGF mRNA within the mammary gland 
is expressed by the extra-parenchymal stroma (Coleman-Krnacik and Rosen, 1 994; 
Chakravorti and Sheffield, 1 996a), while others report that bFGF is primarily expressed 
by the myoepithelium, and to a lesser extent by stromal fibroblasts (Barrac1ough et al. , 
1 990). Although bFGF immunolocalises to myoepithelial cells in the rat (Rudland et 
al., 1 993), human (Go mm et aI. , 1 99 1 ), and bovine (Schams et al., 1 995) mammary 
gland, the high affinity of bFGF for components of the extracellular matrix (Barrac1ough 
et aI., 1 990) may confound the interpretation of such results. A role for locally-derived 
bFGF during postnatal mammogenesis is indicated by the fact that bFGF mRNA 
expression within the mammary gland is regulated by stage of development (Coleman­
Krnacik and Rosen, 1 994; Chakravorti and Sheffield, 1 996a) and mammogenic 
hormones (Chakravorti and Sheffield, 1 996b). Furthermore, stromal expression of 
bFGF may be influenced locally by the adjacent mammary epithelium (Coleman­
Krnacik and Rosen, 1 994). 
The objective of these experiments was to evaluate a role for the local expression of 
these growth factors within the ruminant mammary gland. Results show that the HGF 
and bFGF genes are transcribed by tissues of the ruminant mammary gland in vivo and 
in vitro, and that their products may act via paracrine mechanisms to exert pronounced 
mitogenic and morphogenic effects during ruminant mammogenesis. 
11.3 MATERIALS AND METHODS 
1 1.3.1 Tissues 
Mammary tissue samples were from surgically modified ewes sacrificed at various 
stages of development in a previous study (Chapter 8). Briefly, the epithelial 
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parenchyma was excised from one mammary gland of these ewes when they were 
neonates to leave a mammary fat pad that was devoid of endogenous epithelium (cleared 
fat pad, CFP). The contralateral gland remained intact to allow parenchymal growth 
into the surrounding extra-parenchymal mammary fat pad (MFP). Ewes were 
subsequently sacrificed in groups at several stages of prepuberty (6, 1 0, 1 5 ,  23 weeks), 
puberty (35 and 53 weeks) and gestation (days 50, 1 00 and 140); one ewe was also 
killed 1 day postpartum. The udder was removed and tissue was sampled from the 
mammary parenchyma, the extra-parenchymal MFP, and the contralateral CFP, and was 
snap frozen. 
The effects of ovariectomy and exogenous oestrogen were investigated using mammary 
tissue samples from a trial reported elsewhere (Ellis et al., 1 996a). Ewe lambs that were 
either intact or had been neonatally ovariectomised were treated with daily s.c. 
injections of 17�-oestradiol (Sigma; 0. 1 mg/kg liveweight) or excipient for 7 days prior 
to slaughter at 1 2  weeks of age. Samples of mammary parenchyma and extra­
parenchymal MFP were collected at slaughter and snap frozen. 
11.3.2 Cell cultures 
Cultures of bovine mammary fibroblasts and epithelial cells were prepared by gradient 
separation of enzymatically-digested mammary parenchyma as described previously 
(Chapter 1 0). The procedure used to prepare epithelial organoids from mammary 
parenchyma obtained from prepubertal ewe lambs has been detailed elsewhere (Chapter 
1 0). These organoids were cast into gels of rat tail collagen (McGrath, 1 987) and were 
maintained in 10% FCS (Gibco) for 24 h prior to the application of treatments. 
DNA synthesis by COMMA- ID mouse mammary epithelial cells was used as a 
bioassay in these experiments, as described earlier (Chapter 2) and by others (Riss and 
Sirbasku, 1987). Cells were seeded into 24- or 96-well plates at 1 x 1 05 and 1 .5 x 1 04 
cells/well, respectively. Monolayers were quiesced in DMEM (Gibco) basal medium 
(BM) for 48 h before treatments were applied for a further 24 h. DNA synthesis was 
measured as the incorporation of radioactivity into the TCA precipitable fraction after 2 
h incubation with eH]-thymidine ( l  /lCi/ml; specific activity 85 Ci/mM; Amersham). 
Cultures of MAC-T bovine mammary epithelial cells (Huynh et al. , 199 1 )  were 
maintained in BM supplemented with 10% FCS, 5 /lg/ml insulin (Sigma), and 1 /lg/ml 
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hydrocortisone (Sigma), and were plated at 5 x 104 cells/well for similar assay of DNA 
synthesis. 
11 .3.3 Probes and Northern analysis 
RNA was extracted from tissues and cell monolayers using guanidinium isothiocyanate 
and phenollchloroform (Chomczynski and Sacchi ,  1987). Samples of total RNA (20 
Ilg) were electrophoresed and transferred to Hybond N+ (Amersham). Membranes were 
hybridised with e2PJ-Iabelled cDNA probes for 1 6  h at 60°C in 0.5 M NaHP04, 1 mM 
EDTA, 7% SDS buffer (Church and Gilbert, 1 984) . The bFGF probe was a 1 .4 kb 
fragment of the bovine bFGF cDNA (Abraham et al., 1 986) kindly provided by Dr 
Judith Abraham. The bovine HGF probe was a 300 bp cDNA (Parrott et al. , 1 994) 
kindly provided by Dr Jeff Parrott. Membranes were washed to Ix  SSC at 60°C, 
exposed to x-ray film, and rep robed for 28S rRNA using a 26-mer oligonucleotide. 
Abundance of autoradiographed mRNA was quantified by scanning densitometry 
(Image Quant, Molecular Dynamics) where appropriate. 
1 1.3.4 Conditioned medium 
Ovine mammary fibroblasts were grown to confluence in 75 cm2 flasks in DMEM 
supplemented with 1 0% FCS. Fibroblast-conditioned medium (CM) was prepared 
according to previously described procedures (Enami et al. , 1 983; Rubin et ai. , 1 989). 
Fibroblast monolayers were rinsed twice with BM (5 mls) and incubated in 20 ml BM 
for 48 h. The resultant CM was collected, filtered (0.2 Jlm) and stored at -80°C. 
Control BM was similarly prepared in the absence of mammary fibroblasts. 
1 1.3.5 Fractionation of CM 
CM (450 ml) was concentrated 50-fold by ultrafiltration ( 1 0  kDa molecular weight 
cutoff, Amicon), and the retentate resuspended in PBS .  Protein concentration was 
determined using the BCA reaction (Pierce, ll...,). Approximately 200 JlI of concentrated 
CM was applied to a Superose 1 2  column for size-fractionation by FPLC (Pharmacia) .  
The column had been equilibrated in 0.01 M NH4HC03 (pH 7.3), and the sample was 
eluted in this buffer at a flow rate of 0.5 mllmin. Fractions were dessicated under 
vacuum and stored at -20°C prior to their use in culture. 
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11.3.6 Statistical analyses 
All statistical analyses were performed using SAS. Means for the ontogeny of bFGF 
expression were compared using a mixed model within the REML procedure to test the 
effects of stage of development and tissue type, and their interaction. Ewe was included 
as a random term across stage of development, and tissue type was analysed within ewe. 
The significance of ovariectomy, oestrogen and mammary tissue effects and their 
interactions were analysed using the GLM procedure. The results of cell growth 
experiments were analysed by one way ANOV A. 
11.4 RESULTS 
1 1.4.1 Expression of growth factor mRNA in the ovine mammary gland 
Northern analysis detected two bFGF mRNA transcripts of approximately 6.9 and 4.5 
kb in postnatal ovine mammary tissues (Figure 1 1 . 1  a). Densitometry indicated that the 
total level of this expression in the extra-parenchymal MFP and the CFP was typically 
greater (P<0.05) than in the parenchyma throughout development (Figure 1 1 . 1  b) . Prior 
to 35 weeks of age, abundance of bFGF mRNA was significantly (P<0.08) higher in the 
extra-parenchymal MFP than in the contralateral CFP. In addition, gene expression for 
bFGF declined significantly in both fat pads between 6 and 1 0  weeks of age (P<0.05), 
and then increased by 1 5  weeks. Thereafter bFGF mRNA levels in the CFP increased to 
a peak at 1 00 days of pregnancy while expression in the extra-parenchymal MFP was 
greatest at day 50 of pregnancy. Expression of bFGF mRNA in mammary parenchyma 
was maximal in 53-week old virgins and at day 50 of pregnancy. 
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Figure 11.1 (A) Northern analysis of bFGF mRNA in postnatal ovine mammary 
tissues. Total RNA (20 �g) from the CFP, extra-parenchymal MFP and mammary 
parenchyma (PAR) at the indicated stages of development was hybridised with a bovine 
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Figure 11.1 (B) Densitometric quantification of bFGF mRNA in ovine mammary 
tissues. Each data point represents the total amount of bFGF mRNA normalised to 28S 
rRNA levels. Data are means ± SEM. Number of replicates are n=4 for virgins and day 
50 gestation, n=2 for days 100 and 140 of gestation, and n= 1 in lactation. *P<0.08 vs 
respective CFP value. 
Expression of HGF mRNA was detected at low levels in mammary fat pads, but not in 
parenchyma, as four transcripts of approximately 5.7, 3 .5, 2.0 and 1 .2 kb (Figure 1 1 .2). 
Although low levels precluded densitometric quantification, it was apparent from 
replicate blots that the abundance of HGF mRNA within the CFP increased with 
developmental age and was highest during pregnancy. In contrast, expression of HGF 
mRNA in the contralateral extra-parenchymal MFP appeared to be higher prior to 
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Figure 11.2 Northern analysis of HGF mRNA expression in ovine mammary tissues 
during postnatal development. Membranes described in Figure 1 1 . 1  a were stripped and 
hybridised with a bovine HGF cDNA probe (7 day exposure). 
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Quantification of bFGF mRNA expression in mammary tissues from ovariectomised 
and/or oestrogen-treated ewe lambs revealed substantial effects of these treatments. 
Oestrogen markedly suppressed (P<O.O I )  bFGF mRNA levels within the extra­
parenchymal MFP and tended (P<O. 1 5) to reduce its expression in parenchyma (Figure 
1 1 .3) .  Ovariectomy increased (P<O.05) bFGF mRNA abundance in both tissues, 
although this effect was abrogated when lambs were also treated with oestrogen. No 
appreciable levels of HGF mRNA were detected in these samples by Northern analysis, 
even after extensive exposures. 
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Figure 11.3 Effect of ovariectomy (ovex) and oestrogen (E2) on bFGF mRNA levels in 
mammary parenchyma and extra-parenchymal MFP of prepubertal ewe lambs. Total 
expression of bFGF mRNA was quantified by densitometry and normalised for loading 
against 28S rRNA levels. Data are means ± SEM (n=3) .  a,b,c Means with different 
superscripts are significantly different (P<O.05). 
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11.4.2 In vitro expression of growth factor mRNA by mammary cells 
To determine the cel lular expression of growth factor mRNA within the ruminant 
mammary gland, RNA isolated from cultures of bovine mammary epithelial and 
fibroblast cells was subjected to Northern analysis. HGF mRNA was expressed only by 
fibroblasts as four transcripts of approximately 5.7, 3 .5, 2.0 and 1 . 1  kb (Figure 1 1 .4a) . 
HGF mRNA was also detected in virgin mouse mammary tissue as a predominant 5.7 
kb mRNA, and as a less abundant 2.0 kb mRNA. The abundance of bFGF mRNA was 
greatest in cultures of mammary epithelium, whereas mammary fibroblasts expressed 
approximately 20% of this level (Figure I I .4b). bFGF mRNA was predominant in both 
cell types as transcripts of approximately 6.9 and 4.5 kb, and to a lesser extent as 2.5 and 
1 . 1  kb transcripts. No expression of bFGF mRNA was detected in mouse mammary 
tissue after this exposure. 
This experiment also investigated whether various supplements could influence the 
expression of mRNA for these growth factors by mammary cells. Of those tested, only 
dexamethasone altered levels of HGF mRNA when it was added alone or with insulin, 
down-regulating mRNA expression by 60% (Figure 1 1 .4a). In contrast, none of the 
treatments altered bFGF mRNA expression in either cell type (Figure 1 1 .4b). 
11.4.3 Growth stimulation by mammary fibroblasts 
Given the stromal expression of mRNA for these growth factors both in vivo and in 
vitro, and the fact that ruminant mammary epithelium grows within a fibroblastic stroma 
in vivo, it was investigated whether mammary fibroblasts secrete a mitogenic activity in 
vitro. Ovine mammary fibroblast CM stimulated the proliferation of COMMA- I D  cells 
in a dose-dependent manner to maximally increase their DNA synthesis by 380% 
(Figure 1 1 .5a). This response was double that induced by 25 ng/ml EGF. A mitogenic 
activity was retained in the greater than 10  kDa fraction which also stimulated a 
concentration-dependent increase in DNA synthesis (Figure 1 1 .5b). Chromatographic 
fractionation of this preparation eluted a major peak of mitogenic activity with a 
molecular size of approximately 76 kDa, and a second, smaller peak with an 
approximate molecular size of 23 kDa (Figure 1 1 .6). 
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Figure 11.4 In vitro expression of mRNA for (A) HGF and (B) bFGF by cultures of 
bovine mammary epithelial and fibroblast cells. Confluent monolayers were cultured in 
various medium treatments for 24 h prior to RNA extraction for Northern analysis. 
Treatments were dexamethasone (Dex; 250 nm), insulin (Ins; 10 f.lg/rnl), IGF-I ( l OO 
ng/ml), EGF (25 ng/ml), progesterone (P 4; 1 f.lg/ml), and 1 7�-oestradiol (E2; 1 ng/rnl). 
RNA from cultured bovine embryonic lung fibroblasts (BeLu) and mature virgin mouse 
mammary tissue was also used. The position of the 1 8S and 28S rRNA is indicated. 
Ethidium bromide-stained 28S rRNA shows similar loading of RNA. 
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Figure 1 1.5 CA) Dose-dependent response of COMMA- I D  cell proliferation to ovine 
mammary fibroblast CM. Cells were cultured in various treatments for 24 h prior to 
pulse labelling with eH]-thymidine. Data are means ± SEM (n=3). a,b,c Means with 
different superscripts are significantly different (P<O.05) .  CB) DNA synthetic response 
by COMMA- I D  cells cultured with increasing concentrations of the > 1 0  kDa fraction of 
CM. Data are means ± SEM (n=3). 















III 3 c­UI o .. C­III 2 5 
CD 
t 0 '-r-----.-----r------.-----y--'- 0 




Figure 11 .6 DNA synthesis by COMMA- I D  cells in response to size-fractionated CM 
from cultures of ovine mammary fibroblasts. Concentrated CM was appl ied to an FPLC 
Superose 1 2  column and the eluted fractions added to cultures of COMMA- I D  cells in 
DMEM for 24 h.  DNA synthesis was determined after 2 h labelling with eH]­
thymidine. 
The effect of ovine mammary fibroblast CM on the growth of ovine mammary epithelial 
organoids cultured within collagen gels was also examined. Organoids grown for 7 days 
in medium supplemented with 1 0% FCS displayed small outgrowths as broadened 
spikes (Figure 1 1 .7a) .  In contrast, epithelial organoids cultured for the same period in 
1 00% CM demonstrated extensive outgrowth, often occupying large proportions of the 
collagen gel and inducing its contraction (personal observation). This proliferation was 
associated with the formation of elongate, extensively branched cords (Figure 1 1 .7b). A 
similar proliferative and morphological response is promoted by the > 1 0 kDa fraction of 
CM (personal observation). 
Given that different mammary cell types expressed bFGF mRNA in vitro (Figure 
I I .4b) , a comparison was made of the mitogenic effect of bFGF on MAC-T bovine 
mammary epithelial cells and ovine mammary fibroblasts. MAC-T cell s  demonstrated a 
slight but non-significant (P>0.05) mitogenic response to 5 ng/ml bFGF whereas 
substantial DNA synthesis was promoted by IGF-I (Figure 1 1 .8a). In contrast, bFGF 
markedly stimulated the proliferation of mammary fibroblasts, more so at a 
concentration of 5 ng/ml than at 20 ng/ml (Figure 1 1 . 8b). This effect was significantly 
(P<0.05) greater than that induced by IGF-I. 
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Figure 11 .7 Morphological characteristics of ovine mammary epithelial organoids 
cultured within collagen gels for 7 days in the presence of either (A) 1 0% FCS or (B) 
























































Figure 1 1.8 Proliferation of (A) MAC-T bovine mammary epithelial cells and (B) 
ovine mammary fibroblasts in response to bFGF (5 and 20 ng/ml) and IGF-I ( l OO 
ng/ml). MAC-T and mammary fibroblast cells (S x 1 04 cells/well) were cultured for 24 
h in O.S ml of DMEM supplemented with various treatments before labelling with eH]­
thymidine. Data are means ± SEM (n=3). a,b,c Means with different superscripts are 
significantly different (P<O.OS). 
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11.5 DISCUSSION 
Interspersed through both the parenchyma and fat pad of the ruminant mammary gland 
is an abundance of fibroblastic connective tissue which may synthesise various 
polypeptide growth factors capable of regulating epithelial growth and morphogenesis. 
It was hypothesised that HGF and bFGF are two such growth factors involved in 
mediating this epithelial-stromal association. 
The present findings, consistent with those from rodent studies (Sasaki et al., 1 994; 
Niranjan et al., 1 995; Soriano et al., 1 995), suggest that HGF may function as a 
paracrine mitogen and morphogen within the mammary gland. Northern analysis 
revealed relatively low levels of HGF mRNA within the CFP and extra-parenchymal 
MFP while no expression was readily apparent in mammary parenchyma. The presence 
of HGF mRNA in the ovine mammary fat pad corresponds to its expression in the CFP 
of virgin female mice (Niranjan et al. , 1 995). Based on other reports, it is likely that 
HGF mRNA detected within the ovine mammary fat pad was expressed by adipocytes 
(Rahimi et al., 1 994) and/or connective tissue fibroblasts (Sasaki et al., 1 994). The 
detection of HGF mRNA in the stromal fraction of ovine mammary tissue also 
coincides with the finding that bovine mammary fibroblasts, but not epithelial cells, 
express multiple mRNA transcripts for HGF in vitro. Similar cell-specific expression of 
the HGF gene has been reported in cultures of human mammary cells (Wilson et al., 
1 994). Consistent with a paracrine action of HGF, mammary epithelial cells, but not 
fibroblasts, express the receptor for HGF, c-met (Wilson et al., 1 994; Niranjan et ai. , 
1 995). 
Ovine mammary fibroblasts secrete an activity that promotes a substantial mitogenic 
and morphogenic response by mammary epithelial cells. Several lines of evidence 
suggest that these responses were effected by HGF. First, similar experiments have 
shown that CM from mouse mammary fibroblasts stimulates mammary epithelial 
proliferation (En ami et al. , 1 983) due to the presence of HGF (Sasaki et al. , 1 994). 
Second, size fractionation of CM revealed a major peak of mitogenic activity with a 
molecular size of approximately 76 kDa. A similar elution profile has been reported for 
HGF purified from embryonic lung fibroblast CM (Rubin et al., 1 99 1 ). Third, CM not 
only stimulated the growth of ovine epithelial organoids within collagen gels, but also 
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induced them to form elongate, branched cords. Purified HGF and HGF in fibroblast 
CM induce a similar morphogenesis by mouse mammary (Brinkmann et al., 1 995; 
Niranjan et al. , 1 995; Soriano et al. ,  1 995) and kidney epithelial cells (Rosen et al. , 
1 994a; Barros et aI. , 1 995) cultured within collagen gels. Taken together, these results 
I 
suggest that stromal fibroblasts within the ruminant mammary gland may induce 
epithelial proliferation and morphogenesis by secreting HGF. 
The expression of HGF mRNA within the ovine mammary CFP was evidently increased 
in mature virgin and gestational states, a developmental profile similar to that reported 
for the mouse mammary gland (Niranjan et al. , 1 995). Also, levels of HGF mRNA in 
the extra-parenchymal MFP prior to puberty were apparently greater than in the 
contralateral CFP, possibly due to an inductive effect by the adjacent epithelium as it 
underwent rapid proliferation (Chapter 8). This suggestion is consistent with the 
demonstration that HGF synthesis is increased by soluble factors secreted by mammary 
epithelial cells (Rosen et aI., 1 994b). Along these lines, separate evidence suggests that 
the stromal expression of other growth factors is similarly upregulated by the epithelium 
during this period of prepubertal mammogenesis (Chapters 9 and 1 0). 
HGF may also function as a local mediator of hormonal action on the mammary gland. 
Dexamethasone acutely down-regulated the expression of HGF mRNA by mammary 
fibroblasts in vitro, a response that has also been reported for other types of fibroblasts 
(Gohda et al., 1 992; Matsumoto et aI., 1 992). It has also been shown that mammary 
fibroblast expression of another paracrine mitogen, keratinocyte growth factor, is 
similarly down-regulated by this treatment (Chapter 1 0). This effect of dexamethasone 
does, however, bear some degree of specificity in that the level of bFGF mRNA in 
epithelial and fibroblast cultures was unaffected. The basis for this glucocorticoid­
induced response remains to be established, although it may be particularly relevant to 
growth in the peri-parturient ruminant mammary gland where epithelial proliferation 
ceases coincident with a pre-parturient rise in serum glucocorticoid levels (Cowie et al., 
1 980). 
As only negligible levels of HGF mRNA were detected in mammary tissues from 
ovariectomised and oestrogen-treated ewe lambs, the effects of these treatments on HGF 
expression remain unknown. However, it is conceivable that the mitogenic and 
morphogenic effects of oestrogen on mammary epithelium (lmagawa et al., 1 994) are 
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mediated by HGF. Specifically, oestrogen acts upon the stromal constituents of the 
mammary gland (Shyamala and Ferenczy, 1 984) to promote ductal elongation (Imagawa 
et aI., 1 994) similar to that induced by HGF in vitro (Soriano et aI., 1 995). Along these 
lines, the HGF gene is preceded by multiple oestrogen response elements (Liu et al., 
1 994) and oestrogen acutely upregulates HGF mRNA expression in the ovary (Liu et al., 
1 994). Based on these reports, further investigation into the role of HGF as a mediator 
of oestrogenic action on the mammary gland is warranted. 
The precise function of bFGF in the ruminant mammary gland remains unresolved. In 
vivo, mammary fat pads expressed higher levels of bFGF mRNA than parenchyma, 
while in vitro, the level of bFGF mRNA was substantially higher in cultured bovine 
mammary epithelial cells than in mammary fibroblasts. Indeed, it may be that multiple 
cell types express bFGF within the ruminant mammary gland. It has also been 
considered that the cultures of bovine mammary epithelium in these experiments may 
have contained myoepithelial-like cells expressing high levels of bFGF mRNA; such a 
proposal would be in keeping with other reports showing that rodent myoepithel ial-like 
cells, but not mammary epithelial cells, express mRNA for bFGF (Barrac1ough et al., 
1 990) . A further possibility is that as myoepithelial cell s  only constitute a small 
proportion of cells within the mammary gland (Warburton et al., 1 982), the low levels 
of bFGF mRNA detected in ovine mammary parenchyma may simply be due to a 
dilution of myoepithelial RNA. Further analyses are required to confirm which cell 
types synthesise bFGF within the mammary gland. 
Whereas epithelial cultures expressed the greatest amount of bFGF mRNA, mammary 
fibroblasts were most responsive to mitogenic stimulation by bFGF. This finding leads 
to a proposal that bFGF functions as a paracrine/autocrine mitogen for mammary 
fibroblasts in addition to its previously proposed role as a paracrine/autocrine mitogen 
for myoepithelial cel ls  (Smith et aI., 1 984; Barrac10ugh et al., 1 990). This action may 
also serve to regulate the stromal expression of HGF, as bFGF increases the synthesis 
and secretion of HGF by fibroblasts (Roletto et al., 1 996). Myoepithelial and/or 
epithelial cells could therefore secrete bFGF to regulate HGF-induced mammary 
epithelial proliferation and morphogenesis. This proposal may correspond to the 
observation that the expression of mRNA for both of these growth factors displayed 
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similar developmental profiles, particularly prior to puberty when their abundance was 
greater in the extra-parenchymal MFP than in the contralateral CFP. 
The level of bFGF mRNA in mammary tissues of prepubertal ewe lambs was 
suppressed by exogenous oestrogen and increased by ovariectomy. Likewise, it has 
been found that the stromal expression of other growth factors such as IGF-ll and KGF 
is similarly altered (Chapters 9 and 10), prompting a suggestion that the effects of these 
growth factors may be incompatible with the type of growth and morphogenesis 
promoted by oestrogen. Interestingly, the expression of bFGF mRNA in the mammary 
glands of mature virgin mice is unaffected by oestrogen (Chakravorti and Sheffield, 
1 996b), possibly reflecting a developmental state-specific or species-specific effect. 
In conclusion, the results of these experiments suggest that HGF and bFGF may serve as 
paracrine mediators of epithelial-stromal interactions within the developing ruminant 
mammary gland. Furthermore, these growth factors likely function in a physiological 
role given that their expression is regulated by several influences which also direct 
epithelial growth and morphogenesis. Ongoing investigation is required to determine 







12.1 GENERAL DISCUSSION 
The mammary gland must undergo a unique and elaborate course of postnatal 
development before it can assume its ultimate function of synthesising and secreting 
copious volumes of milk to nourish the offspring. Such development involves the 
establishment of epithelial cells as a ductal network within the virgin gland; these cells 
subsequently undergo lobuloalveolar growth and differentiation during pregnancy. This 
fascinating process of epithelial proliferation and morphogenesis occurs within the 
confines of a matrix of adipose and connective tissue collectively referred to as the 
"mammary fat pad". 
It has long been established that specific endocrine hormones serve pivotal roles in 
regulating the growth of epithelium within the normal and neoplastic mammary gland. 
The first evidence for the local regulation of mammary development was provided from 
the transplantation studies of DeOme et al. ( 1 959) and Hoshino (reviewed by Hoshino, 
1 978) which showed that a stromal environment such as the mammary fat pad was 
required for normal epithelial growth. While this fact remained, relatively little 
attention was focussed towards the ability of the mammary fat pad to regulate normal 
and neoplastic development. Only in more recent times has it been recognised that the 
mammary fat pad may fulfil a critical role during mammogenesis, both by its ability to 
locally regulate growth (reviewed by Imagawa et al., 1 994), and to mediate the actions 
of systemic hormones (Shyamala and Ferenczy, 1 984; Haslam and Counterman, 1 99 1 ). 
However, information regarding the specific nature of these mechanisms is limited. The 
objective of this research, therefore, was to investigate some of the pathways by which 
the mammary fat pad may regulate epithelial growth within the normal mammary gland. 
12.1.1 Mitogenic effects of the mammary fat pad 
In seeking to evaluate the net mitogenic capacity of the mouse mammary fat pad, co­
culture and conditioned medium approaches were used to bioassay its effect on 
mammary epithelial growth. Consistent with a previous report (Beck et al. , 1 989), these 
experiments showed that the mouse mammary fat pad liberates a diffusible factor(s) in 
vitro which stimulates the proliferation of mammary epithelial cells (Chapter 2). 
Furthermore, this factor(s) markedly potentiates the mitogenic response of mammary 
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epithelial cells to IGF-I and EGF (Chapters 2 and 3). This modulatory effect may be 
important in regulating epithelial growth within the mouse mammary gland, a proposal 
given credence by subsequent results which showed that this effect was altered during 
the oestrous cycle (Chapter 5), and by stage of development (Chapter 6), ovarian steroid 
hormones (Chapter 6), and the recognised (Cunha and Horn, 1 996) influence of 
epithelial-stromal interactions (Chapters 5 and 6). These alterations were associated 
with substantial changes in mammary gland development in vivo. The present findings 
also indicate that this effect may satisfy particular requirements for the growth of 
mammary epithelial cells (Chapter 3) which have a unique requirement to grow within a 
depot of adipose tissue (reviewed by Hoshino, 1 978). 
Further investigations revealed that the proliferative responses of COMMA-ID cells in 
co-culture are probably due to the l iberation of unsaturated fatty acids by the mouse 
mammary fat pad (Chapter 4). Several previous studies have demonstrated that 
unsaturated fatty acids stimulate the growth of mammary epithelial cells in vitro 
(Kidwell et al., 1 978; Wicha et al., 1 979; Beck et aI., 1 989). Two laboratories have also 
shown that EGF-induced proliferation of mammary epithelial cells is potentiated by 
unsaturated fatty acids (Bandyopadhyay et al., 1 993; Sylvester et al., 1 994) .  The 
research reported in Chapter 4 is, to my knowledge, the first to show that linoleic acid 
also markedly enhances the proliferative effect of IGF-I on mammary epithelial cells .  
Consistent with reports by others (Bandyopadhyay et al . ,  1 993; Sylvester et al. , 1 994; 
Neri et al., 1 994), these studies suggest that the growth factor-potentiating effects of the 
mammary fat pad are likely initiated via the l ipid-activated second messenger, protein 
kinase C (PKC; Chapter 4). 
That unsaturated fatty acids modulate the growth of mouse mammary epithelial cells is 
not surprising given the close proximity of these cells to adipocytes within the 
mammary fat pad. These findings have important potential implications within the 
developing normal and neoplastic mammary gland. The level and composition of 
dietary fat is known to alter mammary gland development and tumorigenic risk in 
rodents (reviewed by Welsch, 1 985; 1 992), while fat intake is  an important factor in the 
determining the risk of human breast cancer (Kelsey and Berkowitz, 1 988). Likewise, 
both IGF-I (Lee and Yee, 1 995 ; Forsyth, 1 996) and EGF (Plaut, 1 993) have substantial 
effects on the growth of normal and tumorous mammary epithelium in vivo and in vitro. 
262 
The combined response to these influences could therefore substantially increase the 
proliferation of mammary epithelium. Obviously a great deal remains to be understood 
about the way in which lipids influence mammary gland growth, and in particular, how 
they interact with the effects of specific growth factors. 
In seeking to elucidate the mechanisms by which the mammary fat pad regulates 
ruminant mammary development, attention was directed toward the role of stroma­
derived, paracrine growth factors. It was previously shown that growth factors such as 
IGF-I and EGF, which are expressed locally within the mouse mammary gland 
(Snedeker et al. , 1 99 1 ;  Ruan et al. , 1 995), can make an important contribution to fat 
pad-induced proliferation (Chapters 2-6). However, the main impetus for examining the 
function of stroma-derived growth factors within the ruminant mammary gland was an 
appreciation that the ruminant mammary epithelium grows whilst continually enveloped 
by a substantial proportion of fibroblastic connective tissue (Sheffield, 1 988b; Akers, 
1 990; Chapter 8). This type of stroma has been shown to be a source of mitogenic and 
morphogenic growth factors in various tissues (Koj i  et al., 1 994; Rosen et al., 1 994a; 
Birchmeier et al. , 1995), leading to the consideration that it may represent a significant 
source of these polypeptides within the ruminant mammary gland. While a full  
comparative study remains to be conducted, the ability to readily detect mRNA for 
several growth factors in ovine mammary stroma, but not mouse mammary tissue 
(Chapters 9- 1 1 ) , would appear to support this proposal . Such a notion does not preclude 
an involvement of l ipids in the regulation of ruminant mammogenesis ;  in fact, dietary 
unsaturated fatty acids have been shown to stimulate ovine mammogenesis (McFadden 
et al. , 1 990a). Rather, it is suggested that the relative contributions of these two 
influences may differ to those within the mouse mammary gland. 
In several cases the results presented are the first demonstration of mRNA expression 
for these growth factors in the mammary stroma of any species. A finding of particular 
significance is that IGF-I mRNA is expressed within the mammary fat pad of the 
postnatal ovine mammary gland (Chapter 9). This result, and those from recent in situ 
hybridisation analysis of ovine (Morgan et al., 1 996) and human (Singer et al. , 1 995) 
mammary parenchyma, unequivocally indicates that IGF-I is expressed by the stromal 
tissues within the developing mammary gland. This finding has a number of far­
reaching implications which extend from the mechanism by which GH and plane of 
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nutrition may influence ruminant mammogenesis, to the local regulation of mammary 
tumorigenesis. Establishment of this fact emphasises the important function of the 
mammary fat pad during postnatal mammogenesis and will enable more preCIse 
investigations into the mechanism by which IGF-I regulates mammogenesis. 
These results also indicate that IGF-II is locally expressed by the fat pad tissues of the 
ovine mammary gland. Of particular significance may be the observation that IGF-II 
mRNA was transcriptionally upregulated within the mammary parenchyma of 
prepubertal ewe lambs. Based on the results of in situ hybridisation studies by Morgan 
et al. ( 1 996), it is likely that this upregulation occurred within the fibroblastic stroma. A 
similar observation has been reported in mammary tumours where malignant epithelium 
induces the stromal expression of IGF-II mRNA (Singer et al. , 1 995). These findings 
suggest the existence of a positive feedback loop on the stromal expression of IGF-II. 
The ful l  significance of this transcriptional modulation is not immediately obvious 
although it may allow for the specification of certain physiological functions. A great 
deal remains to be understood about the role of IGF-II during mammogenesis, where its 
paracrine action may be of particular importance during mammary tumorigenesis (Ellis 
et al. , 1 994; Manni et al. ,  1 994). 
Several laboratories have recently focussed a great deal of attention toward the role of 
KGF within the developing mammary gland (Coleman-Kmacik and Rosen, 1 994; 
Imagawa et al., 1 994b; Wilson et al., 1 994; Cunha and Horn, 1 996). Results presented 
in Chapter 1 0  are the first demonstration that KGF truly functions as a stroma-derived, 
paracrine mitogen within the mammary gland. Furthermore, it was found that the KGF 
gene is differentially transcribed in mammary adipocytes and connective tissue 
fibroblasts (Chapter 1 0). The implications of this result are presently unknown, 
although it has been suggested that KGF may fulfil roles in branching morphogenesis 
(Alarid et al. , 1 994; Post et al., 1 996) and l ipid metabolism (Nonogaki et al., 1 995), as 
well as being a mitogen for epithelial cells (Imagawa et al. , 1 994b). It will be 
interesting to determine whether these 1 .5 and 2.4 kb KGF mRNAs are translated into 
different proteins. 
Experimental results indicate that HGF is expressed by the stromal constituents of the 
ruminant mammary gland (Chapter 1 1 ) consistent with recent findings in mice (Niranjan 
et al., 1 995). While only circumstantial , preliminary evidence indicates that ruminant 
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mammary fibroblasts may secrete HGF to influence the morphogenesis of ovine 
mammary epithelial cell s  (Chapter 1 1 ) . Further experiments are required to measure the 
in vitro morphogenic response of ruminant epithelial cells to purified HGF, as well as to 
measure the level of HGF in ovine mammary fibroblast-conditioned medium. 
The expression of bFGF mRNA within the ovine mammary gland indicates that this 
growth factor may also be involved in regulating postnatal mammogenesis. While 
bFGF mRN A was most abundantly expressed within the ovine mammary fat pad 
(Chapter 1 1 ) , consistent with recent findings in the mouse mammary gland (Chakravorti 
and Sheffield, 1 996a), both bovine epithelial and fibroblast cells express mRNA for 
bFGF in vitro. These contrasting results, as well as the finding that bFGF stimulates the 
proliferation of both epithelial and fibroblast cells, suggest that bFGF acts on mUltiple 
cell types within the mammary gland. The specific cel lular expression of bFGF mRNA 
within the mammary gland of any species remains to be determined by in situ 
hybridisation. Personal attempts along these lines have, to date, proven unsuccessful, 
possibly due to the expression of an antisense bFGF mRNA (Li et ai. , 1 996) . 
The demonstration that the ovine mammary stroma expresses mRNA for several growth 
factors provides important information regarding the local regulation of mammary 
development. Future experiments promise to reveal further exciting information in this 
area. It will be important to determine the level of these growth factors in mammary 
tissue, and to relate these levels to in vitro studies which have determined the 
concentration range over which they are mitogenic for mammary epithelial cells (Collier 
et al. , 1 993 ; Chapter 1 0). Other studies are required to localise the cellular expression 
of these growth factors, either by immunohistochemistry or in situ hybridisation. 
Combined together, these results demonstrate that the stromal environment of the 
mammary fat pad can provide a variety of factors capable of directly stimulating the 
growth and morphogenesis of mammary epithelial cells .  Likewise, there are probably 
numerous other factors, either identified or unidentified, which are produced within the 
mammary fat pad and which can subsequently modulate the actions of other factors on 
mammary epithelial cells. While in many cases the ful l  physiological role of these 
factors is unknown or is only just being realised, the diversity of their effects illustrates 
the important function that the mammary fat pad undoubtedly fulfils during 
mammogenesis. 
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12.1.2 Influence of epithelial-stromal interactions on the mitogenic capacity of the 
mammary fat pad 
An aspect of local growth regulation which may be particularly important within the 
mammary gland (Sakakura, 1 99 1 ;  Cunha and Hom, 1 996), and indeed other tissues 
(Cunha et al., 1 980), is the means by which the interaction between epithelial and . 
stromal cells subsequently regulates epithel ial growth and morphogenesis. A number of 
findings from this research emphasise the importance of such a mechanism in regulating 
the proliferation of mammary epithelial cells . 
The results of co-culture experiments indicate that endogenous epithelium may locally 
stimulate the release of mitogenic factors from the virgin mouse mammary fat pad 
(Chapters 5 and 6). Based on the findings of others (Kidwell and Shaffer, 1 984; Levay­
Young et al. , 1 987) and the results presented in Chapter 4, this probably reflects the 
increased l iberation of unsaturated fatty acids from mammary adipocytes. Measurement 
of the level of fatty acids released into the culture media is needed to confirm this 
suggestion. It is presently unclear as to how mammary epithelial cells might stimulate 
the release of unsaturated fatty acids from the mammary fat pad, although several 
molecules including prostaglandin F2a (Kidwell et aI. , 1 982), mast cell-derived 
histamine (Kidwell and Shaffer, 1 984), and an adipocyte lipase-activating factor 
(Masuno et al., 1 98 1 ), are potential candidates. In several ways it is not surprising that 
proliferating mammary epithelial cells induce lipolysis within surrounding adipocytes, 
given that epithelial cells are responsive to unsaturated fatty acids, that there exists an 
intimate relationship between epithelial cells and adipocytes, and that an extensive 
reaction occurs as mammary parenchyma ramifies into the fatty stroma. The importance 
of this mechanism during mammary tumorigenesis, particularly within the human 
breast, has not been adequately addressed within the literature. 
The present findings also indicate that the interaction between epithelial cells  and the 
mammary stroma may function to modulate the actions of ovarian steroids on the mouse 
mammary gland. This was evidenced in two ways. First, the mitogenic effect of co­
cultured CFP was frequently less than that of MFP in medium supplemented with 
progesterone, but not oestrogen (Chapters 5) .  Second, treatment with exogenous 
oestrogen in vivo increased the in vitro mitogenic effect of CFP and decreased that of 
MFP, while the effect of progesterone was independent of the mammary tissue type 
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(Chapter 6). At this stage it is unclear as to how these differential effects were manifest 
in the presence of oestrogen and progesterone. However, such findings further 
underscore the importance of the interaction between epithelial and stromal cells within 
the mammary gland, an importance emphasised by the pivotal roles of oestrogen and 
progesterone during postnatal mammogenesis. 
The presence of endogenous epithelium in ovine mammary stroma also increased its 
proliferative effect on mouse and bovine mammary epithelial cells in co-culture 
(Chapter 7). While further tests are required to determine the cause of this effect, one 
possibility is that endogenous epithelium promoted an increased availability of 
stimulatory fatty acids. If this was in fact the case, the mechanism by which it occurred 
may differ to that within mouse mammary tissue as ruminant epithelium is enveloped by 
an extensive amount of connective tissue and does not abut onto mammary adipocytes. 
However, parenchymal encroachment into the ruminant mammary fat pad is associated 
with a concomitant depletion of lipids from mammary adipocytes and an extensive 
fibrosis (Sheffield, 1 988b; personal observation). Thus, one possibility may be that 
fibroblasts, rather than the epithelial cells, stimulate lipolysis in ruminant mammary 
adipocytes. 
Alternatively, increased mitogenic stimulation from ovine mammary tissue containing 
endogenous epithelium may reflect epithelium-induced growth factor expression within 
the surrounding stroma. This suggestion is supported by the demonstration that the 
level of mRNA for several stroma-derived growth factors (lGF-I and -IT, KGF, HGF, 
and bFGF) is greater in the extra-parenchymal MFP than the contralateral CFP of 
prepubertal ewe lambs (Chapters 9- 1 1 ) . Furthermore, the expression of IGF-IT mRNA 
in mammary parenchyma was increased during this period in a transcript-specific 
manner (Chapter 9). That mammary parenchyma expressed the least mRNA for other 
growth factors would appear, at first, to refute this proposal . However, mammary 
parenchyma comprises a large proportion of epithelial tissue which would lead to the 
substantial dilution of stromal RNA used during Northern analysis. The actual level of 
growth factor expression by stromal cells within the ovine mammary parenchyma needs 
to be assessed by techniques such as in situ hybridisation or immunocytochemistry. 
Certainly results from other studies, both within the mammary gland (Coleman-Krnacik 
and Rosen, 1 994; Singer et al., 1 995) and in other tissues (Smola et al., 1 993), indicate 
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that epithelial cells can induce the surrounding stromal cells to upregulate their 
expression of paracrine growth factors. This growth-regulatory mechanism may be of 
increased importance within the ruminant mammary gland because of the substantial 
presence of fibroblastic connective tissue. 
Viewed together, these findings suggest an important feedback mechanism by which 
mammary epithelium may regulate its growth within the mammary fat pad. 
Proliferating epithelial cells may stimulate lipolysis within mammary adipocytes, either 
directly or indirectly, to increase the local availability of non-esterified unsaturated fatty 
acids. Likewise, epithelial signalling may increase the local expression of specific 
paracrine growth factors. These factors may then act in concert, perhaps via the effects 
of PKC (Bandyopadhyay et al., 1 993; Sylvester et al. , 1 994; Chapter 4), to stimulate 
maximum cell proliferation. The relative contribution of lipids and growth factors may 
depend upon the species in question and the cellular composition of the mammary tissue 
(Chapter 7). This effect may be further regulated by the actions of ovarian steroids on 
both stromal and epithelial cells, perhaps also via PKC (Cho and Katzenel lenbogen, 
1 993 ; Katzenellenbogen, 1 996; Martfnez-Lacaci and Dickson, 1 996) . The physiological 
significance of this combinatory mechanism remains to be established. It is also 
conceivable that this mechanism functions to regulate other aspects of mammogenesis 
including parenchymal morphogenesis and epithelial differentiation. 
12.1.3 The hormonal regulation of mitogenic stimulation by the mammary fat pad 
Several researchers have proposed that stromal constituents within the mammary gland 
serve to mediate the mammogenic effects of various hormones (Kidwell and Shaffer, 
1 984; Shyamala and Ferenczy, 1 984; Hauser et al., 1 990; Haslam and Counterman, 
1 99 1 ) , although information relevant to this suggestion is scant. The present findings 
provide strong evidence to support an important role for the mammary fat pad during 
hormone-stimulated mammogenesis. 
The ovarian steroids exert pronounced effects on mouse mammary development. 
Specifically, oestrogen stimulates ductal elongation (Bresciani, 1 968) while 
progesterone promotes alveolar budding (Bresciani, 1 968). Within the oestrous cycle, 
ductal growth at oestrus corresponds to an increased mitogenic effect of the mammary 
fat pad (Chapter 5). Consistent with this stimulation being due to unsaturated fatty acids 
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(Chapter 4), the pattern of fat pad-induced proliferation parallels that of lipolysis within 
rat adipose tissue during the oestrous cycle (Hansen et aI., 1 980) . Further experiments 
indicated that oestrogen and progesterone do indeed have significant effects on the 
mitogenic capacity of co-cultured mammary tissue. This may represent modification in 
the metabolism of lipids by mammary adipocytes. Such results lead to a new proposal 
that the action of ovarian steroids on the developing mouse mammary gland involves 
their influence on the metabolism of lipids by mammary adipocytes. Specifical ly, 
oestrogen may stimulate lipolysis to increase the local availability of unsaturated fatty 
acids while progesterone may encourage lipogenesis. Further measurements of in vitro 
l ipid metabol ism by mammary adipocytes are required to confirm the nature and extent 
of these effects. In addition, the effects of ovarian steroids on the mammary gland 
apparently involve a great degree of interaction with other factors such as the ovary and 
epithelial-stromal associations (Chapter 6) which remain to be understood. Such effects 
may also encompass the actions of other regulatory pathways including those of the 
pituitary and adrenal gland. Furthermore, these interrelationships may be involved in 
modulating the mitogenic effect of the mammary fat pad during postnatal development 
(Chapter 6). 
Further to this proposed mechanism, a diffusible factor from the mammary fat pad 
enhances the responsiveness of mammary epithelial cells to oestrogen while its effect is 
suppressed by progesterone (Chapters 5 and 6). Several lines of evidence suggest that 
unsaturated fatty acids account for these responses, possibly through PKC. Oestrogen 
and progesterone may therefore act on the mammary gland through at least two distinct 
mechanisms; one whereby they regulate the l iberation of a diffusible activity from the 
mammary fat pad, and a second in which this activity differentially modulates epithelial 
cell responsiveness to oestrogen and progesterone. It is also conceivable that the latter 
pathway converges with those utilised by other mammogenic agents such as polypeptide 
growth factors (Cho and Katzenellenbogen, 1 993; Katzenellenbogen, 1 996; Martfnez­
Lacaci and Dickson, 1 996) . These mechanisms warrant particular attention given the 
paramount role that ovarian steroids play in normal and neoplastic mammogenesis. 
These studies of ruminant mammary development indicate that the stromal expression 
of paracrine growth factors is also regulated by mammogenic hormones. To date there 
has been limited investigation of such regulation within the mammary gland of any 
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species. Levels of IGF-I mRNA expression within the mammary fat pads of prepubertal 
ewe lambs (Chapter 9) fol lowed a profile of serum GH levels reported for ewe lambs 
over this period (Johnsson et ai. , 1 985), indicating that paracrine IGF-I may mediate the 
mammogenic action of GH. Other tissues (Daughaday and Rotwein, 1 989), including 
the rodent mammary gland (Kleinberg et al., 1 990), also increase their expression of 
paracrine IGF-I in response to GH. Furthermore, IGF-I mRNA levels within mammary 
tissues of prepubertal ewe lambs could be increased by exogenous oestrogen (Chapter 
9), consistent with a recent finding in rodents (Ruan et al., 1 995). 
In contrast, the expression of KGF, IGF-ll, and bFGF mRNA within the prepubertal 
ovine mammary gland was substantially down-regulated by exogenous oestrogen and 
was increased following ovariectomy (Chapters 9- 1 1 ) .  Previous to this study, hormonal 
regulation of KGF expression within the mammary gland had not been reported. It will 
be interesting to determine whether progesterone upregulates the stromal expression of 
KGF within the mammary gland as in other tissues (Koji et ai. , 1 994), and whether KGF 
subsequently functions as a paracrine branching morphogen (Alarid et al., 1 994; Post et 
al. , 1 996) for mammary epithelium. 
A recent report showed that the expression of bFGF mRNA within the mouse mammary 
fat pad is unaltered by oestrogen while it is increased by progesterone (Chakravorti and 
Sheffield, 1 996b). Likewise, oestrogen increases, and ovariectomy decreases, the 
expression of IGF-ll mRNA in rat mammary tumours (Manni et al. , 1 994). The 
disparity between these findings and the effect of exogenous oestrogen and ovariectomy 
in the present experiments (Chapter 9) may reflect differences in the species studied or 
the developmental state of the females examined. 
The combined results of these experiments suggest that the mammary fat pad, through 
its mitogenic effects, has the potential to mediate a substantial amount of hormone­
stimulated mammogenesis. The ultimate response to hormone-induced growth may 
represent a combined response to several different effects. It is suggested that oestrogen 
stimulates lipolysis within mouse mammary adipocytes to increase the availability of 
non-esterified unsaturated fatty acids to the mammary epithelium. Growth hormone 
may exert a similar lipolytic effect within the mammary fat pad as in other adipose 
depots (Barber et al., 1 992). At the same time, both of these hormones upregulate the 
expression of IGF-I within the mammary stroma (Kleinberg et al., 1 990; Ruan et al., 
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1 995 ; Chapter 9), while oestrogen increases the local synthesis of EGF-like factors 
(Vonderhaar, 1 984; Liu et al. , 1 987). It was demonstrated in Chapter 4 that unsaturated 
fatty acids markedly potentiate the proliferative effect of these growth factors on mouse 
mammary epithelial cells. Therefore, oestrogen- and GH-induced growth within the 
mammary gland may represent a combined response to the ability of these hormones to 
stimulate the release of unsaturated fatty acids from mammary adipocytes and to 
increase the local synthesis of certain growth factors. This mechanism may be 
particularly relevant to ductal proliferation within the virgin mammary gland, given that 
ductal growth is stimulated by the individual effects of oestrogen (Daniel et aI., 1 987), 
GH (Feldman, 1 993), IGF-I (Ruan et al., 1 992), EGF (Coleman et al., 1 988) and 
unsaturated fatty acids (Miyamoto-Tiaven et al., 1 98 1 ) . Furthermore, this proposal 
corresponds to the recent finding that the major synergistic effect of oestrogen with IGF­
I occurs after IGF-I is produced (Ruan et aI. , 1 995). At the same time, oestrogen down­
regulates the expression of other growth factors such as IGF-II, bFGF and KGF, 
consistent with the demonstration that the mitogenic effect of these growth factors is not 
markedly enhanced by unsaturated fatty acids present in CM (Chapters 3 and 4). This is 
consistent with the suggestion that these particular growth factors may stimulate other 
aspects of parenchymal development such as alveolar proliferation and morphogenesis. 
12.1.4 Effect of ontogenic state on the mitogenic capacity of the mammary fat pad 
The ontogeny of postnatal mammogenesis provides an extremely useful model for 
comparing and contrasting the growth regulatory-effect of the mammary fat pad across 
several physiological states. 
The present findings indicate that the mitogenic capacity of the mouse mammary fat pad 
changes during the course of postnatal mammogenesis (Chapter 6). In particular, 
mitogenic stimulation from the mammary fat pad may promote ductal elongation within 
the virgin mammary gland, consistent with findings during the oestrous cycle (Chapter 
5). This may reflect postnatal changes in the influence of unsaturated fatty acids, a 
suggestion that is consistent with reports that unsaturated fatty acids are an important 
requirement for ductal (Miyamoto-Tiaven et al., 1 98 1 ) , but not alveolar (Faulkin et al., 
1 986) development. Further experiments are required to confirm this suggestion. In 
particular, information is required about changes in mammary adipocyte l ipid 
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metabolism which might occur during this period; information which would 
complement that reported during later development (Bandyopadhyay et al. , 1 995) . Such 
information could be gleaned from in vitro studies of mammary adipocyte lipogenesis 
and lipolysis (Hansen et al., 1 994) and from determinations of the fatty acid 
composition of mammary adipose tissue and the local expression of factors such as 
l ipoprotein l ipase and hormone-sensitive l ipase during this time. 
Another finding of interest was that intact mouse mammary tissue provided increased 
mitogenic stimulation during lactation. The physiological relevance of this observation 
is not, however, immediately obvious. While the rodent mammary gland undergoes 
substantial growth in early lactation (reviewed by Munford, 1 964), maximal mitogenic 
stimulation from this tissue was generally recorded in late lactation (Chapter 6). 
Another possibility is that the active factor is secreted by lactating epithelial cells for a 
purpose such as the stimulation of gut development in the neonate (Koldovsky, 1 996). 
Alternatively, this result may reflect the responsiveness of this in vitro system to 
supplemental lipids (Chapter 4) provided by the milk fat from the lactating tissue. 
Findings from these studies of ovine mammogenesis demonstrate that the stromal 
expression of paracrine growth factors is also altered across the course of development. 
These changes were particularly evident within the virgin mammary gland. An 
elevation in the local expression of IGF-I prior to puberty, possibly in response to 
systemic GH, may be an important finding with regard to the onset of allometric 
mammary growth and the susceptibility of the ruminant mammary gland to the negative 
effects of a high plane of nutrition. In contrast, IGF-ll may fulfil a different requirement 
as its expression by mammary parenchyma remained elevated after IGF-I expression had 
decreased. Furthermore, the expression of bFGF, HGF and KGF mRNA within the 
epithelium-free mammary fat pads of ewe lambs generally increased with age (Chapters 
1 0  and 1 1 ), raising the possibility that they function in roles other than as direct 
mitogens for epithelial cel ls. Along these lines, both HGF and KGF are implicated as 
regulators of branching morphogenesis (Peters et al., 1994; Soriano et al., 1 995; Post et 
al. , 1 996) and may satisfy an important requirement for the extensively-branched 
mammary parenchyma of the virgin ruminant mammary gland. 
The combined findings of these studies in mice and sheep indicate that the mammary fat 
pad may be particularly important in stimulating a phase of prepubertal allometric 
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mammary growth. This effect in mice probably occurred due to an increase in the 
availability of unsaturated fatty acids, while in ewe lambs there was increased stromal 
expression of IGF-I which can have a pronounced proliferative effect on mammary 
epithelial cells . While the level of growth factors such as IGF-I within the mammary 
gland of prepubertal mice has not been reported, it is certainly possible that rapid 
prepubertal mammary growth represents a combined response to an increased local 
availability of both lipids and growth factors such as IGF-I, and perhaps EGF. This 
proposal is consistent with the demonstration that the prepubertal mouse fat pad, 
probably via the release of unsaturated fatty acids, markedly potentiates the proliferative 
effect of IGF-I and EGF in vitro (Chapters 2-4). Furthermore, this proposal may be of 
particular significance to the tumorigenic susceptibility of the mammary gland which is 
greatest in immature females and subsequently declines with age (Haslam, 1 979). 
12.1.5 A combined model for fat pad stimulation of mammogenesis 
The findings of this research and their implications for local growth regulation by the 
mammary fat pad are best assimilated from a depiction of the cellular and chemical 
interrelationships which exist within the mammary gland (Figure 1 2. 1 ) . Mammary 
epithelial cells  are surrounded by stromal fibroblasts, the abundance of which depends 
upon the species under consideration. While ovarian steroids and other mammogenic 
hormones (such as GH and prolactin) may directly target epithelial cells, they may also 
act on the adjacent stromal constituents. This latter action may alter l ipid metabolism in 
mammary adipocytes as well as regulate the expression of paracrine growth factors by 
adipocytes andlor fibroblasts. While not shown, myoepithelial and epithelial cells may 
synthesise paracrine/autocrine mitogens. Where an upregulation in local growth factor 
expression is accompanied by hormone-induced lipolysis, an increased local availability 
of unsaturated fatty acids can potentiate growth factor-stimulated proliferation of 
epithelial cells via the actions of PKC. Unsaturated fatty acids and PKC may also 
modulate the responsiveness of epithelial cells to ovarian steroids. Furthermore, 
proliferating epithelial cells may locally signal to the adjacent stroma to effect an 
increase in stromal growth factor synthesis and fatty acid mobilisation. 
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MEC 
Figure 12.1 Diagrammatic representation of potential growth regulatory mechanisms 
within the mammary gland. Not to scale. 
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12.2 CONCLUSIONS 
Several important conclusions can be drawn from this study which has investigated the 
role of the mammary fat pad during mammogenesis: 
1 .  The mouse mammary fat pad, probably through its l iberation of unsaturated fatty 
acids, provides a mitogenic activity which also markedly and specifically potentiates the 
mitogenic effect of IGF-I and EGF on mammary epithelial cells. 
2. Constituents of the ruminant mammary fat pad express mRNA for several growth 
factors which can exert pronounced effects on the proliferation and morphogenesis of 
mammary epithelial cells . 
3 .  The mitogenic capacity of the mouse mammary fat pad is regulated by systemic 
hormones such as oestrogen and progesterone. Such regulation may be manifest at 
certain stages of the oestrous cycle and ontogenesis. 
4. The stromal expression of paracrine mitogens within the ovine mammary gland is 
regulated by systemic influences such as oestrogen, and potentially by other hormones 
such as GH. Such influences may direct local growth factor expression during the 
course of postnatal mammogenesis. 
5. Endogenous epithelium may regulate the local provision of mitogenic stimulation 
by the mouse mammary fat pad. 
6. Endogenous epithelium may modulate the expression of stroma-derived paracrine 
growth factors within the ovine mammary gland. 
Together, these findings indicate that the stromal environment of the mammary fat pad 
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Appendix 3. IGF-I ligand binding assay parameters. (A) Effect of incubation time at 
4°C on subsequent binding of 1 25I_IGF_I to monolayers of COMMA- I D  cells .  Cells 
were incubated with approximately 3800 cpm/well .  (B) Specific binding of increasing 
concentrations of 1
25I_IGF_I to COMMA- I D  cells. Non-specific binding was 
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Appendix 4. EGF ligand binding assay parameters. (A) Effect of incubation time at 
4°C on subsequent binding of 1 25I_EGF to monolayers of COMMA- ID cells. Cell s  were 
incubated with approximately 1 . 1  x 1 05 cpm/well .  (B) Specific binding of increasing 
concentrations of 1 25I_EGF to COMMA- ID cells. Non-specific binding was determined 
in the presence of 500 ng/ml EGF. Incubation was for 5 hours. 
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Appendix 5. Growth of COMMA- I D  cells in the presence of co-cultured mouse 
mammary fat pad and various combinations of IGF-I ( l OO ng/ml) and insulin (0. 1 and 
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Appendix 6. DNA synthesis by COMMA- I D  cells in response to 5 ng/ml acidic- and 
basic-FGF after 24 h culture. 
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Appendix 7. Effect of trypsin on the mitogenic effect of IGF-I + EGF. COMMA- I D  
cells were cultured for 3 days in the fol lowing treated media. ( 1 )  B M  + IGF-I + EGF 
treated with pre-neutralised trypsin, (2) CM + IGF-I + EGF treated with pre-neutralised 
trypsin, (3) CM treated with trypsin, and subsequently neutralised with protease 
inhibitors prior to supplementation with IGF-I + EGF, (4) CM + IGF-I + EGF which 
was treated with trypsin, and subsequently neutralised with protease inhibitors. 
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Appendix 8. Effect of treating CM with heparin sepharose (HS). Four mls of CM were 
passed through I ml of heparin sepharose, which was subsequently rinsed twice with the 
same volumes of BM. The various media were then added to cultures of COMMA- ID  
cells for 3 days i n  the absence or presence of IGF-I ( l OO ng/ml) + EGF (25 ng/rnl). 
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Appendix 9. Growth of COMMA- ID cells in medium supplemented with IGF-I ( lOO 
ng/ml) + EGF (25 ng/ml) and various concentrations of BSA, or in the presence of co­
cultured mammary fat pad (FP) . Cultures were for 3 days. 
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Appendix 10. Growth of COMMA- I D  cells in the presence of co-cultured mammary 
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Appendix 12. Northern analysis of KGF mRNA expression in various cell l ines. 
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